









































































      
 
 
     







Use of trade names is for identification only and does not imply endorsement by the Agency for Toxic
Substances and Disease Registry, the Public Health Service, or the U.S. Department of Health and Human 
Services.
This information is distributed solely for the purpose of pre dissemination public comment under
applicable information quality guidelines.  It has not been formally disseminated by the Agency for Toxic
Substances and Disease Registry.  It does not represent and should not be construed to represent any
agency determination or policy.


























Toxicological profiles are revised and republished as necessary.  For information regarding the update 
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This toxicological profile is prepared in accordance with guidelines developed by the Agency for Toxic 
Substances and Disease Registry (ATSDR) and the Environmental Protection Agency (EPA).  The
original guidelines were published in the Federal Register on April 17, 1987.  Each profile will be revised 
and republished as necessary.
The ATSDR toxicological profile succinctly characterizes the toxicologic and adverse health effects 
information for these toxic substances described therein. Each peer-reviewed profile identifies and 
reviews the key literature that describes a substance's toxicologic properties.  Other pertinent literature is
also presented, but is described in less detail than the key studies. The profile is not intended to be an
exhaustive document; however, more comprehensive sources of specialty information are referenced.
The focus of the profiles is on health and toxicologic information; therefore, each toxicological profile
begins with a public health statement that describes, in nontechnical language, a substance's relevant
toxicological properties.  Following the public health statement is information concerning levels of
significant human exposure and, where known, significant health effects.  The adequacy of information to 
determine a substance's health effects is described in a health effects summary.  Data needs that are of
significance to the protection of public health are identified by ATSDR and EPA.
Each profile includes the following:
(A) The examination, summary, and interpretation of available toxicologic information and 
epidemiologic evaluations on a toxic substance to ascertain the levels of significant human 
exposure for the substance and the associated acute, subacute, and chronic health effects;
(B) A determination of whether adequate information on the health effects of each substance is 
available or in the process of development to determine levels of exposure that present a 
significant risk to human health of acute, subacute, and chronic health effects; and
(C) Where appropriate, identification of toxicologic testing needed to identify the types or levels 
of exposure that may present significant risk of adverse health effects in humans.
The principal audiences for the toxicological profiles are health professionals at the Federal, State, and
local levels; interested private sector organizations and groups; and members of the public.  We plan to 
revise these documents in response to public comments and as additional data become available.
Therefore, we encourage comments that will make the toxicological profile series of the greatest use.
Electronic comments may be submitted via: www.regulations.gov.
Follow the on-line instructions for submitting comments.
Written comments may also be sent to:
Agency for Toxic Substances and Disease Registry
Division of Toxicology and Human Health Sciences
Environmental Toxicology Branch
Regular Mailing Address: Physical Mailing Address:
1600 Clifton Road, N.E. 4770 Buford Highway
Mail Stop F-57 Building 102, 1st floor, MS F-57
Atlanta, Georgia 30329-4027 Chamblee, Georgia 30341














    
     
     
 
  
    
  
   




   
  
   








The toxicological profiles are developed under the Comprehensive Environmental Response, 
Compensation, and Liability Act of 1980, as amended (CERCLA or Superfund).  CERCLA section
104(i)(1) directs the Administrator of ATSDR to “…effectuate and implement the health related
authorities” of the statute.  This includes the preparation of toxicological profiles for hazardous
substances most commonly found at facilities on the CERCLA National Priorities List and that pose the
most significant potential threat to human health, as determined by ATSDR and the EPA. Section 
104(i)(3) of CERCLA, as amended, directs the Administrator of ATSDR to prepare a toxicological profile
for each substance on the list.  In addition, ATSDR has the authority to prepare toxicological profiles for
substances not found at sites on the National Priorities List, in an effort to “…establish and maintain 
inventory of literature, research, and studies on the health effects of toxic substances” under CERCLA
Section 104(i)(1)(B), to respond to requests for consultation under section 104(i)(4), and as otherwise
necessary to support the site-specific response actions conducted by ATSDR. 
This profile reflects ATSDR’s assessment of all relevant toxicologic testing and information that has been 
peer-reviewed.  Staffs of the Centers for Disease Control and Prevention and other Federal scientists have 
also reviewed the profile.  In addition, this profile has been peer-reviewed by a nongovernmental panel
and is being made available for public review.  Final responsibility for the contents and views expressed 
in this toxicological profile resides with ATSDR.
Patrick N. Breysse, Ph.D., CIH
 
Director, National Center for Environmental Health and
 
Agency for Toxic Substances and Disease Registry
 
Centers for Disease Control and Prevention
 













   
   
  






     
   
     
  
 
    
  
 
   
    
 
    
     





    
      
   
   
 
 
   




       
  
 
   
 
   
  
   
 
SILICA vii
QUICK REFERENCE FOR HEALTH CARE PROVIDERS
Toxicological Profiles are a unique compilation of toxicological information on a given hazardous
substance.  Each profile reflects a comprehensive and extensive evaluation, summary, and interpretation
of available toxicologic and epidemiologic information on a substance.  Health care providers treating
patients potentially exposed to hazardous substances may find the following information helpful for fast
answers to often-asked questions.
Primary Chapters/Sections of Interest
Chapter 1: Public Health Statement: The Public Health Statement can be a useful tool for educating
patients about possible exposure to a hazardous substance.  It explains a substance’s relevant
toxicologic properties in a nontechnical, question-and-answer format, and it includes a review of
the general health effects observed following exposure.
Chapter 2:  Relevance to Public Health: The Relevance to Public Health Section evaluates, interprets,
and assesses the significance of toxicity data to human health.
Chapter 3:  Health Effects: Specific health effects of a given hazardous compound are reported by type
of health effect (e.g.,death, systemic, immunologic, reproductive), by route of exposure, and by
length of exposure (acute, intermediate, and chronic).  In addition, both human and animal studies
are reported in this section.
NOTE: Not all health effects reported in this section are necessarily observed in the clinical
setting.  Please refer to the Public Health Statement to identify general health effects observed
following exposure.
Pediatrics:  Four new sections have been added to each Toxicological Profile to address child health 
issues:
Chapter 1 How Can (Chemical X) Affect Children?
 
Chapter 1 How Can Families Reduce the Risk of Exposure to (Chemical X)?
 
Section 3.7 Children’s Susceptibility
 
Section 6.6 Exposures of Children
 
Other Sections of Interest:
Section 3.8 Biomarkers of Exposure and Effect
Section 3.11 Methods for Reducing Toxic Effects
ATSDR Information Center
Phone: 1-800-CDC-INFO (800-232-4636) or 1-888-232-6348 (TTY)
Internet:  http://www.atsdr.cdc.gov
The following additional materials are available online:
Case Studies in Environmental Medicine are self-instructional publications designed to increase primary
health care providers’ knowledge of a hazardous substance in the environment and to aid in the
evaluation of potentially exposed patients (see https://www.atsdr.cdc.gov/csem/csem.html).














   
  










   
 
   
 
 
   
   
  














    
  
   
 
    
    
 
   
 
 
    
   
SILICA viii
Managing Hazardous Materials Incidents is a three-volume set of recommendations for on-scene 
(prehospital) and hospital medical management of patients exposed during a hazardous materials 
incident (see https://www.atsdr.cdc.gov/MHMI/index.asp).  Volumes I and II are planning guides
to assist first responders and hospital emergency department personnel in planning for incidents
that involve hazardous materials.  Volume III—Medical Management Guidelines for Acute
Chemical Exposures—is a guide for health care professionals treating patients exposed to 
hazardous materials.
Fact Sheets (ToxFAQs™) provide answers to frequently asked questions about toxic substances (see 
https://www.atsdr.cdc.gov/toxfaqs/Index.asp).
Other Agencies and Organizations
The National Center for Environmental Health (NCEH) focuses on preventing or controlling disease, 
injury, and disability related to the interactions between people and their environment outside the
workplace.  Contact:  NCEH, Mailstop F-29, 4770 Buford Highway, NE, Atlanta, GA
30341-3724 • Phone:  770-488-7000 • FAX:  770-488-7015 • Web Page:
https://www.cdc.gov/nceh/.
The National Institute for Occupational Safety and Health (NIOSH) conducts research on occupational
diseases and injuries, responds to requests for assistance by investigating problems of health and
safety in the workplace, recommends standards to the Occupational Safety and Health 
Administration (OSHA) and the Mine Safety and Health Administration (MSHA), and trains
professionals in occupational safety and health.  Contact: NIOSH, 395 E Street, S.W., Suite 9200, 
Patriots Plaza Building, Washington, DC 20201 • Phone:  202-245-0625 or 1-800-CDC-INFO 
(800-232-4636) • Web Page: https://www.cdc.gov/niosh/.
The National Institute of Environmental Health Sciences (NIEHS) is the principal federal agency for
biomedical research on the effects of chemical, physical, and biologic environmental agents on 
human health and well-being.  Contact:  NIEHS, PO Box 12233, 104 T.W. Alexander Drive, 
Research Triangle Park, NC 27709 • Phone:  919-541-3212 • Web Page:
https://www.niehs.nih.gov/.
Clinical Resources (Publicly Available Information)
The Association of Occupational and Environmental Clinics (AOEC) has developed a network of clinics 
in the United States to provide expertise in occupational and environmental issues.  Contact:
AOEC, 1010 Vermont Avenue, NW, #513, Washington, DC 20005 • Phone: 202-347-4976 
• FAX:  202-347-4950 • e-mail: AOEC@AOEC.ORG • Web Page:  http://www.aoec.org/.
The American College of Occupational and Environmental Medicine (ACOEM) is an association of
physicians and other health care providers specializing in the field of occupational and 
environmental medicine.  Contact:  ACOEM, 25 Northwest Point Boulevard, Suite 700, Elk
Grove Village, IL 60007-1030 • Phone:  847-818-1800 • FAX:  847-818-9266 • Web Page:
http://www.acoem.org/.
The American College of Medical Toxicology (ACMT) is a nonprofit association of physicians with
recognized expertise in medical toxicology.  Contact: ACMT, 10645 North Tatum Boulevard, 











    
 
 
   
 
     
   
 
   
 




Suite 200-111, Phoenix AZ 85028 • Phone: 844-226-8333 • FAX:  844-226-8333 • Web Page:
http://www.acmt.net.
The Pediatric Environmental Health Specialty Units (PEHSUs) is an interconnected system of specialists 
who respond to questions from public health professionals, clinicians, policy makers, and the
public about the impact of environmental factors on the health of children and reproductive-aged
adults.  Contact information for regional centers can be found at http://pehsu.net/findhelp.html.
The American Association of Poison Control Centers (AAPCC) provide support on the prevention and 
treatment of poison exposures.  Contact:  AAPCC, 515 King Street, Suite 510, Alexandria VA
22314 • Phone: 701-894-1858 • Poison Help Line: 1-800-222-1222 • Web Page:
http://www.aapcc.org/.
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THE PROFILE HAS UNDERGONE THE FOLLOWING ATSDR INTERNAL REVIEWS:
1.	 Health Effects Review. The Health Effects Review Committee examines the health effects 
chapter of each profile for consistency and accuracy in interpreting health effects and classifying
end points.
2.	 Minimal Risk Level Review.  The Minimal Risk Level Workgroup considers issues relevant to
substance-specific Minimal Risk Levels (MRLs), reviews the health effects database of each
profile, and makes recommendations for derivation of MRLs.
3.	 Data Needs Review. The Environmental Toxicology Branch reviews data needs sections to
assure consistency across profiles and adherence to instructions in the Guidance.
4.	 Green Border Review.  Green Border review assures the consistency with ATSDR policy.
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A peer review panel was assembled for silica. The panel consisted of the following members:
1.	 Dr. Michael Greenberg, Emergency Medicine, Drexel University, Philadelphia, Pennsylvania;
2.	 Dr. Kyle Steenland, Department of Environmental and Occupational Health, Emory University, 
Atlanta, Georgia; and
3.	 Dr. Kenneth D. Rosenman, Department of Medicine, Michigan State University, East Lansing, 
Michigan.
These experts collectively have knowledge of silica’s physical and chemical properties, toxicokinetics,
key health end points, mechanisms of action, human and animal exposure, and quantification of risk to 
humans.  All reviewers were selected in conformity with the conditions for peer review specified in
Section 104(I)(13) of the Comprehensive Environmental Response, Compensation, and Liability Act, as
amended.
Scientists from the Agency for Toxic Substances and Disease Registry (ATSDR) have reviewed the peer
reviewers' comments and determined which comments will be included in the profile.  A listing of the
peer reviewers' comments not incorporated in the profile, with a brief explanation of the rationale for their
exclusion, exists as part of the administrative record for this compound.  
The citation of the peer review panel should not be understood to imply its approval of the profile's final
content.  The responsibility for the content of this profile lies with the ATSDR.
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1. PUBLIC HEALTH STATEMENT FOR SILICA
 
This Public Health Statement summarizes the Agency for Toxic Substances and Disease Registry’s 
(ATSDR) findings on silica, including chemical characteristics, exposure risks, possible health effects 
from exposure, and ways to limit exposure.
Silica is a naturally occurring compound and is widespread in the environment.  It is of particular concern 
in areas adjacent to crystalline silica mining, processing, and transporting facilities.
If you are exposed to silica, many factors determine whether you’ll be harmed. These include how much
you are exposed to (dose), how long you are exposed (duration), how often you are exposed (frequency), 
and how you are exposed (route of exposure).  You must also consider the other chemicals you are
exposed to and your age, sex, diet, family traits, lifestyle, and state of health.
WHAT IS SILICA?
Silica is another name for the chemical compound composed of silicon and oxygen with the chemical
formula SiO2, or silicon dioxide. There are many forms of silica.  All silica forms are identical in
chemical composition, but have different atom arrangements.  Silica compounds can be divided into two 
groups, crystalline (or c-silica) and amorphous silica (a-silica or non-crystalline silica).  c-Silica 
compounds have structures with repeating patterns of silicon and oxygen.  a-Silica chemical structures are 
more randomly linked when compared to c-silica.  All forms of silica are odorless solids composed of
silicon and oxygen atoms.  Silica particles become suspended in air and form non-explosive dusts.  Silica 
may combine with other metallic elements and oxides to form silicates.
Silica is abundant in the environment and has many uses.  Over 95% of the earth’s crust is made of silica-
containing minerals and c-silica.  Quartz is one form of c-silica commonly found in the environment.  
Approximately 12% of the earth’s crust by volume is quartz.  Other less common forms of c-silica,
including tridymite and cristobalite, are found in rocks and soils.  Silica sand and gravel are used for
building and construction, hydraulic fracturing, ceramics, and abrasives.  Silica sand melts to glass and
has been used throughout history to make glass.  Crystal quartz forms of silica are used in jewelry,
electronics, and the optical component industry.  Some gemstones, such as amethyst, tiger's eye, agate,
carnelian, chalcedony, and onyx are forms of silica.
***DRAFT FOR PUBLIC COMMENT***
   
 








   






     





   
   
  




















1.  PUBLIC HEALTH STATEMENT
Kieselguhr or diatomaceous earth, silica gel, and precipitated silica are forms of a-silica.  a-Silica
compounds have uses as fillers, insulators, absorption agents, scourers, catalyst supports, packing
material, and filtration.  Diatomaceous earth and silica gel are also used as carriers for pesticides to
control insects, mites, and ticks.
WHAT HAPPENS TO SILICA WHEN IT ENTERS THE ENVIRONMENT?
Silica is a naturally occurring compound that is abundant in the environment.  Quartz is an important
component of soils and rocks and may be found on every part of every continent.  It is the major
component (90–95%) of all sand and silt fractions in soil.  Silica is also naturally occurring in other less 
common forms, including cristobalite, tridymite, diatomite, agate, amethyst, chalcedony, and flint.  Silica
does not break down in the environment, although it may change forms (e.g., lightning strikes or burning
of agricultural wastes containing silica) or undergo transport by natural processes (e.g., weathering) and 
human activities (e.g., brick and ceramics manufacturing).  As part of the natural movement of silica
between earth and organisms, silica particles are carried by wind and water currents, and settle out of
water into sediment.  Dissolved silica is extracted by certain species of microscopic marine organisms,
such as diatoms and radiolarians, to form their structures and shells, and some forms of silica accumulate 
in plants or crops (e.g., rice and wheat).
HOW MIGHT I BE EXPOSED TO SILICA?
You may be exposed to silica compounds from the air, indoor dust, food, water, soil, and various
consumer products.  Silica compounds can be released into the environment by natural, industrial, and 
farming activities.
Silica is a common air contaminant.  The primary nonwork-related silica exposure route is thought to be
inhalation of c-silica during the use of commercial products containing quartz.  Silica is found in many
commercial products.
c-Silica is emitted as a component of particulate emissions into the environment.  Residents near quarries 
or sand and gravel operations or drilling involving fracking may be exposed to elevated levels of
respirable c-silica.  Local meteorological conditions, such as wind and rain, especially in deserts and areas 
near recent volcanic eruptions and mine dumps, are expected to influence the location and spread of
silica-containing dust.
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3SILICA
1.  PUBLIC HEALTH STATEMENT
People may be exposed to silica through their diet.  a-Silica compounds are used as pesticides that are 
applied to crops and are used near food handling and preparation areas.  Silica is used in food packaging;
therefore, food is expected to be an important source of exposure to silica for most people. 
Human exposure to c-silica that have the potential to impact human health occurs mainly in industrial and 
occupational settings.  c-Silica is used throughout industry and is recognized as an important occupational
hazard.  People who work where silica is mined or used are exposed to higher levels of these substances 
than the general population.  Workplace exposure also occurs for people with jobs that require frequent
handling or use of silica substances, such as ceramic manufacturing, construction, and foundries.  
Industrial hygiene practices, such as engineering controls, tailored work practices, respirators, and worker
training, are used to minimize potential silica health hazards.
HOW CAN SILICA ENTER AND LEAVE MY BODY?
The most important route of exposure to c-silica and a-silica is through air containing these compounds.  
Only very small particles of silica, less than 5 microns, are more likely to be deposited in the lungs.  
Small amounts of silica compounds deposited in the lungs may be coughed up and swallowed.  Once in 
your body, silica compounds remain for long periods of time in the lungs and tissues surrounding the
lungs.  Some silica is distributed to the kidneys and the lymphatic system, an important part of the
immune system.  Silica compounds are not broken down by the body.  Small amounts of silica
compounds leave the body in the urine.
HOW CAN SILICA AFFECT MY HEALTH?
Health effects of c-silica and a-silica in people are found in workers exposed for long periods of time
(typically ≥10 years) or with extremely heavy exposure over a short period of time (acute silicosis).  
There is no evidence that breathing small amounts of silica compounds found in the environment causes
any health effects in humans.  No health effects are shown to occur in humans from eating food or
drinking water contaminated with c-silica or a-silica or from exposure of the skin to these compounds.
Crystalline Silica. Many studies have examined the health effects of c-silica in workers.  Results of these
studies show that potential effects of long-term occupational exposure to c-silica might include silicosis (a
lung disease), chronic obstructive pulmonary disease (COPD), lung cancer, increased risk of tuberculosis, 
effects on the kidney, and autoimmune diseases.  Of these, silicosis and lung cancer pose the greatest risks
to human health.
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1.  PUBLIC HEALTH STATEMENT
Silicosis is a progressive, irreversible lung disease.  No other chemical, including a-silica, can cause
silicosis.  Silicosis is classified as several different types (simple silicosis, progressive massive fibrosis 
[PMF], acute silicosis, and accelerated silicosis).  All types of silicosis can cause death due to failure of
the respiratory system.  The time from first exposure to c-silica to the development of silicosis may be as 
short as a few weeks for acute silicosis or as long as 20 or more years for simple silcosis and PMF. The 
severity of silicosis may continue to slowly increase over decades even after exposure has been stopped.  
The current number of silicosis cases in the United States is not known; however, it has been estimated
that during the period of 1987–1997, approximately 3,600–7,300 new silicosis cases were diagnosed
yearly in workers in the United States.  
Several government agencies have classified c-silica as a lung carcinogen in humans.  Results of studies 
indicate that c-silica can cause lung cancer in workers, with increased risks in smokers.  However, 
conflicting results regarding the association between inhalation of respirable c-silica and lung cancer, as 
well as adverse effects to the kidney and autoimmune diseases, have been reported.  Despite inconsistent
results, available evidence supports an association between occupational exposure to c-silica and
increased risks for these effects.  Available data in humans and laboratory animals are not sufficient to
demonstrate a causal relationship between oral exposure to c-silica and any adverse effect outcome.
Adverse effects of dermal exposure to c-silica have not been reported.
Some studies have shown harmful effects to the kidneys and associations with autoimmune diseases.
These could have been caused by exposure to c-silica or could occur spontaneously or could have
developed from exposure to other chemicals or mixtures of chemicals.  Some studies examining the
relationship between c-silica exposure and kidney effects and autoimmune diseases show an association
between c-silica exposure and kidney and autoimmune diseases, while others do not show an association.  
Therefore, it is difficult to interpret the results of these studies.  Compared to silicosis, kidney and
autoimmune diseases are observed in a small number of workers.
Amorphous Silica. Compared to the large number of studies on c-silica, few studies have studied the 
effects of breathing a-silica, with most data obtained from animal studies.  In workers, lung fibrosis
(thickened, stiffened tissue of the lungs due to damage and scarring) has been reported in a-silica workers,
although it is possible that these workers were also exposed to c-silica at the same time.  Animal studies
show reversible damage to the lung.  Other than lung effects, no other effects associated with inhaled
a-silica have been established.
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1.  PUBLIC HEALTH STATEMENT
For more information on health effects of c-silica and a-silica, see Chapters 2 and 3.
HOW CAN SILICA AFFECT CHILDREN?
 
This section discusses potential health effects of c-silica and a-silica exposure in humans from when 
they’re first conceived to 18 years of age.
Health effects of c-silica and a-silica have been shown only to occur in people working in silica
industries, most typically following prolonged exposure.  Exposures to children during sensitive 
developmental windows of time/time periods may put them at increased or decreased risk of health 
effects from exposure to hazardous substances.  Based on available scientific evidence, it is not known
with certainty, if children, when similarly exposed to silica, will have the same health effects as adults.
HOW CAN FAMILIES REDUCE THE RISK OF EXPOSURE TO SILICA?
If your doctor finds that you have been exposed to significant amounts of c-silica or a-silica, ask whether
your children might also be exposed.  Your doctor might need to ask your state health department to 
investigate.  You may also contact the state or local health department with health concerns.
To date. exposure to c-silica and a-silica at levels that produce health effects has on been reported in 
workers who have been exposed for a prolonged period of time in silica industries.  There are no known 
human health effects that occur from exposure to any silica compound at levels typically found in general
non-workplace environments.  Several regulations and recommendations are in place to protect workers 
from adverse effects from exposure to silica.
ARE THERE MEDICAL TESTS TO DETERMINE WHETHER I HAVE BEEN EXPOSED TO
SILICA? 
There are no known medical tests to determine if you have been exposed to c-silica or a-silica.  For
workers exposed to silica compounds, periodic x-rays and tests for lung function are recommended to 
look for abnormalities.  Workers should also be evaluated for tuberculosis, kidney function, and 
autoimmune diseases.
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6SILICA
1.  PUBLIC HEALTH STATEMENT
WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO PROTECT
HUMAN HEALTH?
The federal government develops regulations and recommendations to protect public health.  Regulations
can be enforced by law.  Federal agencies that develop regulations for toxic substances include the
Environmental Protection Agency (EPA), the Occupational Safety and Health Administration (OSHA),
and the Food and Drug Administration (FDA).  Recommendations provide valuable guidelines to protect
public health but are not enforceable by law.  Federal organizations that develop recommendations for
toxic substances include the Agency for Toxic Substances and Disease Registry (ATSDR) and the 
National Institute for Occupational Safety and Health (NIOSH).
Regulations and recommendations can be expressed as “not-to-exceed” levels; that is, levels of a toxic 
substance in air, water, soil, or food that do not exceed a critical value usually based on levels that affect
animals; levels are then adjusted to help protect humans.  Sometimes these not-to-exceed levels differ
among federal organizations.  Different organizations use different exposure times (e.g., an 8-hour
workday or a 24-hour day), different animal studies, or emphasize some factors over others, depending on 
their mission.
Recommendations and regulations are also updated periodically as more information becomes available.
For the most current information, check with the federal agency or organization that issued the regulation
or recommendation.
The Department of Energy (DOE), NIOSH, and OSHA have set limits for exposure to c-silica levels air
in occupational settings.  For a-silica, DOE, NIOSH, and OSHA have set limits of levels in air in
occupational settings.  EPA has not recommended guidelines for c-silica or a-silica in water.
WHERE CAN I GET MORE INFORMATION?
If you have any questions or concerns, please contact your community or state health or environmental
quality department, or contact ATSDR at the address and phone number below.  You may also contact
your doctor if experiencing adverse health effects or for medical concerns or questions.  ATSDR can also
provide publicly available information regarding medical specialists with expertise and experience 
recognizing, evaluating, treating, and managing patients exposed to hazardous substances.
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1.  PUBLIC HEALTH STATEMENT
•	 Write to:
 
Agency for Toxic Substances and Disease Registry

Division of Toxicology and Human Health Sciences
 






Toxicological profiles and other information are available on ATSDR’s web site:
http://www.atsdr.cdc.gov.
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2. RELEVANCE TO PUBLIC HEALTH
 
2.1  	 BACKGROUND AND ENVIRONMENTAL EXPOSURES TO SILICA IN THE UNITED 
STATES 
Silica occurs naturally in crystalline and amorphous (or non-crystalline) forms, referred to as c-silica and
a-silica, respectively.  In general, silica is considered poorly water soluble and chemically unreactive in 
the environment.  Both c- and a- forms of silica have surfaces composed of siloxane (covalently bonded 
silicon and oxygen; Si-O-Si) and silanol groups (Si-OH).  Exposure to water will break silicon-oxygen 
bonds on the surface of silica to form silanols.  In general, c-silica surfaces tend to have more order,
although some c-silica is found with an outer layer of a-silica.  a-Silica may contain a c-silica component
from exposure to high temperatures and pressures (e.g., flux calcination).  Thus, for a single polymorph of
c- or a-silica, surface chemistry of the compound may vary, depending upon production method and 
degree of hydration. The water solubility of silica has some variability due to differences in trace metal
impurities, hydration, temperature, and particle size.  Solubility is lower for c-silica polymorphs than for
a-silica, and anhydrous a-silica dissolves less rapidly than hydrated a-silica.  Silica particles may be 
transported by wind or water currents as part of the biogeochemical silica cycle. As part of the
biogeochemical silica cycle, silica deposits settle out of water into sediment.
Silica is ubiquitous; over 95% of the earth’s crust is made of minerals containing silica and c-silica.  At
least a trace amount of c-silica, in the form of quartz, is present in all soils.  Silica is naturally released
into the environment through the weathering of rocks, volcanic activity, and biogenic sources (e.g., 
diatoms).  Human activities such as mining and farming also result in the release of silica into the 
environment.  Silica levels in environmental media vary depending upon the location and sampling site.  
Local meteorological conditions, such as wind and rain, especially in deserts and areas near recent
volcanic eruptions and mine dumps, are expected to influence the location and spread of silica-containing
dust.  Remote continental air has a background gravimetric airborne dust concentration of 0.04 mg/m3 
with ≥10% c-silica content.  In urban areas across the United States, the measured mean 24-hour average 
ambient c-silica concentration ranged from 0.0009 to 0.008 mg/m3 for particles in the size range of 2.5– 
15 µm (aerodynamic diameter).  Dissolved silica concentrations of natural waters are 13 ppm for lakes, 
3–15 ppm for major rivers, 1–10 ppm for sea water, 2–60 ppm for wells, and 50–300 ppm for wells in 
volcanic fields or oil fields.
Human exposure to c-silica is known to occur in industrial and occupational settings.  c-Silica is 
recognized as an important occupational inhalation hazard.  The general population is exposed to silica
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2. RELEVANCE TO PUBLIC HEALTH
through air, indoor dust, food, water, soil, and various consumer products.  Both c-silica and a-silica are 
found in many commercial products (e.g., bricks, mortar, plaster, caulk, granite and engineered stone
kitchen counter tops, roofing granules, wallboard, concrete cleansers, skin care products and soaps, art
clays and glazes, talcum powder).  Inhalation of c-silica during the use of commercial products containing
quartz is expected to be the predominant, non-occupational silica exposure route.  Silica is also a common 
air contaminant. Industrial emissions, forest fires, crop burning, and wind erosion of soil may spread both
a-silica and c-silica particles. Exposure to silica is also expected to occur for the general public through 
the diet.  a-Silica compounds are used as pesticides for crops and are used near food handling and 
preparation areas.  a-Silica is used in food packaging, and in food, cosmetics, and pharmaceuticals as
anticaking agents or carriers.  a-Silica accumulates in some plants and crops including rice, millet,
sugarcane, and wheat.  Although quantitative data are not available, water containing diatomite fragments 
and quartz particles is a potential source of exposure for the general population. 
All forms of silica are considered to be poorly soluble particles. There are limited analytical methods 
reported for the analysis of silica in biological materials.  Very limited information is available regarding
absorption of silica following dermal or oral contact; however, these pathways of exposure are not
expected to be significant. Inhaled silica particles, not cleared by mucociliary escalators or coughing, are
embedded and remain in the lung.
2.2  SUMMARY OF HEALTH EFFECTS 
Throughout this toxicological profile, the term c-silica refers to crystalline silica; non-crystalline 
amorphous silica is referred to as a-silica. Note that due to significant differences in toxicokinetics of
ultrafine and nanoparticles compared to larger respirable particles, silica nanoparticles are not considered
in this profile.
c-Silica and a-silica are not single entities. Each exists in several forms (polymorphs) with different
surface chemistry characteristics.  For a single polymorph (e.g., quartz, cristobalite), surface 
characteristics may vary due to processing and particle aging, even for polymorphs within the same silica 
industry.  Biological activity (potency) of both c-silica and a-silica is affected by particle surface
chemistry. These differences in surface chemistry may, in part, play a role in differences observed for
exposure-response relationships and inconsistent results for some health effects.
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SILICA 11
2. RELEVANCE TO PUBLIC HEALTH
The exposure route of concern for c-silica and a-silica compounds is inhalation.  Adverse health effects of
inhalation exposure to c-silica and a-silica have been observed in studies of occupational exposure to
particles that are of respirable size (<10 µm).  Respirable particles of c-silica, which are deposited
throughout the alveolar region of the lung and distributed to associated lymph tissue, produce a cascade of
effects that result in the development of silicosis, a progressive, irreversible, fibrotic lung disease. It has 
been hypothesized that the severity of silicosis is related to the c-silica particle burden in the lung. No
known adverse effects occur from exposure to particles that exceed the respirable size range or from
incidental exposure to low levels of c-silica in the environment (e.g., at beaches).  Regarding oral
exposure to c-silica, available data in humans and laboratory animals are not sufficient to demonstrate an
association for any adverse effect outcome. No information on the effects of oral a-silica in humans was 
identified, and very few studies evaluating adverse effects of oral a-silica in animals have been conducted.
Available animal studies either do not identify adverse effects at the doses tested or do not provide
sufficient data to determine the toxicological significance of observed effects (e.g., changes in organ
weights in the absence of histopathological changes). No association between dermal exposure and 
adverse effects has been reported.
Health Effects of Crystalline Silica
Silicosis Morbidity and Mortality:  Health effects associated with occupational exposure to c-silica are 
silicosis (a progressive, fibrotic lung disease), COPD, lung cancer, renal toxicity, increased risk of
tuberculosis, and autoimmune diseases.  Of these, silicosis and lung cancer pose the greatest concern to
human health.
Silicosis is a progressive, irreversible, fibrotic lung disease resulting from inhalation and pulmonary
deposition of respirable dust containing c-silica. The causal relationship between inhalation of c-silica 
and development of this severe, debilitating lung disease is well-established and has been recognized
since ancient times.  Silicosis does not result from inhalation of any other substance, including a-silica.
Silicosis is not a single disease entity, but is classified as different types (simple silicosis, progressive 
massive fibrosis [PMF], acute silicosis, and accelerated silicosis).  All types of silicosis can result in death
due to respiratory failure.  Cumulative c-silica exposure, expressed as mg/m3-year, is the most important 
factor in the development of silicosis.  Cumulative exposures typically are reported as stratified ranges or
as the median of stratified ranges. Time from first exposure to onset of disease varies inversely with
cumulative exposure and may be as short as a few weeks for acute silicosis or as long as 20 or more years 
for simple silicosis and PMF.  Due to the long latency period, silicosis may not be diagnosed until after
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2. RELEVANCE TO PUBLIC HEALTH
exposure has ended.  Disease severity continues to slowly increase over decades even after exposure has 
been discontinued, possibly due to c-silica dust that is retained in the lungs.  
The current number of silicosis cases in the United States is not known; however, it has been estimated
that during the period of 1987–1997, approximately 3,600–7,300 new silicosis cases were diagnosed
yearly in the United States.  Reported risk estimates for silicosis in occupational exposure studies vary,
with many factors potentially influencing study outcome, including study design (inclusion of decedents, 
length of follow-up period, frequency of health assessments, adjustment for smoking), and c-silica surface 
characteristics.  These likely factors contribute to the wide range of reported incidences of silicosis (<10%
to as high as approximately 80%).  In the United States, 13,744 deaths were attributed to silicosis from
1968 to 1990 and 4,313 deaths were attributed to silicosis from 1979 to 1990.  Silicosis mortality trends 
have shown a marked decline over the past 50 years due to improved industrial hygiene standards and 
more stringent regulatory standards and guidelines.  However, silicosis deaths in younger adults (ages 15– 
44 years) have not declined since 1995, which may reflect more recent, intense exposures, such as those 
associated with construction and abrasive blasting industries.
Several occupational studies have demonstrated exposure-response relationships for silicosis and 
mortality due to silicosis.  However, a no-observed-adverse-effect level (NOAEL) for silicosis has not
been defined, with silicosis and death due to silicosis observed for the lowest cumulative exposure ranges
reported.  For the lowest cumulative exposure range reported in the available literature (0–0.2 mg/m3-
year), silicosis was observed in 5 of 3,330 gold miners.  At the cumulative exposure range of 0.1– 
1.23 mg/m3-year, death due to silicosis was observed in 2,857 of 74,040 mining and pottery workers in 
China.  Cumulative exposure levels reported in other occupational studies have been higher.
Lung Cancer: The International Agency for Research on Cancer, the National Institute of Occupational
Safety and Health, and the National Toxicology Program 13th Report on Carcinogens have classified 
c-silica (respirable size) as a Group 1 (definite) human lung carcinogen.  IARC acknowledged that some
occupational exposure studies did not show an association between c-silica exposure and lung cancer,
possibly due to the characteristics of c-silica in different occupational settings or other factors affecting its
biological activity; in addition, other confounding factors and biases may have influenced study results
(e.g., errors in estimating c-silica exposure levels, absence [or presence and severity] of silicosis, adequate
control of confounding from smoking, and unaccounted occupational co-exposures that may have 
contributed to lung cancer risk).  
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2. RELEVANCE TO PUBLIC HEALTH
Compared to other occupational lung carcinogens, such as asbestos, the occupational risk of c-silica-
induced lung cancer is low, requiring large study populations to achieve adequate power to detect and 
quantify c-silica-related cancer risk.  Results of pooled and meta-analyses, which provide the strongest
support for the carcinogenicity of c-silica in the lung, show increased risks of lung cancer in c-silica 
workers, with risks exhibiting dependence upon cumulative exposure. Results of a cohort study of over
30,000 workers in China indicate that c-silica can induce lung cancer in the absence of silicosis.
Smoking, as in all studies of potential lung carcinogens, could be a confounding factor in studies
examining the relationship between c-silica exposure and lung cancer.  However, results of a pooled 
analysis of over 65,000 workers show that smoking was not a confounder in studies with data on 
smoking.
Other Adverse Health Effects of Inhaled Crystalline Silica:  Occupational exposure to respirable c-silica is
also associated with adverse effects to the kidney and autoimmune diseases.  However, these effects have 
been studied much less than silicosis, and study results have not been consistent regarding associations 
between c-silica exposure and increased risks.  Unlike silicosis, no renal or autoimmune diseases are
uniquely associated with exposure to c-silica.
A wide-spectrum of renal pathologies (called silicon nephropathy) have been associated with
occupational exposure to c-silica, including acute and chronic renal nephritis/nephrosis, end-stage renal
failure, glomerulonephritis, and renal damage associated with autoimmune disorders (e.g., anti-neutrophil
cytoplasm antibody [ANCA]-associated vasculitis).  Relative to silicosis, the incidence of renal disease is 
very low in silica-exposed cohorts (<1 versus <10–80%).  Results of a pooled analysis show that the risk
of renal disease and mortality due to renal disease increased with cumulative exposure.  Comparison of
exposure-response data for renal effects and silicosis shows that renal toxicity typically occurs at higher
cumulative exposure levels than silicosis.
Exposure to respirable c-silica has been associated with increased risks of a wide spectrum of
autoimmune disorders, including systemic sclerosis (scleroderma), rheumatoid arthritis, systemic lupus 
erythematosus, ANCA-associated vasculitis, and sarcoidosis.  Similar to renal effects, the incidence of
autoimmune disorders is low compared to silicosis.  Data for each specific disease are inadequate to
determine exposure-response relationships.  
Health Effects of Amorphous Silica.  Relative to the abundance of data on c-silica, few studies have 
evaluated the effects of inhaled a-silica.  Data are insufficient to determine whether or not a-silica causes 
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2. RELEVANCE TO PUBLIC HEALTH
lung disease in humans; however, silicosis has not been observed in epidemiological studies in workers
with long-term exposure to a-silica with no known exposure to c-silica.  Numerous occupational studies
in the 1930s–1980s report an increased incidence of pneumoconiosis in diatomaceous earth workers
exposed to a-silica; however, interpretation of results is complicated due to co-exposures to c-silica.
Results of animal studies indicate that inhalation exposure to a-silica causes pulmonary toxicity,
including inflammation, cellular infiltrates, reversible fibrosis, and reduced lung function, following
acute-, intermediate-, and chronic-duration exposure.  However, in contrast to c-silica, progressive 
fibrosis was not observed and most effects were reversible.  Results of a study examining the effects of a 
5-day inhalation exposure of rats to a-silica polymorphs yield NOAEL and lowest-observed-adverse-
effect level (LOAEL) values for bronchial hypertrophy and cellular infiltrates of 1 and 5 mg/m3, 
respectively.  Similar pulmonary effects have been reported in animals following intermediate- and 
chronic-duration inhalation exposure; however, NOAEL values were not identified.
Other than pulmonary effects, no other effects associated with inhaled a-silica have been established.
2.3  MINIMAL RISK LEVELS (MRLs)
Crystalline Silica. Effects on the respiratory system are the most sensitive effects of inhaled c-silica.
However, identification of a no-effect or threshold level for silicosis is highly uncertain due to several
factors.  For example, in one study for the lowest reported cumulative exposure range of 0–0.2 mg/m3-
year, silicosis was observed (Steenland and Brown 1995a).  Cumulative exposure ranges identifying a no-
effect level for silicosis have not been identified.  In addition, the long latency period between exposure
and time to onset of symptoms or diagnosis of silicosis could affect identification of a no-effect level for
silicosis if follow-up periods are not sufficiently long.  Exclusion of decedents and poor or inadequate
health records also contribute uncertainty of risks for silicosis.  Furthermore, due to the variable surface 
chemistry characteristics, the biological potency of c-silica can vary between and among c-silica 
polymorphs.  Therefore, even if a no-effect level could be identified for a particular occupational cohort, 
that level may cause silicosis in a different occupational cohort due to differences in surface chemistry of
c-silica.
LOAEL values for silicosis have been identified in several studies; however, silicosis is a serious adverse 
effect that has the potential to cause death due to respiratory failure or lung cancer.  Given the serious 
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2. RELEVANCE TO PUBLIC HEALTH
nature of silicosis and the uncertainties associated with identification of a no-effect level, no MRLs were 
derived for inhaled c-silica for any exposure duration.  
Available data for oral exposure to c-silica are insufficient to derive oral MRLs for any exposure duration.
Amorphous Silica. Relative to the abundance of data on c-silica, few studies have evaluated the effects 
of inhaled a-silica.  Data are insufficient to determine whether or not a-silica causes lung disease in
humans; however, silicosis has not been observed in epidemiological studies in workers with long-term 
exposure to a-silica with no known exposure to c-silica (Choudat et al. 1990; Plunkett and Dewitt 1962;
Volk 1960; Wilson et al. 1979).  Numerous occupational studies in the 1930s–1980s report an increased 
incidence of pneumoconiosis in diatomaceous earth workers exposed to a-silica; however, interpretation
of results is complicated due to co-exposures to c-silica (Beskow 1978; Caldwell 1958; Cooper and 
Jacobson 1977; Cooper and Sargent 1984; Dutra 1965; Legge and Rosencrantz 1932; Smart and 
Anderson 1952; Vigliani and Mottura 1948).
As reviewed below, available data from animal studies indicate that inhalation exposure to a-silica causes
pulmonary toxicity, including pulmonary inflammation, increases in cellular infiltrates, reversible 
fibrosis, reduced lung function, and respiratory distress (Arts et al. 2007; Groth et al. 1981; Johnston et al. 
2000; Lee and Kelly 1992; Reuzel et al. 1991; Warheit et al. 1991, 1995).  Pulmonary effects observed
following exposure to a-silica are reversible and progressive fibrosis is not observed, in contrast to the
pulmonary effects of c-silica.  Results of animal studies also indicate that different polymorphs of a-silica 
have different toxicological potencies (Arts et al. 2007; Warheit et al. 1991, 1995).  Other than pulmonary
effects, no other effects associated with inhaled a-silica have been established.
Acute-Duration Exposure: Arts et al. (2007) examined the effects of a 5-day inhalation exposure of rats
to three types of a-silica polymorphs:  silica gel (Syloid 74), precipitated silica (Zeosil 45), and pyrogenic
silica (Cab-O-Sil M5).  After the final day of exposure, microscopic examination of lung tissue showed 
differences between the three polymorphs.  For silica gel, NOAEL and LOAEL values of 5 and 
25 mg/m3, respectively, were identified for accumulation of alveolar macrophages in male rats (females 
not examined).  For precipitated silica, NOAEL and LOAEL values for alveolar granulocyte infiltrates 
were 1 and 5 mg/m3, respectively, in males and 5 and 25 mg/m3, respectively, in females.  For pyrogenic
silica, NOAEL and LOAEL values for accumulation of alveolar macrophages were 1 and 5 mg/m3, 
respectively, in male rats (females not examined). The incidence of bronchial/bronchiolar hypertrophy
was increased in rats exposed to precipitated and pyrogenic silica at 25 mg/m3, although the incidence of
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2. RELEVANCE TO PUBLIC HEALTH
hypertrophy was not increased for silica gel.  Warheit et al. (1991, 1995) observed increased neutrophils
in bronchoalveolar lavage fluid of rats exposed to colloidal silica (Ludox) and precipitated silica (Zeofree 
80) for 2 weeks.  The NOAEL and LOAEL values for colloidal silica were 10.1 and 50.5 mg/m3, 
respectively.  The LOAEL value for precipitated silica was 10 mg/m3; a NOAEL was not identified.  
However, NOAEL and LOAEL values for the Arts et al. (2007) and Warheit et al. (1991, 1995) studies
are not directly comparable, as microscopic examination of lung tissue was not conducted in the Warheit
et al. (1991, 1995) studies.  Respiratory distress, a serious adverse effect, was observed in rats exposed for
2 weeks to three a-silica polymorphs:  fumed hydrophilic silica (Aerosil 200), fumed hydrophobic silica
(Aerosil R 974), and precipitated hydrophobic silica (Sipernat 22S) (Reuzel et al. 1991).  For all three
polymorphs, respiratory distress was observed at the lowest concentration tested, with LOAEL values of
17, 31, and 46 mg/m3 for fumed hydrophilic silica, fumed hydrophobic silica, and precipitated 
hydrophobic silica, respectively.  However, relative potency of the different polymorphs cannot be
determined from this study, as respiratory effects were observed at the lowest tested concentration for
each polymorph.  Although all a-silica polymorphs have not been evaluated for acute respiratory toxicity,
results of acute inhalation studies in rats indicate that the biological activity of a-silica varies between
polymorphs.
Intermediate-Duration Exposure:  Results of intermediate-duration inhalation studies show a wide range
of toxicological potencies for a-silica polymorphs (Johnston et al. 2000; Lee and Kelly 1992; Reuzel et al. 
1991; Warheit et al. 1991, 1995).  Respiratory effects, including fibrosis, increased cellularity, 
inflammation, accumulation/aggregation of alveolar macrophages (granulomas), and increased collagen
content were observed in rats exposed to ≥1 mg/m3 of fumed hydrophilic silica (Aerosil 200) for
13 weeks (Reuzel et al. 1991); a NOAEL was not identified.  Similar effects, except fibrosis, were also
observed following exposure to fumed hydrophobic silica (Aerosil R974) and precipitated silica (Sipernat
22S) at 30 mg/m3; no other exposure levels were tested (Reuzel et al. 1991).  In contrast, NOAEL and 
LOAEL values of 10 and 50 mg/m3, respectively, were identified for less serious respiratory effects 
(inflammation, hyperplasia, increased neutrophils in bronchoalveolar lavage fluid) following a 4-week
exposure to colloidal silica (Ludox) (Johnston et al. 2000; Lee and Kelly 1992).  Additional information 
on intermediate-duration inhalation exposure is provided in Section 3.2.1.2.
Chronic-Duration Exposure: Studies in monkeys, rats, guinea pigs, and rabbits also show adverse 
respiratory effects, including fibrosis, reduced lung function, and macrophage accumulation, following
chronic-duration inhalation exposure to several a-silica polymorphs (Groth et al. 1981; Schepers 1981)
(see Section 3.2.1.2 for additional information).  However, comparison of potency between polymorphs
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2. RELEVANCE TO PUBLIC HEALTH
cannot be conducted as studies only evaluated single exposure levels.  Furthermore, as only single 
exposure levels were evaluated, data are not suitable to serve as the basis for a chronic-duration inhalation 
MRL for a-silica.
Conclusions: The biological activity of silica compounds varies based upon surface chemistry of the
compound (Donaldson and Borm 1998; Greenberg et al. 2007; Guthrie 1995; Mossman and Churg 1998;
Mossman and Glenn 2013).  Even for a single polymorph, surface chemistry may vary depending upon 
production method, degree of hydration, and aging (Fubini et al. 1995; Rimola et al. 2013; Zhuravlev
2000).  Numerous polymorphs of a-silica exist, each with different surface chemistry properties and,
therefore, the potential for different biological potencies.  Although analytical techniques exist to 
distinguish between a-silica polymorphs, most are too sophisticated for routine measurements (IARC
1997). Therefore, exposures typically are reported as a-silica, rather than as specific a-silica polymorphs.
As reviewed above, results of the animal studies provide evidence that toxicological potency for
respiratory effects can differ between different a-silica polymorphs.  Given the important role of surface 
chemistry in the toxicological potency of silica compounds, there is considerable uncertainty regarding
identification of NOAEL or LOAEL values that could serve as the basis of development of inhalation
MRLs, as values based on a single a-silica polymorph may not apply to all forms of a-silica.  Therefore,
inhalation MRLs for a-silica have not been developed for any exposure duration.
As discussed in Section 2.2, no information on the effects of oral a-silica in humans was identified, and
available animal studies either do not identify adverse effects at the doses tested or do not provide
sufficient data to determine the toxicological significance of observed effects. Therefore, available data 
for a-silica are insufficient to derive oral MRLs for a-silica for any exposure duration.
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3.1  INTRODUCTION 
The primary purpose of this chapter is to provide public health officials, physicians, toxicologists, and 
other interested individuals and groups with an overall perspective on the toxicology of silica.  It contains
descriptions and evaluations of toxicological studies and epidemiological investigations and provides
conclusions, where possible, on the relevance of toxicity and toxicokinetic data to public health.
A glossary and list of acronyms, abbreviations, and symbols can be found at the end of this profile.
Selection of Literature.  Studies in humans identify effects to the respiratory, renal, and immune systems
as the targets of inhaled respirable c-silica.  These effects are the focus of the health effect sections on 
inhaled c-silica. The literature on the health effects of occupational exposure of humans to inhaled 
respirable c-silica is extensive, including numerous recently published reviews.  This profile describes 
results of a subset of these studies that provide information on exposure-response relationships.  There is
also extensive literature on the effects of inhaled c-silica in laboratory animals; however, due to the
abundance of information on the effects of c-silica in humans, animal studies on c-silica are not included
in this profile. In contrast to the large amount of information available on the effects of inhaled c-silica,
information about the effects of oral exposure to c-silica and inhalation and oral exposure to a-silica is
sparse; therefore, studies in laboratory animals are reviewed and included in these sections to supplement
human data.  Studies on adverse effects of dermal exposure to c-silica and a-silica in humans or
laboratory animals were not identified. Studies included in Chapter 3 were identified primarily from 
recent reviews, literature searches, and tree-searching of important literature.  General descriptions of
health effects of c-silica and a-silica were taken from numerous, recent reviews, as indicated throughout
Chapter 3.
Surface Structure and Biological Activity.  As discussed in Section 4.2 (Chemical and Physical
Properties), c-silica and a-silica exist in several forms (polymorphs), each with different surface chemistry
characteristics, including incorporation of trace metals or other compounds.  The biological activity and, 
thereby, the potency to induce adverse effects is likely related to surface characteristics (see Section 3.5.2, 
Mechanism of Toxicity).  Furthermore, for the same polymorph, biological potency may vary due to 
modifications of surface characteristics from processing or aging.  Due to differences in biological
activity, in addition to other factors (e.g., study design, length of follow-up period, inclusion of decedents, 
adjustments for smoking status, etc.), exposure-response relationships across silica industries and even
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within the same silica industry can differ, making it difficult to define exposure-response relationships
that apply to general c-silica or a-silica categories.
Note that due to significant differences in toxicokinetics of ultrafine and nanoparticles compared to larger
respirable particles, silica nanoparticles are not considered in this profile.
Overview: Health Effects Crystalline Silica.  Health effects associated with inhalation of respirable 
c-silica are silicosis, lung cancer, renal toxicity, autoimmune disorders, COPD, and increased risk of
tuberculosis. Silicosis, a progressive fibrotic, potentially fatal lung disease caused by occupational
exposure to respirable c-silica, is a well-established effect that has been recognized since ancient times.
Silicosis does not result from inhalation of any other substance, including a-silica, and is not associated
with incidental exposure to low levels of c-silica in the environment (e.g., at beaches). Numerous
occupational exposure studies provide evidence that inhaled c-silica causes lung cancer, and IARC 
(2012), NIOSH (2002), and NTP (2014) classify c-silica as a carcinogen.  Although the studies on renal
toxicity and autoimmune diseases are not as extensive as those for silicosis and lung cancer, available 
evidence supports an association between occupational exposure to c-silica and increased risks for these 
effects. Results of a recent study of over 42,000 workers in China showed a significant positive trend for
cumulative c-silica exposure and mortality from heart disease (Liu et al. 2014).  Available data in humans 
and laboratory animals are not sufficient to demonstrate a causal relationship between oral exposure to
c-silica and any adverse effect outcome.  Adverse effects of dermal exposure to c-silica have not been
reported.
Overview: Health Effects of Amorphous Silica. Relative to the abundance of data on the effects of
c-silica, few studies have evaluated the health effects from exposure to a-silica, with most data obtained
from animal studies.  Pulmonary fibrosis has been reported in a-silica workers, although co-exposure to 
c-silica could not be ruled out.  Animal studies show that inhalation of a-silica produces pulmonary
inflammation, and reversible fibrosis, but silicosis is not observed.  Other than pulmonary effects, no 
other effects associated with inhaled a-silica have been established.  Available data in humans and
laboratory animals are not sufficient to demonstrate a causal relationship between oral exposure to a-silica
and any adverse effect outcome.  Adverse effects of dermal exposure to a-silica have not been reported.
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3.2  DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE 
To help public health professionals and others address the needs of persons living or working near
hazardous waste sites, the information in this section is organized first by route of exposure (inhalation, 
oral, and dermal) and then by health effect (e.g., death, systemic, immunological, neurological, 
reproductive, developmental, and carcinogenic effects).  These data are discussed in terms of three 
exposure periods:  acute (14 days or less), intermediate (15–364 days), and chronic (365 days or more).
Levels of significant exposure for each route and duration are presented in tables and illustrated in 
figures.  The points in the figures showing no-observed-adverse-effect levels (NOAELs) or lowest-
observed-adverse-effect levels (LOAELs) reflect the actual doses (levels of exposure) used in the studies.
LOAELs have been classified into "less serious" or "serious" effects. "Serious" effects are those that 
evoke failure in a biological system and can lead to morbidity or mortality (e.g., acute respiratory distress 
or death).  "Less serious" effects are those that are not expected to cause significant dysfunction or death, 
or those whose significance to the organism is not entirely clear.  ATSDR acknowledges that a 
considerable amount of judgment may be required in establishing whether an end point should be
classified as a NOAEL, "less serious" LOAEL, or "serious" LOAEL, and that in some cases, there will be
insufficient data to decide whether the effect is indicative of significant dysfunction.  However, the 
Agency has established guidelines and policies that are used to classify these end points.  ATSDR
believes that there is sufficient merit in this approach to warrant an attempt at distinguishing between 
"less serious" and "serious" effects. The distinction between "less serious" effects and "serious" effects is 
considered to be important because it helps the users of the profiles to identify levels of exposure at which
major health effects start to appear.  LOAELs or NOAELs should also help in determining whether or not
the effects vary with dose and/or duration, and place into perspective the possible significance of these 
effects to human health.  
The significance of the exposure levels shown in the Levels of Significant Exposure (LSE) tables and 
figures may differ depending on the user's perspective.  Public health officials and others concerned with 
appropriate actions to take at hazardous waste sites may want information on levels of exposure
associated with more subtle effects in humans or animals (LOAELs) or exposure levels below which no
adverse effects (NOAELs) have been observed.  Estimates of levels posing minimal risk to humans 
(Minimal Risk Levels or MRLs) may be of interest to health professionals and citizens alike.
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3. HEALTH EFFECTS
3.2.1 Inhalation Exposure 
The highest NOAEL values and all LOAEL values for a-silica from each reliable study for each end point
in each species and duration category are recorded in Table 3-1 and plotted in Figure 3-1. As noted 
previously, animal studies for c-silica were not considered due to the extensive literature on c-silica 
toxicity in humans.  Summaries of epidemiology studies and exposure-response data are presented in 
Tables 3-2 through 3-16.
3.2.1.1  Death 
Crystalline Silica. Prolonged occupational exposure can result in death due to silicosis or lung cancer.  
Details are provided in Sections 3.2.1.2 (Systemic Effects, Respiratory Effects) and 3.2.1.7 (Cancer).
Amorphous Silica. No studies evaluating death in humans following inhalation exposure to a-silica were 
identified.
In an acute study, no mortalities were observed in rats exposed to a-silica at 477 mg/m3 for 4 hours
(Lewinson et al. 1994).  In a 2-week study in rats, 4/10 males and 2/10 females died following exposure
to 209 mg/m3 6 hours/day for 5 days/week; no mortalities were observed at ≤87 mg/m3 (Reuzel et al.
1991).  In other studies, no treatment-related changes in survival were reported in laboratory animals 
(rats, rabbits, guinea pigs, and monkeys) exposed to a-silica for 6 hours/day, 5 days/week at
concentrations up to 25 mg/m3 for 1 week (Arts et al. 2007), 150 mg/m3 for 4 weeks (Lee and Kelly
1992), 30 mg/m3 for 13 weeks (Reuzel et al.1991), up to 9.9 mg/m3 for up to 18 months (Groth et al. 
1981), or 126 mg/m3 for 8 hours/day, 7 days/week for 12–24 months (Schepers 1981).  
3.2.1.2  Systemic Effects
Respiratory Effects.
Crystalline Silica.
Silicosis:  Pathologic Features and Clinical Presentation. Unless otherwise noted, information in the
following section was taken from these reviews:  Bang et al. (2015); Banks et al. (1986); Beckett et al.
(1997); Castrainova and Vallyathan (2000); Ding et al. (2002); EPA (1996); Fujimura 2000); Greaves
(2000); Greenberg et al. (2007); IARC (1997); Leung et al. (2012); Mossman and Churg (1998);
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Reuzel et al. 1991 
Fumed hydrophobic silica 












Arts et al. 2007 
Silica gel (Syloid 74) 











Arts et al. 2007 
Precipitated silica (Zeosil 45) 













Arts et al. 2007 
Pyrogenic silica (Cab-O-Sil M5) 
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Table 3-1  Levels of Significant Exposure to Amorphous Silica  - Inhalation (continued) 
a 














































Resp 46 (respiratory distress, 












10.1 M 50.5 M (25-fold increase of 
neutrophils in BAL) 
10 M (40% increased 
neutrophils and 200% 
increased LDH activity in 
BAL) 
Reference 
Chemical Form Comments 
Reuzel et al. 1991 
Fumed hydrophilic silica 
(Aerosil 200) 
Reuzel et al. 1991 
Fumed hydrophobic silica 
(Aerosil R 974) 
Reuzel et al. 1991 
Precipitated hydrophobic 
(Sipernat 22S) 
Warheit et al. 1991, 1995 
Colloidal silica (Ludox) 
Warheit et al. 1995 
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Johnston et al. 2000 









Resp 10 M 50 M (inflammation, 
hyperplasia) 
Lee and Kelly 1992 
Colloidal silica (Ludox) 
No treatment-related 
changes in hepatic or 
renal clinical chemistry. 
Hepatic 150 M 
Renal 150 M 
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Table 3-1  Levels of Significant Exposure to Amorphous Silica  - Inhalation (continued) 
Exposure/ LOAEL 
Duration/
a FrequencyKey to Species NOAEL Less Serious Serious(Route)Figure (Strain) System (mg/m³) (mg/m³) (mg/m³) 












Bd Wt 30 
Reference 
Chemical Form Comments 
Reuzel et al. 1991 
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Table 3-1  Levels of Significant Exposure to Amorphous Silica  - Inhalation	 (continued) 
Exposure/ LOAEL 
Duration/
a FrequencyKey to Species	 NOAEL Less Serious(Route)Figure (Strain)	 System (mg/m³) (mg/m³) 











Bd Wt 30 
Serious 
(mg/m³) 






Chemical Form Comments 
Reuzel et al. 1991 
Fumed hydrophobic silica 
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Resp 10.1 M 
30 
50.5 M (200-fold increase of 
neutrophils in BAL) 
Warheit et al. 1991, 1995 
Colloidal silica (Ludox) 
Reuzel et al. 1991 
Fumed hydrophilic silica 
(Aerosil 200) 
No treatment-related 
changes in immune 
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Table 3-1  Levels of Significant Exposure to Amorphous Silica  - Inhalation	 (continued) 
a 
































30 Reuzel et al. 1991 
Fumed hydrophobic silica 





30 Reuzel et al. 1991 






30 Reuzel et al. 1991 
Fumed hydrophobic silica 





30 Reuzel et al. 1991 






30 Reuzel et al. 1991 
Fumed hydrophobic silica 
(Aerosil R 974) 
Comments 
No treatment-related 
changes in immune 
organ weight or 
histology. 
No treatment-related 
changes in brain weight 
or nervous tissue 
histology. 
No treatment-related 
changes in brain weight 
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9.9 M (macrophage/mononuclea 




Groth et al. 1981 
Fumed silica (NS) 
Comments 
Cardio 9.9 M 
Gastro 9.9 M 
Hemato 9.9 M 
Hepatic 9.9 M 
Renal 9.9 M 
Endocr 9.9 M 
Dermal 9.9 M 
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Resp 9.4 M (macrophage/mononuclea 
cell aggregates, impaired 
pulmonary function) 
Groth et al. 1981 
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Key to Species Frequency 
Figure (Strain) (Route) 



































Chemical Form Comments 
6.9 M (macrophage/mononuclea 
cell aggregates, impaired 
pulmonary function) 
Groth et al. 1981 









9.9 M Groth et al. 1981 
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Key to Species Frequency 









































Chemical Form Comments 
9.4 M Groth et al. 1981 








6.9 M Groth et al. 1981 
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Table 3-1  Levels of Significant Exposure to Amorphous Silica  - Inhalation (continued) 
Exposure/ LOAEL 
Duration/
a FrequencyKey to Species NOAEL Less Serious Serious(Route)Figure (Strain) System (mg/m³) (mg/m³) (mg/m³) 
28 Rat 8 hr/d Resp 126 (increased lung weight,7 d/wk(NS) macrophage15 mo accumulation)
(WB) 
29 Gn Pig 6 hr/d Resp 9.9 M5 d/wk(Hartley) 
12 mo 
(WB) 
Cardio 9.9 M 
Gastro 9.9 M 
Hemato 9.9 M 
Hepatic 9.9 M 
Renal 9.9 M 
Endocr 9.9 M 
Dermal 9.9 M 
Bd Wt 9.9 M 
Reference 
Chemical Form Comments 
Schepers 1981
 
Precipitated silica (HI-SIL 233)
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Key to Species Frequency 
Figure (Strain) (Route) 



































Chemical Form Comments 
9.4 M Groth et al. 1981 









6.9 M Groth et al. 1981 
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Resp 126 (macrophage 
accumulation) 
Schepers 1981 
Precipitated silica (HI-SIL 233) 









9.9 M Groth et al. 1981 







9.4 M Groth et al. 1981 







6.9 M Groth et al. 1981 
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Table 3-1  Levels of Significant Exposure to Amorphous Silica  - Inhalation	 (continued) 
a 











40	 Gn Pig 
(Hartley) 




















9.9 M Groth et al. 1981 





9.4 M Groth et al. 1981 





6.9 M Groth et al. 1981 





9.9 M Groth et al. 1981 





9.4 M Groth et al. 1981 
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9.9 M Groth et al. 1981 







9.4 M Groth et al. 1981 







6.9 M Groth et al. 1981 








9.9 M Groth et al. 1981 
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Table 3-1  Levels of Significant Exposure to Amorphous Silica  - Inhalation	 (continued) 
a 








49	 Gn Pig 
(Hartley) 
50	 Gn Pig 
(Hartley) 




















9.4 M Groth et al. 1981 





6.9 M Groth et al. 1981 





9.9 M Groth et al. 1981 





9.4 M Groth et al. 1981 





6.9 M Groth et al. 1981 




















lesions in reproductive 
organs. 
a The number corresponds to entries in Figure 3-1. 
BAL = bronchoalveolar lavage fluid; Bd Wt = body weight; Cardio = cardiovascular; d = day(s); Endocr = endocrine; F = Female; Gastro = gastrointestinal; Gn pig = guinea pig; 
Hemato = hematological; hr = hour(s); Immuno/Lymphoret = immunological/lymphoreticular; LDH = lactate dehydrogenase; LOAEL = lowest-observed-adverse-effect level; M = male; 
mo = month(s); Musc/skel = musculoskeletal; (N) = nose-only; NOAEL = no-observed-adverse-effect level;NS = not specified (trade name not reported); Resp = respiratory; x = 
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Mossman and Glenn (2013); NIOSH (2002); Peters (1986); Rimal et al. (2005); Steenland (2005);
Steenland and Ward (2014); and Stratta et al. (2001a).
Silicosis is one of the oldest known occupational diseases, reported by ancient Greeks and Romans.  It has 
only been observed following occupational exposure to respirable c-silica and not through exposure to 
c-silica in ambient air (Beckett et al. 1997; Steenland and Ward 2014).  As stated by Steenland and Ward 
(2014), “while there is also some low-level c-silica exposure on beaches and in ambient air in general, 
there is no evidence such low-level exposure causes health effects.”  Silicosis is a progressive,
irreversible, fibrotic lung disease resulting from inhalation and pulmonary deposition of respirable dust
containing c-silica. The causal relationship between inhalation of c-silica and development of this severe,
debilitating lung disease is well-established and not under dispute.  No other substances are known to 
produce the unique pathological changes observed in silicosis.  In the United States, despite improved 
industrial hygiene methods and more stringent recommended exposure limits, new cases of silicosis
continue to be diagnosed.  There is no known curative treatment for silicosis.
Silicosis is not a single disease entity, but is classified as different types: acute silicosis (also called
silicoproteinosis or alveolar proteinosis), simple silicosis (also called chronic or nodular silicosis), 
progressive massive fibrosis (PMF) (also called conglomerate silicosis or complicated silicosis; a 
progression of simple silicosis), and accelerated silicosis (a rapidly progressive form of simple (chronic)
silicosis).  Type and severity of silicosis can be influenced by the intensity (frequently referred to as
concentration), frequency, and duration of exposure.  Cumulative c-silica dose, expressed as mg/m3-year, 
is the most important factor in the development of silicosis. All types of silicosis can be fatal, with death 
resulting from respiratory failure. Time from first exposure to onset of disease (i.e., the latency period)
varies inversely with intensity of exposure and may be as short as a few weeks for acute silicosis to as 
long as 20 or more years for simple silicosis and PMF.  Due to the long latency period, patients may not
be diagnosed until several years after exposure has ended.  Disease severity may continue to slowly
increase over decades even after exposure has been discontinued, possibly due to c-silica dust that is
retained in the lung.  Thus, cessation of exposure does not necessarily prevent development or
progression of silicosis. Silicosis is diagnosed based on a known history of exposure to dust containing
c-silica and radiographic findings, including the presence of nodules on chest radiograph or computed 
tomography (CT) scan, along with ruling out other diseases that may mimic silicosis (e.g., fungal
infections, sarcoidosis).  Pulmonary function tests are useful for determining severity, but not as useful
diagnostic tool for silicosis as no pattern of lung function abnormality is specific for c-silica exposure or
silicosis.
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Simple silicosis. Simple silicosis, also called chronic or nodular silicosis, is the most common type of
silicosis.  It occurs following long periods (10–≥20 years) of continuous exposure to relatively low levels 
of c-silica dust, although “relatively low levels” has not been defined in quantitative terms.  Simple 
silicosis can be either a restrictive, obstructive, or mixed lung disease characterized by diffuse, multiple
nodular lesions in lung parenchyma and associated lymphoid tissue and lymph nodes, and fibrotic lesions
of the pleura.  Nodules, are typically small (≤1 mm in diameter) and more prominent in upper lobes of the
lung; those in close proximity to small and medium airways cause narrowing and distortion of the airway
lumen.  Fibrotic nodules appear as concentric arrangements of whorled collagen fibers with central
hyalinized zones; calcification and necrosis occur to varying degrees.  Nodules also may contain c-silica 
inclusions.  Macrophages, fibroblasts, and lymphocytes are observed at the periphery of the nodules, and 
the pleura may appear thickened.  Early in disease development, radiography typically shows small,
round opacities of the upper lung.  With disease progression, nodules become larger and denser and may
be observed in the lower lung in more severe cases.  Scarring and hypertrophy of bronchial-associated
lymphoid tissue and intrapulmonary lymph nodes lead to compression of larger airways.
Early symptoms of simple silicosis are dyspnea on heavy exertion and dry cough; however, some patients
may be asymptomatic.  Pulmonary function and general health typically may not be compromised during
the early stages.  As the disease progresses, frequency and intensity of cough increases and sputum
production may occur; dyspnea also occurs more frequently with less exertion. Decrements in lung
function are often observed (e.g., nonreversible airflow obstruction, volume restriction, impaired gas
exchange, pulmonary hypertension, right heart strain, and cor pulmonale), which may lead to right heart
enlargement.  In the later stages, hypoxemia may develop.  
Progressive Massive Fibrosis (PMF). PMF, also called conglomerate silicosis or complicated silicosis, is
a progression of simple silicosis. The factors that determine progression of simple silicosis to
complicated silicosis have not been defined, but cumulative exposure and tuberculosis are risk factors.  
Complicated silicosis can develop after exposure to c-silica ceases.
Nodular lung lesions become larger (diameter >1–2 cm) and coalesce to form masses of hyalinized
connective tissue, leading to destruction of the surrounding pulmonary architecture, including bronchioles
and blood vessels. Necrosis and cavitation of lesions occur and PMF develops.  Restricted lung volume, 
reduced pulmonary compliance, and poor gas exchange are observed.  Compromised pulmonary function 
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can lead to right ventricular failure, congestive heart failure, and increased risk of pneumothorax. General
health significantly declines, and severe pulmonary damage can result in death.
Acute silicosis. Acute silicosis, also called silicoproteinosis or alveolar proteinosis, is a rapidly 
progressive alveolar filling disease associated with heavy, intense exposure (not quantitatively defined) to
fine c-silica dusts, such as those generated during sandblasting, rock drilling, or milling and tunneling.  
The time to onset for acute silicosis varies from a few weeks to <10 years after the start of exposure, but
most cases typically occur within 1–5 years. Acute silicosis frequently results in death due to respiratory
failure.  Like simple and complicated silicosis, acute silicosis progresses in the absence of further
exposure. 
Pathologically, acute silicosis is characterized by alveolar filling with an eosinophilic-granular, lipid-rich 
fluid containing debris from damaged cells, and interstitial inflammation with infiltration by neutrophils 
and alveolar macrophages containing lamellar bodies.  Diffuse interstitial fibrosis often develops and
extensive damage to the alveolar epithelium occurs.  On radiography, diffuse alveolar opacification is 
observed in the middle and lower lobes.
Symptoms of acute silicosis include dyspnea, labored breathing, dry cough, decreased pulmonary
function, compromised gas exchange, fever, fatigue, and weight loss. As the disease progresses, cyanosis 
and respiratory failure develop.  Death from respiratory failure often occurs within a few months of the
onset of symptoms.
Accelerated silicosis. Accelerated silicosis, associated with intense exposure to fine c-silica dusts, is a 
rapidly progressive form of simple (chronic) silicosis.  It develops 5–10 years after the start of exposure
and is typically associated with more moderate exposure (compared to simple silicosis). Symptoms are 
similar to those of simple silicosis. Accelerated silicosis is associated with significant morbidity and
mortality.
Silicotuberculosis—a complication of silicosis. A complication of silicosis is superimposed pulmonary
infection with mycobacteria or fungi. The most common form of infection in c-silica-exposed workers is 
tuberculosis (silicotuberculosis).  The risk of tuberculosis infection increases with the severity of silicosis, 
although some occupational exposure studies have reported an increased risk of tuberculosis in c-silica
workers in the absence of silicosis (Cowie 1994; teWaterNaude et al. 2006). Based on worker
compensation claims in California during the period 1946–1979, Goldsmith et al. (1995) estimated the
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rate of death in males with silicotuberculosis as approximately 50 times greater than that of the general
population.  The prevalence of silicotuberculosis in the United States decreased with advances in
tuberculosis drug therapy.  However, due to the recent increase in drug-resistant tuberculosis, the
potential for superimposed tuberculous infection in c-silica workers is a growing concern. The
prevalence of silicotuberculosis is exacerbated by human immunodeficiency virus (HIV) epidemics, 
particularly in low-income countries (Rees and Murray 2007).
Silicosis Morbidity: Incidence and Exposure-Response Data. The current number of silicosis cases in the
United States is not known (NIOSH 2002).  Rosenman et al. (2003) estimated that during the period of
1987–1997, approximately 3,600–7,300 new silicosis cases were diagnosed yearly in the United States.
However, it is likely that this incidence is underestimated due to the lack of a national surveillance system
for silicosis (Steenland and Ward 2014).  Recent surveillance data for silicosis showed no decrease in 
hospitalization due to silicosis in the United States over the time period 1993–2011 (Filios et al. 2015).  
The incidence of silicosis is higher in less-developed countries; for example, approximately 6,000 new
cases of silicosis per year are diagnosed in China (Leung et al. 2012; Steenland and Ward 2014).
Several studies provide exposure-response data for silicosis incidence based on cumulative exposure
(expressed as mg/m3-year) for various industries, including underground hardrock mining (Chen et al. 
2001; Churchyard et al. 2004: Hnizdo and Sluis-Cremer 1993; Kreiss and Zhen 1996; Muir et al. 1989a,
1989b; Steenland and Brown 1995a), granite quarry mining and production (Ng and Chan 1994), 
diatomaceous earth mining and milling (Hughes et al. 1998; Park et al. 2002), and porcelain production 
(Mundt et al. 2011).  Study details are provided in Table 3-2.  Results of these studies show that the risk
of silicosis increases with cumulative exposure.  However, risk estimates are not directly comparable 
across study designs that used different outcome metrics, follow-up periods, or statistical approaches to
estimate risk. Another complication is that various industrial processes generate different types of c-silica 
particles (e.g., particle size, surface reactivity, fibrogenic potential) (see Section 3.5.2, Mechanism of
Toxicity; Section 4.2, Chemical and Physical Properties).
Chen et al. (2001) compared cumulative risks of silicosis for four hardrock mining cohorts (Chen et al. 
2001; Hnizdo and Sluis-Cremer 1993; Kreiss and Zhen 1996; Steenland and Brown 1995a) (Figure 3-2).  
Relationships between cumulative exposure and cumulative risks (estimated through the end of the
follow-up periods) were similar across the cohorts, with each showing an exponential increase in
cumulative risk with increasing cumulative exposure.  For a cumulative exposure of 4.5 mg/m3-year (a
45-year exposure to 0.1 mg/m3), cumulative risks ranged from approximately 55 to 90%.  Cumulative
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Table 3-2.  Exposure-Response Data for Silicosis Morbidity in Workers Exposed to c-Silica
Study design and Cumulative exposure
 
Reference industry Cohort and methods (mg/m3-year) Outcome
 





Cohort: 3,010 male 
(92.9%) and female tin
miners employed for at









Categories (C) for cumulative 
exposure to c-silica dust,
calculated using reported 
cumulative total dust exposure 
and the mean c-silica dust
concentration of 3.6%
(midpoint):
- C1: <0.36 (0.18)
- C2: 0.36–0.72 (0.54)
- C3: >0.72–1.4 (1.08)
- C4: >1.4–2.2 (1.80)
- C5: >2.2–2.9 (2.52)
- C6: >2.9–3.6 (3.24)
- C7: >3.6–5.4 (4.50)
- C8: >5.4 (>5.4)
Silicosis cases: 1,015 (33.7% of cohort)
Silicosis diagnosed post-exposure:
684 (67.4% of silicosis cases)
Time after first exposure to onset of
silicosis (mean±SD): 21.3±8.6 years



















Lifetime risk exposure to 0.1 mg/m3 for
45 years (4.5 mg/m3 -year): 55%
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Table 3-2.  Exposure-Response Data for Silicosis Morbidity in Workers Exposed to c-Silica
Reference
Study design and 
industry Cohort and methods
Cumulative exposure
(mg/m3-year) Outcome
Churchyard et al. Study design: cross- Cohort: 520 current Cumulative exposure to Silicosis cases: 93 (19%)
2004 (with some sectional black gold miners, 37– respirable quartz:
data reported in Industry: gold mining 60 years of age, Mean±SD: 8.2±2.88 Miners with silicosis per exposure group 
Collins et al. 2005) Location: South Africa recruited during Median: 7.95 (%) (as reported in Collins et al. 2005):
November 2000 through Range: 0–22.68 - C1: 11 (10.7)
March 2001; no follow- Categories (C) for cumulative - C2: 8 (8.2)
up period or assessment exposure (mid-point): - C3: 18 (17.5)
of previously employed - C1: 0–0.80 (0.4) - C4: 23 (22.1)
miners - C2: 0.80–0.99 (0.9) - C5: 33 (32.0)
Adjustments: none - C3: 0.99–1.24 (1.12)
Statistical analysis: - C4: 1.24–1.48 (1.36) The prevalence of silicosis (%)
logistic regression - C5: 1.48–3.08 (2.28) significantly increased with cumulative
Duration of exposure (mean): exposure (p<0.001).  Estimated 
2.18 years prevalence of silicosis by cumulative 
exposure (number with silicosis/number
workers in exposure category):
- C1: 10.7 (11/103)
- C2: 8.2 (8/97)
- C3: 17.5 (18/103)
- C4: 22.1 (23/104)
- C5: 32.0 (33/103)
For each unit increase for cumulative 
exposure (mg/m3 -year), the odds of
silicosis increased by 3.2.
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Table 3-2.  Exposure-Response Data for Silicosis Morbidity in Workers Exposed to c-Silica
Study design and Cumulative exposure
 
Reference industry Cohort and methods (mg/m3-year) Outcome
 





Cohort: 2,235 white gold Cumulative respirable c-silica Silicosis cases: 313 (14% of cohort)
miners employed as exposure (composed mainly of Number of silicosis cases/workers in
underground gold miners quartz and silicates, based on exposure group:
from 1938 for at least a 30% c-silica content in dust): - C1: 0/2,218
10 years, with follow-up Mean (SD): 6.6 (2.7) - C2: 9/2,014
to 1991 Range: 1.2–18.7 - C3: 48/1,540
Adjustments: cumulative Cumulative exposure category - C4: 85/984
risk was adjusted for loss (C) midpoints: - C5: 93/515
of workers who did not - C1: 0.3 - C6: 53/197
develop silicosis but - C2: 0.9 - C7: 20/55
whose exposure reached - C3: 1.5 - C8: 5/11
only a certain level (not - C4: 2.1
specified); no adjustment - C5: 2.7 Silicosis risk increased exponentially with
was made for exposure - C6: 3.3 cumulative dust exposure. The increase 
to radon daughters in the - C7: 3.9 in risk accelerated at the cumulative 
mines - C8: 4.5 exposure category C4.  Risk per unit of
Statistical analysis: cumulative c-silica dust exposure [mean 
cumulative risk (SE)]:
calculated by Kaplan- - C1: –
Meier method - C2: 0.002 (0.001)
- C3: 0.016 (0.002)
- C4: 0.045 (0.005)
- C5: 0.099 (0.010)
- C6: 0.156 (0.021)
- C7: 0.222 (0.048)
- C8: 0.227 (0.060)
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Table 3-2.  Exposure-Response Data for Silicosis Morbidity in Workers Exposed to c-Silica
Study design and Cumulative exposure
 
Reference industry Cohort and methods (mg/m3-year) Outcome
 











Cohort: 1,809 white 
workers in the 
diatomaceous earth 
industry with a minimum
of 12 months of
employment during 





Cohort: 100 miners and 
34 controls ≥40 years of
age; range of follow-up 
period for individual
miners: 0–56 years





Categories for cumulative 












Total silicosis cases: 81 (4.5%)
Risk of silicotic opacities on radiography
significantly increased with cumulative




- C2: 4.35 (1.7, 11.06)
 
- C3: 20.13 (8.2, 49.7)
 
- C4: 40.37 (16.1, 101.3)
 
Risks of radiographic opacities for
cumulative exposure of 2.0 mg/m3-year for
dust concentrations:
- <0.50 mg/m3: 1.1%
 
- >0.50 mg/m3: 3.7%
 
Risks of radiographic opacities for
cumulative exposure of 4.0 mg/m3-year for
dust concentrations:
- <0.50 mg/m3: 3.3%
- >0.50 mg/m3: 12.4%
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Table 3-2.  Exposure-Response Data for Silicosis Morbidity in Workers Exposed to c-Silica
Reference
Study design and 
industry Cohort and methods
Cumulative exposure
(mg/m3-year) Outcome
Muir et al. Study design: Cohort: 2,109 gold Categories of cumulative Silicosis cases: 32
1989a,1989b longitudinal and uranium miners exposure and numbers of
retrospective cohort
Industry: gold and 
employed during the 
period 1940–1959, with
miners in each category:
- C1: 0–0.499 (1,313)
Estimates of cumulative exposures [in 
mg/m3-year (95% CI)] associated with 
uranium mining follow-up to 1982 or end - C2: 0.5–0.999 (582) risks of developing silicosis:
Location: Ontario of exposure, whichever - C3: 1.0–1.499 (103) - 1% risk: 6.1 (4.1, 8.9)
occurred first; no follow- - C4: 1.5–1.999 (48) - 2% risk: 8.5 (5.6, 12.8)
up period. - C5: >2.0 (63) - 5% risk: 13.2 (7.8, 22.5)




Mundt et al. 2011 Study design: Cohort: 17,644 workers Cumulative exposure to Cumulative exposure to >3 mg/m3-year
epidemiological cohort (46.8% male) employed respirable c-silica: was associated with an increased risk of
Industry: porcelain more than 6 months and - ≤0.5 (referent) silicosis.
manufacturing participating in a - >0.5–1.0
(100 plants) screening program for - >1.0–1.5 Number of silicosis cases per cumulative 
Location: Germany silicosis in 1985–1987, - >1.5–3.0 exposure, not lagged:
with follow-up through - >3 - ≤0.5 (referent): 4
2005 - ≤3 (referent) - >0.5–1.0: 1
Adjustments: age, sex, - >3–4 - >1.0–1.5: 2
smoking - >4–5 - >1.5–3.0: 2
Statistical analysis: Cox - >5–6 - >3: 31





Silicosis hazard ratios (95% CI), not
lagged:
- ≤0.5: reference
- >0.5–1.0: 0.3 (<0.1–2.6)
- >1.0–1.5: 0.7 (0.1–3.8)
- >1.5–3.0: 0.4 (0.1–2.2)
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Table 3-2.  Exposure-Response Data for Silicosis Morbidity in Workers Exposed to c-Silica
Study design and Cumulative exposure
 
Reference industry Cohort and methods (mg/m3-year) Outcome
 




- >3–4: 0.9 (0.1–7.5)
 
- >4–5: 5.3 (1.6–17.3)
 
- >5–6: 7.3 (2.6–20.8)
 
- >6: 6.8 (3.0–15.3)
 
Number of silicosis cases per cumulative 
exposure, lagged by 10 years:
























- >0.5–1.0: 0.7 (0.1–3.7)
 
- >1.0–1.5: 0.4 (0.1–3.7)
 
- >1.5–3.0: 0.5 (0.1–2.4)
 




- >3–4: 2.9 (0.8–10.6)
 
- >4–5: 4.9 (1.5–15.7)
 
- >5–6: 5.2 (1.6–16.9)
 
- >6: 6.7 (3.0–14.9)
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Table 3-2.  Exposure-Response Data for Silicosis Morbidity in Workers Exposed to c-Silica
Study design and Cumulative exposure
 
Reference industry Cohort and methods (mg/m3-year) Outcome
 





Park et al. 2002	 Study design: historical 
cohort study
Industry: diatomaceous
earth mining and 
processing
Location: California
Cohort: 206 current and 
132 previous granite 
workers employed for at
least 1 year in 1967– 
1985; decedents were 
not included; specific
follow-up period was not
specified





male workers employed 









Cumulative exposure to 
respirable quartz: <0.25–>10




Prevalence (%) of rounded opacities on 






Prevalence (%) of irregular opacities on 






Analysis by linear regression predicted 
risks of 6 and 8% for rounded and 
irregular opacities, respectively, for a 
50-year-old worker with a cumulative 
exposure of 2.0 mg/m3-year.
Workers diagnosed with silicosis: 70
Excess lifetime risk estimates (per
1,000 workers) for radiographic silicosis
increased with increasing dust
concentration (mg/m3).  Risk estimates
were based on the assumption of
exposure to a constant respirable c-silica
concentration for 45 years.
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Table 3-2.  Exposure-Response Data for Silicosis Morbidity in Workers Exposed to c-Silica
Study design and Cumulative exposure
 
Reference industry Cohort and methods (mg/m3-year) Outcome
 
Excess lifetime risk (per 1,000 workers)





























Excess lifetime risk for cumulative 
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Table 3-2.  Exposure-Response Data for Silicosis Morbidity in Workers Exposed to c-Silica
Reference
Study design and 










Cohort: 3,330 white male 
underground gold miners
employed for at least
1 year during 1940– 
1965, with follow-up 









- C1: 0–0.2 (0.1)
- C2: 0.2–0.5 (0.35)
- C3: 0.5–1.0 (0.75)
- C4: 1.0–2.0 (1.5)
- C5: 2.0–3.0 (2.5)
- C6: 3.0–4.0 (3.5)
- C7: >4.0
Silicosis cases: 170









Lifetime risk for each exposure category
based on a 45-year exposure (first and 
second numbers of risk range are 









Estimated lifetime risk for exposure to 
0.09–0.1 mg/m3 for 45 years: 35–47%
CI = confidence interval; SD = standard deviation; SE = standard error
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♦ Steenland and Brown (1995)
■ Hnizdo and Sluis-Cremer (1993)
▲ Chen et al. (2001)
× Kreiss and Zhen (1996)
Cumulative exposure to respirable crystalline
silica (mg/m3-year)
Source:  Reproduced from Chen et al. (2001) with permission from BMJ Publishing Group Ltd.
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risks will vary depending on length of follow-up period.  Substantially lower risk estimates in a mining
cohort were reported by Muir et al. (1989a, 1989b).  For example, risks of 1 and 10% were associated 
with cumulative exposures of 6.1 and 18.7 mg/m3-year, respectively.  However, it is possible that risks 
were underestimated due to the lack of a post-employment follow-up period (EPA 1996; NIOSH 2002).  
A study of a mining cohort published after Chen et al. (2001) showed that the incidence of silicosis
significantly increased with cumulative exposure (p for trend <0.001) (Churchyard et al. 2004).  For the
highest cumulative exposure category of 1.48–3.08 mg/m3-year, the incidence of silicosis was 32%.
Similar risks were predicted for a cohort of granite workers, with predicted risks of 6 and 8% for rounded 
and irregular radiographic opacities, respectively, for a cumulative exposure of 2.0 mg/m3-year (Ng and
Chan 1994).  However, risks in this cohort may have been underestimated because decedents were not
included.  
In a study of white male diatomaceous earth workers, excess lifetime risk (extrapolated to age 85 years)
of silicosis for a 45-year exposure to 0.1 mg/m3 respirable silica was estimated to be 10% (Park et al.
2002).  In a previous study of these workers, Hughes et al. (1998) estimated the risks of silicosis for a
cumulative exposure of 2 mg/m3-year of 1.1 and 3.7% for exposures to c-silica dust concentrations of
<0.5 and >0.5 mg/m3 respectively.  For porcelain workers, risks for silicosis were significantly increased
for cumulative exposures of ≥3 mg/m3-year (Mundt et al. 2011).  For a cumulative exposure range of 4– 
5 mg/m3-year, lagged by 10 years (to account for latency period), the hazard ratio was 4.9 (95% CI 1.5, 
15.7) when combining all exposure categories <3.0 mg/m3 as referent.
The exposure-response data on silicosis reported in the studies above are briefly summarized in Table 3-3.  
For the lowest cumulative exposure range reported in the available literature (0–0.2 mg/m3-year), silicosis 
was observed in 5 of 3,330 gold miners (Steenland and Brown 1995a).  Churchyard et al. (2004) reported
that at a cumulative exposure range of 0–0.8 mg/m3-year, 11/520 gold miners were diagnosed with 
silicosis. In summary, data from morbidity studies consistently demonstrate an exposure-response 
relationship between cumulative exposure to respirable c-silica and silicosis over a wide range of
exposure scenarios in several industries.
Silicosis Mortality: Exposure-Response Data. Progression of silicosis can result in death due to 
respiratory failure. There is considerable uncertainty regarding the number of annual deaths that occur
worldwide due to silicosis.  Driscoll et al. (2005) estimated that approximately 8,800 deaths per year
occur worldwide due to silicosis. The Global Burden of Disease Study (GBD 2015) estimated that
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Table 3-3.  Summary of Exposure-Response Data for Silicosis Morbidity





Gold mining Longitudinal retrospective 
cohort
0–0.2 Silicosis cases/exposed workers: 5/3,330
Churchyard et al. 2004 
(as reported in Collins et
al. 2005)
Gold mining Cross-sectional 0–0.80 Silicosis cases/exposed workers: 11/103




>0-1 Prevalence of silicosis (%): 12.5
Steenland and Brown 
1995a
Gold mining Longitudinal retrospective 
cohort
0.2–0.5 Silicosis cases/exposed workers: 5/1,800
Ng and Chan 1994 Granite Cross-sectional <0.25 Prevalence of silicosis (%): 0
Ng and Chan 1994 Granite Cross-sectional 0.25–<1.00 Prevalence of silicosis (%): 0
Hnzido and Sluis-
Cremer 1993
Gold mining Retrospective longitudinal 0.3 Silicosis cases/exposed workers: 0/2,218
Chen et al. 2001 Tin mining Retrospective cohort <0.36 Silicosis cases/exposed workers: 2/3,010
Chen et al. 2001 Tin mining Retrospective cohort 0.36–0.72 Silicosis cases/exposed workers: 24/3,010
Mundt et al. 2011 Porcelain Epidemiological cohort
study
>0.5–1.0 (no lag) HR (95% CI): 0.3 (<0.1–2.6)
Mundt et al. 2011 Porcelain Epidemiological cohort
study
>0.5–1.0 (10-year lag) HR (95% CI): 0.7 (0.1–3.7)
Steenland and Brown 
1995a
Gold mining Longitudinal retrospective 
cohort
0.5–1.0 Silicosis cases/exposed workers: 15/1,060
Chen et al. 2001 Tin mining Retrospective cohort >0.72–1.4 Silicosis cases/exposed workers: 126/3,010
Churchyard et al. 2004 
(as reported in Collins et
al. 2005)
Gold mining Cross-sectional 0.80–0.99 Silicosis cases/exposed workers:8/97
Hnzido and Sluis-
Cremer 1993
Gold mining Retrospective longitudinal 0.9 Silicosis cases/exposed workers: 9/2,014
Churchyard et al. 2004 
(as reported in Collins et
al. 2005)
Gold mining Cross-sectional 0.99–1.24 Silicosis cases/exposed workers:18/103
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Table 3-3.  Summary of Exposure-Response Data for Silicosis Morbidity
Reference Industry Study type
Cumulative exposure
(mg/m3-year) Outcome
Mundt et al. 2011 Porcelain Epidemiological cohort >1.0–1.5 (no lag)
study
Mundt et al. 2011 Porcelain Epidemiological cohort >1.0–1.5 (10-year lag)
study
Kreiss and Zhen 1996 Gold and uranium Longitudinal retrospective >1–2
mining cohort
Steenland and Brown Gold mining Longitudinal retrospective 1.0–2.0
1995a cohort
Hughes et al. 1998 Diatomaceous Retrospective cohort >1–≤3
earth
Ng and Chan 1994 Granite Cross-sectional 1.00–<5.00
Churchyard et al. 2004 Gold mining Cross-sectional 1.24–1.48
(as reported in Collins et
al. 2005)
Chen et al. 2001 Tin mining Retrospective cohort >1.4–2.2
Churchyard et al. 2004 Gold mining Cross-sectional 1.48–3.08
(as reported in Collins et
al. 2005)
Hnzido and Sluis- Gold mining Retrospective longitudinal 1.5
Cremer 1993
Mundt et al. 2011 Porcelain Epidemiological cohort >1.5–3.0 (no lag)
study
Mundt et al. 2011 Porcelain Epidemiological cohort >1.5–3.0 (10-year lag)
study
Steenland and Brown Gold mining Longitudinal retrospective 2.0–3.0
1995a cohort
Kreiss and Zhen 1996 Gold and uranium Longitudinal retrospective >2–3
mining cohort
Hnzido and Sluis- Gold mining Retrospective longitudinal 2.1
Cremer 1993
HR (95% CI): 0.7 (0.1, 3.8)
 
HR (95% CI): 0.4 (0.1, 3.7)
 
Prevalence of silicosis (%): 26.3
 
Silicosis cases/exposed workers: 33/684
 
RR (95% CI): 4.35 (1.7, 11.06)
 
Prevalence of silicosis (%): 12.77
 
Silicosis cases/exposed workers: 23/104
 
Silicosis cases/exposed workers: 127/3,010
Silicosis cases/exposed workers: 33/103
Silicosis cases/exposed workers: 48/1,540
HR (95% CI): 0.4 (0.1, 2.2)
HR (95% CI): 0.5 (0.1, 2.4)
Silicosis cases/exposed workers: 44/331
Prevalence of silicosis (%): 55.6
Silicosis cases/exposed workers: 85/984
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Table 3-3.  Summary of Exposure-Response Data for Silicosis Morbidity
Reference Industry Study type
Cumulative exposure
(mg/m3-year) Outcome
Park et al. 2002 Diatomaceous Historical cohort 2.16 Silicosis cases/exposed workers: 70/2,342
earth
Chen et al. 2001 Tin mining Retrospective cohort >2.2–2.9 Silicosis cases/exposed workers: 196/3,010
Hnzido and Sluis- Gold mining Retrospective longitudinal 2.7 Silicosis cases/exposed workers: 93/515
Cremer 1993
Kreiss and Zhen 1996 Gold and uranium Longitudinal retrospective >3 Prevalence of silicosis (%): 83.3
mining cohort
Mundt et al. 2011 Porcelain Epidemiological cohort >3 (no lag) HR (95% CI): 3.1 (1.1, 9.3)
study
Mundt et al. 2011 Porcelain Epidemiological cohort >3.0 (10-year lag) HR (95% CI): 3.7 (1.4, 9.9)
study
Steenland and Brown Gold mining Longitudinal retrospective 3.0–4.0 Silicosis cases/exposed workers: 42/125
1995a cohort
Hughes et al. 1998 Diatomaceous Retrospective cohort >3–≤6 RR (95% CI): 20.13 (8.2, 49.7)
earth
Hnzido and Sluis- Gold mining Retrospective longitudinal 3.3 Silicosis cases/exposed workers: 53/197
Cremer 1993
Chen et al. 2001 Tin mining Retrospective cohort >3.6–5.4 Silicosis cases/exposed workers: 141/3,010
Hnzido and Sluis- Gold mining Retrospective longitudinal 3.9 Silicosis cases/exposed workers: 20/55
Cremer 1993
Steenland and Brown Gold mining Longitudinal retrospective >4.0 Silicosis cases/exposed workers: 26/52
1995a cohort
Hnzido and Sluis- Gold mining Retrospective longitudinal 4.5 Silicosis cases/exposed workers: 5/11
Cremer 1993
Ng and Chan 1994 Granite Cross-sectional 5.00–<10.00 Prevalence of silicosis (%): 25.00
Chen et al. 2001 Tin mining Retrospective cohort >5.4 Silicosis cases/exposed workers: 155/3,010
Hughes et al. 1998 Diatomaceous Retrospective cohort >6 RR (95% CI): 40.37 (16.1, 101.3)
earth
Ng and Chan 1994 Granite Cross-sectional >10.00 Prevalence of silicosis (%): 21.67
Ci = confidence interval; HR = hazard ratio; RR = rate-ratio
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55,000 and 46,000 deaths occurred worldwide in 1990 and 2013, respectively.  In the United States, 
13,744 deaths were attributed to silicosis from 1968 to 1990 and 4,313 deaths were attributed to silicosis
from 1979 to 1990 (Beckett et al. 1997; Castranova and Vallyathan 2000).  Due to improved industrial
hygiene standards and more stringent regulatory standards and guidelines, silicosis mortality trends show
a marked decline over the past 50 years (Bang et al. 2008, 2015).  In 1965, 1,065 deaths were attributed to 
silicosis compared to 165 deaths in 2004 (Bang et al. 2015).  During the period 2001–2010, silicosis was
identified as the underlying or contributing cause of 1,437 deaths, with 164 deaths (death rate: 0.74 per
1 million; 95% CI: 0.62, 0.85) in 2001 and 101 deaths (death rate: 0.39 per 1 million; 95% CI: 0.31, 0.47)
in 2010 (p for trend =0.002) (Bang et al. 2015).  However, silicosis deaths in younger adults (ages 15–44)
have not declined since 1995, which may reflect more recent, intense exposures, such as those associated
with construction, abrasive blasting, and fracking industries (CDC 1998a, 1998b; Esswein et al. 2013;
Mazurek and Attfield 2008).
Cohorts show that silicosis mortality increases with cumulative exposure (Checkoway et al. 1997; Chen et
al. 2012; Hedlund et al. 2008; Hughes et al. 2001; McDonald et al. 2005; Park et al. 2002; Vacek et al. 
2011).  Study details are provided in Table 3-4.  Results of these studies show statistically significant
exposure-related trends for mortality rate and odds ratios (ORs) for workers exposed to c-silica in the
diatomaceous earth, metal and ore mining, granite, pottery, and sand industries.  A study of iron ore
workers found that silicosis mortality increased with cumulative exposure; at the highest exposure
category examined, >7 mg/m3-year, the adjusted mortality rate, was 140 deaths per 100,000 person years
of exposure (Hedlund et al. 2008).  Based on data from a cohort of white male U.S. diatomaceous earth 
workers, Park et al. (2002) estimated an excess lifetime risk of death from silicosis of 54 per 1,000 (95%
CI: 17, 150) for exposure to a c-silica dust concentration of 0.05 mg/m3 over a working lifetime. As a 
reference, OSHA (1997) seeks to keep excess lifetime risks of serious disease below 1 per 1,000.
Results and details of pooled analyses on the relationship between c-silica exposure and silicosis mortality
are summarized in Table 3-5 (Mannetje et al. 2000a, 2000b).  
Mannetje et al. (2002b) conducted a pooled analysis of 65,980 workers from 10 cohorts from the
diatomaceous earth, granite, sand, mining, and pottery industries.  The risk of death was increased for all
exposure levels (range: 4.45–42.33 mg/m3-years), with standardized risk ratios ranging from 3.1 (95% CI:
2.5, 4.0) to 4.8 (95% CI: 3.7, 6.2) (Mannetje et al. 2002b). Similar results were observed in a pooled 
analysis of 18,364 workers from six cohorts from the diatomaceous earth, granite, sand, and mining
industries (Mannetje et al. 2002a).  Mannetje et al. (2002a) pooled data from six of the cohorts evaluated
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Table 3-4.  Exposure-Response Data for Mortality Due to Silicosis and Nonmalignant Respiratory Disease in
 
Workers Exposed to c-Silica
 
Study design and Cohort and Cumulative exposure
 
Reference industry methods (mg/m3-year) Outcome
 
Checkoway et al.	 Study design: historical 
1997	 cohort study
Industry: diatomaceous
earth mining and 
processing
Location: California
Cohort: 2,342 white, Cumulative exposure for SMR for all deaths due to nonmalignant
 
male workers respirable c-silica: respiratory disease (except infections)
 
employed for at least - <0.5 (referent) was significantly increased.
 
12 months during - 0.5–<1.1 - Number of deaths: 67
 
1942–1987, with - 1.1–<2.1 - SMR (95% CI): 2.01 (1.56, 2.55).
 
follow-up through - 2.1–<5.0
 
1994 - ≥5.0 Deaths due to nonmalignant respiratory
 
Adjustments: age, disease increased with cumulative 

calendar year, exposure.  Rate ratios (95% CI) lagged by
 




Statistical analysis: 0-year lag:
 
Poisson regression - <0.5 (reference): 7 [1]
 
model - 0.5–<1.1: 8 [1.52 (0.55, 4.20)]
 
- 1.1–<2.1: 10 [1.98 (0.75, 5.22)]
- 2.1–<5.0: 12 [2.34 (0.91, 6.00]
- ≥5.0: 30 [4.79 (2.01, 11.9)]
- Trend slope: 1.08 (1.03, 1.13)
15-year lag:
- <0.5 (reference): 10 [1]
- 0.5–<1.1: 9 [2.04 (0.77, 5.45)]
- 1.1–<2.1: 8 [1.96 (0.71, 5.43)]
- 2.1–<5.0: 13 [3.17 (1.25, 8.05)]
- ≥5.0: 27 [5.35 (2.23, 12.8)]
- Trend slope: 1.08 (1.03, 1.14)
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Table 3-4.  Exposure-Response Data for Mortality Due to Silicosis and Nonmalignant Respiratory Disease in
 
Workers Exposed to c-Silica
 
Study design and Cohort and Cumulative exposure
 
Reference industry methods (mg/m3-year) Outcome
 





tin) and pottery factories
Location: China
Cohort: Cumulative c-silica dust exposure:
74,040 workers - Control: <0.01
(85.8% males) - Low: 0.01–1.23
employed for at least - Medium: 1.24–4.46















HR (95% CI) for death due to 
nonmalignant respiratory disease (p-value
for positive trend: <0.001):
- Control: 1
- Low: 1.89 (1.60, 2.24)
- Medium: 4.28 (3.74, 4.91)
- High: 6.68 (5.85, 7.61)
HR increase for death due to 
nonmalignant respiratory disease per
1 mg/m3-year increase in cumulative 
c-silica dust exposure: 1.069 (1.064,
1.074)
SMR (95% CI) for death due to 
nonmalignant respiratory disease for the 
period 1970–2003:
- 2.32 (2.24, 2.40)
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Table 3-4.  Exposure-Response Data for Mortality Due to Silicosis and Nonmalignant Respiratory Disease in
 
Workers Exposed to c-Silica
 
Study design and Cohort and Cumulative exposure
 
Reference industry methods (mg/m3-year) Outcome
 
Hedlund et al. 2008 Study design: follow-up 
mortality study
Industry: iron ore mining
Location: Sweden
Cohort: 7,729 miners
employed for at least





birth and attained age
Statistical analysis: 
Poisson regression
Cumulative exposure quintiles for
respirable quartz:





Number of deaths from silicosis: 58







Study authors stated that “cumulative 
respirable quartz exposure of
approximately 3 mg/m3-year and higher is
associated with an increased risk of
mortality due to silicosis.”
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Table 3-4.  Exposure-Response Data for Mortality Due to Silicosis and Nonmalignant Respiratory Disease in
 
Workers Exposed to c-Silica
 
Study design and Cohort and Cumulative exposure
 
Reference industry methods (mg/m3-year) Outcome
 
Hughes et al. 2001	 Study design: nested
case referent study




Cohort: (reported in 
McDonald et al. 2001)
2,670 men; employed
before 1980 for at







Cumulative exposure quartiles for
c-silica:










Deaths from silicosis: 29
Deaths due to silicosis increased with
cumulative exposure.  A statistically
significant positive trend (p=0.03, one-
tailed) was observed mortality lagged for
15 years.
Mortality ORs (95% CI not reported)
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Table 3-4.  Exposure-Response Data for Mortality Due to Silicosis and Nonmalignant Respiratory Disease in
 
Workers Exposed to c-Silica
 
Study design and Cohort and Cumulative exposure
 
Reference industry methods (mg/m3-year) Outcome
 
McDonald et al.	 Study design: historical 
2005	 cohort study with nested 
case-referent analysis




Cohort: 2,452 male Cumulative exposure quartiles for Note: This study is an update of the 
workers employed for c-silica: cohort evaluated in Hughes et al. (2001),
at least 3 years, with For 0-year lag time: with an additional 5-year follow-up period 
≥1 month during - Q1: ≤1.5 and exclusion of workers from one 
1940–1979, with - Q2: 1.5–≤5.0 Canadian plant.
follow-up through - Q3: >5.0–≤9.0
2000 - Q4: >9.0 Deaths from nonmalignant respiratory
Adjustments: case- For 15-year lag time: disease: 116
referent analysis was - Q1: ≤0.7
adjusted for matching - Q2: >0.7–≤1.8 SMR (nonmalignant respiratory disease):
and three categories - Q3: >1.8–≤5.1 164 (p<0.001)
of smoking - Q4: >5.1
Statistical analysis: Deaths from silicosis: 26
SMR: Poisson 
regression model Deaths due to silicosis increased with
Case-referent: cumulative exposure.  A statistically
conditional multiple significant positive trend (p=0.017, one-
logistic regression tailed) was observed mortality lagged for
15 years.
Mortality ORs (95% CI not reported)
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Table 3-4.  Exposure-Response Data for Mortality Due to Silicosis and Nonmalignant Respiratory Disease in
 
Workers Exposed to c-Silica
 
Study design and Cohort and Cumulative exposure
 
Reference industry methods (mg/m3-year) Outcome
 
Park et al. 2002	 Study design: historical 
cohort study
Industry: diatomaceous
earth mining and 
processing
Location: California
Cohort: 2,342 white, Cumulative exposure to c-silica Note: This is the same cohort reported in 
male workers estimated for each worker using Checkoway et al. (1997), but with an 
employed for at least historical exposure data and additional 5-year follow-up period.
12 months during detailed work history files.
1942–1987, with Number of deaths due to LDOC: 67
follow-up through Mean: 2.16
1994 Maximum: 62.52 Rate ratio at mean cumulative exposure:
Adjustments: calendar 4.2 (p<0.0001)
time, age, smoking,
Hispanic ethnicity, Rate ratio at maximum cumulative 
time since first exposure: 18.4
observation
Statistical analysis: Rate ratio at a cumulative exposure of
Poisson regression 1 mg/m3-year: 1.55
model; lifetime risks of
death from lung Excess lifetime risk for white men 
disease other than exposed to 0.05 mg/m3 for 45 years:
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Table 3-4.  Exposure-Response Data for Mortality Due to Silicosis and Nonmalignant Respiratory Disease in
 
Workers Exposed to c-Silica
 
Reference











Cohort: 7,052 men 
employed in the
Vermont granite 
industry from 1947 to 
1998
Cumulative exposure quintiles for
respirable quartz:
- Q1: ≤1.04 (referent)
- Q2: 1.05–3.64
- Q3: 3.65–6.71
Number of deaths due to silicosis: 55










Deaths due to silicosis increased with
cumulative exposure.  A statistically
significant positive trend (p=0.001) was
observed. Mortality ORs (95% CI);
statistical significant relative to Q1:
- Q1: 1
- Q2: 2.02 (0.45, 9.09); p=0.358
- Q3: 8.62 (1.86, 39.95). p=0.006
- Q4: 12.36 (2.67, 57.2); p=0.001
- Q5: 10.55 (2.30, 48.40); p=0.002
CI = confidence interval; HR = hazard ratio; OR = odds ratio; SMR = standardized mortality ratio
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Reference Cohorts	 Methods Outcomes for pooled cohort
Mannetje et	 Six cohorts
al. 2002a	 Checkoway et al. 1997:
- Diatomaceous earth workers: 2,342
- Location: United States
- Deaths due to silicosis: 15
- Mean exposure duration (years): 4.3
- Mean cumulative exposure (mg/m3-year): 1.05
Koskela et al. 1994
- Granite workers: 1,026
- Location: Finland
- Deaths due to silicosis: 14
- Mean exposure duration (years): 9.2
- Mean cumulative exposure (mg/m3-year): 4.63a 
Costello and Graham 1988
- Granite workers: 5,408
- Location: United States
- Deaths due to silicosis: 43
- Mean exposure duration (years): 18.0
- Mean cumulative exposure (mg/m3-year): 0.71a 
Steenland et al. 2001a
- Industrial sand workers: 40,27
- Location: United States
- Deaths due to silicosis: 15
- Mean exposure duration (years): 3.7
- Mean cumulative exposure (mg/m3-year): 0.13a 
Steenland et al. 1995a
- Gold miners: 3,348
- Location: United States
- Deaths due to silicosis: 39
- Mean exposure duration (years): 5.4
- Mean cumulative exposure (mg/m3-year): 0.23a 
Study type: Pooled exposure-
response analysis for mortality




calendar period, original study
cohort
Nested case-control: age, sex,
date of birth, original cohort
study
Literature search dates: not
reported
Statistical analysis: Poisson 
regression for standard life 
table analysis using
10 cumulative exposure 
categories; conditional logistic
regression for nested case-
control analysis
Exposure for pooled cohort: 
- Mean exposure duration 
(years): 10.4
- Mean cumulative exposure 
(mg/m3-year): 0.62
Total number of workers in pooled cohort:
18,364 
Deaths due to silicosis: 150
Deaths due to pneumoconiosis: 20
Age of death (range): 32–91 years
Silicosis mortality: 28.8 per 100,000 person 
years












Adjusted risk ratio (95% CI):
- 0-0.99: 1.00 (referent)
- 0.99–1.97: 3.39 (1.42, 8.08)
- 1.97–2.87: 6.22 (2.56, 15.12)
- 2.87–4.33: 9.40 (3.71, 23.80)
- 4.33–7.12: 13.69 (5.04, 37.18)
- 7.12–9.58: 22.64 (7.88, 65.10)
- 9.58–13.21: 23.97 (8.05, 71.32)
- 13.21–15.89: 40.25 (13.25, 122.3)
- 15.89–28.10: 25.11 (8.09, 77.91)
- >28.10: 63.63 (19.87, 203.8)
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Reference Cohorts	 Methods Outcomes for pooled cohort
de Klerk and Musk 1998
- Gold miners: 2,213
- Location: Australia
- Deaths due to silicosis: 44
- Mean exposure duration (years): 26.8
- Mean cumulative exposure (mg/m3-year): 11.37a 
Risk ratio (95% CI%) for nested case 
control analysis based on:
- Cumulative exposure (mg/m3-year):
1.04 (1.03, 1.06)
- Log transformed cumulative exposure 
(log mg/m3-year): 2.08 (1.71, 2.53)
- Average exposure over working period 
(mg/m3): 2.77 (1.80, 4.26)
-	 Exposure duration (years): 1.04 (1.02,
1.06)
Cumulative risk of death for exposure from
ages 20 to 65 years for concentrations of:
- 0.1 mg/m3 (equivalent to 4.5 mg/m3-
year): 13 per 1,000
- 0.05 mg/m3 (equivalent to 2.25 mg/m3-
year): 6 per 1,000
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Reference Cohorts Methods Outcomes for pooled cohort
Mannetje et Studies (n=29) by location and industry:
al. 2002b - United States, diatomaceous earth workers
(Checkoway et al. 1993, 1996, 1997; Seixas et al.
1997)
- Finland, granite workers (Koskela 1995; Koskela 
et al. 1987a, 1987b, 1994)
- United States, granite workers (Costello and 
Graham 1988; Davis et al. 1983; Eisen et al. 1984;
Theriault et al. 1974)
- United States, industrial sand workers (Steenland 
et al. 2001a)
- China, pottery workers (Chen et al. 1992;
Dosemeci et al. 1993; McLaughlin et al. 1992)
- South Africa, gold miners (Hnizdo and Murray
1998; Hnizdo and Sluis-Cremer 1991, 1993;
Hnizdo et al. 1997; Page-Shipp and Harris 1972;
Reid and Sluis-Cremer 1996)
- United States, gold miners (Brown et al. 1986;
Steenland and Brown 1995a, 1995b; Zumwalde et
al. 1981)
- Australia, gold miners (de Klerk and Musk 1998;
de Klerk et al. 1995; Hewson 1993)
10 occupational cohorts (C) identified from the studies
 
above (number of workers):
 
C1: United States, diatomaceous earth workers (2,342)
 
C2: Finland, granite workers (1,026)
 
C3: United States, granite workers (5,408)
 
C4: United States, industrial sand workers (4,027)
 
C5: China, pottery workers (9,017)
 
C6: China, tin miners (7,858)
 
C7: China, tungsten miners (28, 481)
 
C8: South Africa, gold miners (2,260)
 
C9: United States, gold miners (3,348)
 
Study type: Pooled exposure-
response analysis for mortality
due to silicosis, by location 
and industry
Literature search dates: not
reported













Respirable c-silica (mg/m3; 











Total number of workers: 65,980
 




- Q2: 3.1 (2.5, 4.0)
 
- Q3: 4.6 (3.6, 5.9)
 
- Q4: 4.5 (3.5, 5.8)
 
- Q5: 4.8 (3.7, 6.2)
 
SRRs and p-value for trend for silicosis
























***DRAFT FOR PUBLIC COMMENT***
   
 











     












































Reference Cohorts Methods Outcomes for pooled cohort
C10: Australia, gold miners (2,213) C9: 0.05; 0.24
C10:0.43; 1.55
Cumulative exposure (mg/m3-





















C8: SRRs could not be calculated because 









aExposures were estimated by Mannetje et al. (2002b) (not reported in original publication), based on data provided by the original investigators.
bSRRs cannot be calculated as there were no deaths in the lowest exposure quartile; trend test can be conducted.
CI = confidence interval; OR = odds ratio; SRR = standardized rate ratio
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3. HEALTH EFFECTS
in the Mannetje et al. (2002b) study; however, four cohorts were excluded because of a different
classification of disease for silicosis, which included silicosis, pneumoconiosis, and silicotuberculosis.
The adjusted silicosis mortality rate increased from 4.7 per 100,000 person years for the lowest (non-
referent) exposure category (0–0.99 mg/m3-year) to 299.1 per 100,000 person years for the highest
exposure category (>28 mg/m3-year). The adjusted rate ratio increased with increasing exposure and was 
significantly increased for all exposure categories, ranging from 3.39 to 63.63 in the 0.99–1.97 and 
>28 mg/m3-year categories, respectively.  The study authors estimated risks of death through age 65 for a
45-year exposure to 0.1 and 0.05 mg/m3 to be 13 per 1,000 and 6 per 1,000, respectively. 
Exposure-response data on silicosis mortality reported in the studies discussed above are summarized in
Table 3-6.  Note that effect estimates in Table 3-6 generally are not comparable to each other, as reference
groups differ. At the lowest reported cumulative exposure range of 0.01–1.23 mg/m3-year, risk of death 
due to silicosis in 74,040 metal miners and potters was increased by approximately 90% (hazard ratio 
[HR]: 1.89; 95% CI: 1.60, 2.24) (Chen et al. 2012).  At the next highest cumulative exposure range of
0.5–<1.1 mg/m3-year, eight silicosis-related deaths were reported in 2,342 diatomaceous earth workers,
although the rate ratio (RR: 1.52 [95% CI: 0.55, 4.20]) did not indicate an increase in risk (Checkoway et
al. 1997).  Data summarized in Table 3-6 are from several different silica industries and, therefore, it is 
likely that that differences in study methods, exposure settings, or other external factors may explain risk
differences between and within industries.  However, overall, these data demonstrate that the risk of death
due to silicosis increases with cumulative exposure to respirable c-silica.
In addition to the studies discussed above, numerous studies published since 1987 report significantly
increased standardized mortality ratios (SMRs), mortality odds ratios, or hazard ratios for death due to 
silicosis and associated nonmalignant respiratory diseases, but do not report quantitative cumulative 
exposure estimates or exposure-response data specifically expressed in terms of mg/m3-year (Bang et al. 
2008; Brown et al. 1997; Calvert et al. 2003; Checkoway et al. 1993; Chen et al. 1992; Cherry et al. 2013;
Chiyotani et al. 1990; Costello et al. 1995; Costello and Graham 1988; deKlerk and Musk 1998; deKlerk 
et al. 1995; Goldsmith et al. 1995; Koskela et al. 1987b, 1994; Marinaccio et al. 2006; Mehnert et al.
1995; Ng et al. 1990; Steenland and Brown 1995b; Thomas and Stewart 1987; Tse et al. 2007; Ulm et al. 
2004; Zambon et al. 1987).
Decreased Lung Function in the Absence of Silicosis. Several studies have shown that occupational
exposure to c-silica causes decreases in lung function in workers with no radiographic evidence of
silicosis (Ehrlich et al. 2011; Hertzberg et al. 2002; Malmberg et al. 1993; Meijer et al. 2001; Mohner et
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3. HEALTH EFFECTS
Table 3-6.  Summary of Exposure-Response Data for Death Due to Silicosis for Studies Reporting Risk Ratios,
 
Hazard Ratios, or Odds Ratios
 
Reference Industry Study type
Cumulative exposure 
(mg/m3-year) Outcome
Chen et al. 2012 Metal mining; pottery Retrospective cohort 0.01–1.23 HR: 1.89 (1.60, 2.24)
Checkoway et al. 1997 Diatomaceous earth Historical cohort 0.5–<1.1 (0 lag time) Number of deaths: 8/2,342
RR (95% CI): 1.52 (0.55, 4.20)
Checkoway et al. 1997 Diatomaceous earth Historical cohort 0.5–<1.1 (15-year lag) Number of deaths: 9/2,342
RR (95% CI): 2.04 (0.77, 5.45)
Hughes et al. 2001 Sand plants Nested case referent >0.7–≤1.8 (15-year lag) ORa: 2.54
Mannetje et al. 2002a Diatomaceous earth; granite; Pooled analysis 0.99–1.97 RR (95% CI): 3.39 (1.42, 8.08)
sand; gold mining
Vacek et al. 2011 granite historical cohort study 1.05–3.64 OR: 2.02 (0.45, 9.09); p=0.358
Checkoway et al. 1997 Diatomaceous earth Historical cohort 1.1–<2.1 (0 lag time) Number of deaths: 10/2,342
RR (95% CI): 1.98 (0.75, 5.22)
Checkoway et al. 1997 Diatomaceous earth Historical cohort 1.1–<2.1 (15-year lag) Number of deaths: 8/2,342
RR (95% CI): 1.96 (0.71, 5.43)
Chen et al. 2012 Metal mining Retrospective cohort 1.24–4.46 HR: 4.28 (3.74, 4.91)
Hughes et al. 2001 Sand plants Nested case referent 1.5–≤5.0 (0 lag time) ORa: 1.27
Hughes et al. 2001 Sand plants Nested case referent >1.8–≤5.1 (15-year lag) ORa: 4.55
Mannetje et al. 2002a Diatomaceous earth; granite; Pooled analysis 1.97–2.87 RR (95% CI): 6.22 (2.56, 15.12)
sand; gold mining
Checkoway et al. 1997 Diatomaceous earth Historical cohort 2.1–<5.0 (0 lag time) Number of deaths: 12/2,342
RR (95% CI): 2.34 (0.91, 6.00)
Checkoway et al. 1997 Diatomaceous earth Historical cohort 2.1–<5.0 (15-year lag) Number of deaths: 13/2,342
RR (95% CI): 3.17 (1.25, 8.05)
Park et al. 2002 Diatomaceous earth Historical cohort 2.16 RR: 4.2 (p<0.0001)
Mannetje et al. 2002a Diatomaceous earth; granite; Pooled analysis 2.87–4.33 RR (95% CI): 9.40 (3.71, 23.80)
sand; gold mining
Vacek et al. 2011 granite historical cohort study 3.65–6.71 OR: 8.62 (1.86, 39.95); p=0.006
Mannetje et al. 2002a Diatomaceous earth; granite; Pooled analysis 4.33-7–12 RR (95% CI): 13.69 (5.04, 37.18)
sand; gold mining
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Table 3-6.  Summary of Exposure-Response Data for Death Due to Silicosis for Studies Reporting Risk Ratios,
 
Hazard Ratios, or Odds Ratios
 
Reference Industry Study type
Cumulative exposure 
(mg/m3-year) Outcome
Mannetje et al. 2002b Diatomaceous earth; granite; Pooled analysis 4.45 OR (95% CI): 3.1 (2.5, 4.0)
sand; gold mining; pottery
Chen et al. 2012 Metal mining Retrospective cohort >4.46 HR: 6.68 (5.85, 7.61)
Checkoway et al. 1997 Diatomaceous earth Historical cohort ≥5.0 (0 lag time) Number of deaths: 30/2,342
RR (95% CI): 4.79 (2.01, 11.9)
Checkoway et al. 1997 Diatomaceous earth Historical cohort ≥5.0 (15-year lag) Number of deaths: 27/2,342
RR (95% CI): 5.35 (2.23, 12.8)
Hughes et al. 2001 Sand plants Nested case referent >5.0–≤9.0 (0 lag time) ORa: 2.62
Hughes et al. 2001 Sand plants Nested case referent >5.1 (15-year lag) ORa: 5.16
Vacek et al. 2011 Granite historical cohort study 6.72–10.21 OR: 12.36 (2.67, 57.2); p=0.001
Mannetje et al. 2002a Diatomaceous earth; granite; Pooled analysis 7.12–9.58 RR (95% CI): 22.64 (7.88, 65.10)
sand; gold mining
Hughes et al. 2001 Sand plants Nested case referent >9.0 (0 lag time) ORa: 2.13
Mannetje et al. 2002a Diatomaceous earth; granite; Pooled analysis 9.58–13.21 RR (95% CI): 23.97 (8.05, 71.32)
sand; gold mining
Mannetje et al. 2002b Diatomaceous earth; granite; Pooled analysis 9.08 OR (95% CI): 4.6 (3.6, 5.9)
sand; gold mining; pottery
Vacek et al. 2011 Granite historical cohort study >10.21 OR: 10.55 (2.30, 48.40); p=0.002
Mannetje et al. 2002a Diatomaceous earth; granite; Pooled analysis 13.21–15.89 RR (95% CI): 40.25 (13.25, 122.3)
sand; gold mining
Mannetje et al. 2002a Diatomaceous earth; granite; Pooled analysis 15.89–28.10 RR (95% CI): 25.11 (8.09, 77.91)
sand; gold mining
Mannetje et al. 2002b Diatomaceous earth; granite; Pooled analysis 16.26 OR (95% CI): 4.5 (3.5, 5.8)
sand; gold mining; pottery
Mannetje et al. 2002a Diatomaceous earth; granite; Pooled analysis >28.10 RR (95% CI): 63.63 (19.87, 203.8)
sand; gold mining
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Table 3-6.  Summary of Exposure-Response Data for Death Due to Silicosis for Studies Reporting Risk Ratios,
 
Hazard Ratios, or Odds Ratios
 
Reference Industry Study type
Cumulative exposure 
(mg/m3-year) Outcome
Mannetje et al. 2002b Diatomaceous earth; granite; Pooled analysis 42.33 OR (95% CI): 4.8 (3.7, 6.2)
sand; gold mining; pottery
a95% CI not reported.
 
CI = confidence interval; HR = hazard ratio; OR = odds ratio; RR = risk ratio
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Study design and 
Reference industry Cohort and methods Exposure Outcome













Cohort: 520 male, black
gold miners; 37– 
60 years of age; mean 
years of service 
21.8 (range: 6.3–34.5);











and current (18.3 years)
workers, employed
















- Mean (SD): 8.2 (2.90)
- Median: 7.95
- Range: 0–22.68











For workers without silicosis in this cohort
(based on cumulative dust data), for a 
30-year exposure to a mean respirable
dust concentration of 0.37 mg/m3 
(0.01 mg/m3-year), the loss in FVC would 
be 208 mL (95% CI: 3, 412).
In smokers, but not nonsmokers, percent
predicted values for FVC, FEV1, and 
FEV1/FVC decreased with increasing
exposure.
Smokers
FVC % predicted (SD):
- Q1: 93.47 (11.85)
 
- Q2: 90.54 (15.53)
 
- Q3: 88.83 (13.43)
 
- Q4: 84.36 (18.55)
 
- p-value for trend: 0.0013
 
FEV1 % predicted (SD):
- Q1: 94.97 (14.85)
- Q2: 92.58 (18.75)
- Q3: 93.72 (15.88)
- Q4: 85.24 (22.67)
- p-value for trend: 0.011
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Study design and 
Reference industry Cohort and methods Exposure Outcome
FEV1/FVC % predicted (SD):
- Q1: 77.1 (7.2)
- Q2: 77.7 (8.3)
- Q3: 77.3 (6.4)
- Q4: 70.4 (11)
- p-value for trend: 0.0013
Nonsmokers
FVC % predicted (SD):
- Q1: 96.31 (10.56)
- Q2: 94.1 (10.92)
- Q3: 85.41 (23.06)
- Q4: 89.89 (10.9)
- p-value for trend: 0.1468
FEV1 % predicted (SD):
- Q1: 108.1 (15.15)
- Q2: 100.31 (14.44)
- Q3: 91.44 (22.87)
- Q4: 97.29 (15.47)
- p-value for trend; 0.1037
FEV1/FVC % predicted (SD):
- Q1: 79.6 (4.4)
- Q2: 81.2 (3.9)
- Q3: 76.2 (7.5)
- Q4: 79.2 (4.7)
- p-value for trend: 0.5696
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Study design and 
Reference industry Cohort and methods Exposure Outcome
Malmberg et al.	 Study design: 





Cohort: 45 granite Average respirable Statistically significant differences in lung 

crushers without pleural concentration (mg/m3) 1976– function values (percent predicted 

plaques and 45 age- and 1988: mean±SD) were observed for workers
 
smoking-matched - Dust: 0.83 compared to referents for the FEV1/VC,
 
referents; pulmonary - c-Silica: 0.18 FEF50, and Phase III (slope of alveolar
 
function evaluated in - Percent c-silica in dust: flow). However, differences were very
 
1976 and 1988; mean 23 small and not are not likely to represent a 





22 years FEV1/VC (%):
 
Adjustments: none - Referent: 76.2 (6.55)
 
reported - Worker: 73.0 (9.45)
 
Statistical analysis: - p-value: <0.01
 
Wilcoxon’s signed rank FEF50:
 
test, Mann-Whitney U - Referent: 5.1 (1.52)
 




- Referent: 1.1 (0.63)
- Worker: 1.45 (1.66)
- p-value: <0.0.05
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Study design and 
Reference industry Cohort and methods Exposure Outcome




Cohort: 144 concrete Mean (SD) (mg/ m3-year) 

workers with no cumulative exposure:
 












No statistically significant increases in the 
prevalence of chronic respiratory
symptoms (asthma, cough, phlegm,
wheeze, and dyspnea) in workers
compared to controls.
A statistically significant increase was
observed for work-related upper
respiratory symptoms (WRURS) and 
work-related lower respiratory symptoms
(WRLRS) for workers compared to
controls.
Percent with WRURS (SD):
- Control: 7 (6.4)
 




Percent with WRLRS (SD):
- Control: 4 (3.6)
- Workers: 17 (11.8)
- p=0.02
A statistically significant (p=0.02)
decrease was observed for FEV1/FVC
(%), although the difference was very
small (2.2%) and not likely to be clinically
significant.  No differences were observed 
for FVC, FEV1, or MMEF.
OR (95% CI) for self-reported symptoms
of COPD: 11.1 (2.8, 43.5)
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Study design and 
Reference industry Cohort and methods Exposure Outcome
Mohner et al. Study design: nest Cohort: 1,421 uranium Cumulative exposure groups ORs (95% CI) for incidence of stage I
2013a, 2013b case-control
Industry: uranium mine
miners born between 
1954 and 1956 with no
(EG) for respirable quartz
(mg/m3-year):
COPD (based on spirometry):
- EG1: 1
Location: Germany radiographic evidence of - EG1: <0.1412 (referent) - EG2: 1.83 (1.05, 3.19)
silicosis (mean - EG2: 0.1412–0.2950 - EG3: 2.65 (1.54, 4.58)
employment duration: - EG3: 0.2950–0.5660 - EG4: 2.47 (1.39, 4.38)
12.8 years) - EG4: 0.5560–0.9386 - EG5: 1.78 (0.86, 3.69)




Cumulative exposure to1 mg/m3-year
(respirable quartz) was calculated 
associated with a 2.75% decrease in 
FEV1/FVC (p<0.001) and an increased 
OR for COPD (stage I) of 1.81 (95% CI:
1.27, 2.56).
CI = confidence interval; COPD = chronic obstructive pulmonary disease; FEF50 = forced mid-expiratory flow; FEV1 = forced expiratory volume in 1 second;
FVC = forced vital capacity; MMEF = maximal mid-expiratory flow; OR = odds ratio; SD = standard deviation; VC = vital capacity
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al. 2013a, 2013b); see Table 3-7 for study details.  In general, decrements in lung function are small and,
while statistically significant, are of questionable clinical significance.  Statistically significant trends 
(p≤0.01) were observed for decreased forced vital capacity (FVC), forced expiratory volume in 1 second 
(FEV1), and FEV1/FVC in smokers in an automotive foundry; however, decreases from the lowest
(<0.66 mg/m3-year) to the highest (>5.9 mg/m3-year) exposure groups were small (approximately 9%).
No effects on lung function were observed for nonsmokers in this cohort.  In a cohort of granite industry
workers, a statistically significant decrease in FEV1/VC (vital capacity) was observed in workers 
compared to referents, although the decrease in workers was only 4% (Malmberg et al. 1993).  Similarly, 
in concrete workers, a 2.2% decrease in FEV1/FVC was statistically significant (p=0.02) (Meijer et al.
2001).  Based on results of spirometry testing in a cohort of uranium miners, cumulative exposure to 
1 mg/m3-year was associated with a 2.75% decreased in FEV1/FVC (p<0.001) and an increased risk of
stage I COPD (OR: 1.81; 95% CI: 1.27, 2.56) (Mohner et al. 2013a, 2013b).  Other studies showed
similar small changes in lung function, although exposure data were not reported (Chia et al. 1992; Eisen 
et al. 1995).  
Chronic Obstructive Pulmonary Disease (COPD). The American Thoracic Society defines COPD as a 
progressive lung disease involving the airways and/or pulmonary parenchyma, resulting in airflow
obstruction that is not fully reversible (Qaseem et al. 2011).  It manifests with a wide range of symptoms, 
including dyspnea, poor exercise tolerance, chronic cough with or without sputum production, and 
wheezing to respiratory failure or cor pulmonale (Qaseem et al. 2011).  A diagnosis of COPD includes
respiratory symptoms and airflow obstruction defined as postbronchodilator FEV1:FVC ratio of 
<0.70 (Qaseem et al. 2011).  Chronic obstructive pulmonary disease is associated with an abnormal
inflammatory response to inhaled noxious gases, vapors, fumes, cigarette smoke, and respirable 
particulates, including c-silica (Brüske et al. 2014; Hnizdo and Vallyathan 2003; Qaseem et al. 2011).
Results of several occupational exposure studies show that COPD occurs in the presence and absence of
radiological evidence of silicosis (Begin et al. 1995; Brüske et al. 2014; Cowie et al.1993; Ehrlich et al.
2011; Hertzberg et al. 2002; Hnizdo 1990; Hnizdo and Vallyathan 2003).  A recent meta-analysis of six
studies (Bakke et al. 2004; Hertzberg et al. 2002; Jorna et al. 1994; Malmberg et al. 1993; Meijer et al.
2001; Ulvestad et al. 2001) evaluated the association between occupational exposure to c-silica and
COPD (Brüske et al. 2014).  Statistically significant decreases in the mean difference of FEV1 % 
predicted (-4.62; 95% CI: -7.17, -2.06) and the standard mean difference in FEV1 (-0.27; 95% CI: -0.40, 
-0.14) were observed in workers exposed to c-silica dust compared to workers with “no/low” exposure.
The standard mean difference of the FEV1:FVC ratio also was significantly decreased in exposed workers 
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compared to “no/low” exposure workers (-0.41; 95% CI: -0.54, -0.28).  Results of this meta-analysis are 
consistent with COPD.  However, it remains unclear if inhalation of c-silica causes pathological changes 
in the lungs that lead to the development of COPD or if COPD represents changes that lead to the
development of silicosis (Hnizdo and Vallyathan 2003). 
Lung Cancer. The association between occupational exposure to respirable c-silica and lung cancer is 
reviewed in Section 3.2.1.7.
Amorphous Silica. Human data are insufficient to determine whether or not a-silica causes lung disease 
in humans.  Silicosis has not been observed in epidemiological studies in workers with long-term 
exposure to a-silica with no known exposure to c-silica (Choudat et al. 1990; Plunkett and Dewitt 1962;
Volk 1960; Wilson et al. 1979).  However, a German case-series study reported silicosis in 4/28 workers
exposed to a-silica that was not contaminated by quartz, although contamination by small amounts of
cristobalite could not be ruled out (reviewed by Merget et al. 2002).  Similarly, Vitums et al. (1977)
reported pulmonary fibrosis in 11/40 workers exposed to a-silica dust, characterized by reticular and/or
nodular abnormalities in chest radiographs.  Numerous occupational studies in the 1930s–1980s reported
an increased incidence of pneumoconiosis in diatomaceous earth workers exposed to a-silica; however,
the majority of reports indicated that it was exposure to calcined diatomite (which also contains c-silica),
rather than raw diatomite, that was associated with pneumoconiosis (Beskow 1978; Caldwell 1958;
Cooper and Jacobson 1977; Cooper and Sargent 1984; Dutra 1965; Legge and Rosencrantz 1932; Smart
and Anderson 1952; Vigliani and Mottura 1948).  No evidence of pneumoconiosis was observed in potato 
workers exposed to inorganic dusts with high levels of diatomaceous earth and crystalline quartz (~10%)
(Jorna et al. 1994).
Reduced pulmonary function has been reported in cross-sectional studies of workers exposed to a-silica; 
however, exposures to c-silica as well as other inorganic dusts were often present.  Evidence for a
potential link between a-silica and impaired lung function includes statistically significant (p<0.05)
reduced forced expiratory flow volume in factory workers exposed to a-silica dust (Choudat et al. 1990), 
reduced FVC in grape workers exposed to mixed silica-dust (Gamsky et al. 1992), and reduced forced 
expiratory flow volume in potato workers exposed to inorganic dusts with high levels of diatomaceous
earth and crystalline quartz (~10%) (Jorna et al. 1994).  However, neither pulmonary function nor
subjective complaints of respiratory symptoms were correlated with a calculated cumulative exposure 
index in a cohort of 165 workers exposed to a-silica for 1–35 years (Wilson et al. 1979, 1981).  Similarly, 
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lung function was not impaired in three a-silica workers diagnosed with pulmonary fibrosis (Vitums et al. 
1977).
As reviewed below, available data from animal studies indicate that inhalation exposure to a-silica
induces pulmonary toxicity, including pulmonary inflammation, granuloma formation, increased cellular
infiltrates, and reduced lung function.  Pulmonary effects observed following exposure to a-silica are 
generally reversible and no progressive fibrosis is observed, in contrast to pulmonary effects of c-silica.  
Results of acute animal studies also indicate that different polymorphs of a-silica have different
toxicological potencies, with precipitated and pyrogenic a-silica showing greater toxicity than a-silica gel
and colloidal a-silica following acute exposure (Arts et al. 2007; Warheit et al. 1995).  However,
numerous polymorphs of a-silica exist, each with different surface chemistry properties and, therefore, 
different biological potencies (see Section 3.5.2 for additional details).  In addition, as discussed in
Section 4.2, even for the same polymorph, surface chemistry and, thereby, toxicological potency can vary
based on production method and degree of hydration.  
Acute inhalation studies indicate that exposure to various a-silica polymorphs leads to inflammatory
responses in the rat lung; however, the concentrations at which these effects occur can differ between
polymorphs.  Elevated biomarkers of cytotoxicity and inflammation in bronchoalveolar lavage fluid, 
increased lung and tracheobronchial lymph node weights, and mild histopathological changes 
(accumulation of alveolar macrophages, bronchial/bronchiolar hypertrophy, and/or intra-alveolar
granulocytic infiltrates) were observed in Wistar rats following exposure to precipitated or pyrogenic
silica at ≥5 mg/m3 for 5 days (6 hours/day), but effects were only observed following a 5-day exposure to 
silica gel at 25 mg/m3 (Arts et al. 2007).  Additionally, minor histopathological lesions (hyperemia and/or
macrophage aggregates) persisted after recovery periods of 1–3 months following exposure to 
precipitated or pyrogenic silica, but not silica gel (Arts et al. 2007).  These data indicate that silica gel is 
less potent than precipitated or pyrogenic silica under the same test conditions.  More serious respiratory
effects were observed in Wistar rats exposed to fumed hydrophilic silica at 17 mg/m3, fumed hydrophobic
silica at 31 mg/m3, or precipitated hydrophobic silica at 46 mg/m3 for 2 weeks (6 hours/day, 
5 days/week), including respiratory distress, inflammation, pneumonia, granuloma, edema, increased
cellularity, and/or increased lung weight (Reuzel et al. 1991).  However, relative potency of the different
polymorphs cannot be determined from this study, as respiratory effects were observed at the lowest
tested concentration for each polymorph; the rationale for different concentration selection was not
provided (Reuzel et al. 1991).  In Crl:CD BR rats, exposure to colloidal silica for 2 weeks (6 hours/day, 
5 days/week) at concentrations ≥50.5 mg/m3, but not 10.1 mg/m3, led to significantly elevated biomarkers 
***DRAFT FOR PUBLIC COMMENT***
   
 








    
    
 
     
        
      
      
    
      
     
  
      
   
    
    
   
   
   
    
   






    
    
     
     
    
     
     
SILICA 89
3. HEALTH EFFECTS
of inflammation in bronchoalveolar lavage fluid; however, these changes were observed following only 3 
days of exposure to precipitated silica at ≥10 mg/m3 (6 hours/day), suggesting that precipitated silica is
more potent than colloidal silica (Warheit et al. 1991, 1995).
Intermediate-duration inhalation studies also reported that exposure to precipitated, fumed, or colloidal 
a-silica for 4 or 13 weeks (6 hours/day, 5 days/week) leads to inflammatory responses in the rat lung; 
however, available studies have limited information regarding direct comparison of potency across
different polymorphs. In 4-week studies, colloidal a-silica led to elevated biomarkers of inflammation in
bronchoalveolar lavage fluid, inflammation, and hyperplasia in Crl:DC BR rats at ≥50 mg/m3, but not at
10 mg/m3 (Lee and Kelly 1992; Warheit et al. 1991, 1995).  In a 13-week study in Wistar rats, Reuzel et
al. (1991) reported serious respiratory effects at the lowest tested concentrations for each polymorph 
tested (fumed hydrophilic silica at ≥1 mg/m3, fumed hydrophobic silica at 30 mg/m3, and precipitated 
hydrophobic silica at 30 mg/m3).  Observed effects for all polymorphs included increased lung weight and
histopathological changes including increased cellularity, inflammation, accumulation/aggregation of
alveolar macrophages (granulomas), and increased collagen content; however, focal interstitial fibrosis
was only observed following exposure to fumed hydrophilic silica (Reuzel et al. 1991).  Focal interstitial
fibrosis changes and increased collagen content persisted, but not did progress, up to 1 year following
exposure to fumed hydrophilic silica at concentrations ≥6 mg/m3; for other polymorphs, increased 
cellularity, leukocytic infiltration, alveolar macrophage accumulation, and increased collagen content
persisted for 13–39 weeks, but recovered by 1 year (Reuzel et al. 1991). Lung inflammation, proliferative
responses, and alveolar septal fibrosis were also observed in F344 rats exposed to fumed hydrophilic
silica for 13 weeks (6 hours/day, 5 days/week) at 50.4 mg/m3 (the only concentration tested); these 
findings decreased during the 8-month recovery period (Johnston et al. 2000).
Chronic-duration studies also show adverse respiratory effects of a-silica; however, both available studies
only utilized a single exposure concentration (precluding a dose-response analysis). Early nodular
pulmonary fibrosis, characterized by macrophage and mononuclear cell aggregates and reduced lung
function were observed in monkeys exposed to a-silica (fume, precipitated, or gel) at 15 mg/m3 for 
6 hours/day, 5 days/week for up to 18 months; respirable concentrations were reported as 9.9 mg/m3 for 
a-silica fume, 6.9 mg/m3 for precipitated a-silica, and 9.4 mg/m3 for a-silica gel (Groth et al. 1981).  
Collagen fibers were observed in cell aggregates in lungs from monkeys exposed to a-silica fume, but
total lung collagen content was not elevated; no treatment-related changes in lung collagen were observed
in monkeys exposed to precipitated a-silica or a-silica gel. Pathological changes in the lungs were not
observed in rats or guinea pigs similarly exposed for up to 12 months, compared with controls (Groth et
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al. 1981).  Another chronic study reported increased lung weights and accumulation of macrophages in 
alveoli, bronchioles, and lymphoid tissue in rats, guinea pigs, and rabbits exposed to precipitated a-silica
at 126 mg/m3 for 8 hours/day, 7 days/week for 12–24 months; however, no epithelization or fibrosis were
observed (Schepers 1981).  Near-complete reversal of adverse effects was observed during a recovery
period of 3–9 months. 
Renal Effects.
Crystalline Silica.
Renal Effects Associated with Crystalline Silica Exposure. General information on renal effects 
associated with exposure to c-silica was taken from the following publications: Beckett et al. (1997); 
Ghahramani (2010); Goldsmith and Goldsmith (1993); Gomez-Puerta et al. (2013); IARC (1997); NIOSH 
(2002); Steenland (2005); and Steenland et al. (2002a).
“Silicon nephropathy” was first described in the mid-1970s in c-silica-exposed workers with overt
silicosis, and was characterized by a wide-spectrum of renal pathologies, including acute and chronic
renal nephritis/nephrosis, end-stage renal failure, and glomerulonephritis.  During the 1980s, renal
damage associated with autoimmune disease was described in c-silica-exposed workers in the absence of
silicosis (e.g., ANCA-associated vasculitis; see Section 3.2.1.3 Immunological and Lymphoreticular
Effects for more details).  Based on these findings, there appears to be two types of c-silica-induced renal
disease: (1) caused by direct toxic effect of excessive c-silica accumulation in the kidney, and (2) caused
by indirect toxic effects secondary to autoimmune disease (see Section 3.5.2 Mechanisms of Toxicity for
more details).
Subsequent to initial case reports of renal disease in c-silica-exposed workers, associations between
exposure to c-silica and risk of renal disease have been examined in retrospective and cross-sectional
studies (Birk et al. 2009; Boujemaa et al. 1994; Calvert et al. 1997, 2003; Cocco et al. 1994; El-Safty et
al. 2003; Fenwick and Main 2000; Hotz et al. 1995; Ibrahim et al. 2011; Koskela et al. 1987b; McDonald
et al. 2001, 2005; Millerick-May et al. 2015; Ng et al. 1992, 1993; Rapiti et al. 1999; Rosenman et al. 
2000; Steenland and Brown 1995b; Steenland et al. 1990, 1992, 2001b, 2002a, 2002b; Vupputuri et al.
2012; Wyndham et al. 1986). In general, these studies have found increased risk of kidney disease and/or
subclinical signs of renal dysfunction in workers exposed to c-silica, and a limited number of studies have 
found increasing risk in association with increasing cumulative exposure to c-silica.  Most of these studies 
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have estimated risk in terms of incidence or mortality in the cohort in comparison life table analysis of
data from regional or national reference populations. Most studies did not evaluate the potential
contribution of other work-related factors to renal disease, including exposure to other nephrotoxicants
(e.g., metals), complications from lung disease or silicosis, or differential prevalence of other risk factors
(e.g., diabetes, cardiovascular disease, smoking, etc.).
Renal Disease: Incidence and Exposure-Response Data. Studies examining the exposure-relationship
between c-silica and incidence of renal disease are summarized in Table 3-8 (Calvert et al. 1997; Rapiti et 
al. 1999; Steenland et al. 2001b).  Calvert et al. (1997) evaluated the exposure-response relationship for
renal disease in male gold miners exposed to mean cumulative c-silica dust levels of 0.39 mg/m3-year.  
The overall incidence of end-stage renal disease in this study population was 0.46% (11/2,412 workers).  
The standardized incidence ratio (SIR) for nonsystemic end-stage renal disease (end-stage renal disease 
associated with glomerulonephritis or interstitial nephritis) was 4.22 (95% CI: 1.54, 9.18), suggesting a
4-fold greater risk for gold miners compared to the U.S. population. The SIR for all end-stage renal
disease was 1.37 (95% CI: 0.68, 2.46).  When stratified by exposure duration, the risk of nonsystemic
end-stage renal disease was markedly increased (SIR: 7.70; 95% CI: 1.59, 22.48) for workers exposed for
<10 years.  When stratified by cumulative exposure, the risk of nonsystemic end-stage renal disease was 
increased for cumulative exposures in the 0.22–<0.55 mg/m3-year tertile (SIR: 11.05; 95% CI: 3.01, 
28.03), but not for higher (≥0.55 mg/m3-year) cumulative exposures. The SIR for all end-stage renal
disease was 1.37 (95% CI: 0.68, 2.46).  In a population of male ceramic workers, the incidence of end-
stage renal disease was 0.21%, with a 3.12-fold (95% CI: 1.17, 6.98) elevated increased risk over the full
cumulative exposure range of 0.2–3.8 mg/m3-year (Rapiti et al. 1999).  However, exposure duration was
not consistently associated with increased risk of renal disease. The SIR for end-stage renal disease was 
increased in a population of industrial sand workers (SIR: 1.97; 95% CI: 1.25, 2.96); however, no trend 
was observed with increasing exposure (Steenland et al. 2001b).
The remaining exposure-response data for renal disease come from the review of death certificates that
list the presence of renal disease at death, whether or not it was the underlying cause of death (see 
discussion below, “Renal Disease Mortality: Exposure-Response Data”).
Results of a pooled-analysis of three cohorts provide stronger evidence for the increased risk of renal
disease in workers exposed to c-silica. Steenland et al. (2002a) analyzed mortality findings from three
cohorts in a pooled-cohort analysis of industrial sand workers (Steenland et al. 2001b), gold miners
(Steenland and Brown 1995b), and granite workers (Costello and Graham 1988) (Table 3-9).  Based on 
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Table 3-8.  Renal Disease Morbidity in Workers Exposed to Respirable c-Silica
Study design and 
Reference industry Cohort and methods Cumulative exposure Outcome




Cohort: 2,412 male miners
employed for at least 1 year
Mean cumulative c-silica
dust exposure (mg/m3-
The SIR for all cases of end-stage renal disease 
was not increased; however, the SIR for
study between 1940 and 1965, year): 0.39 nonsystemic cases (caused by glomerulo-








- Number of cases: 11
Dakota, United analysis c-silica dust: - SIR (95% CI): 1.37 (0.68, 2.46)
States Statistical analysis: SIR with - T1: <0.22 Nonsystemic cases
U.S. population as the - T2: 0.22–<0.55 - Number of cases: 6
reference.  Life-table - T3: ≥0.55 - SIR (95% CI): 4.22 (1.54, 9.18)
analysis, which accounts for - SIR (95% CI) [number of cases] by exposure
age, race, sex, and time Exposure duration tertiles tertile:
and calendar intervals for (years): T1: 1.27 (0.03, 7.08) [1]
the U.S. population - T1: <5 T2: 11.05 (3.01, 28.30) [4]
- T2: 5–9.9 T3: 3.68 (0.09, 20.52) [1]
- T3: ≥10 - SIR (95% CI) [number of cases] by duration 
tertile:
T1: 2.59 (0.31, 9.36) [2]
T2: 3.86 (0.10, 21.50) [1]
T3: 7.70 (1.59, 22.48) [3]
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Table 3-8.  Renal Disease Morbidity in Workers Exposed to Respirable c-Silica
Study design and 
Reference industry Cohort and methods Cumulative exposure Outcome







Cohort: 2,820 male ceramic
workers followed from 1974
to 1991 in a health 




Statistical analysis: SIR with
regional disease registry
data as the reference.  Life-
table analysis, which
accounts for age, race, sex,
and time and calendar
intervals for the U.S.
population
Range of cumulative c-silica The SIR for incidence of end-stage renal disease 

dust exposure in end-stage was elevated.
 
renal cases (mg/m3-year): - Number of cases: 6
 
0.2–3.8 - SIR (95% CI): 3.21 (1.17, 6.98)
 
- SIR (95% CI) [number of cases] by latency
since first exposure:
<10 years: 25.0 (0.65, 139) [1]
10–19 years: 4.65 (1.26, 11.9) [4]
20–29 years: N/A [0]
≥30 years: 2.85 (0.07, 15.9) [1]
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Table 3-8.  Renal Disease Morbidity in Workers Exposed to Respirable c-Silica
Study design and 
Reference industry Cohort and methods Cumulative exposure Outcome





employed in 18 plants for at
least 1 week from 1940s to 
to respirable c-silica
(mg/m3-year): 0.13a 
was increased, but did not show an exposure-
related trend over exposure quartiles.
Industry: industrial 1980s and lived past 1960, - Number of cases: 23




adequate work histories to 
quartiles for respirable 
c-silica (mg/m3-year):
1.97 (1.25, 2.96)
- SRR by quartile (number of cases)
estimate exposure Q1: <0.10 (referent) Q1: 1.00 (2) (referent)
Adjustments: age, race, Q2: 0.10–<0.51 Q2: 3.09 (5)
sex, calendar time Q3: 0.51–<1.28 Q3: 5.22 (6)
Statistical analysis: SMR
with U.S. population as the
Q4: ≥1.28 Q4: 7.79 (5)
- Slope [change in rate per 1 mg/m3-year
reference; standard life- increase (95% CI)]: 0.00043 (0.00027,
table analysis 0.00062)
The SIR (95% CI) for glomerular disease was
increased:
- Number of cases: 7
- SIR: 3.85 (1.55, 7.93)
Comparative lifetime risks (age 75) for end-stage 
kidney disease incidence after 45 years of
exposure:
- 0.1 mg/m3 exposure: 5.1% (95% CI: 3.3, 7.3)
- 0.01 mg/m3 exposure: 0.5% (95% CI: 0.3, 0.8)
- Background risk: 2%
aExposures were estimated by Mannetje et al. (2002a, 2002b) (not reported in original publication) for Steenland and Sanderson (2001), using the same cohort of
industrial sand workers as Steenland et al. (2001b).  Estimates were based on job-exposure matrices data provided by the original investigators.
CI = confidence interval; N/A = not applicable; SIR = standardized incidence ratio; SMR = standardized mortality ratio; SRR = standardized rate 
ratio
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Table 3-9.  Exposure-Response Analysis for Renal Disease Mortality in a Pooled Cohort of 13,382 Workers
Cohorts	 Methods Outcomes for pooled cohort
Pooled cohort: 
- 13,382 workers exposed to c-silica from 3 cohorts (12,783 with
exposure data)
- Total deaths with renal disease listed as underlying cause:
51 (50 deaths with exposure data)
- Total deaths with renal disease listed as underlying or contributory
cause: 204 (193 deaths with exposure data)
- Mean exposure duration (years): 13.6a 
- Mean cumulative exposure (mg/m3-year): 1.2a 
Three cohorts:
Steenland et al. 2001b
- Industrial sand workers: 4,027
- Location: United States
- Deaths due to renal disease (underlying cause): 13
- Deaths due to multiple causes (renal disease listed on death 
certificate): 52
- Mean exposure duration (years): 3.7b 
- Mean cumulative exposure (mg/m3-year): 0.13b 
Steenland and Brown 1995b
- Gold miners: 3,328
- Location: United States
- Deaths due to renal disease (underlying cause): 13
- Deaths due to multiple causes (renal disease listed on death 
certificate): 42
- Mean exposure duration (years): 5.4c 
- Mean cumulative exposure (mg/m3-year): 0.23c 
Costello and Graham 1988
- Granite workers: 5,408
- Location: United States
- Deaths due to renal disease: Not reported by study authors;
determined by Steenland et al. (2002a) via review of death 
Cause of death: renal
disease (acute and chronic
glomerulonephritis, nephrotic
syndrome, acute and chronic
renal failure, renal sclerosis,
and nephritis/nephropathy)
Cumulative exposure 






Adjustments: age, race, sex,
calendar time
Statistical analysis: SMR
with U.S. population as the
reference; conventional life 
table analyses
The SMR for renal disease as the 
underlying cause for death was
significantly increased in an exposure-
related manner:
- Number of deaths: 50
- SMR for whole cohort (95% CI): 
1.41 (1.05, 1.85)





p-value for trend = 0.0007
Deaths due to renal disease increased 
with increasing cumulative exposure.
OR (95% CI) by quartile of cumulative:
- Q1: 1.00
- Q2: 1.88 (0.62, 5.70)
- Q3: 1.96 (0.66, 5.84)
- Q4: 3.93 (1.31, 11.76)
p-value (linear) = 0.21
p-value (log) = 0.03
The SMR for presence of renal disease at
death was significantly elevated in an 
exposure-related manner:
- Number of cases present at death: 193
- SMR for whole cohort (95% CI):
1.28 (1.10, 1.47).
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Table 3-9.  Exposure-Response Analysis for Renal Disease Mortality in a Pooled Cohort of 13,382 Workers
Cohorts Methods Outcomes for pooled cohort
certificates (calculated number not reported)
- Mean exposure duration (years): 18.0d 
- Mean cumulative exposure (mg/m3-year): 0.71d 
Q4: 1.60 (62)
p-value for trend <0.000001
The presence of renal disease at death 
increased with increasing cumulative 




- Q2: 1.24 (0.77, 2.01)
 
- Q3: 1.77 (1.10, 2.85)
 
- Q4: 2.86 (1.73, 4.72)
 
p-value (linear) = 0.004
 
p-value (log) = 0.0002
 
Comparative lifetime risks at age 

75 (95% CI) for end-stage kidney disease 

incidence after 45 years of exposure:
 
- 0.1 mg/m3 exposure: 1.8% (0.8, 9.7%)
 
- 0.01 mg/m3 exposure: 0.8% (0.1, 3.4)
 
- Background risk: 0.3%
 
aMean exposure durations and cumulative exposures were estimated by Steenland et al. (2002a) (not reported in original publication), based on job-exposure
 
matrices data provided by the original investigators for each cohort.  Estimated values for each cohort were not reported by Steenland et al. (2002a).
 
bExposure estimates reported here were calculated by Mannetje et al. (2002a, 2002b) for Steenland and Sanderson (2001), using the same cohort of industrial
 
sand workers as Steenland et al. (2001b).

cExposure estimates reported here were calculated by Mannetje et al. (2002a, 2002b) for Steenland and Brown (1995a, 1995b).

dExposure estimates reported here were calculated by Mannetje et al. (2002a, 2002b) for Costello and Graham (1988).
 
CI = confidence interval; OR = odds ratio; SMR = standardized mortality ratio 

Sources: Steenland et al. (2002a); Steenland (2005)
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SMRs for the entire cohort (exposure range: 0.15–≥1.67 mg/m3-year), excess mortality due to renal
disease was observed (SMR: 1.41; 95% CI: 1.05, 1.47), with a monotonic increase over exposure
quartiles (linear trend test; p=0.0007).  Based on ORs, an increased risk for renal disease as the
underlying cause of death was observed in the highest quartile of ≥1.67 mg/m3-year (OR: 3.93; 95% CI:
1.31, 11.76), but not in quartiles <1.67 mg/m3-year.  Although the log-trend value across quartiles for
renal disease as the underlining cause of death was statistically significant (p=0.03), the p-value for linear
trend was not significant (p=0.21). For the presence of renal disease at death (multiple cause), a positive 
linear trend was observed for SMRs across the exposure range (linear trend test; p<0.000001).  Based on
ORs across quartiles, the presence of renal disease at death was increased in the 0.55–<1.67 mg/m3-year
quartile (OR: 1.77; 95% CI: 1.10, 2.86) and the ≥1.67 mg/m3-year quartile (OR: 2.86; 95% CI: 1.73, 
4.72); positive trends were observed by both linear (p=0.004) and log (p=0.0002) trend analyses.  Results 
of this study suggest that exposure to c-silica is associated with increased risk of death from renal disease.
Based on the pooled data, comparative lifetime risks (age 75) for death from chronic end-stage renal
disease after 45 years of exposure were estimated to be 0.8% (95% CI: 0.1, 3.4%) at 0.01 mg/m3 and 
1.8% (95% CI: 0.8, 9.7%) at 0.1 mg/m3 (background risk: 0.3%) (Steenland 2005; Steenland et al. 2002a).  
In addition to the studies discussed above, other studies reported statistically significant increased
incidence, SIRs, or ORs for renal disease in c-silica-exposed workers, but did not report quantitative
cumulative exposure estimates or exposure-response data (Fenwick and Main 2000; Steenland et al. 1990, 
1992; Vupputuri et al. 2012).  However, SIRs were not statistically significant for increased end-stage 
renal disease in a cohort of individuals diagnosed with silicosis from a silicosis registry (Steenland et al. 
2002b) or for chronic pyelonephritis in a cohort of male granite workers (Koskela et al. 1987b). 
Impaired Renal Function. Several cross-sectional studies provide evidence that occupational exposure to
c-silica can lead to subclinical signs of renal dysfunction; however, exposure levels were not reported in 
these studies (Boujemaa et al. 1994; El-Safty et al. 2003; Hotz et al.1995; Ibrahim et al. 2011; Millerick-
May et al. 2015; Ng et al. 1992, 1993; Rosenman et al. 2000). Statistically significant (p<0.05)
alterations observed in exposed workers from various industries (e.g., granite quarry workers, ceramic 
and glass workers, and miners), compared with unexposed or low-exposed referents, include increased
urinary excretion of albumin, transferrin, α-1-microglobulin (AMG), and retinol-binding protein, elevated 
serum creatinine levels, and/or altered urinary β-N-acetyl-glucosaminidase (NAG) activity (Boujemaa et
al. 1994; El-Safty et al. 2003; Hotz et al. 1995; Ibrahim et al. 2011; Ng et al. 1992, 1993; Rosenman et al. 
2000).  These effects have been observed in exposed workers with silicosis (Boujemaa et al. 1994; El-
Safty et al. 2003; Ng et al. 1992; Rosenman et al. 2000) as well as in workers without silicosis (El-Safty
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et al. 2003; Hotz et al. 1995; Ibrahim et al. 2011; Ng et al. 1992;).  However, two studies reported a lack
of correlation between severity of silicosis and the measures of renal function listed above (Boujemaa et
al. 1994; Rosenman et al. 2000).  Results of these studies suggest that renal damage may occur prior to,
and independently of, the development of silicosis.
Renal Disease Mortality: Exposure-Response Data. Several studies have evaluated risk of death from
renal disease in c-silica-exposed workers; see study details in Table 3-10 (McDonald et al. 2005;
Steenland and Brown 1995b; Steenland et al. 2001b). Steenland et al. (2001b) reported a 2.22-fold (95%
CI: 1.06, 4.08) increase in the number of deaths from chronic kidney disease in industrial sand workers
exposed to a mean cumulative exposure of 0.13 mg/m3-year (exposure levels estimated by Mannetje et al.
2002b).  A positive trend was observed for acute renal disease (slope [change in disease rate per 1 mg/m3-
year increase in exposure]: 0.00007; 95% CI: 0.00003, 0.00012), but not chronic renal disease. The risk
of death from acute kidney disease was not elevated in this cohort (Steenland et al. 2001b).  Similarly, a
study of industrial sand workers reported a significant 2.8-fold increase (p<0.001) in deaths due to 
nephritis/nephrosis (McDonald et al. 2005).  In gold miners exposed to a mean cumulative exposure of
11.37 mg/m3-year, there was no significant increase in the SMR for death due to either acute or chronic 
kidney disease; however, the SMRs for death due to chronic renal disease showed statistically significant
(p≤0.05) associations with increased cumulative dust exposure (Steenland and Brown 1995b; exposure
levels estimated by Mannetje et al. 2002b).  Findings from these studies are not consistent and are 
difficult to compare due to different study designs, follow-up periods, and categorization of renal disease
at death. Several other studies without quantitative exposure data have evaluated SMRs due to
nonmalignant renal diseases.  Increased SMRs and/or mortality odds ratios were reported in industrial 
sand workers, and gold, lead, and zinc miners (Cocco et al. 1994; McDonald et al. 2001; Wyndham et al. 
1986).  However, SMRs were not increased in pottery workers (Birk et al. 2009), granite cutters
(Steenland et al. 1992), or workers from various industries categorized as having high or very-high 
c-silica exposure (Calvert et al. 2003).
Steenland et al. (2002a) evaluated mortality due to renal disease in a pooled analysis of 13,382 workers
from three cohorts of industrial sand workers (Steenland et al. 2001b), gold miners (Steenland and Brown 
1995b), and granite workers (Costello and Graham 1988); study details are summarized in Table 3-9.  
SMRs were estimated based on life table analysis of data from the U.S. population.  For the entire cohort
(exposure range: 0.15–≥1.67 mg/m3-year), increased risks were observed for renal disease as the 
underlying cause of death (SMR: 1.41; 95% CI: 1.05, 1.85).  Examined by exposure quartiles, the risk of
death due to renal disease was increased in the highest exposure quartile (≥1.67 mg/m3-year; OR: 3.93;
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Table 3-10.  Renal Disease Mortality in Workers Exposed to Respirable c-Silica
Study design and 





Cohort: 2,452 male workers
employed in eight plants for
Cumulative exposure 
(mg/m3-year) for respirable
The SMR for all deaths due to nephritis/ 
nephrosis showed a statistically significant
study with nested at least 3 years, working for c-silica: increase:
case-referent ≥1 month during 1940– - ≤1 (referent) - Number of deaths: 18
analysis 1979, with follow-up through - 1–≤1.5 - SMR: 2.8 (p<0.001)
Industry: industrial 2000 - 1.5–≤ 5
sand workers Cases: 18 individuals that - >5 Deaths due to nephritis/nephrosis did not show
Location: United died from renal disease statistically significant increases with cumulative 
States (five states)a Referents: two referents exposure. Adjusted ORs (lagged by 0 and 
were identified for each 15 years to accommodate disease latency):
case from cohort members 0-year lag
employed at the same - ≤ 1 (referent): 1.00
plant, born within 5 years - >1–≤1.5: 0.61
(3 years if possible) of the - >1.5–≤5: 0.16
case, first hired within - >5: 0.16
5 years (3 years if possible) 15-year lag
of the case, and who - ≤0.3 (referent): 1.00
survived the case - >0.3–≤1.2: 0.79
Adjustments: case-referent - >1.2–≤4: 0.19




(SMR); conditional multiple 
logistic regression (case-
referent)
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Table 3-10.  Renal Disease Mortality in Workers Exposed to Respirable c-Silica
Study design and 







employed for at least 1 year




The SMRs for kidney disease were not elevated.
Acute kidney disease:
- Number of deaths: 2
Industry: gold with follow-up until 1990 - SMR (95% CI): 1.19 (0.14, 4.29)
miners (mean exposure duration: Chronic kidney disease:
Location: South 9 years) - Number of deaths: 11
Dakota, United Adjustments: see statistical - SMR (95% CI): 1.25 (0.62, 2.23)
States analysis
Statistical analysis: life-table The SMRs for chronic renal disease showed 
analysis (which accounts for statistically significant increases with increased 
age, race, sex, and time cumulative dust exposure (dust-days)c:
and calendar intervals for - <8,000: 0.40
the U.S. population) with χ2 - 8,000–<32,000: 0.34
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Table 3-10.  Renal Disease Mortality in Workers Exposed to Respirable c-Silica
Study design and 
Reference industry Cohort and methods Exposure Outcome
Steenland et al. Study design: Cohort: 4,626 workers Mean cumulative exposure The SMRs for chronic, but not acute, kidney
2001b historical cohort
study 
employed in 18 plants for at





Industry: industrial 1980s and lived past 1960, - Number of deaths: 3
sand workers with follow-up through 1996; Cumulative exposure - SMR (95% CI): 3.37 (0.70, 9.86)
Location: United 
States (11 states)
4,027 with adequate work
histories to estimate 
quartiles for respirable 
c-silica (mg/m3-year):
- A positive trend over exposure quartiles:
Slope [change in rate per 1 mg/m3-year
exposure Q1: <0.10 (referent) increase (95% CI)]: 0.00007 (0.00003,
Adjustments: age, race, Q2: 0.10–<0.51 0.00012)
sex, calendar time Q3: 0.51–<1.28
Statistical analysis: Q4: ≥1.28 Chronic kidney disease:
standard life-table analysis - Number of deaths: 10
- SMR (95% CI): 2.22 (1.06, 4.08)
- No trend over exposure quartiles: slope 
[change in rate per 1 mg/m3-year increase 
(95% CI)]: 0.00043 (0.00027, 0.00062)
aStates were identified in the companion study (McDonald et al. 2001).

bExposures were estimated by Mannetje et al. (2002a, 2002b) (not reported in original publication), based on data provided by the original investigators.
 
cOne dust-day is 1 day with an exposure of 1 mmpcf dust; 10 mmpcf of respirable dust = 0.1 mg c-silica/m3.
 
dExposures were not reported in the original publication; however, they were estimated by Mannetje et al. (2002a, 2002b) for Steenland and Sanderson (2001),
 




CI = confidence interval; mppcf = millions of particles per cubic foot of air; OR = odds ratio; SMR = standardized mortality ratio
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95% CI: 1.31, 11.76).  Over all exposure quartiles, a positive exposure trend was observed for renal
disease as the underlying cause of death (p=0.0007).
Amorphous Silica. No studies evaluating renal effects in humans following inhalation exposure to 
a-silica were identified.
No treatment-related changes in kidney clinical chemistry were observed in rats exposed to colloidal 
a-silica at concentrations up to 150 mg/m3 for 6 hours/day, 5 days/week for 4 weeks (Lee and Kelly
1992). No treatment-related changes in kidney clinical chemistry, organ weight, or histology were
observed in rats exposed to fumed or precipitated a-silica at 30 mg/m3 for 6 hours/day, 5 days/week for
13 weeks (Reuzel et al. 1991).  Similarly, no changes in renal clinical chemistry or histology were
observed in monkeys, rats, or guinea pigs following exposure to fumed, precipitated, or gel a-silica at up
to 9.9 mg/m3 for 6 hours/day, 5 days/week for up to 18 months, compared with controls (Groth et al.
1981).
Gastrointestinal Effects.
Amorphous Silica. No studies evaluating gastrointestinal effects in humans following inhalation 
exposure to a-silica were identified.
No treatment-related changes in gastrointestinal histology were observed in rats exposed to fumed or
precipitated a-silica at concentrations up to 30 mg/m3 for 6 hours/day, 5 days/week for 13 weeks (Reuzel
et al. 1991) or monkeys exposed to fumed, precipitated, or gel a-silica at up to 9.9 mg/m3 for 6 hours/day, 
5 days/week for up to 18 months (Groth et al. 1981).
Hematological Effects.
Amorphous Silica. No studies evaluating hematological effects in humans following inhalation exposure
to a-silica were identified.
A significant 2–3-fold increase in neutrophil counts and slight increases in hemoglobin, packed cell 
volume, and erythrocyte counts were observed in rats exposed to fumed a-silica at 30 mg/m3 for 13 weeks
(6 hours/day, 5 days/week), compared with controls, but not at concentrations ≤6 mg/m3; after a 3-month 
recovery period, hematological parameters no longer differed from controls (Reuzel et al. 1991).  Other
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acute- and intermediate-duration studies reported hematological changes following exposure to a-silica,
including increased hemoglobin, packed cell volume, and erythrocyte count in rats exposed to fumed or
precipitated a-silica at ≥87 mg/m3 for 2 weeks (Reuzel et al. 1991) and increased mean neutrophil count
and hemoglobin levels and decreased mean lymphocyte count in rats exposed to colloidal a-silica at
150 mg/m3 for 4 weeks (Lee and Kelly 1992); however, the biological relevance of the findings could not
be assessed due to the absence of quantitative data reporting.
In a chronic study, rabbits exposed to precipitated a-silica at a concentration of 126 mg/m3 for 
8 hours/day, 7 days/week for 12 months showed a 22% increase in erythrocyte counts, a 40% increase in
hemoglobin levels, and a 12% increase in packed cell volume, compared with controls (Schepers 1981).  
Increased levels persisted to some degree after a 12-month recovery period. These findings are consistent
with an adaptive response to observed cardiopulmonary distress in exposed rabbits, rather than evidence
of an adverse hematological response to silica exposure.  No treatment-related changes in hematological
parameters were observed in monkeys, rats, or guinea pigs following exposure to fumed, precipitated, or
gel a-silica at up to 9.9 mg/m3 for 6 hours/day, 5 days/week for up to 18 months (Groth et al. 1981).
Musculoskeletal Effects.
Amorphous Silica. No studies evaluating musculoskeletal effects in humans following inhalation 
exposure to a-silica were identified.
No treatment-related changes in skeletal muscle histology were observed in rats exposed to fumed or
precipitated a-silica at concentrations up to 30 mg/m3 for 6 hours/day, 5 days/week for 13 weeks (Reuzel
et al. 1991)
Hepatic Effects.
Amorphous Silica. No studies evaluating hepatic effects in humans following inhalation exposure to 
a-silica were identified.
No treatment-related changes in liver clinical chemistry were observed in rats exposed to colloidal a-silica
at concentrations up to 150 mg/m3 for 6 hours/day, 5 days/week for 4 weeks (Lee and Kelly 1992).  No
treatment-related changes in liver clinical chemistry, organ weight, or histology were observed in rats 
exposed to fumed or precipitated a-silica at 30 mg/m3 for 6 hours/day, 5 days/week for 13 weeks (Reuzel
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et al. 1991).  Similarly, no changes in liver clinical chemistry or histology were observed in monkeys,
rats, or guinea pigs following exposure to fumed, precipitated, or gel a-silica at up to 9.9 mg/m3 for 
6 hours/day, 5 days/week for up to 18 months, compared with controls (Groth et al. 1981).
Endocrine Effects.
Amorphous Silica. No studies evaluating endocrine effects in humans following inhalation exposure to 
a-silica were identified.
No treatment-related changes in adrenal weight or endocrine organ histology were observed in rats
exposed to fumed or precipitated a-silica at concentrations up to 30 mg/m3 for 6 hours/day, 5 days/week
for 13 weeks (Reuzel et al. 1991).  No changes in adrenal, thyroid, or pancreas histology were observed in 
monkeys, rats, or guinea pigs following exposure to fumed, precipitated, or gel a-silica at up to 9.9 mg/m3 
for 6 hours/day, 5 days/week for up to 18 months, compared with controls (Groth et al. 1981).
Dermal Effects.
Amorphous Silica. No studies evaluating dermal effects in humans following inhalation exposure to
a-silica were identified.
No treatment-related changes in skin histology were observed rats exposed to fumed or precipitated 
a-silica at concentrations up to 30 mg/m3 for 6 hours/day, 5 days/week for 13 weeks (Reuzel et al. 1991)
or in monkeys, rats, or guinea pigs following exposure to fumed, precipitated, or gel a-silica at up to
9.9 mg/m3 for 6 hours/day, 5 days/week for up to 18 months (Groth et al. 1981).
Ocular Effects.
Amorphous Silica. No studies evaluating ocular effects in humans following inhalation exposure to
a-silica were identified.
No treatment-related changes in eye histology were observed in rats exposed to fumed or precipitated 
a-silica at concentrations up to 30 mg/m3 for 6 hours/day, 5 days/week for 13 weeks (Reuzel et al. 1991).  
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Amorphous Silica. No studies evaluating body weight effects in humans following inhalation exposure
to a-silica were identified.
In concentration range-finding studies, decreased body weight gain was observed in rats exposed to 
a-silica 6 hours/day, 5 days/week at concentrations as low as 44 mg/m3 for 2 weeks, compared with 
controls (Reuzel et al. 1991); however, the biological significance of these findings is unclear as the 
magnitude of effect was not reported.  In other studies, no body weight effects were observed in rats
exposed for 6 hours/day, 5 days/week at concentrations up to 25 mg/m3 pyrogenic, precipitated, or gel
a-silica for 1 week (Arts et al. 2007), 150 mg/m3 colloidal a-silica for 4 weeks (Lee and Kelly 1992), 
30 mg/m3 fumed or precipitated a-silica for 13 weeks (Reuzel et al.1991), or up to 9.9 mg/m3 fumed, 
precipitated, or gel a-silica for up to 18 months (Groth et al. 1981).
3.2.1.3  Immunological and Lymphoreticular Effects 
Crystalline Silica.
Autoimmune Disorders Associated with Crystalline Silica Exposure: Pathologic Features and Clinical 
Presentation. Unless otherwise noted, information in the following section is from the following reviews
and meta-analyses: Beckett et al. (1997); Deane and El-Gabalawy (2014); Demoruelle et al. (2014); 
Ghahramani (2010); Gibelin et al. (2011); Gomez-Puerta et al. (2013); Hinchcliff and Varga (2008); 
Hogan et al. (2001); Iannello et al. (2002); IARC (1997); Lee et al. (2012, 2014); Maeda et al. (2010); 
Manson and Rahman (2006); McCormic et al. (2010); NIOSH (2002); Otsuki et al. (2007); Parks et al.
(1999); Steenland and Goldsmith (1995); Stratta et al. (2001a); Thomeer et al. (2005); and Wu and Schiff
(2004).
No immune disorders are uniquely associated with exposure to c-silica.  However, a link between c-silica 
exposure and autoimmune disease has been proposed since the late 1950s.  Since the late 1960s, 
numerous retrospective cohort and case-control studies have evaluated potential associations between c-
silica exposure and a wide spectrum of autoimmune disorders, including systemic sclerosis (scleroderma),
rheumatoid arthritis, systemic lupus erythematosus, ANCA-associated vasculitis, and sarcoidosis 
(Bartunkova et al. 2006; Beaudreuil et al. 2005; Bovenzi et al. 1995, 2004; Brown et al. 1997; Burns et al.
1996; Calvert et al. 2003; Conrad et al. 1996; Cooper et al. 2010; Cowie 1987; Diot et al. 2002; Englert et
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al. 2000; Finckh et al. 2006; Gold et al. 2007; Gregorini et al. 1993; Hogan et al. 2001; Klockars et al.
1987; Lacey et al. 1997; Koskela et al. 1987b; Makol et al. 2011; Maitre et al. 2004; Marie et al. 2014;
Nuyts et al. 1995; Rafnsson et al. 1998; Rihova et al. 2005; Rodnan et al. 1967; Rosenman and Zhu 1995;
Rosenman et al. 1999; Silman and Jones 1992; Sluis-Cremer et al. 1985, 1986; Steenland and Brown 
1995b; Steenland et al. 1992, 2001b; Stolt et al. 2005, 2010; Stratta et al. 2001b; Turner and Cherry 2000;
Walsh 1999).  In general, results of these studies indicate that c-silica-exposed workers, some with other
risk factors for autoimmune diseases (e.g., genetic predisposition, other chemical exposures), may be at
increased risk for developing general autoimmunity, although data for each specific disease are
inadequate to determine a clear exposure-response relationship.  There is some evidence that observed 
autoimmunity may be a complication of silicosis, but autoimmunity may occur subsequent to direct toxic
effects of excessive c-silica accumulation in the lymphatic system (see Section 3.5.2 Mechanisms of
Toxicity for more details). It is important to note that mortality studies underestimate the prevalence of
nonlethal disorders, and occupational cohort studies are often too small to accurately estimate the risk of
rare diseases, such as autoimmune disorders.  Thus, quantitative risk estimates should be interpreted with 
caution.  Brief descriptions of autoimmune diseases potentially associated with c-silica exposure are listed
below.  
Systemic sclerosis (SSc). SSc is a multisystem disease of unknown etiology, but hypothesized causes
include genetic, autoimmune, and environmental factors.  Certain SSc subtypes have been associated with 
specific autoantibodies, including antinuclear antibody, anticentromere antibody, and antitopoisomerase-1 
antibody.  The disease is characterized by tissue thickening and fibrosis throughout the body.  The most
common clinical manifestations of the disease are scleroderma (hardening of the skin) and Raynaud
phenomenon (recurrent vasospasm typically in the distal extremities).  Fibrosis can also cause various 
types of internal organ dysfunction, which can be life threatening, such as decreased pulmonary function
and pulmonary arterial hypertension. Other clinical signs include musculoskeletal complaints (arthralgia,
myalgia, contractures), gastrointestinal complaints (reflux, intestinal dysmotility), and abnormal cardiac 
conduction.  The estimated prevalence of SSc in the United States is 0.0009–0.03% (Hemlick et al. 2008;
Hinchcliff and Varga 2008; Makol et al. 2011; Rosenman et al. 1999).  Reported incidence of SSc in 
retrospective cohorts of c-silica-exposed workers ranges from 0.02 to 17% (Brown et al. 1997; Calvert et
al. 2003; Gold et al. 2007; Makol et al. 2011; Rosenman et al. 1999; Walsh 1999).
Rheumatoid arthritis (RA). RA is an autoimmune disease characterized by systemic inflammation, with
the hallmark of the disease being joint inflammation (synovitis) leading to progressive arthritic
symptoms.  Other tissues with inflammation associated with RA include the oral mucosa, pulmonary, and 
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gastrointestinal tissues.  RA is associated with specific autoantibodies, including rheumatoid factor and 
anti-citrullinated peptide antibody (ACPA).  The etiology is unknown, but multiple genetic, epigenetic, 
and environmental risk factors have been proposed. The estimated prevalence of RA in the general U.S.
population is 0.6–1.85%; in older adults (≥60 years of age), the estimated prevalence increases to 2.00– 
2.34% (Hemlick et al. 2008; Makol et al. 2011; Rasch et al. 2003; Rosenman et al. 1999). Reported 
incidences of RA in cohorts of workers exposed to c-silica range from 0.4 to 5.2% (Brown et al. 1997;
Klockars et al. 1987; Koskela et al. 1987b; Makol et al. 2011; Rosenman and Zhu 1995; Rosenman et al.
1999; Steenland et al. 2001b; Turner and Cherry 2000).  
Systemic lupus erythematosus (SLE). SLE is an autoimmune disease that causes systemic inflammation.
It is characterized by the presence of the antinuclear autoantibody. The etiology is unknown, but multiple 
genetic, epigenetic, and environmental risk factors have been proposed.  Since it is a multi-system
disease, clinical presentation often varies between patients.  Common symptoms include a classic “malar” 
rash (fixed erythema over the malar eminences, tending to spare the nasolabial folds), a discoid rash, 
photosensitivity, oral ulcers, arthritis, serositis, renal disorder, neurological (psychological) disorder, 
hematological disorder, and/or general symptoms of fatigue, weight loss, and fever. The estimated
prevalence of SLE in the general U.S. population is 0.02–0.05% (Hemlick et al. 2008; Rosenman et al.
1999; Ward 2004).  Estimates vary based on gender and race, with higher estimates for women (0.1% for
white and Hispanic women and 0.4% for black women) compared with men (0.01 for white men and 
0.05% for black men) (Hemlick et al. 2008; Makol et al. 2011; Ward 2004).  Reported incidence of SLE
in cohorts of c-silica-exposed workers ranges from 0.2 to 0.9% (Conrad et al. 1996; Makol et al. 2011;
Rosenman et al. 1999).  
ANCA-associated vasculitis (AAV). Vasculitides associated with serum positivity for ANCA are 
autoimmune disorders that affect blood vessels systemically. The most commonly associated diseases 
include granulomatosis with polyangiitis (GPA; formerly Wegener granulomatosis), microscopic 
polyangiitis (MPA), and Churg-Strauss syndrome (CSS). These diseases are clinically associated with
lung involvement, including diffuse alveolar hemorrhage (which can be lethal), parenchymal nodules and 
masses (in GPA), asthma and eosinophilic pneumonia (in CSS), or interstitial lung disease (in MPA).
These diseases are often associated with renal damage (glomerulonephritis) as well, including focal
glomerular necrosis and crescent formation. The estimated prevalences of GPA and vasculitis (not
specified) in the United States are 0.003 and 0.03%, respectively (Gibelin et al. 2011; Makol et al. 2011).  
Prevalence of AAV in c-silica-exposed workers who were diagnosed with silicosis ranged from 0.8 to 
2.23% (Makol et al. 2011).
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Sarcoidosis. Sarcoidosis is a systemic granulomatous disease of unknown etiology, but hypothesized 
causes include genetic, autoimmune, and environmental factors.  It is proposed that genetically
susceptible individuals exposed to unknown environmental triggers may develop an exaggerated
inflammatory immune response.  Sarcoidosis predominantly affects the lungs, although granulomas can
also occur in skin, eyes, heart, liver, spleen, salivary glands, muscles, bones, kidneys, and central nervous
system.  It is characterized by noncaseating epitheloid granulomas that cannot be attributed to other
granulomatous diseases.  Patients with sarcoidosis often present with generalized symptoms (fever,
fatigue, weight loss, malaise, myalgia, lymphadenopathy) as well as symptoms specific to affected organs 
(e.g., skin lesions, vision impairment, coughing, reduce lung function, arrhythmias, neuropathy, renal
dysfunction).  The estimated prevalence of sarcoidosis in the United States is 0.005–0.3% (Thomeer et al.
2005).  Prevalence or incidence of sarcoidosis in c-silica-exposed workers has not been reported.  
Autoimmune Disease: Incidence and Exposure-Response Data.  
Systemic sclerosis/scleroderma (SSc). Two studies providing exposure data have evaluated the risk of
SSc in c-silica-exposed workers (Steenland and Brown 1995b; Steenland et al. 2001b); however, these
studies are of limited usefulness based on methods of analysis (e.g., grouping SSc with related disorders).  
Study details are provided in Table 3-11. In gold miners exposed to mean cumulative respirable c-silica 
levels of 11.37 mg/m3-year, the incidences of “other musculoskeletal diseases” and “other diseases of the 
skin” at death (including SSc) were increased by 2.14-fold (95% CI: 1.03, 3.94) and 2.45-fold (95%
CI: 1.17, 4.51), respectively (Steenland and Brown 1995b; exposure estimates calculated by Mannetje et
al. 2002b).  However, the incidence of SSc, specifically, was not reported or analyzed.  In industrial sand 
workers exposed to lower cumulative levels of respirable c-silica (0.13 mg/m3-year), the incidence of
“other musculoskeletal diseases” (including SSc) was not increased (Steenland et al. 2001b; exposure
estimates calculated by Mannetje et al. 2002b).  
Numerous studies evaluated the potential association between SSc diagnosis and c-silica exposure;
however, these studies did not report quantitative cumulative exposure estimates or exposure-response
data. Several studies reported an elevated risk for SSc incidence or mortality in c-silica-exposed workers,
often in individuals with silicosis (Brown et al. 1997; Cowie 1987; Diot et al. 2002; Englert et al. 2000;
Marie et al. 2014; Rodnan et al. 1967; Walsh 1999), while others did not show associations with c-silica 
exposure (Bovenzi et al. 1995, 2004; Burns et al. 1996; Calvert et al. 2003; Gold et al. 2007; Lacey et al.
1997; Makol et al. 2011; Maitre et al. 2004; Rosenman et al. 1999; Silman and Jones 1992; Sluis-Cremer 
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Table 3-11. Autoimmune Disease in Workers Exposed to Respirable c-Silica
Study design and 
Reference industry Cohort and methods Exposure Outcome
Rheumatoid arthritis (RA)
Klockars et al. Study design: historical 
1987; Koskela et cohort study
al. 1987b Industry: granite 
workers
Location: Finland
Cohort: 1,026 male 
workers employed for at
least 3 months between 
1940 and 1971, with 
follow-up until 1981 
(mean exposure 
duration: 12 years):
- 170 quarry and drill
workers















Geometric mean exposure to 
quartz particles <5 µm diameter
(mg/m3):
- Drilling: 1.47
- Block surfacing: 0.82 
- Other tasks: 0.12–1.44 
Granite workers had a significantly
higher incidence of free medicine grants
for RA from national sickness insurance 
than the general population.  Subjects




Granite workers had a significantly
higher incidence of disability pensions
for RA than the general population.





Incidence rate/1,000 person years of
awards of disability pensions for RA
among granite workers and in general
male population:
- Granite workers: 1.69
- General population: 0.24
p<0.001
Note: The proportions of workers with 
RA in the various occupational
categories (e.g. drillers, cutters, general
workers, etc.) were comparable to the 
proportion in the total cohort.
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Table 3-11. Autoimmune Disease in Workers Exposed to Respirable c-Silica
Study design and 
Reference industry Cohort and methods Exposure Outcome
Steenland and 	 Study design: historical Cohort: 3,328 workers
Brown 1995b	 cohort study employed for at least
Industry: gold miners 1 year between 1940
Location: South Dakota, and 1965, with follow-up 






table analysis (which 
accounts for age, race,
sex, and time and 
calendar intervals for the 
U.S. population) with χ2
tests
Median cumulative exposure The SMR for deaths that listed the 
(mg/m3-year): 0.23a presence of arthritis (including RA) was
elevated:
- Number of cases at death: 17
- SMR (95% CI): 2.19 (1.27, 3.50)
Note: The number of RA cases was not
specified.
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Table 3-11. Autoimmune Disease in Workers Exposed to Respirable c-Silica
Study design and 
Reference industry Cohort and methods Exposure Outcome
Steenland et al.	 Study design: historical 
2001b	 cohort study




Cohort: 4,626 workers Mean cumulative exposure to The SMR for deaths that listed the 

employed in 18 plants for respirable c-silica (mg/m3-year): presence of arthritis (including RA) was
 
at least 1 week from 0.13b elevated:
 
1940s to 1980s and lived - Number of cases at death: 23 

past 1960, with follow-up Cumulative exposure quartiles - SMR (95% CI): 4.36 (2.76, 6.54)
 
through 1996; for respirable c-silica - SRR (number of deaths) by quartile
 
4,027 workers with (mg/m3-year): (95% CI not reported):
 
adequate work histories Q1: <0.10 (referent) Q1: 1.00 (1) (referent)
 
to estimate exposure Q2: 0.10–<0.51 Q2: 1.73 (3)
 
Adjustments: age, race, Q3: 0.51–<1.28 Q3: 3.73 (7)
 
sex, calendar time Q4: ≥1.28 Q4: 6.91 (7)
 




analysis Slope [change in rate per 1 mg/m3-
year increase (95% CI)]: 0.00018 
(0.00017, 0.00019)
Note: Of the death certificates
mentioning arthritis, 12/23 specified RA.
A SMR specific for RA was not reported.
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Table 3-11. Autoimmune Disease in Workers Exposed to Respirable c-Silica
Study design and 
Reference industry Cohort and methods Exposure Outcome
Turner and Cherry
2000
Study design: historical 











1,972 women) born in 
1916–1945 and
employed in pottery or
related industries
Cases: 58 workers
(43 men, 15 women)
who responded “yes” to 







(172 men, 60 women);
4 referents matched to 
each case based on sex
and as closely as
possible to date of birth 
and date of first
exposure to pottery
Adjustments: smoking,






Mean cumulative exposure to 
respirable c-silica (mg/m3-year ):
- Cases: 2.525 
- Referents: 2.872 
Mean (±SD) exposure 
concentration to respirable 
c-silica (mg/m3): 
- Cases: 0.1329±0.0769 
- Referents: 0.1329±0.0741
There was no increased risk of RA
based on analysis of mean c-silica
concentrations, cumulative exposure, or
duration of employment.
ORs (95% CI):
Mean c-silica concentration/100 (µg/m3):
- Men: 0.79 (0.40, 1.57)
- Women: 1.56 (0.36, 6.75)
- Combined: 0.97 (0.56, 1.70)
Cumulative exposure/1,000 (µg/m3-
year):
- Men: 0.71 (0.52, 0.97)
- Women: 1.13 (0.73, 1.73)
- Combined: 0.80 (0.64, 1.02)
Duration/1 (year):
- Men: 0.29 (0.11, 0.76)
- Women: 0.61 (0.18, 2.02)
- Combined: 0.31 (0.16, 0.61)
The prevalence of RA in this cohort
(58/8325; 0.7%) is equal to the 
prevalence in the general United 
Kingdom population for individuals aged 
45–64 years (0.7%).
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Table 3-11. Autoimmune Disease in Workers Exposed to Respirable c-Silica
Study design and 
Reference industry Cohort and methods Exposure Outcome
Systemic sclerosis (SSc) and systemic lupus erythematosus (SLE)












Uranium workers had a “higher than 
expected” prevalence of SLE.
Number of cases:
- Definite (4+ diagnostic criteria): 28
- Probable (2–3 diagnostic criteria): 15
Estimated prevalence in uranium
workers:
- 93 in 100,000
Background incidence in male 
population:
- Male population: 3.6 in 100,000










employed for at least
1 year between 1940
and 1965, with follow-up 






table analysis (which 
accounts for age, race,
sex, and time and 
calendar intervals for the 
Median cumulative exposure 
(mg/m3-year): 0.23c 
The SMRs for deaths that listed the 
presence of “other” musculoskeletal
diseases (including SLE and SSc) and 
“other” skin diseases (including SSc and 
SLE) were increased:
Other musculoskeletal diseases:
- Number of cases at death: 10
- SMR (95% CI): 2.14 (1.03, 3.94)
Other diseases of the skin:
- Number of cases at death: 10
- SMR (95% CI): 2.45 (1.17, 4.51)
U.S. population) with χ2
tests
Note: The number of individual SLE or
SSc cases was not specified.
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Table 3-11. Autoimmune Disease in Workers Exposed to Respirable c-Silica
Reference
Study design and 
industry Cohort and methods Exposure Outcome
Steenland et al.
2001b
Study design: historical 
cohort study
Industry: industrial sand 
workers
Cohort: 4,626 workers
employed in 18 plants for
at least 1 week from
1940s to 1980s and lived 
Mean cumulative exposure to 
respirable c-silica (mg/m3-year):
0.13b 
The SMR for deaths that listed the 
presences of “other” musculoskeletal




past 1960, with follow-up 
through 1996;












- Number of cases at death: 8 
- SMR (95% CI): 2.18 (0.93, 4.28)
Note: Among the eight deaths reporting 
musculoskeletal diseases, three deaths














Cases: eight cases of
sarcoidosis (four men,
four women) diagnosed 
either at the healthcare
center in the town of
Husavik or at a routine 
occupational health 
examination at the a 
diatomaceous earth plant
in the district; diagnoses




the population of the 
district served by the 
Husavik health 
center/hospital
Mean exposure to respirable 
cristobalite in 1978 (mg/m3):
- Loading: 0.3
- Packers: 0.6
- Over operators: 0.3
- Maintenance men: 0.2
- Cleaners: 0.1
Mean exposure to respirable 
cristobalite in 1981 (mg/m3):
- Loading: 0.02
- Packers: 0.05
- Over operators: 0.002
- Maintenance men: 0.01
- Cleaners: 0.06
Number of total sarcoidosis cases
with a history of exposure (employed 
at diatomaceous earth plant): 6/8
Number of incidental sarcoidosis
cases diagnoses at the healthcare 
center (not part of routine
occupational health exam) with a 
history of exposure: 4/6
Number of referents with a history of
exposure (employed at
diatomaceous earth plant): 13/70
The risk of both total and incidental
sarcoidosis cases were increased in
exposed individuals.
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Table 3-11. Autoimmune Disease in Workers Exposed to Respirable c-Silica
Study design and 
Reference industry Cohort and methods Exposure Outcome
Adjustments: the study
authors did stratify for
age; however, the age
range of the cases
determined the age 
section of the population 




ORs (95% CI): 
- Total: 13.2 (2.0, 140.9)
- Incidental: 8.8 (1.1, 102.5)
Estimated annual incidence of
sarcoidosis:
- Population of Husavik region:
9.3/100,000
- Total population of Iceland: 0.5– 
2.7/100,000 
Note: The six cases with c-silica
exposure were distributed into 
different job categories; therefore,
increased risk was not associated 
with a specific job.
aExposures were estimated by Mannetje et al. (2002a, 2002b) (not reported in original publication), based on data provided by the original investigators.

bExposures were estimated by Mannetje et al. (2002a, 2002b) (not reported in original publication) for Steenland and Sanderson. (2001), using the same cohort of
 
industrial sand workers as Steenland et al. (2001b).  Estimates were based on job-exposure matrices data provided by the original investigators.
 




CI = confidence interval; OR = odds ratio; SD = standard deviation; SMR – standard mortality ratio; SRR = standardized rate ratio
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et al. 1985).  However, a meta-analysis of 16 studies in c-silica-exposed workers (see Table 3-12 for study
details) reported an increased combined estimator of relative risk (CERR) for SSc of 3.20 (95% CI: 1.89, 
5.43) (McCormic et al. 2010).  The risk was increased in males (CERR: 3.02; 95% CI: 1.24, 7.35), but not
females (CERR: 1.03; 95% CI: 0.74, 1.44).  Additional analysis indicated that increased risk was 
predominantly due to studies published prior to 2000 (CERR: 4.22; 95% CI: 1.64, 10.86), with more
recent studies not showing an increased risk for SSc (CERR: 1.96; 95% CI: 0.95, 4.07).  Location of
study was also an important factor, with an increased risk of SSc in c-silica-exposed individuals in 
European studies (CERR: 5.91; 95% CI: 3.06, 11.42), but not U.S. studies (CERR: 1.23; 95% CI: 0.97, 
1.56).  Results of this meta-analysis indicate that c-silica exposure may increase the risk of SSc in men;
however, available data are inadequate to determine the exposure-response relationship.
Rheumatoid arthritis (RA). Two studies providing exposure data have evaluated the risk of RA in 
c-silica-exposed workers (see Table 3-11 for study details).  The incidence of RA was significantly
(p<0.001) increased in a cohort of male granite workers exposed to quartz particles (<5 µm diameter) at a
geometric mean exposure concentration of 0.82–1.47 mg/m3, with an incidence rate of 1.69/1,000 (0.2%)
compared with that of the general population (0.24/1,000; (0.02%) (Klockars et al. 1987; Koskela et al.
1987b).  However, the risk of RA was not increased in a cohort of male and female workers from pottery
or related industries exposed to mean air levels of respirable c-silica of 0.1329 mg/m3 (Turner and Cherry
2000).  A nested case-referent study in the same cohort showed that mean cumulative exposure to
respirable c-silica did not differ between cases (2.525 mg/m3-year) and referents (2.872 mg/m3-year).  
Two additional occupational studies with exposure information evaluated the risk of arthritis (including
RA) in c-silica-exposed workers; however, these studies are of limited usefulness based on methods of
analysis (e.g., grouping RA with osteoarthritis); study details are provided in Table 3-11.  Steenland and 
Brown (1995b) reported a 2.19-fold (95% CI: 1.27, 3.50) increase in the presence of arthritis (including
RA) at death in gold miners exposed to mean cumulative respirable c-silica levels of 11.37 mg/m3-year,
and Steenland et al. (2001b) reported a 4.36-fold (95% CI: 2.76, 6.54) increase in the presence of arthritis
(including RA) at death in industrial sand workers exposed to mean cumulative respirable c-silica levels
of 0.13 mg/m3-year (exposure estimates calculated by Mannetje et al. 2002b).  When analyzed by
exposure quartile, a positive trend was observed for arthritis (including RA) in the sand workers cohort
(slope: 0.00018; 95% CI: 0.00017, 0.00019); exposure by quartile was not assessed in gold miners. The
numbers of arthritis cases were 17 in gold miners and 23 in sand workers.  Steenland et al. (2001b) also
reported the specific number of RA cases (12) in sand workers; however, SMR analysis was not
conducted specifically for RA.  Additionally, a study lacking exposure information reported a 2.01-fold 
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Bonvenzi et al. 1995 (case-control) Silman and Jones 1992 (case-control) Selection of studies: All studies:
- Cases: 5 males, 16 females - Cases: 56 males Medline, Toxline, BIOSIS, and An increased risk of SSc with 
- Controls: 10 males, 32 females - Controls: 86 males (age-matched) Embase searches were c-silica exposure was
(age- and sex-matched) - Location: United Kingdom performed to identify studies identified; studies showed
- Location: Trento, Italy - Exposure: occupational history evaluating the association significant heterogeneity.
- Exposure: occupational history - OR (95% CI): 1.40 (0.12, 16.1) between c-silica exposure 
- OR (95% CI): 5.20 (0.48, 74.1) and SSc published between CERR (95% CI):
Brown et al. 1997 (cohort) 1949 and November 2009. - Both sexes: 3.20 (1.89,
Bonvenzi et al. 2004 (case-control) - Silicosis patients: 1,130 men Of the 20 studies identified, 5.43)
- Cases: 9 males, 46 females - Location: Sweden only 16 studies had measures
- Controls: 18 males, 153 females - Exposure: diagnosis of silicosis as of RR (OR, SIR, SMR, or Stratified by sex:
(age- and sex-matched) proxy for c-silica exposure PMR) or sufficient data for An increased risk of SSc with 
- Location: Verona, Italy - Number of scleroderma cases: 5 calculation of RR for SSc in c-silica exposure was
- Exposure: occupational history - RR (95% CI): 37 (11.9, 86.3) c-silica-exposed workers.  A identified in men, but not in 
- RR (95% CI): 1.7 (0.4, 7.6) total of 16 studies including women; male data showed
Mehlhorn et al. 1999 (cohort) 1,030,152 subjects were significant heterogeneity and 
Burns et al. 1996 (case-control) - Uranium mine workers: 243,900 men selected (781,882 men, female data showed 
- Cases: 274 females with “high” exposure and 50,000 men 233,324 women, 14,946 sex nonsignificant heterogeneity.
- Controls: 1184 females (age-, with “low” exposure not specified).
race-, and region-matched)
- Location: Michigan, United States
- Location: Germany
- Exposure: “high” versus “low;” levels Data analysis:
CERR (95% CI):
- Men: 3.02 (1.24, 7.35)
- Exposure: self-reported past not reported Measures of RRs and 95% - Men (two studies
exposure (job/hobby history), - Number of scleroderma cases: not CIs were abstracted from data excluded): 2.06 (1.04,
c-silica exposure in abrasive available presented in primary reports. 4.08)
grinding/sandblasting, pottery
making, and dental laboratories
- RR (95% CI): 7.41 (6.14, 8.93) A meta-analysis was
conducted using the Meta-
- Females: 1.03 (0.74, 1.44)
- OR (95% CI): 1.50 (0.76, 2.93) analysis of Observational Stratified by location:
Studies in Epidemiology An increased risk of SSc with 
(MOOSE) Group’s c-silica exposure was
recommendations. identified in European studies,
Heterogeneity of the studies but not in studies conducted in
Diot et al. 2002 (case-control) Rosenman et al. 1999 (cohort)
were analyzed using Cochran 
Q and I2 statistics.  The
the United States.  Data for
both locations showed 
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- Cases: 11 males, 69 females - Silicosis patients: 583 men and women CERR and 95% CI were 	 significant heterogeneity.
- Controls: 22 males, 138 females - Location: United States calculated using fixed or
(age-, sex-, and smoking-habit- - Exposure estimate: diagnosis of random effect models. CERR (95% CI):
matched) silicosis as proxy for c-silica exposure Further analysis were - Europe: 5.91 (3.06,11.42)
- Location: France - Number of scleroderma cases: 1 conducted on studies - United States: 1.23 (0.97,
 
- Exposure: occupational history - RR (95% CI): 15.65 (0.21, 87.03) stratified by sex, location, 1.56)
 
- OR (95% CI): 5.57 (1.69, 18.37) Calvert et al. 2003 (mortality) publication date, and study
 
- 17,238 deaths design. Stratified by publication date:
Englert et al. 2000 (case-control) - Location: United States An increased risk of SSc with 
- Cases: 160 males - Exposure estimate: job title (high An additional analysis in men c-silica exposure was
- Controls: 83 males (age- and c-silica exposure in drillers, crushing only was conducted with two identified in studies published 
region-matched) and grinding machinists, miners, pottery studies excluded (Mehlhorn et prior to 2000, but not in 2000 
- Location: Australia workers, and foundry workers) al. 1999 and Ziegler et al. or later.  Data for both time 
- Exposure: occupational history - Number of scleroderma cases: 1997) in order to reduce bias. periods showed significant
(c-silica exposure in construction, 976 males, 1,899 females These studies were excluded heterogeneity.
mining, and manufacturing) - OR (95% CI): 2.00 (0.39, 10.31) because they did not use a 
- OR (95% CI): 2.51 (1.28, 4.98) typical cohort or case-control CERR (95% CI):
Gold et al. 2007 (mortality) design; rather, they started - Pre-2000: 4.22 (1.64,
Lacey et al. 1997 (case-control) - 72,732 male and 197,479 female historically with a case series 10.86)
- Cases: 189 females deaths and tried to construct a study - Since 2000: 1.96 (0.95,
- Controls: 1,043 females (age-, - Location: United States post-hoc. 4.07)
race-, and region-matched) - Exposure estimate: job title
- Location: Ohio, United States - Number of scleroderma cases: Stratified by study design:
- Exposure: self-reported past 1,298 males, 4,344 females An increased risk of SSc with 
exposure (job/hobby history) - OR (95% CI): 1.02 (0.92, 1.13)	 c-silica exposure was
- OR (95% CI): 0.87 (0.19, 4.0)	 identified in in case-control
studies and cohort studies,
but not the case-series study.




Walsh 1999 (mortality)	 heterogeneity.
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Maître et al. 2004 (case-control)
- Cases: 10 men, 83 women
- Controls: 40 men, 166 women 
(age- and sex-matched)
- Location: France
- Exposure: based on job title
- RR (95% CI): 0.89 (0.26, 3.2)
Rodnan et al. 1967 (case-control)
- Cases: 60 males
- Controls: 86 males (age- and 
race-matched)
- Location: United States
- Exposure: based on job title 
(c-silica exposure in coal miners,
sandblasters, rock drillers, brick
molders, and foundry, enamel,
pottery, and cement factory
workers)
- RR (95% CI): 3.34 (1.59, 7.05)
- 411,404 male and 30,563 female 
deaths
- Location: United States
- Exposure estimate: job title (c-silica
exposure in mining machine operators
and numerous non-mining jobs such as
brick/stone mason, grinders/polishers,
various construction workers)
- Number of scleroderma cases:
128 males, 32 females
- PMR (95% CI): 1 (0.80,1.10)
Ziegler et al. 1997 (case series)
- Cases: 54 males
- Location: Germany
- Exposure: occupational history
- RR (95% CI): 10.40 (6.10, 17.8)
CERR (95% CI):
- Case-control: 2.24 (1.65,
3.31)
- Cohort: 15.49  (4.54,
52.87)
- Mortality studies: 1.01 
(0.94, 1.08)
CERR = combined estimator of relative risk; CI = confidence interval; OR = odds ratio; PMR = proportionate mortality ratio; RR = relative risk or risk ratio; SIR =
standardized incidence ratio; SMR = standardized mortality ratio
Source: McCormic et al. (2010)
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(95% CI: 1.17–3.21) increase in the presence of arthritis (including RA) at death for male granite workers 
in a mortality cohort (Steenland et al. 1992). The number of arthritis cases in this cohort was 17.
Several additional studies reported a 2–8-fold increase in risk or incidence of RA in cohorts of men with
occupational exposure to c-silica, the majority of which were diagnosed with silicosis; however, these
studies did not provide quantitative estimates of exposure (Brown et al. 1997; Makol et al. 2011;
Rosenman and Zhu 1995; Rosenman et al. 1999; Stolt et al. 2005, 2010).  A case-referent study of
c-silica-exposed miners showed an increased risk of RA in miners with silicosis compared with c-silica-
exposed miners without silicosis, although these findings could not be accounted for based on estimates
of cumulative exposure (c-silica exposure levels not reported) (Sluis-Cremer et al. 1986).  Results of
cohort mortality yielded conflicting results; Calvert et al. (2003) reported an increased OR for RA in 
c-silica-exposed workers with “high silica exposure,” including miners, crushing and grinding machine
workers, pottery workers, and foundry workers, while no increase was observed in workers with potential
c-silica exposure from various industries (based on work history and job-exposure matrix) (Gold et al. 
2002). 
Taken together, available evidence indicates that c-silica exposure may increase the risk of RA; however,
available data are inadequate to determine an exposure-response relationship.
Systemic lupus erythematosus (SLE). Two studies providing exposure data have evaluated the risk of
SLE in c-silica-exposed workers (Steenland and Brown 1995b; Steenland et al. 2001b); see Table 3-11 for 
study details.  However, these studies are of limited usefulness based on methods of analysis (e.g.,
grouping SLE with related disorders, statistical analysis not conducted). The incidence of SLE was
“higher than expected” in a 15,000 group of “heavily exposed” (>20 mg/m3) uranium miners with 
silicosis, with 28 definite cases (4+ American Rheumatism Association [ARA] criteria) and an additional
15 probable cases (2–3 ARA criteria) (Conrad et al. 1996).  Based on these findings, the estimated
prevalence of SLE was 93 in 100,000 in uranium workers, compared with the background incidence of
3.6 in 100,000 in the male population and 20–50 in 100,000 in the general Caucasian population (Conrad 
et al. 1996).  In gold miners exposed to mean cumulative respirable c-silica levels of 11.37 mg/m3-year,
the incidences of “other musculoskeletal diseases” and “other diseases of the skin” at death (including
SLE) were increased by 2.14-fold (95% CI: 1.03, 3.94) and 2.45-fold (95% CI: 1.17, 4.51), respectively
(Steenland and Brown 1995b; exposure estimates calculated by Mannetje et al. 2002b).  However, the 
incidence of SLE, specifically, was not reported or analyzed.  In industrial sand workers exposed to lower
cumulative levels of respirable c-silica (0.13 mg/m3-year), the incidence of “other musculoskeletal
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diseases” (including SLE) was not increased (Steenland et al. 2001b; exposure estimates calculated by
Mannetje et al. 2002b).  
Other available case-control and cohort studies reported inconsistent findings; however, these studies did 
not provide quantitative cumulative exposure estimates or exposure-response data.  Two population-based
case-control studies reported a 1.6–4-fold increase in risk of SLE diagnosis in individuals with a history
of occupational exposure to c-silica (Cooper et al. 2010; Finckh et al. 2006).  Women exposed for
>5 years had an increased risk (OR: 4.9; 95% CI: 1.1, 21.9) compared to women exposed for 1–5 years
(OR: 4.0; 95% CI: 1.2, 12.9); these findings showed a significant duration-related trend (p=0.01) (Finckh 
et al. 2006).  Additionally, the relative risk for SLE was increased 24-fold in a cohort of men with 
silicosis (Brown et al. 1997).  In this cohort, a 6-fold excess mortality from musculoskeletal diseases,
including RA, SLE, and Sjogren’s syndrome, was identified (6/1130 deaths, 0.5%) (Brown et al. 1997).  
However, the incidence of SLE was not elevated in other cohorts of patients with silicosis (Makol et al.
2011; Rosenman et al. 1999) and the incidence of SLE at death was not elevated in c-silica-exposed 
individuals (Calvert et al. 2003; Gold et al. 2007).  
Taken together, available data are inadequate to determine if there is an association between c-silica 
exposure and increased risk of SLE.
ANCA-associated vasculitis (AAV). Studies evaluating the potential association between AAV and
c-silica exposure did not report quantitative exposure data.  Using studies with qualitative measures of
exposure (e.g., occupational history), a meta-analysis of six case-referent studies showed increased ORs 
for AAV (OR: 2.57; 95% CI: 1.15, 4.36) and AAV with renal involvement (OR: 3.13; 95% CI: 1.63, 
5.84) in c-silica-exposed workers (Gomez-Puerta et al. 2013; study details provided in Table 3-13).
Additional analysis showed that ORs for specific AAV-associated diseases were also increased, including
GPA (OR: 3.56; 95% CI: 1.85, 6.82) and MPA (OR: 3.95; 95% CI: 1.89, 8.24).  However, when studies
were stratified into those that adjusted for smoking status and occupational risk (n=2) and those that did 
not (n=4), studies with unadjusted ORs showed an increase in risk of AAV with c-silica exposure (OR:
2.99; 95% CI: 1.43, 6.25), but studies with adjusted ORs did not (OR: 2.24; 95% CI: 0.74, 6.80).  
Individually, four of the case-control studies used in the meta-analysis reported an increase in AAV risk
in c-silica exposed individuals (Gregorini et al. 1993; Hogan et al. 2001; Nuyts et al. 1995; Stratta et al. 
2001b), while the other two did not (Hogan et al. 2007; Lane et al. 2003).  After adjustment for smoking
status and occupational risk factors, risk was no longer increased in the study by Hogan et al. (2001).
Additional studies not included in the meta-analysis also reported an increase in the incidence of AAV or
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Studies Methods Outcomes for meta-analysis
Gregorini et al. 1993 Lane et al. 2003 Selection of studies: EMBASE The risk of AAV and AAV with 
- Cases: 16 patients with ANCA- - Cases: 75 patients with primary and MEDLINE searches were renal involvement was increased 
positive glomerulonephritis systemic vasculitis performed to identify case- in c-silica-exposed individuals.
- Controls: 32 patients with - Controls: 220 patients with non- control and cohort studies
nephropathy without vasculitis inflammatory musculoskeletal evaluating the association OR (95% CI):
(age- and date-of-admission- disease (age- and sex-matched) between c-silica exposure and - All studies: 2.57 (1.15, 4.36)
matched) - Location: United Kingdom ANCA-associated vasculitis - AAV with renal involvement:
- Location: Italy - Exposure: occupational history published between January 1965 3.13 (1.68, 5.84)
- Exposure: occupational history
- OR (95% CI): 14.0 (1.7, 113.8)
- OR (95% CI): 1.4 (0.7, 2.7)
- Adjusted OR (95% CI): 1.4 (0.73,
and April 2013.  Studies were 
assessed for quality using the 
- GPAa: 3.56 (1.85, 6.82)
- MPAb: 3.95 (1.89, 8.24)
- Quality score: S2/C1/E1 6.79) Newcastle-Ottawa Scale; quality
- Quality score: S2/C2/E2 scores were assigned based on Studies reporting unadjusted 
Hogan et al. 2001 selection of comparison groups estimates of association showed 
- Cases: 65 patients with ANCA- Nuyts et al. (1995 (S; 0–4 points), comparability an increased risk of AAV in
associated vasculitis - Cases: 16 patients with between the two groups (C; 0– c-silica-exposed individuals, but
- Controls: 65 patients with granulomatosis with polyangiitis 2 points), and exposure studies that adjusted for smoking 
nephropathy without vasculitis (formerly called Wegener’s ascertainments (E; 0–3 points). and occupational risk factors did 
(age-, sex-, and region-matched) granulomatosis) not.
- Location: United States - Controls: 32 randomly selected Data analysis:
- Exposure: occupational history age-, sex-, and region-matched ORs were abstracted from OR (95% CI):
- Adjusted OR (95% CI): 4.43 individuals published reports.  Two studies - Unadjusted studies: 2.99
(1.36,14.4)
- Quality score: S3/C1/E1
- Location: Belgium
- Exposure: occupational history
reported adjusted ORs (adjusted 
for smoking status and
(1.43, 6.25)
- Adjusted studies: 2.24 (0.74,
- OR (95% CI): 5.0 (1.4, 11.6) occupational risk factors). 6.80)
Hogan et al. 2007
- Cases: 129 patients with ANCA-
- Quality score: S3/C1/E2 Heterogeneity of the studies was
analyzed using Q and I2 
positive glomerulonephritis Stratta et al. 2001b statistics.  Data showed
- Controls: 109 randomly selected 
age-, sex-, and state-matched 
- Cases: 31 patients with renal
vasculitis
significant heterogeneity, so ORs
and 95% CI were calculated 
individuals - Controls: 58 patients with using random effect models.
- Location: United States nephropathy without vasculitis Further analyses were conducted 
- Exposure: occupational history - Location: Italy on studies stratified by OR
- OR (95% CI): 1.6 (0.9, 2.8) - Exposure: occupational history adjustment and renal
- Quality score: S3/C1/E1 - OR (95% CI): 2.4 (1.02, 6.5)
- Quality score: S2/C1/E1
involvement.  Comprehensive 
meta-analysis software 
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Studies Methods Outcomes for meta-analysis
(www.meta-analysis.com;
©Biostat, Inc.) was used for
statistical analysis.
aGPA = granulomatosis with polyangiitis (formerly Wegener granulomatosis).
 
bMPA = microscopic polyangiitis.
 
ANCA = antineutrophil cytoplasmic autoantibodies; CI = confidence interval; OR = odds ratio
 
Source: Gomez-Puerta et al. (2013)
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ANCA-positivity with a history of c-silica exposure, including two silicosis cohort studies (Bartunkova et
al. 2006; Makol et al. 2011) and two case-referent studies (Beaudreuil et al. 2005; Rihova et al. 2005).
Based on the meta-analysis, evidence suggests that c-silica exposure may increase the risk of AAV;
however, the lack of exposure-response data and the lack of increased risk following adjustments for
smoking and occupational risk factors preclude the ability to determine if there is an association between
c-silica exposure and increased risk of AAV.
Sarcoidosis. In a case-referent study, the risk of sarcoidosis was increased 13-fold (95% CI: 2.0, 140.9)
in men and women exposed to c-silica at a diatomaceous earth plant in the Husavik region of Iceland;
mean exposure levels to respirable cristobalite at the plant ranged from 0.002 to 0.06 mg/m3; see study
details in Table 3-11 (Rafnsson et al. 1998). The annual incidence of sarcoidosis in the Husavik region
was estimated to be 9.3 per 100,000, compared to the national average of 0.5–2.7 per 100,000 (Rafnsson 
et al. 1998). A study evaluating the potential association between c-silica exposure and sarcoidosis found
a decreased risk of sarcoidosis in c-silica-exposed individuals in a mortality cohort (OR: 0.66; 95% CI:
0.54, 0.80) (Calvert et al. 2003), and a statistically significant decrease in the risk of sarcoidosis-related
mortality was observed in silica workers in the United States (mortality OR: 0.65; 95% CI: 0.42, 0.74;
p<0.05) (Liu et al. 2016).  Available data are inadequate to determine if there is an association between c-
silica exposure and increased risk of sarcoidosis.
Amorphous Silica. No studies evaluating immunological or lymphoreticular effects in humans following
inhalation exposure to a-silica were identified.
No treatment-related changes in immune organ weight or histology were observed in rats exposed to 
fumed or precipitated a-silica at concentrations up to 30 mg/m3 for 6 hours/day, 5 days/week for 13 weeks
(Reuzel et al. 1991).  No changes in spleen or lymph node histology were observed in monkeys, rats, or
guinea pigs following exposure to fumed, precipitated, or gel a-silica at up to 9.9 mg/m3 for 6 hours/day, 
5 days/week for up to 18 months, compared with controls (Groth et al. 1981).
3.2.1.4  Neurological Effects 
Amorphous Silica. No studies evaluating neurological effects in humans following inhalation exposure
to a-silica were identified.
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No changes in brain weight or central or peripheral nervous tissue histology were observed in rats
exposed to fumed or precipitated a-silica at concentrations up to 30 mg/m3 for 6 hours/day, 5 days/week
for 13 weeks (Reuzel et al. 1991).
3.2.1.5  Reproductive Effects
Amorphous Silica. No studies evaluating reproductive effects in humans following inhalation exposure
to a-silica were identified.
No changes in male or female reproductive organ weight or histology were observed in rats exposed to 
fumed or precipitated a-silica at concentrations up to 30 mg/m3 for 6 hours/day, 5 days/week for 13 weeks
(Reuzel et al. 1991).  No changes in testicular or prostate histology were observed in monkeys, rats, or
guinea pigs following exposure to fumed, precipitated, or gel a-silica at up to 9.9 mg/m3 for 6 hours/day, 
5 days/week for up to 18 months, compared with controls (Groth et al. 1981).
3.2.1.6  Developmental Effects 
Amorphous Silica. No studies evaluating developmental effects in humans or animals following
inhalation exposure to a-silica were identified.
3.2.1.7  Cancer
Crystalline Silica. Well over 100 studies examining the relationship between occupational exposure to 
c-silica and lung cancer have been published, including several recent reviews (Brown 2009; Checkoway
and Franzblau 2000; Cox 2011; Gamble 2011; IARC 2012; NIOSH 2002; Soutar et al. 2000; Steenland 
2005; Steenland and Ward 2014). The information reviewed in this section focuses on studies published 
after the 1997 IARC evaluation of c-silica.
Carcinogenicity Classifications Based on Lung Cancer. In 1997, IARC revised the classification of
c-silica from Group 2A (probably carcinogenic to humans) to Group 1 (carcinogenic to humans) citing
sufficient evidence for carcinogenicity in humans and animals (IARC 1997).  The IARC working group 
noted that “carcinogenicity in humans was not detected in all industrial circumstances studied.
Carcinogenicity may be dependent on inherent characteristics of the c-silica or on external factors
affecting its biological activity or distribution of its polymorphs.”  In 2012, IARC conducted a re-
evaluation of the carcinogenicity of c-silica, incorporating data available after the 1997 assessment.
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IARC retained the Group 1 classification for c-silica, concluding that “there is sufficient evidence in
humans for the carcinogenicity of c-silica in the form of quartz or cristobalite. c-Silica in the form of
quartz or cristobalite dust causes cancer of the lung. There is sufficient evidence in experimental animals 
for the carcinogenicity of quartz dust.”  IARC (2012) also noted that c-silica is carcinogenic to rats 
following exposure by inhalation or intratracheal instillation, but no evidence of lung cancer has been 
observed in c-silica-exposed mice or hamsters; the basis of these species differences has not been
established.  NIOSH (2002) and the NTP 13th Report on Carcinogens (NTP 2014) also have concluded 
that c-silica (respirable size) is a human carcinogen.
Issues and Confounding Factors for Lung Cancer. The IARC (1997) Group 1 classification for c-silica
was considered controversial due, in part, to inconsistent results of occupational exposure studies and the
lack of exposure-response data (Brown 2009; Cox 2011; Gamble 2011; NIOSH 2002; Pelucchi et al. 
2006; Soutar et al. 2000; Steenland 2005; Steenland and Ward 2014).  The IARC working group 
acknowledged that some occupational exposure studies did not show an association between c-silica 
exposure and lung cancer, possibly due to the characteristics of c-silica in different occupational settings
or other factors affecting its biological activity.  However, other confounding factors and biases may
influence study results, including errors in estimating c-silica exposure levels, absence of (or presence and 
severity of) silicosis, adequate control of confounding from smoking, and unaccounted occupational co-
exposures that may have contributed to lung cancer risk.  In addition, compared to other occupational
lung carcinogens, such as asbestos, the risk of c-silica-induced lung cancer is low, requiring large study
populations to achieve adequate power to detect c-silica-related cancer risk.  Therefore, pooled and meta-
analyses provide the strongest support of the carcinogenicity of c-silica in the lung. Several pooled and 
meta-analyses have been published since the IARC (1997) evaluation, providing information on the
exposure-response relationship between c-silica and lung cancer and the relationship between silicosis 
status and lung cancer.
Exposure-Response Data for Lung Cancer. Pooled and meta-analyses of the relationship between
cumulative exposure to c-silica and lung cancer are summarized in Table 3-14 (Finkelstein 2000; Lacasse 
et al. 2009; Steenland et al. 2001a, 2005).  Steenland et al. (2001a, 2005) conducted a pooled exposure-
response analysis of 65,980 c-silica exposed workers from diatomaceous earth, granite, pottery, and 
mining industries.  Silicosis status of each worker was undefined in the analysis.  For the pooled cohort
(mean cumulative exposure: 4.27 mg/m3-year), the SMR for lung cancer was 1.2 (95% CI: 1.1, 1.3), 
indicating a 20% increase in the risk of lung cancer.  Increasing exposure was significantly associated
with increased lung cancer risk. The exposure-response relationship for the pooled cohort stratified by
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Table 3-14.  Meta- or Pooled-Analysis of Exposure-Response Data for Lung Cancer in Workers Exposed to 
c-Silica
Reference Studies in analysis	 Methods and exposure Outcomes
Finkelstein 2000	 Hnizdo and Sluis-Cremer 1993
- Nested case-control study (data from
Hnizdo and Sluis-Cremer 1991)
- South Africa; gold miners
Checkoway et al. 1997 
- Cohort study
- United States; diatomaceous earth 
workers
Lacasse et al.	 Cohort studies: Checkoway et al. 1997
2009	 (United States; diatomaceous earth 
workers); Steenland and Sanderson 2001 
(United States; industrial sand workers);
Brown and Rushton 2005 (United Kingdom;
industrial sand workers); Pukkala et al. 2005 
(Finland; miscellaneous)
Case-control studies: Ulm et al. 1999 
(Germany; miners, foundry and quarry
workers); Bruske-Hohlfeld et al. 2000 (China;
miners and pottery workers); Cocco et al.
2001 (China; miners and pottery workers);
Chen et al. 2007 (China; miners and pottery
workers); Westberg and Bellander 2003 
(Sweden; aluminum foundry workers);
Hughes et al. 2001 [updated by McDonald et
Study type: meta-analysis on lung
cancer in c-silica-exposed workers
with undefined silicosis status
Literature search dates: not reported
Adjustments:  no adjustment for
exposure to radon daughters in gold 
mining cohorts
Statistical analysis: weighted least
squares estimate of the regression 
slope of the logarithm of the OR (or
RR) versus exposure was computed 
for each study; inverse of the variance 
of log (OR) used as the regression 
weight; regression slopes were 
combined using an inverse variance-
weighted average
Exposure: not reported
Study type: dose-response meta-
analysis examining the relationship 
between cumulative exposure 
(mg/m3-year) to c-silica and lung
cancer in workers with undefined 
silicosis status
Literature search dates: 1966– 
December 2007
Statistical analysis: data from all
studies were pooled into a joint
analysis; spline regression models
were used; heterogeneity between 
different studies was modeled by an 
additional random component of
variance; responses were evaluated 
for no lag time; post-hoc analysis of
subset of more homogenous studies
Slope (95% CI) of log (RR) versus lagged 
cumulative exposure (mg/m3-year):
- Hnzido et al. 1997: 0.48 (0.18, 0.78);
lagged 20 years
- Checkoway et al. 1997: 0.10 (0.01,
0.20); lagged 15 years
- Weighted average: 0.14 (0.05, 0.23)
Estimated RR of lung cancer relative to 





- 1 mg/m3-year: 1
 
- 2 mg/m3-year: 1.15 (1.09, 1.20)
 
- 3 mg/m3-year: 1.32 (1.26, 1.38)
 
- 4 mg/m3-year: 1.51 (1.44, 1.59)
 
- 5 mg/m3-year: 1.74 (1.65, 1.82)
 
Number of c-silica-exposed workers in all
cohort studies: 1,608,635a 
Number of workers in all case control
studies: 1,726 cases; 4,746 controls
Results including all studies: 
Heterogeneity was observed across
studies.
The risk of lung cancer increased with
 
increasing exposure to c-silica.





- 1.0 mg/m3-year: 1.22 (1.01, 1.47)
 
- 6.0 mg/m3-year: 1.84 (1.48, 2.28)
 
Estimated threshold for lung cancer:
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Table 3-14.  Meta- or Pooled-Analysis of Exposure-Response Data for Lung Cancer in Workers Exposed to 
c-Silica




al. 2005] (United States; industrial sand 
workers)
10 Cohorts (C)
- C1: Checkoway et al. 1997; United 
States; diatomaceous earth workers (non-
mine)
- C2: Koskela et al. 1994: Finland; granite 
workers (non-mine)
- C3:Costello and Graham (1998); United 
States; granite workers (non-mine)
- C4: Steenland et al. 2001a; United States;
industrial sand workers (non-mine)
- C5: Chen et al. 1992; China; pottery
workers (non-mine)
- C6: Chen et al. 1992; China; tin miners
- C7: Chen et al. 1992: China; tungsten
miners
- C8: Hnizdo et al. 1997; South Africa; gold 
miners
- C9: Steenland et al. 1995b; United States;
gold miners
was conducted
Exposure: not reported for overall
cohort or individual studies
Study type: pooled exposure-
response analysis examining the 
relationship between cumulative 
exposure (mg/m3-year) to c-silica and
lung cancer in workers with undefined 
silicosis status
Literature search dates: not reported
Adjustments: not applicable
Statistical analysis: nested case-
control analyses using conditional
logistic regression; matched for age,
race, sex, date of birth; excess
lifetime risk estimated by spline model
with 15-year lag 





Post-hoc analysis of a subset of more 
homogenous studies (n=8; excluding Ulm
et al. 1999 and Hughes et al. 2001)
revealed similar results (numeric data not
reported).
Study authors note that interpretation of
results “is however limited by the wide 
range of exposure to respirable c-silica
reported in the original studies, the 
heterogeneity across studies, and the 
confounding effect of silicosis that cannot
be fully assessed.”
SMRs (95% CI) for lung cancer
C1:
- Number of workers: 2,342
- Number of lung cancer deaths: 77
- SMR: 1.3 (1.0, 1.6)
C2:
- Number of workers: 1,026
- Number of lung cancer deaths: 38
- SMR: 1.4 (1.0, 2.0)
C3:
- Number of workers: 5,408
- Number of lung cancer deaths: 124
- SMR: 1.2 (1.0, 1.3)
C4:
- Number of workers: 4,027
- Number of lung cancer deaths: 85
- SMR: 1.6 (1.2, 1.98)
C5:
- Number of workers: 9,017
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Table 3-14.  Meta- or Pooled-Analysis of Exposure-Response Data for Lung Cancer in Workers Exposed to 
c-Silica
Reference Studies in analysis Methods and exposure Outcomes


















- Number of lung cancer deaths: 68
- SMR: 1.1 (0.84, 1.4)
C6:
- Number of workers: 7,858
- Number of lung cancer deaths: 97
- SMR: 2.1 (1.7, 2.6)
C7:
- Number of workers: 28,481
- Number of lung cancer deaths: 135
- SMR: 0.63 (0.53, 0.75)C8:
- Number of workers: 2,260
- Number of lung cancer deaths: 77
- SMR: not calculated (no comparison 
rates available for South Africa)
C9:
 
- Number of workers: 3,348
 
- Number of lung cancer deaths: 156
 




- Number of workers: 2,213
 
- Number of lung cancer deaths: 135
 
- SMR: 1.8 (1.5, 2.1)
 
Pooled cohort (study authors note “that
 




- Number of workers: 65,980
 
- Number of lung cancer deaths: 992
 
- SMR: 1.2 (1.1, 1.3)
 






Q2: 1.0 (0.85, 1.3)
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Table 3-14.  Meta- or Pooled-Analysis of Exposure-Response Data for Lung Cancer in Workers Exposed to 
c-Silica
Reference Studies in analysis Methods and exposure Outcomes
Q3: 1.3 (1.1, 1.7)
 
Q4: 1.5 (1.2, 1.9)
 
Q5: 1.6 (1.3, 2.1)
 
Spline curve analysis showed an 

exposure-related monotonic increase in 

risk of death due to lung cancer.
 






Q2: 1.0 (0.83, 1.3)
 
Q3: 1.3 (1.0, 1.6)
 
Q4: 1.5 (1.2, 1.8)
 
Q5: 1.5 (1.2, 1.9)
 






Q2: 0.9 (0.66, 1.2)
 
Q3: 0.81 (0.59, 1.1)
 
Q4: 1.2 (0.89, 1.6)
 
Q5: 1.4 (1.0, 1.9)
 






Q2: 1.2 (0.92, 1.6)
 
Q3: 2.1 (1.6, 2.8)
 
Q4: 1.7 (1.2, 2.4)
 
Q5: 1.5 (0.97, 2.4)
 
Estimated excess lifetime risk (95% CI),
above background risk lifetime risk of 3– 
6% for death due to lung cancer, for
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Table 3-14.  Meta- or Pooled-Analysis of Exposure-Response Data for Lung Cancer in Workers Exposed to 
c-Silica
Reference Studies in analysis Methods and exposure Outcomes
exposure to 0.1 mg/m3 respirable c-silica
 
for 45 years, by location:
 
- China: 1.1% (0.1, 2.3)
 
- United States: 1.7% (0.2, 3.6)
 
- Finland: 1.3% (0.1, 2.9)
 
aHigh number due 1.6 million c-silica-exposed workers participating in the 1970 Finnish national census (Pukkala et al. 2005).
CI = confidence interval; OR = odds ratio; RR = risk ratio; SMR = standardized mortality ratio
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SILICA 132
3. HEALTH EFFECTS
cumulative exposure quintiles (<0.4 [referent]; 0.4–2.0; 2.0-5.4, 5.4–12.8, and >12.8 mg/m3-year) showed
increased ORs for lung cancer at cumulative exposures >2.0 mg/m3-year, based on both no lag time and a
15-year lag time.  A significant positive trend was observed using the log of cumulative exposure lagged 
for 15 years (p=0.015; coefficient=0.062).  For a 45-year exposure to 0.1 mg/m3, the estimated excess for
death due to lung cancer was 1.1–1.7% above a background lifetime risk for death due to lung cancer of
3–6%.  A meta-analysis of over 1.6 million c-silica-exposed workers with undefined silicosis status from
diatomaceous earth, industrial sand, mining, foundry, quarry, and pottery industries showed an exposure-
response relationship between cumulative c-silica exposure and lung cancer (Lacasse et al. 2009).  For
cumulative exposures of 1.0 and 6.0 mg/m3-year, estimated risk ratios (95% CI) were 1.22 (1.01, 1.47)
and 1.84 (1.48, 2.28), respectively.  The exposure-response relationship between cumulative exposure to 
c-silica and relative risk of lung cancer (no lag time) is shown in Figure 3-3.  The study authors stated that
results showed an exposure-response relationship with an estimated exposure threshold for lung cancer of
>1.84 mg/m3-year.  Based on a meta-analysis of two studies, Finkelstein (2000) estimated increased risk
ratios for cumulative exposures ≥2.0 mg/m3-year, with estimated RRs (95% CI) ranging from 1.15 (1.09, 
1.20) to 1.74 (1.65, 1.82) for exposures ranging from 2.0 to 5 mg/m3-year, respectively.
Lung Cancer and the Role of Silicosis. Numerous studies have explored the relationship between
silicosis and increased risk of lung cancer (Brown 2009; Checkoway 2000; Checkoway and Franzblau 
2000; Cox 2011; NIOSH 2002; Pelucchi et al. 2006; Smith et al. 1995; Soutar et al. 2000; Steenland and 
Ward 2014).  Details of recent meta- or pooled analyses providing information on the relationship 
between silicosis status and increased risk of lung cancer are provided in Table 3-15 (Erren et al. 2009b; 
Kurihara and Wada 2004; Pelucchi et al. 2006).  In general, studies show that the risk of lung cancer is 
increased in workers with and without silicosis, but the association between workers with silicosis and
lung cancer is stronger than for workers without silicosis.  For workers with silicosis, risk ratios and
SMRs (95% CI) ranged from 1.52 (1.02, 2.26) to 4.47 (3.17, 6.30), compared to a range of 0.97 (0.69,
1.38) to 1.2 (1.0, 1.4) for workers without silicosis.
Crystalline Silica, Smoking, and Lung Cancer. Adjusting for potential confounding bias from smoking is
important in studies examining the association between c-silica and lung cancer, because smoking is a 
risk factor for lung cancer (Brown 2009; Cox 2011; NIOSH 2012).  However, smoking may also interact
with silica to produce lung cancer. Results of a retrospective study in China showed increased lung
cancer risk in never-smokers in association with c-silica exposure and that the change in risk with 
increasing exposure was similar in never-smokers and ever-smokers (Table 3-16) (Liu et al. 2013).  The
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Figure 3-3.  Dose-Response Relationship Between Exposure to Silica and Relative 

Risk of Lung Cancer with its 95% Confidence Limit (No Lag Time)
 
Source:  Lacasse et al. (2009); reproduced with permission of Kluwer Academic Publishers (Dordrecht) via Copyright
Clearance Center.
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Table 3-15.  Meta- or Pooled-Analyses for Lung Cancer in c-Silica Workers Based on Silicosis Status
Reference Studies in analysis Exposure and methods Outcomes
Erren et al. A. Workers without silicosis
2009a, 2009b
Cohort studies: Armstrong et al. 1979 
(Australia; miners); Puntoni et al. 1988 (Italy;
refractory brick workers); Mehnert et al. 1990 
(Germany; quarry workers); Amandus and
Costello 1991 (United States; miners); Dong 
et al. 1995 (China; refractory brick workers);
Finkelstein 1995 (Canada; miscellaneous
industries); Meijers et al. 1996 (Netherlands;
ceramic workers); Checkoway et al. 1999
(United States; diatomaceous earth workers)
Case-control studies: Armstrong et al. 1979 
(Australia; miners); Mastrangelo et al. 1988 
(Italy; miscellaneous industries); Lagorio et
al. 1990 (Italy; ceramic workers); Sherson et
al. 1991 (Denmark; foundry workers)
B. Workers with undefined silicosis status
Cohort studies: Armstrong et al. 1979 
(Australia; miners); Neuberger et al. 1986 
(Austria; miscellaneous); Westerholm et al.
1986 (Sweden; miscellaneous); Finkelstein et
al. 1987 (Canada; miners); Zambon et al.
1987 (Italy; miscellaneous); Puntoni et al.
1988 (Italy; refractory brick); Infante-Rivard et
al. 1989 (Canada; miscellaneous); Mehnert
et al. 1990 (Germany; quarry workers); Ng et
al. 1990 (China; miscellaneous); Tornling et
al. 1990 (Sweden; miscellaneous); Amandus
and Costello 1991 (United States, miners);
Amandus et al. 1991 (miscellaneous); Chen 
et al. 1992 (China; miscellaneous); Dong et
al. 1995 (China; refractory brick workers);
Study type: meta-analysis on lung A. For c-silica-exposed workers without
cancer in c-silica-exposed workers: silicosis
(A) without silicosis, and (B) with 
undefined silicosis status
Total number of workers included in 
Literature search dates: 1966 through analysis: not reported
January 2007
Risk ratios (95% CI) for:
Adjustments: Three studies adjusted - Entire cohort: 1.2 (1.1, 1.3)
for smoking (Dong et al. 1995; Lagorio - Cohorts adjusted for smoking 
et al. 1990; Mastrangelo et al. 1988); (three studies):1.0 (0.8, 1.3)
no smoking adjustment was made for - Cohorts not adjusted for smoking 
other studies (eight studies): 1.2 (1.1, 1.4)
Adjustments: except for smoking, The increased risk of 20% appears to be 
adjustments for individual studies influenced by smoking.
were not reported
B. For c-silica-exposed workers with 
Statistical analysis: a multi-stage undefined silicosis status
strategy approach was used to 
examine heterogeneity between 
studies (fixed-effect summaries and Total number of workers included in 
95% CI for various combinations of analysis: not reported
studies were calculated, with 
individual studies weighted by Risk ratios (95% CI) for:
precision); homogeneity of - All studies combined: 2.1 (1.9, 2.3)
contributing results was analyzed by - Cohort studies: 2.0 (1.7, 2.3)
χ2 statistics; interactions with - Case-control studies: 2.3 (1.8, 2.9)
covariates was examined by meta- - SIR studies: 2.6 (2.1, 3.3)
regression. - Mortality OR studies: 1.8 (1.3, 2.7)
- Studies adjusted for smoking 
Exposure: Not reported for overall (nine studies): 2.2 (1.8, 2.7)
cohort or individual studies - Studies not adjusted for smoking:
2.0 (1.8, 2.3)
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Table 3-15.  Meta- or Pooled-Analyses for Lung Cancer in c-Silica Workers Based on Silicosis Status
Reference Studies in analysis Exposure and methods Outcomes
Goldsmith et al. 1995 (miscellaneous);
Meijers et al. 1996 (Netherlands; ceramic
workers); Starzynski et al. 1996 (Poland;
miscellaneous); Wang et a; 1996 (China;
metal workers); de Klerk and Musk 1998 
(Australia; gold miners); Checkoway et al.
1999 (United States; diatomaceous earth 
workers); Chan et al. 2000 (China;
miscellaneous); Carta et al. 2001 (Italy; metal
miners); Berry et al. 2004 (Australia;
miscellaneous); Ulm et al. 2004 (Germany;
quarry)
Case-control studies: Steenland and 
Beaumont 1986 (United States; granite 
workers); Mastrangelo et al. 1988 (Italy;
miscellaneous); Cocco et al. 1990 (Italy,
miscellaneous); Lagorio et al. 1990 (Italy;
miscellaneous); Hnzido et al. 1997 (South 
Africa; gold miners); Finkelstein 1998 
(Canada; miscellaneous); Cocco et al. 2001 
(China; miscellaneous); Tsuda et al. 2002
(Japan; refractory brick)
SIR studies: Chia et al. 1991 (Singapore;
miscellaneous); Sherson et al. 1991 
(Denmark; foundry workers); Partanen et al.
1994 (Finland; miscellaneous); Oksa et al.
1997 (Finland; miscellaneous).
Mortality OR studies: Schuler et al. 1986
(Switzerland; miscellaneous); Forastiere et
al. 1989 (Italy; ceramic workers)
Homogeneity statistics indicated a
substantial difference between studies,
although tests for publication bias were 
negative.
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Table 3-15.  Meta- or Pooled-Analyses for Lung Cancer in c-Silica Workers Based on Silicosis Status
Reference Studies in analysis Exposure and methods Outcomes
Kurihara and A. Workers without silicosis
Wada 2004
Cohort studies: Mehnert et al. 1990 
(Germany; quarry workers); Amandus et al.
1995 (United States; dusty trade workers);
Dong et al. 1995 (China; brick workers);
Finkelstein 1995 (Canada; miners and other
workers); Meijers et al. 1996 (Netherlands;
ceramic workers); Checkoway et al. 1999
(California; diatomaceous earth miners)
Case-control studies: Mastrangelo et al. 1988 
(Italy; miscellaneous industries); Forastiere et
al. 1986 (Italy; quarry workers; ceramic
workers)
B. Workers with undefined silicosis status
Cohort studies: Costello and Graham 1988 
(Vermont; granite workers); Guenel et al.
1989 (Denmark; stone workers); Mehnert et
al. 1990 (Germany; quarry workers); Merlo et
al. 1991 (Italy; brick workers); Sherson et al.
1991 (Denmark; foundry workers); Cocco et
al. 1994 (Italy; miners); Costello et al. 1995 
(United States; stone crushers); Dong et al.
1995 (China; brick workers); Steenland and 
Brown 1995b (South Dakota; gold miners);
Meijers et al. 1996 (Netherlands; ceramic
workers); Rafnsson and Gunnarsdottir 1997 
(Iceland; diatomaceous earth workers);
Cherry et al. 1998 (United Kingdom; pottery
workers); de Klerk and Musk 1998 (Australia;
gold miners); Checkoway et al. 1999 
(California; diatomaceous earth workers);
McDonald et al. 2001 (United States and 
Study type: meta-analysis on lung A. Workers without silicosis
cancer in c-silica-exposed workers: Risk ratios (95% CI) for lung cancer
(A) without silicosis; (B) with (combined cohort and case-control
undefined silicosis status; (C) with studies: 0.96 (0.81, 1.15)
silicosis; and (D) with silicosis by
smoking status B. Workers with undefined silicosis
status
Literature search dates: 1966–2001 Risk ratios (95% CI) for lung cancer:
- Cohort studies: 1.29 (1.20, 1.40)
Adjustments: adjustments in individual - Case-control studies: 1.42 (1.22, 1.65)
studies included, age, sex, calendar - All studies: 1.32 (1.23, 1.41)
period, race, region, smoking;
individual studies may not have C. Workers with silicosis
included all adjustments listed Risk ratios (95% CI) for lung cancer:
- Cohort studies: 2.49 (2.08, 2.99)
Statistical analysis: random effects - Case-control studies: 1.89 (1.45, 2.48)
model; publication bias assessed by - All studies: 2.37 (1.98, 2.84)
funnel plot and Kendall rank
correlation test; association between D. Workers with silicosis by smoking
standardized effects and precision status
assessed by linear regression test - Risk ratio (95% CI) for lung cancer in 
intercept analysis smokers with silicosis: 4.47 (3.17,
6.30)
Exposure: not reported for overall - Risk ratio (95% CI) for lung cancer in 
cohort or individual studies nonsmokers with silicosis: 2.24 (1.46,
3.43)
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Table 3-15.  Meta- or Pooled-Analyses for Lung Cancer in c-Silica Workers Based on Silicosis Status
Reference Studies in analysis Exposure and methods Outcomes
Canada; sand workers); Steenland et al.
2001a (United States; sand workers); Stern 
et al. 2001 (plasterers and masons)
Case-control studies: Forastiere et al. 1986 
(Italy; quarry workers; ceramic workers);
McLaughlin et al. 1992 (China; iron-copper
miners; potteries workers; tin miners;
tungsten miners); De Stefani et al. 1996 
(Uruguay; miscellaneous); Cherry et al. 1998
(United Kingdom; pottery and sandstone
workers); Ulm et al. 1999 (Germany; ceramic
workers; quarry workers); Bruske-Hofeld et
al. 2000 (Germany; miscellaneous); Martin et
al. 2000 (France; miscellaneous);
Szadkowska-Stanczyk and Szymczak 2001
(Poland; pulp and paper workers)
C. Workers with silicosis
Cohort studies: Infante-Rivard et al. 1989 
(Canada; miscellaneous); Ebihara et al. 1990 
(Japan; miscellaneous); Mehnert et al. 1990 
(Germany; quarry workers); Amandus et al.
1995 (United States; dusty trade workers);
Dong et al. 1995 (China; brick workers);
Meijers et al. 1996 (Netherlands; ceramic
workers); Brown et al. 1997 (Sweden;
miscellaneous); Oksa et al. 1997 (Finland;
miscellaneous); Finkelstein 1998 (Canada;
miners); Checkoway et al. 1999 (California;
diatomaceous earth workers); Chan et al.
2000 (Hong Kong; miscellaneous)
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Table 3-15.  Meta- or Pooled-Analyses for Lung Cancer in c-Silica Workers Based on Silicosis Status
Reference Studies in analysis Exposure and methods Outcomes
Case-control studies: Mehnert et al. 1990 
(Germany; quarry workers); Amandus et al.
1992 (North Carolina; dusty trade workers);
Dong et al. 1995 (China; brick workers); 
Finkelstein 1995 (Canada; miners and other
workers); Meijers et al. 1996 (Netherlands;
ceramic workers); Checkoway et al. 1999
(California; diatomaceous earth miners)
D. Workers with silicosis by smoking status
Cohort studies with silicosis based on 
smoking: Dong et al. 1995 (China; brick
workers); Amandus et al. 1995 (United 
States; dusty trade workers); Ebihara et al.
1990 (Japan; miscellaneous); Ebihara and 
Kawami 1998 (Japan; miscellaneous);
Infante-Rivard et al. 1989 (Canada;
miscellaneous); Oksa et al. 1997 (Finland;
miscellaneous)
Case-control studies: Mastrangelo et al. 1988 
(Italy; miscellaneous industries); Hnizido et
al. 1997 (South Africa; gold miners)
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Table 3-15.  Meta- or Pooled-Analyses for Lung Cancer in c-Silica Workers Based on Silicosis Status
Reference Studies in analysis Exposure and methods Outcomes
Pelucci et al. A. Workers without silicosis
Cohort studies: Checkoway et al. 1999
(United States; diatomaceous earth workers);
Case-control studies: Ulm et al. 1999 
(Germany; stone, quarry, and ceramic
workers)
B. Workers with undefined silicosis status
Cohort studies: Brown and Rushton 2005 
(United Kingdom; industrial sand workers);
Checkoway et al. 1997 (United States;
diatomaceous earth workers); Checkoway et
al. 1996 (United States; phosphate industry);
Cherry et al. 1998 (United Kingdom; pottery 
refractory and sandstone workers); Chiazze
et al. 1997 (United States; filament glass
workers); Coggiola et al. 2003 (Italy; talc
miners and millers); de Klerk and Musk 1998 
(Australia; gold miners); Finkelstein and 
Verma 2005a (Canada; brick workers);
Graham et al. 2004 (United States; granite 
workers); Kauppinen et al. 2003 (Finland;
asphalt workers); McDonald et al. 2005 
(United States; industrial sand workers);
Merlo et al. 2004 (Italy; graphite electrode 
manufacturing); Moshammer and Neuberger
2004 (Austria; miscellaneous); Moulin et al.
2000 (France; stainless steel workers);
Ogawa et al. 2003 (stone cutters); Pukkala et
al. 2005a (Finland; miscellaneous); Rafnsson 
and Gunnarsdottir 1997 (Iceland;
diatomaceous earth workers); Smailyte et al.
2004 (Lithuania; cement production);
Study type: pooled-analysis on lung A. Workers without silicosis
cancer in c-silica-exposed workers: Relative risks (95% CI) (random effects
(A) without silicosis; (B) with model)
 
undefined silicosis status; and (C) with - Cohort studies: 1.19 (0.87, 1.57)
 
silicosis - Case-control studies: 0.97 (0.68, 1.38)
 
Literature search dates: 1996–July B. Workers with undefined silicosis
2005 (studies published after the status
IARC 1997 assessment) Relative risks (95% CI) (random effects
model)
Adjustments: not reported for overall - Cohort studies: 1.25 (1.18, 1.33)
cohort; some adjustments reported for - Case-control studies: 1.41 (1.18, 1.70)
individual studies
Statistical analysis: pooled relative C. Workers with silicosis
risks calculated according to study Relative risks (95% CI) (random effects
design, using fixed and random effect model)
models - Cohort studies: 1.69 (1.32, 2.16)
- Case-control studies: 3.27 (1.32, 8.2)
Exposure: not reported for overall
cohort All cohort studies, for any silicosis status
- Relative risk (95% CI) (random effects
model): 1.34 (1.25, 1.45)
- Relative risk (95% CI) (fixed effects
model): 1.19 (1.16, 1.21)
All case-control studies, for any silicosis 
status
- Relative risk (95% CI) (random effects
model): 1.41 (1.18, 1.67)
- Relative risk (95% CI) (fixed effects
model): 0.99 (0.98, 1.00)
By occupational setting
Cohort studies (number of cohorts) and 
relative risks (95% CI)
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Table 3-15.  Meta- or Pooled-Analyses for Lung Cancer in c-Silica Workers Based on Silicosis Status
Reference Studies in analysis Exposure and methods Outcomes
Steenland and Greenland 2004 (United 
States; industrial sand workers); Stone et al.
2004 (United States; fiberglass workers)
Case-control studies: Bruske-Hohlfeld et al.
2000 (Germany; miscellaneous); Calvert et
al. 2003 (United States; miscellaneous);
Chen and Chen 2002a (China; tin miners);
Cocco et al. 2001a (miners and pottery 
factory workers); De Stefani et al. 1996 
(Uruguay; miscellaneous); Hnizdo et al.
1997a (South Africa; cold miners); Martin et
al. 2000 (France; electricity and gas
workers); Menvielle et al. 2003 (New
Caledonia; miscellaneous); Rodriguez et al.
2000a (Spain; iron and steel foundry
workers); Szadkowska-Stanczyk and 
Szymczak 2001 (Poland; pulp and paper
workers); Tsuda et al. 2002 (China; refractory
brick workers); Watkins et al. 2002a (United 
States; roofing manufacturing and asphalt
production workers); Westberg and Bellander
2003a (Sweden; foundry workers)
C. Workers with silicosis
Cohort studies: Berry et al. 2004 (South New
Wales; miscellaneous); Brown et al. 1997 
(Sweden; miscellaneous); Carta et al. 2001 
(Italy; miners and quarry workers); Chan et
al. 2000 (China; miscellaneous); Checkoway
et al. 1999 (United States; diatomaceous
earth workers); Starzynski et al. 1996 
(Poland, miscellaneous); Ulm et al. 2004 
(Germany; stone and quarry workers)
- Miners (3): 1.17 (1.03, 1.32)
- Sand workers (3) 1.29 (1.03, 1.61)
- Ceramic, diatomaceous earth, and 
refractory brick workers (4): 1.40 (1.11,
1.75)
- Miscellaneous exposure (10):
1.17 (1.12, 1.22)
Case-control studies (number of cohorts)
and relative risks (95% CI)
- Miners (4): 1.47 (1.19, 1.82)
- Sand workers (0): –
- Ceramic, diatomaceous earth, and 
refractory brick workers (3): 1.26 (0.99,
1.62)
- Miscellaneous exposure (10):
1.24 (1.02, 1.52)
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Table 3-15.  Meta- or Pooled-Analyses for Lung Cancer in c-Silica Workers Based on Silicosis Status
Reference Studies in analysis Exposure and methods Outcomes
Case-control studies: Finkelstein 1998 
(Canada; miscellaneous)
aStudies included in analysis by occupational setting.
 
CI = confidence interval; OR = odds ratio; SIR = standardized incidence ratio
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Table 3-16.  Lung Cancer Risk in Smokers and Nonsmokers Exposed to c-Silica
Study design and 
Reference industry Cohort and methods Exposure Outcome
Liu et al. 2013	 Study design:
retrospective cohort
Industry: metal miners,
pottery workers in China
Cohort: 34,018 Chinese workers Exposure quartiles (Q) Nonsmokers
(86% male) not likely exposed to (mg/m3-year): Lung cancer/nonsmokers in quartile:
other lung carcinogens; employed - Q1: 0 - Q1: 27/4960
during 1960–1974, with follow-up to - Q2: >0 - Q2: 50/7211
2003 - Q3: <1.12 - Q3: 34/7285
- Q4: ≥1.12 - Q4: 43/4886
Methods: To investigate the joint HRs (95% CI):
effect of silica and smoking, hazard - Q1: 1
ratios were estimated by crossed - Q2: 1.10 (0.68-1.78)
dichotomized silica exposure - Q3: 1.0
(exposed = A+, unexposed = A−) - Q4: 1.60 (1.01, 2.55)
and smoking (ever smokers = B+,
never smokers = B−) Smokers
Lung cancer deaths in smokers/smokers
Adjustments: facility, sex, year of in quartile:







HRs (95% CI) in smokers:
 
- Q1: 2.75 (1.74, 4.35)
 
- Q2: 3.83 (2.48, 5.90)
 
- Q3: 3.42 (2.32, 5.05)
 
- Q4: 5.07 (3.41, 7.52)
 
Study authors stated that “the joint effect
of [c-]silica and smoking was more than 
additive and close to multiplicative.”
CI = confidence interval; HR = hazard ratio
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study authors stated that “the joint effect of [c-]silica and smoking on lung cancer was more than additive
and close to multiplicative.”
Other Cancers. Cancers of the esophagus, stomach, intestine, and kidney have been reported in c-silica-
exposed workers; however, associations between c-silica and these cancers have not been thoroughly
studied or established (IARC 2012; NIOSH 2002).  In general, findings of these studies have been 
inconsistent and studies often include co-exposures to other risk factors (Brown 2009).  In many cases, 
observations of cancers other than lung were made in studies investigating the association between
c-silica exposure and lung cancer, and appropriate adjustments for confounding factors were not
considered (Chen and Tse 2012; NIOSH 2002).  
Amorphous Silica. A limited number of human studies have reported an increased risk of lung cancer or
mesothelioma in industries with occupational exposure to a-silica; however, the usefulness of these
studies is limited due to potential co-exposure to c-silica and lack of quantitative exposure data.
The mortality from lung cancer was increased in workers exposed to silica (both amorphous and quartz)
(SMR: 1.43; 95% CI: 1.09, 1.84) in a cohort of 2,570 diatomaceous earth workers (Checkoway et al. 
1993).  However, the contribution of a-silica to increased mortality is unknown, as a separate analysis for
the population of workers exposed only to a-silica (n=129) was not conducted.  Similarly, an increased 
risk for lung cancer was observed in a cohort of 231 refractory brick workers exposed to a mixture of
a-silica and c-silica; however, only c-silica levels were measured (McLaughlin et al. 1997; Merget et al.
2002).  
A limited number of reports from the sugarcane industry suggest a potential increased risk for lung cancer
and/or mesothelioma in sugarcane farmers, although available data are inconclusive.  Since sugarcane
farmers are exposed to biogenic a-silica fibers (IARC 1997), this suggests a possible association between 
biogenic a-silica fiber exposure and lung cancer and/or mesothelioma; however, exposure levels to 
a-silica were not available in these studies, and sugarcane workers are also exposed to c-silica during the
harvesting process when sugarcane plants are burned (Le Blond et al. 2010). A case-series report from
India suggested that five observed cases of mesothelioma in sugarcane workers with no known exposure 
to asbestos could have been due to biogenic a-silica fiber exposure (Das et al. 1976).  In a case-control
study, an increased risk of lung cancer was observed in sugarcane farmers in Southern Louisiana (RR:
2.3; 95% CI: 1.8–3.0) (Rothschild and Mulvey 1982).  When stratified by smoking, the association was
only observed in farmers who were also smokers (OR: 2.6; 95% CI 1.8–4.0).  However, other case-
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control studies did not find associations between working at, or living near, a sugarcane farm and 
increased risk for lung cancer or mesothelioma (Brooks et al. 1992; Sinks et al. 1994).
No treatment-related tumors were reported in monkeys, rats, or guinea pigs following exposure to fumed, 
precipitated, or gel a-silica at up to 9.9 mg/m3 for 6 hours/day, 5 days/week for up to 18 months (Groth et
al. 1981) or rats, guinea pigs, or rabbits following exposure to precipitated a-silica at 126 mg/m3 for 
8 hours/day, 7 days/week for 12–24 months (Schepers 1981).
3.2.2 Oral Exposure
Studies in humans and animals have evaluated potential health effects associated with silica levels in
drinking water (Aschengrau et al. 1989; Dobbie and Smith 1982; Gillette-Guyonnet et al. 2005; Jacqmin-
Gadda et al. 1996; Öner et al. 2005, 2006; Radovanovic et al. 1991); however, little information regarding
the potential adverse health effects following oral exposure to silica is available. For most human 
drinking water studies, the silica species is not identified; thus, for the purposes of this assessment, it is
assumed that exposure is to forms of c-silica.  Information on oral a-silica exposure includes a series of
dietary studies in animals reported by Lewinson et al. (1994) and a 2-year dietary bioassay in rats and
mice with 6- and 12-month interim sacrifices (Takizawa et al, 1988).
The highest NOAEL values and all LOAEL values from each reliable study for each end point in each
species and duration category are recorded in Table 3-17 and plotted in Figure 3-4.
3.2.2.1  Death 
Crystalline Silica. No studies evaluating mortality in humans following oral exposure to c-silica were 
identified.
No mortalities were observed in 3-month-old albino rats exposed to 50 mg c-silica/kg/day as sodium
metasilicate in drinking water for 8 days (Öner et al. 2005, 2006).  No mortalities were observed in guinea
pigs exposed to 51 mg c-silica/kg/day as crushed quartz or granite in drinking water for 5 days/week for
4 months (Dobbie and Smith 1982).
Amorphous Silica. In an LD50 study in Sprague-Dawley rats, no deaths were observed during the 4-week
observation period following single oral doses of a-silica up to 7,900 mg/kg in the precipitated 
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Table 3-17  Levels of Significant Exposure to Silica  - Oral 
Exposure/ LOAEL 
Duration/














2 wk 16000 (20% mortality)
(F) 
once Bd Wt 5000
(GO) 
once Bd Wt 7900
(GO) 
8 d Renal 50 M
(W) 
Bd Wt 50 M 
Reference 
Chemical Form 
Lewinson et al. 1994 
Amorphous (fumed Aerosil R 
972) 
Lewinson et al. 1994 
Amorphous (fumed Aerosil R 
972) 
Lewinson et al. 1994 
Amorphous (precipitated 
Sipernat D 17) 




The same animals 
were used in each 
dose group (dose was 
increased in step-wise 
manner every 2 wks). 
No treatment-related 
change in renal 
function (glomerular 
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Lewinson et al. 1994 
Amorphous (fumed Aerosil R 
972) 
Comments 




every 2 wks). 
Hepatic 7500 (severe atrophy of liver 
epithelium) 
Renal 7500 





Resp 500 Lewinson et al. 1994 
Amorphous (fumed Aerosil R 
972) 
No treatment-related 
changes in organ 









Bd Wt 500 
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Table 3-17  Levels of Significant Exposure to Silica  - Oral	 (continued) 
Exposure/ LOAEL 
Duration/
a FrequencyKey to Species	 NOAEL Less Serious Serious(Route)Figure (Strain) 











System (mg/kg/day) (mg/kg/day)	 (mg/kg/day) 










Dobbie and Smith 1982 
Crystalline (Quartz) 
Lewinson et al. 1994 
Amorphous (fumed Aerosil R 
972) 
Lewinson et al. 1994 
Amorphous (fumed Aerosil R 
972) 
Lewinson et al. 1994 




changes in immune 
organ weight or 
histology. 
No treatment-related 
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Takizawa et al. 1988 
Amorphous (Syloid 244 silicon 
dioxide) 
Comments 
Organ system NOAELs 
indicate no 
treatment-related 
changes in organ 
weight, histology, or 
clinical chemistry. 
Hemato 2220 M 
2410 F 
Hepatic 2220 M 
2410 F 
Renal 2220 M 
2410 F 
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Cardio 2030 M 
2220 F 
Takizawa et al. 1988 
Amorphous (Syloid 244 silicon 
dioxide) 
No treatment-related 
changes in organ 
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Cardio 1900 M 
2020 F 
Takizawa et al. 1988 
Amorphous (Syloid 244 silicon 
dioxide) 
Organ system NOAELs 
indicate no 
treatment-related 
changes in organ 
weight, histology, or 
clinical chemistry. 
Hemato 1900 M 
2020 F 
Hepatic 1900 M 
480 F 
980 F (14% decrease in liver 
weight) 
Renal 1900 M 
2020 F 
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Cardio 6700 M 
2070 F 
3780 F (19% decrease in heart 
weight) 
Takizawa et al. 1988 
Amorphous (Syloid 244 silicon 
dioxide) 
Organ system NOAELs 
indicate no 
treatment-related 
changes in organ 
weight, histology, or 
clinical chemistry. 
Hemato 6700 M 
9810 F 
Hepatic 6700 M 
3780 F 
9810 F (16% decrease in liver 
weight) 
Renal 6700 M 
2070 F 
3780 F (15% decrease in kidney 
weight) 
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Cardio 6100 M 
1640 F 
2970 F (13% decrease in heart 
weight) 
Takizawa et al. 1988 
Amorphous (Syloid 244 silicon 
dioxide) 
Organ system NOAELs 
indicate no 
treatment-related 
changes in organ 
weight, histology, or 
clinical chemistry. 
Hemato 6100 M 
7560 F 
Hepatic 6100 M 
7560 F 
Renal 6100 M 
7560 F 
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Key to Species Frequency 












































Less Serious Serious 
(mg/kg/day) (mg/kg/day) 




Takizawa et al. 1988 
Amorphous (Syloid 244 silicon 
dioxide) 
Takizawa et al. 1988 
Amorphous (Syloid 244 silicon 
dioxide) 
Takizawa et al. 1988 
Amorphous (Syloid 244 silicon 
dioxide) 
Takizawa et al. 1988 




changes in organ 
weight, histology, or 
clinical chemistry. 
No treatment-related 
changes in spleen 
histology. 
No treatment-related 
changes in spleen 
weight or histology. 
No treatment-related 
changes in spleen 
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Table 3-17  Levels of Significant Exposure to Silica  - Oral (continued) 
a 








































Less Serious Serious 
(mg/kg/day) (mg/kg/day) 




Takizawa et al. 1988 
Amorphous (Syloid 244 silicon 
dioxide) 
Takizawa et al. 1988 
Amorphous (Syloid 244 silicon 
dioxide) 
Takizawa et al. 1988 
Amorphous (Syloid 244 silicon 
dioxide) 
Gillette-Guyonnet et al. 2005 
Unspecified 




changes in spleen 
weight or histology. 
No treatment-related 
changes in spleen 
weight or histology. 
Cognitive function did 
not decline with 
increasing silica 
content in drinking 
water. 
Cognitive function did 
not decline with 
increasing silica 
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Takizawa et al. 1988 








Takizawa et al. 1988 








Takizawa et al. 1988 








Takizawa et al. 1988 








Takizawa et al. 1988 




changes in brain weight 
or histology. 
No treatment-related 
changes in brain weight 
or histology. 
No treatment-related 
changes in brain weight 
or histology. 
No treatment-related 
changes in brain weight 
or histology 
No treatment-related 
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Table 3-17  Levels of Significant Exposure to Silica  - Oral	 (continued) 
a 





























Takizawa et al. 1988 












Lewinson et al. 1994 
Amorphous (fumed Aerosil R 
972) 
Lewinson et al. 1994 




changes in brain weight 
or histology. 
Analysis was adjusted 
for other trace 
elements and water 
characteristics in tap 
water. 
No changes in 
reproductive function. 
No gross anomalies, 
no changes in pup 
growth or survival. 
a The number corresponds to entries in Figure 3-4. 
Bd Wt = body weight; Cardio = cardiovascular; d = day(s); Endocr = endocrine; (F) = feed; F = Female; (G) = gavage; Gastro = gastrointestinal; Gd = gestational day; gen = 
generation; (GO) = gavage in oil; Hemato = hematological; Immuno/Lymphoret = immunological/lymphoreticular; LOAEL = lowest-observed-adverse-effect level; M = male; mo = 
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Figure 3-4  Levels of Significant Exposure to Silica - Oral (Continued)
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SILICA 163
3. HEALTH EFFECTS
hydrophobic silica (PHS) form via gavage in olive oil or 5,000 mg/kg in the fumed hydrophobic silica
form (FHS) via gavage in peanut oil (Lewinson et al. 1994).  
In an intermediate-duration dietary study in Wistar rats, 2/10 males and 2/10 females died during the 8th 
(and final) week of exposure to time-weighted average (TWA) a-silica (FHS) doses of 7,500 mg/kg/day
(Lewinson et al. 1994).  Daily doses were 2,000 mg/kg/day during weeks 0–2, 4,000 mg/kg/day during
weeks 2–4, 8,000 mg/kg/day during weeks 4–6, and 16,000 mg/kg/day during weeks 6–8.  Mortalities
were attributed to acute exposure to the highest administered dose of 16,000 mg/kg/day.  Clinical signs of
toxicity observed during weeks 6–8 included shyness, dirty fur, reduced activity, cachexia, and 
hemorrhage in the mucous membranes of the eyes and nose.  No deaths were observed in rats exposed to 
dietary a-silica (FHS) at doses up to 1,000 mg/kg/day for 5 weeks or 500 mg/kg/day for 6 months
(Lewinson et al. 1994). Mortality in F344 rats and B6C3F1 mice exposed to dietary a-silica (silicon 
dioxide) for 6 months was comparable to controls at doses up to 2,413 and 9,810 mg/kg/day, respectively
(Takizawa et al. 1988)
In a 2-year bioassay, mortality in animals exposed to dietary a-silica (silicon dioxide) was similar to 
controls at doses up to 2,010 mg/kg/day in F344 rats and 6,010 mg/kg/day in B6C3F1 mice (Takizawa et
al. 1988).  Similarly, mortality in Wistar rats exposed to dietary a-silica (FHS) at 100 mg/kg/day for
24 months was comparable to historical controls (concurrent controls were not evaluated) (Lewinson et
al. 1994).  
3.2.2.2  Systemic Effects
The systemic effects reported in a limited number of human and animal studies evaluating oral exposure
to c-silica and a-silica are described below.
Respiratory Effects.
Crystalline Silica. No studies evaluating respiratory effects in humans or animals following oral
exposure to c-silica were identified.
Amorphous Silica. No significant changes in lung weight or histology were observed in Wistar rats
exposed to dietary a-silica (FHS) at 500 mg/kg/day for 6 months, compared with controls (Lewinson et al.
1994).  No changes in lung histology were observed in Wistar rats exposed to dietary a-silica (FHS) at
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100 mg/kg/day for 24 months, compared with historical controls (concurrent controls were not evaluated)
(Lewinson et al. 1994). 
Cardiovascular Effects.
Crystalline Silica. No studies evaluating cardiovascular effects in humans following oral exposure to 
c-silica were identified.
Changes in endothelial vasoactivity of the aorta were observed in 3-month-old albino rats exposed to 
50 mg c-silica/kg-day as sodium metasilicate in drinking water for 8 days, compared with controls;
baseline c-silica content in drinking water was 267 µg/L (Öner et al. 2006).  Observed changes included 
significantly (p<0.05) increased ex vivo contractile responses to phenylephrine and dilation responses to 
acetylcholine, sodium nitroprusside, and the calcium ionophore A-23187 in aortic rings isolated from
exposed rats, compared with aortic rings isolated from controls.  The toxicological significance of these 
findings is not known.
Amorphous Silica. No significant changes in heart weight or histology were observed in Wistar rats 
exposed to dietary a-silica (FHS) at 500 mg/kg/day for 6 months, compared with controls (Lewinson et al.
1994). A significant 19% decrease in heart weight was observed in female B6C3F1 mice exposed to 
dietary a-silica (silicon dioxide) at ≥3,780 mg/kg/day for 26 weeks; heart weights were not decreased in
female B6C3F1 mice at 2,070 mg/kg/day, male B6C3F1 mice at doses up to 6,700 mg/kg/day, or F344 
rats at doses up to 2,410 mg/kg/day (Takizawa et al. 1988).  In the same study, no treatment-related
changes in heart histology were reported in rats or mice exposed for 26 weeks at doses up to 2,410 or
9,810 mg/kg/day, respectively (Takizawa et al. 1988)
In a 2-year dietary bioassay with a-silica (silicon dioxide), no significant changes in heart weight or
histology were observed at doses up to 2,010 mg/kg/day in F344 rats or 6,010 mg/kg/day in B6C3F1 mice
(Takizawa et al. 1988).  However, in the 12-month interim sacrifice, a significant 13–18% decrease in 
heart weight was observed in female mice at ≥2,970 mg/kg/day; heart weights were not decreased in
female mice at 1,640 mg/kg/day, male mice at doses up to 6,100 mg/kg/day, or rats at doses up to 
2,220 mg/kg/day (Takizawa et al. 1988).  No histopathological changes were observed in the heart at the 
12-month interim sacrifice at doses up to 2,220 in rats or 7,560 mg/kg/day in mice (Takizawa et al. 1988).  
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Crystalline Silica. No studies evaluating gastrointestinal effects in humans or animals following oral
exposure to c-silica were identified.
Amorphous Silica. No histopathological changes were observed in the stomach, small intestine, or large
intestine of Wistar rats exposed to dietary a-silica (FHS) at 500 mg/kg/day for 6 months, compared with 
controls (Lewinson et al. 1994).
Hematological Effects.
Crystalline Silica. No studies evaluating hematological in humans or animals following oral exposure to 
c-silica were identified.
Amorphous Silica. No significant changes in hemoglobin, erythrocytes, leukocytes, or differential
leukocyte counts were observed in Wistar rats exposed to dietary a-silica (FHS) at doses up to
1,000 mg/kg/day for 5 weeks, TWA doses of 7,500 mg/kg/day for 8 weeks, or 500 mg/kg/day for
6 months, compared with controls (Lewinson et al. 1994).  In F344 rats, no biologically relevant changes 
in hemoglobin, hematocrit, erythrocytes, leukocytes, or differential leukocyte counts were observed 
following exposure to dietary a-silica (silicon dioxide) at doses up to 2,410 mg/kg/day for 26 weeks, 
2,220 mg/kg/day for 52 weeks, or 2,020 mg/kg/day for 103 weeks, compared with controls (Takizawa et
al. 1988). Similarly, no biologically relevant changes in hemoglobin, hematocrit, erythrocytes, 
leukocytes, or differential leukocyte counts were observed in B6C3F1 mice exposed to dietary a-silica 
(silicon dioxide) at doses up to 9,810 mg/kg/day for 26 weeks, 7,560 mg/kg/day for 52 weeks, or
6,010 mg/kg/day for 93 weeks, compared with controls (Takizawa et al. 1988).
No significant changes in bone marrow histology were observed in Wistar rats exposed to dietary a-silica 
(FHS) at 500 mg/kg/day for 6 months, compared with controls (Lewinson et al. 1994).  
Musculoskeletal Effects. No studies evaluating musculoskeletal effects in humans or animals 
following oral exposure to c-silica or a-silica were identified.
***DRAFT FOR PUBLIC COMMENT***
   
 








     
 
         
  
 
     
    
     
      
     
     
 
    
 
   
    
     
  
   
    
   
 
 
   
   
 
   
   
   
   
    





Crystalline Silica. No studies evaluating hepatic effects in humans or animals following oral exposure to 
c-silica were identified.
Amorphous Silica. Severe atrophy of the hepatic epithelium was observed in male and female Wistar
rats following dietary exposure to TWA a-silica (FHS) doses of 7,500 mg/kg/day for 8 weeks; incidence
data were not provided (Lewinson et al. 1994).  Daily concentrations were 2,000 mg/kg/day during
weeks 0–2, 4,000 mg/kg/day during weeks 2–4, 8,000 mg/kg/day during weeks 4–6, and 
16,000 mg/kg/day during weeks 6–8.  Liver cells showed condensation of the cytoplasm, loss of
basophilic structure, and hyperchromatic and contracted nuclei. These changes were seen sporadically in
females (2/10) exposed to dietary a-silica (FHS) at 1,000 mg/kg/day for 5 weeks, but not males at
1,000 mg/kg/day or either sex at ≤500 mg/kg/day (Lewinson et al. 1994).
No significant changes in liver weight or histology were observed in Wistar or F344 rats exposed to 
dietary a-silica (FHS or silicon dioxide) at doses up to 2,410 mg/kg/day for 6 months, compared with 
controls (Lewinson et al. 1994; Takizawa et al. 1988).  In B6C3F1 mice, a significant 16% decrease in 
liver weight was observed in females exposed to dietary a-silica (silicon dioxide) at a dose of
9,810 mg/kg/day; liver weights were not decreased in female mice at 3,780 mg/kg/day or male mice at
doses up to 6,700 mg/kg/day (Takizawa et al. 1988).  No treatment-related changes in liver histology
were reported in male or female B6C3F1 mice exposed to dietary a-silica (silicon dioxide) for 26 weeks 
at doses up to 6,700 or 9,810 mg/kg/day, respectively (Takizawa et al. 1988).
A significant 14–15% decrease in liver weight was observed in female F344 female rats exposed to
dietary a-silica (silicon dioxide) at doses ≥980 mg/kg/day for 103 weeks; liver weights were not
decreased in females at 480 mg/kg/day for 103 weeks, males at doses up to 910 mg/kg/day for 103 weeks, 
or males or females at doses up to 2,220 mg/kg/day for 52 weeks (Takizawa et al. 1988).  No treatment-
related histopathological lesions in the liver were observed in rats exposed to dietary a-silica (silicon
dioxide) for 52 or 103 weeks at doses up to 2,220 mg/kg/day (Takizawa et al. 1988).  Similarly, no 
histopathological changes in the liver were observed in Wistar rats exposed to dietary a-silica (FHS) at
100 mg/kg/day for 24 months, compared with historical controls (concurrent controls were not evaluated)
(Lewinson et al. 1994). In B6C3F1 mice, no significant changes in liver weight or histology were
observed following exposure to dietary a-silica (silicon dioxide) at doses up to 7,560 mg/kg/day for
52 weeks or 6,010 mg/kg/day for 93 weeks (Takizawa et al. 1988).  
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Crystalline Silica. The relationship between Balkan nephropathy (BN; an endemic chronic kidney
disease of the Balkan Peninsula) and well water chemical composition and characteristics was evaluated
in 366 inhabitants of Petka, Serbia, a village affected by BN, from January 1974 to December 1985 
(Radovanovic et al. 1991).  Silicon dioxide and nitrate content of the 85 wells used by study subjects were 
measured during June and August 1974. Wells used by each study subject for at least 1 year during the 
12-year period, as well as during the 30 preceding years, were identified, and the data were analyzed as 
“person/wells”.  A total of 28 individuals using 24 wells were diagnosed with BN.  Using a multiple
logistic regression model, silicon dioxide levels were significantly positively correlated with developing
BN (regression coefficient ± standard error: 0.0611±0.023; standardized regression coefficient=2.63;
p=0.008).  The mean (± standard deviation) well water silicon dioxide levels in the BN-affected group
(33.79±6.09 mg/L) was 11% greater than the mean (± standard deviation) silicon dioxide levels in the
BN-spared group (30.52±8.02 mg/L).  Additionally, well altitude was significantly negatively correlated 
with developing BN (regression coefficient ± standard deviation: -0.4075±0.016; standardized regression 
coefficient: -2.97; p=0.001).  While significant findings suggest a correlation between silicon dioxide
content in well water and BN, Radovanovic et al. (1991) suggested that the magnitude of change is too 
small to be a biologically plausible cause-effect mechanism.  Additionally, silicon dioxide content of well 
water only explained 6.9% of the total variability.  The study authors proposed that it is more likely that 
the silicon dioxide content in well water is correlated with the disease, rather than the underlying cause of
the BN.  Although the etiology of BN remains unknown, several possible causes have been proposed 
including viral, environmental, and genetic risk factors.  Exposure to trace elements, including silica, are
included in the list of potential risk factors, but current research has been more focused on mycotoxins, 
phytotoxins (particularly aristolochic acid), and genetic predisposition (reviewed by Schiller et al. 2008;
Voice et al. 2006).  Additionally, lower silica content (unspecified form, assumed to be c-silica) has been
reported in wells from BN-endemic villages, compared to higher silica content in well water of the
control villages (reviewed by Voice et al. 2006).
Focal nephritis in the distal tubule and collecting duct was observed in two of six male guinea pigs 
exposed to 51 mg c-silica/kg/day as crushed quartz in drinking water for 5 days/week for 4 months; no 
kidney lesions were observed in the six control animals (Dobbie and Smith 1982).  Observed renal lesions
were most evident in the subcapsular and corticomedullary regions, and included dilation, cystic changes, 
chronic inflammatory infiltrate, increased collagen fibers, and proteinaceous material. No renal lesions
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were observed in animals similarly exposed to 51 mg c-silica/kg/day as crushed granite (Dobbie and 
Smith 1982).  This study indicates that the form of c-silica is important with regard to the degree and
extent of renal toxicity.
No significant changes in glomerular filtration rate or urine output were observed in 3-month-old albino 
rats exposed to 50 mg c-silica/kg-day as sodium metasilicate in drinking water for 8 days, compared with 
controls; the baseline c-silica content in drinking water was 267 µg/L (Öner et al. 2005, 2006).  After
exposure, rats were sacrificed and renal cortical slices were obtained for culture. Total ammonia levels,
ammonia secretion rate, and gamma-glutamyl transpeptidase (γ-GT) were significantly (p<0.05) elevated 
and total glutamine content was significantly (p<0.05) decreased in renal slices from exposed rats,
compared with controls. Ammoniagenesis associated with c-silica exposure could potentially lead to 
altered function of renal proximal tubule cells. The toxicological significance of these findings is not
established.
Amorphous Silica. No histopathological changes in the kidney were observed in Wistar rats exposed to
dietary a-silica (FHS) at doses up to 1,000 mg/kg/day for 5 weeks or at TWA doses of 7,500 mg/kg/day
for 8 weeks, compared with controls (Lewinson et al. 1994).  
No significant changes in liver weight or histology were observed in Wistar or F344 rats exposed to 
dietary a-silica (FHS or silicon dioxide) at doses up to 2,410 mg/kg/day for 6 months, compared with 
controls (Lewinson et al. 1994).  In B6C3F1 mice, a significant 15–22% decrease in kidney weight was 
observed in females exposed to dietary a-silica (silicon dioxide) at ≥3,780 mg/kg/day; kidney weights 
were not decreased in female mice at 2,070 mg/kg/day or male B6C3F1 mice at doses up to 
6,700 mg/kg/day (Takizawa et al. 1988).  No treatment-related changes in kidney histology were reported 
in male or female B6C3F1 mice exposed to dietary a-silica (silicon dioxide) for 26 weeks at doses up to
6,700 or 9,810 mg/kg/day, respectively (Takizawa et al. 1988).
No changes in kidney histology were observed in Wistar rats exposed to dietary a-silica (FHS) at
100 mg/kg/day for 24 months, compared with historical controls (concurrent controls were not evaluated)
(Lewinson et al. 1994). Similarly, no significant changes in kidney weight or histology were observed in 
F344 rats exposed to dietary a-silica at doses up to 2,200 mg/kg/day for 52 weeks or 2,010 mg/kg/day for
103 weeks (Takizawa et al. 1988).  In B6C3F1 mice, no significant changes in kidney weight or histology
were observed following exposure to dietary a-silica at doses up to 7,560 mg/kg/day for 52 weeks or
6,010 mg/kg/day for 93 weeks (Takizawa et al. 1988). 
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Crystalline Silica. No studies evaluating endocrine effects in humans or animals following oral exposure
to c-silica were identified.
Amorphous Silica. No significant changes in adrenal, pituitary, ovary, or testes weights or histology
were observed in Wistar rats exposed to dietary a-silica (FHS) at 500 mg/kg/day for 6 months, compared 
with controls (Lewinson et al. 1994).  Additionally, no histopathological changes were observed in the
thyroid (thyroid weights not recorded).  No changes in testes or ovary histology were observed in male
and female Wistar rats exposed to dietary a-silica (FHS) at 100 mg/kg/day for 24 months, compared with 
historical controls (concurrent controls were not evaluated)  (Lewinson et al. 1994).
Dermal Effects. No studies evaluating dermal effects in humans or animals following oral exposure 
to c-silica or a-silica were identified.
Ocular Effects. No studies evaluating ocular effects in humans or animals following oral exposure to 
c-silica or a-silica were identified.
Body Weight Effects.
Crystalline Silica. No studies evaluating changes in body weight in humans following oral exposure to 
c-silica were identified.
No significant body weight effects were observed in 3-month-old albino rats exposed to 50 mg
c-silica/kg/day as sodium metasilicate in drinking water for 8 days, compared with controls (Öner et al.
2005, 2006); the baseline c-silica content in drinking water was 267 µg/L.
Amorphous Silica. In an LD50 study in Sprague-Dawley rats, no effects on body weight were observed 
during the 4-week observation period following single oral doses of silicon dioxide at PHS doses up to 
7,900 mg/kg or FHS doses up to 5,000 mg/kg (Lewinson et al. 1994).  
In an intermediate-duration study, mean body weight was decreased in male and female Wistar rats 
exposed to TWA a-silica (FHS) doses of 7,500 mg/kg/day for 8 weeks, compared with controls
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(Lewinson et al. 1994).  Dose concentrations were 2,000 mg/kg/day during weeks 0–2, 4,000 mg/kg/day
during weeks 2–4, 8,000 mg/kg/day during weeks 4–6, and 16,000 mg/kg/day during weeks 6–8.  Body 
weight effects were observed during weeks 4–8.  No body weight effects were observed in Wistar rats
exposed to dietary a-silica (FHS) at doses up to 1,000 mg/kg/day for 5 weeks or 500 mg/kg/day for
6 months (Lewinson et al. 1994). Similarly, no significant effects on body weight were observed in F344
rats or B6C3F1 mice exposed to dietary a-silica (silicon dioxide) at doses up to 2,410 or 9,810 mg/kg/day,
respectively, for 26 weeks (Takizawa et al. 1988).
In a chronic-duration study, body weights in Wistar rats exposed to dietary a-silica (FHS) at 
100 mg/kg/day for 24 months were comparable to historical controls (concurrent controls were not
evaluated) (Lewinson et al. 1994). Similarly, no significant body weight effects were observed in F344 
rats exposed to dietary a-silica (silicon dioxide) at doses up to 2,200 mg/kg/day for 52 weeks or
2,010 mg/kg/day for 103 weeks (Takizawa et al. 1988).  In B6C3F1 mice, no significant body weight
effects were observed following exposure to dietary a-silica (silicon dioxide) at doses up to
7,560 mg/kg/day for 52 weeks or 6,010 mg/kg/day for 93 weeks (Takizawa et al. 1988).  
3.2.2.3  Immunological and Lymphoreticular Effects 
Crystalline Silica. No studies evaluating immunological or lymphoreticular effects in humans or animals 
following oral exposure to c-silica were identified.
Amorphous Silica. A significant 18% decrease in spleen weight was observed in female F344 rats 
exposed to dietary a-silica (silicon dioxide) at 2,410 mg/kg/day for 26 weeks (Takizawa et al. 1988).
Spleen weights were not decreased in female F344 rats at ≤1,160 mg/kg/day or male F344 rats at doses up 
to 2,220 mg/kg/day, and no treatment-related histopathological lesions were reported (Takizawa et al.
1988).  No significant changes in thymus or spleen weight or histology were observed in Wistar rats 
exposed to dietary a-silica (FHS) at 500 mg/kg/day for 6 months, compared with controls (Lewinson et al.
1994).  Additionally, no histopathological changes were observed in the lymph nodes.  In B6C3F1 mice, 
a significant 20% decrease in spleen weight was observed in males exposed to dietary a-silica (silicon
dioxide) at 6,700 mg/kg/day for 26 weeks (Takizawa et al. 1988).  Spleen weights were not decreased in
male B6C3F1 mice at ≤3,280 mg/kg/day or female B6C3F1 mice at doses up to 2,220 mg/kg/day, and no 
treatment-related histopathological lesions were reported (Takizawa et al. 1988).  
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No changes in spleen histology were observed in Wistar rats exposed to dietary a-silica (FHS) at 
100 mg/kg/day for 24 months, compared with historical controls (concurrent controls were not evaluated)
(Lewinson et al. 1994). Similarly, no significant changes in spleen weight or histology were observed in 
F344 rats exposed to dietary a-silica (silicon dioxide) at doses up to 2,200 mg/kg/day for 52 weeks or
2,010 mg/kg/day for 103 weeks (Takizawa et al. 1988).  In B6C3F1 mice, no significant changes in 
spleen weight or histology were observed following exposure to dietary a-silica (silicon dioxide) at doses 
up to 7,560 mg/kg/day for 52 weeks or 6,010 mg/kg/day for 93 weeks (Takizawa et al. 1988).  
3.2.2.4  Neurological Effects 
Crystalline Silica. Silica levels in drinking water were not associated with cognitive impairment using
the Mini-Mental State Examination (MMSE) in 3,777 French subjects >65 years of age; median silica 
(form not specified, assumed to be c-silica) levels in drinking water were 11.2 mg/L (range 4.2– 
22.4 mg/L)  (Jacqmin-Gadda et al. 1996).  Using a reference water intake of 1.046 L for populations
>65 years of age and a reference body weight of 80 kg (EPA 2011), estimated mean daily intakes were 
calculated to be 0.15 mg/kg/day (range 0.05–0.29 mg/kg/day).  These findings were supported by a
second study, which found a negative association between silica (form not specified, assumed to be
c-silica) levels in drinking water and cognitive impairment in the Short Portable Mental Status 
Questionnaire in 7,598 French females ≥75 years of age; the average daily intake was of 10.17 mg/day
(Gillette-Guyonnet et al. 2005).  Using reference body weight of 80 kg (EPA 2011), daily intakes were
calculated to be 0.13 mg/kg/day for this study.  A 5-year follow-up study in this cohort indicated that
women with low silica intake (≤4 mg/day) had a 2.7-fold increased risk of Alzheimer’s disease (OR: 2.74;
95% CI: 1.09, 6.86), while high silica intake (9–12 mg/day) was not associated with Alzheimer’s disease 
(OR: 2.00; 95% CI: 0.56, 7.07) (Gillette-Guyonnet et al. 2005).  
No studies evaluating neurological effects in animals following oral exposure to c-silica were identified.
Amorphous Silica. No clinical signs of neurotoxicity or significant changes in brain weight or histology 
were observed in Wistar rats exposed to dietary a-silica (FHS) at 500 mg/kg/day for 6 months, compared 
with controls (Lewinson et al. 1994).  Similarly, no clinical signs of neurotoxicity or significant changes
in brain weight or histology were observed in F344 rats or B6C3F1 mice exposed to dietary a-silica 
(silicon dioxide) at doses up to 2,410 or 9,810 mg/kg/day, respectively, for 26 weeks (Takizawa et al. 
1988). 
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No clinical signs of neurotoxicity were observed in Wistar rats exposed to dietary a-silica (FHS) at
100 mg/kg/day for 24 months (Lewinson et al. 1994). No clinical signs of neurotoxicity or significant 
changes in brain weight or histology were observed in F344 rats exposed to dietary a-silica (silicon
dioxide) at doses up to 2,200 mg/kg/day for 52 weeks or 2,010 mg/kg/day for 103 weeks (Takizawa et al. 
1988).  In B6C3F1 mice, no clinical signs of neurotoxicity or significant changes in brain weight or
histology were observed following exposure to dietary a-silica (silicon dioxide) at doses up to
7,560 mg/kg/day for 52 weeks or 6,010 mg/kg/day for 93 weeks (Takizawa et al. 1988).  
3.2.2.5  Reproductive Effects
Crystalline Silica. The risk of spontaneous abortion in a case-control study of 286 women with 
spontaneous abortions through 27 weeks of gestation and 1,391 women with live births was correlated 
with high silica (form not specified, assumed to be c-silica) content in drinking water in Boston 
(Aschengrau et al. 1989).  The adjusted OR for the highest silica tertile (3.7–32.0 mg/L) was increased
compared to the lowest tertile (0–2.7 mg/L); OR: 1.9, 95% CI: 1.1, 3.2.  The risk of spontaneous abortion 
was not increased in the middle tertile (2.8–3.6 mg/L); OR: 0.5; 95% CI: 0.3, 0.8.  The ORs were adjusted 
for other trace elements (arsenic, chromium, lead, mercury, sodium, potassium, iron, sulfate, chloride, 
nitrate, and copper) and water characteristics (pH, alkalinity, hardness, Langelier index, and water
source).  Using a reference water intake of 1.043 L for populations ≥21 years of age and a reference body
weight of 80 kg (EPA 2011), estimated daily intakes for exposure in the lowest, middle, and highest
tertiles were 0–0.035, 0.036–0.047, and 0.048–0.42 mg/kg/day, respectively.  Other trace elements
associated with increased risk of spontaneous abortion in this study included any detectable levels of
mercury and high levels of arsenic or potassium.  Limitations of this study include lack of actual water
consumption data and lack of control for unmeasured water quality parameters (e.g., organic
contaminants, groundwater treatment) and other environmental exposures. 
No studies evaluating reproductive effects in animals following oral exposure to c-silica were identified.
Amorphous Silica. Reproductive performance was not impaired during the generation of two litters in
male and female Wistar rats exposed to dietary a-silica (FHS) at 500 mg/kg/day for a total of 6 months;
mating for the first litter occurred after 8 weeks of exposure and mating for the second litter occurred after
17 weeks of exposure (Lewinson et al. 1994).  There were no significant changes in the breeding rate, 
number of pregnant females, number of live and dead pups, or mean litter size in exposed rats, compared 
with controls.  
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No significant changes in testes or ovary weight or histology were observed in Wistar male and female
rats exposed to dietary a-silica (FHS) at 500 mg/kg/day for 6 months, compared with controls (Lewinson 
et al. 1994).  Additionally, no histopathological changes were observed in the uterus (uterus weight not
recorded).  No changes in testes, ovary, or uterus histology were observed in Wistar rats exposed to 
dietary a-silica (FHS) at 100 mg/kg/day for 24 months, compared with historical controls (concurrent
controls were not evaluated) (Lewinson et al. 1994).
3.2.2.6  Developmental Effects 
Crystalline Silica. No studies evaluating developmental effects in humans or animals following oral
exposure to c-silica were identified.
Amorphous Silica. There were no significant changes in mean birth weight, number of runts, gross pup 
abnormalities at birth, growth or survival during lactation, or gross pathological findings at the postnatal
week 4 sacrifice from the first or second litter produced by male and female Wistar rats exposed to dietary 
a-silica (FHS) at 500 mg/kg/day for a total of 6 months, compared with controls (Lewinson et al. 1994).  
Mating for the first litter occurred after 8 weeks of exposure, and mating for the second litter occurred 
after 17 weeks of exposure.
3.2.2.7 Cancer
Crystalline Silica. No studies evaluating cancer in humans or animals following oral exposure to c-silica
were identified.
Amorphous Silica. In a 2-year bioassay that utilized small animal groups (18–21/sex/group per species),
neoplastic lesions attributable to dietary a-silica (silicon dioxide) exposure were not observed at doses up 
to 2,010 mg/kg/day in F344 rats or doses up to 6,010 in B6C3F1 mice (Takizawa et al. 1988).  In another
study, neoplastic lesions attributable to dietary a-silica (FHS) exposure were not observed in Wistar rats 
exposed to 100 mg/kg/day for 24 months, compared with historical controls (concurrent controls were not
evaluated) (Lewinson et al. 1994).  However, the reliability of this study is low because it utilized small 
animal groups (20/sex/group), lacked a concurrent control, and used a single dose level that did not
approach the maximum tolerable dose (MTD) (e.g., no systemic toxicity was observed).
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3.2.3 Dermal Exposure 
No association between dermal exposure to c-silica or a-silica and adverse health effects has been
reported.  
3.3  GENOTOXICITY
Crystalline Silica. Available evidence indicates that c-silica is a genotoxic agent in mammalian cells,
with the ability to cause mutagenicity, clastogenicity, and DNA damage.  Results of in vivo human 
studies, in vivo animal studies, and in vitro studies evaluating the genotoxicity of c-silica are summarized
below and in Tables 3-18, 3-19, and 3-20, respectively.
Human Occupational Studies. Chromosomal and DNA damage have been reported in a limited number
of studies evaluating workers with occupational exposure to c-silica.
DNA strand breaks were significantly increased (p<0.001) in peripheral lymphocytes from a cohort of
foundry and pottery workers exposed to c-silica for an average of 14–15 years, compared with unexposed 
referents (Basaran et al. 2003). The mean occupational exposure levels to respirable dust and respirable 
quartz in foundry workers were 16.7±1.01 and 0.72±0.35 mg/m3, respectively; exposure levels were not
reported for pottery workers (et Basaran al. 2003).
Chromosomal aberrations and sister chromatid exchanges were significantly increased (p<0.01) by 1.5– 
2-fold in whole-blood samples (cell types not specified) from a cohort of stone crushers exposed to
c-silica, compared with unexposed referents (Sobti and Bhardwaj 1991).  Findings remained significant
when workers were stratified by alcohol use and smoking status.  Exposure levels and duration of
exposure were not reported.  Micronuclei frequency was significantly (p<0.001) increased by 2–3-fold in 
peripheral lymphocytes and nasal epithelial cells from a cohort of glass industry workers, sand blasters,
and stone grinders exposed to c-silica for an average of 7 years, compared with unexposed referents
(Demircigil et al. 2010).  The cumulative exposure to c-silica was significantly associated with
micronuclei frequencies in both cell types (regression coefficient [95% CI] = 6.71 [5.06–8.37] for
peripheral lymphocytes and 5.47 [4.56–6.37] for nasal epithelial cells; p<0.001); however, cumulative
exposure levels were not reported (Demircigil et al. 2010).
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Table 3-18. Genotoxicity of c-Silica in Occupational Studies
Exposure group Silica species End point Results Reference
Patients diagnosed with c-Silica (not specified) Gene mutation frequency + Liu et al. 2000
lung cancer and silicosisa of p53 gene
Foundry and pottery Quartz DNA strand breaks in + Basaran et al.
workersb peripheral lymphocytes 2003
Stone crushersb c-Silica (not specified) Chromosomal + Sobti and 
aberrations in peripheral Bhardwaj 1991
whole-blood samples
Stone crushersb c-Silica (not specified) Sister chromatid + Sobti and 
exchanges in peripheral Bhardwaj 1991
whole-blood samples
Glass industry workers, c-Silica (not specified) Micronuclei in peripheral + Demircigil et al.
sand blasters, and stone lymphocytes 2010
grindersc
Glass industry workers, c-Silica (not specified) Micronuclei in nasal + Demircigil et al.
sand blasters, and stone epithelial cells 2010
grindersc
aDiagnosis of silicosis as a proxy for c-silica exposure.
 
bIt was not reported whether or not exposed workers had silicosis.
 
cSilicosis was diagnosed in 50% of former workers (n=10) and 24% of current workers (n=40); micronuclei were 

increased in both current and former worker populations.
 
+ = positive result; DNA = deoxyribonucleic acid
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Table 3-19. Genotoxicity of c-Silica In Vivo Animal Studies
Species Silica species End point Results Reference
Rat (inhalation) Cristobalite Gene mutation at hprt locus in + Johnston et al. 2000
alveolar type II epithelial cells
Rat Quartz Gene mutation at hprt locus in + Driscoll et al. 1997
(intratracheal) alveolar type II epithelial cells
Rat Quartz DNA strand breaks in lung + Knaapen et al. 2002
(intratracheal) epithelial cells
Rat Quartz 8-OHdG modified DNA in + Seiler et al. 2001a
(intratracheal) alveolar cells
Rat Quartz 8-OHdG modified DNA in + Seiler et al. 2001b
(intratracheal) alveolar cells
Rat Quartz 8-OHdG modified DNA in + Seiler et al. 2001c
(intratracheal) alveolar cells
Hamster Quartz 8-OHdG modified DNA in – Seiler et al. 2001c
(intratracheal) alveolar cells
+ = positive result; – = negative result; 8-OHdG = 8-hydroxydeoxyguanosine; DNA = deoxyribonucleic acid
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SILICA 177
3. HEALTH EFFECTS
Table 3-20. Genotoxicity of c-Silica In Vitro
Results
With Without
Species (test system) Silica species End point activation activation Reference
Prokaryotic organisms:
Bacillus subtilis (H17 c-Silica (not DNA repair NT – Kada et al. 1980
Rec+, M45 Rec-) specified)
B. subtilis (H17 Rec+, c-Silica (not DNA repair NT – Kanematsu et al.
M45 Rec-) specified) 1980
Mammalian cells:
RLE-6TN rat alveolar BAL cells from Mutation at hprt NT + Driscoll et al. 1997
epithelial cells quartz-exposed locus
ratsa
MutaTMMouse lung Quartz cII and lacZ NT – Jacobsen et al.
epithelial cells mutant frequency 2007
Human small airway Quartz DNA strand NT + Msiska et al. 2010
epithelial cells breaks
A549 human bronchial Quartz DNA strand NT + Msiska et al. 2010
epithelial cancer cells breaks
A549 human bronchial Quartz DNA strand NT + Fanizza et al. 2007
epithelial cancer cells breaks
A549 human bronchial Quartz DNA strand NT + Cakmak et al. 2004
epithelial cancer cells breaks
A549 human bronchial Quartz DNA strand NT + Schins et al. 2002a
epithelial cancer cells breaks
A549 human bronchial Quartz DNA strand NT + Schins et al. 2002b
epithelial cancer cells breaks
Hel 299 human Quartz DNA strand NT + Zhong et al. 1997b
embryonic lung cells breaks
RLE-6TN rat alveolar Quartz DNA strand NT + Li et al. 2007
epithelial cells breaks
RLE-6TN rat alveolar Quartz DNA strand NT + Schins et al. 2002b
epithelial cells breaks
Rat alveolar c-Silica (not DNA strand NT + Zhang et al. 2000
macrophages specified) breaks
Rat alveolar c-Silica (not DNA strand NT + Zhang et al. 1999
macrophages specified) breaks
MutaTMMouse lung Quartz DNA strand NT – Jacobsen et al.
epithelial cells breaks 2007
V79 Chinese hamster Quartz DNA strand NT + Zhong et al. 1997b
lung fibroblasts breaks
MutaTMMouse lung Quartz Oxidative DNA NT ± Jacobsen et al.
epithelial cells damage 2007
A549 human bronchial Quartz 8-OHdG modified NT + Schins et al. 2002
epithelial cancer cells DNA
RLE-6TN rat alveolar Quartz 8-OHdG modified NT + Li et al. 2007
epithelial cells DNA
***DRAFT FOR PUBLIC COMMENT***
   
 








    
 
     


























    
 
     
 
    
   
 
   
 





    
 
 




      
  
 
      
  
 




      
 
      
 
      
 
   
 
 
   
 























   
SILICA 178
3. HEALTH EFFECTS
Table 3-20. Genotoxicity of c-Silica In Vitro
Results
With Without
Species (test system) Silica species End point activation activation Reference
RLE-6TN rat alveolar Quartz 8-OHdG modified NT + Schins et al. 2002a
epithelial cellsa DNA
Hel 299 human Quartz Chromosomal NT – Nagalakshmi et al.
embryonic lung cells aberrations 1995
V79 Chinese hamster Quartz Chromosomal NT – Nagalakshmi et al.
lung fibroblasts aberrations 1995
V79 Chinese hamster Quartz Chromosomal NT – Price-Jones et al.
lung fibroblasts aberrations 1980
SHE cells Quartz Chromosomal NT + Elias et al. 2006
aberrations
SHE cells Quartz Chromosomal NT – Oshimura et al.
aberrations 1984
SHE cells Diatomaceous Chromosomal NT + Elias et al. 2006
earth (~50% aberrations
cristobalite)
Hel 299 human Quartz Micronuclei NT + Nagalakshmi et al.
embryonic lung cells 1995
V79 Chinese hamster Quartz Micronuclei NT + Zhong et al. 1997a
lung fibroblasts
V79 Chinese hamster Quartz Micronuclei NT + Liu et al. 1996b
lung fibroblasts
V79 Chinese hamster Quartz Micronuclei NT + Nagalakshmi et al.
lung fibroblasts 1995
V79 Chinese hamster Quartz Micronuclei NT – Price-Jones et al.
lung fibroblasts 1980
CHO cells Quartz Micronuclei NT + Hart and Hesterberg 
1998
CHO cells Cristobalite Micronuclei NT + Hart and Hesterberg 
1998
CHO cells Diatomaceous Micronuclei NT + Hart and Hesterberg 
earth (42% 1998
c-silica)
SHE cells Quartz Micronuclei NT – Oshimura et al.
1984
Human peripheral Quartz Sister chromatid NT ± Pairon et al. 1990
lymphocytes and exchanges
monocytes
Human peripheral Quartz Sister chromatid NT – Pairon et al. 1990
lymphocytes exchanges
Human peripheral Tridymite Sister chromatid NT + Pairon et al. 1990
lymphocytes and exchanges
monocytes
Human peripheral Tridymite Sister chromatid NT – Pairon et al. 1990
lymphocytes exchanges
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Table 3-20. Genotoxicity of c-Silica In Vitro
Results
With Without
Species (test system) Silica species End point activation activation Reference
BALB/3T3 mouse Quartz Cell NT + Keshava et al. 1999
embryo cells transformation
SHE cells Quartz Cell NT + Elias et al. 2000
transformation
SHE cells Quartz Cell NT + Elias et al. 2006
transformation
SHE cells Quartz Cell NT + Hesterberg and
transformation Barret 1984
SHE cells Quartz Cell NT – Oshimura et al.
transformation 1984
SHE cells Cristobalite Cell NT + Elias et al. 2000
transformation
SHE cells Diatomaceous Cell NT + Elias et al. 2000
earth (>50% transformation
c-silica) 




Herring sperm Quartz DNA damage NT + Daniel et al. 1993
genomic DNA
λHindIII-digested DNA Quartz DNA damage NT + Shi et al. 1994
λHindIII-digested DNA Quartz DNA damage NT + Daniel et al. 1993
λHindIII-digested DNA Quartz DNA damage NT + Daniel et al. 1995
λHindIII-digested DNA Tridymite DNA damage NT + Daniel et al. 1995
λHindIII-digested DNA Cristobalite DNA damage NT + Daniel et al. 1995
PM2 supercoiled DNA Quartz DNA damage NT + Daniel et al. 1995
PM2 supercoiled DNA Tridymite DNA damage NT + Daniel et al. 1995
PM2 supercoiled DNA Cristobalite DNA damage NT + Daniel et al. 1995
Calf thymus DNA Quartz DNA binding NT + Mao et al. 1994
aRLE-6TN cells were incubated with BAL cells collected from rat lungs 15 months after a single intratracheal
exposure to 10 or 100 mg/kg of α-quartz.
+ = positive result; - = negative result; ± = marginal result; 8-OHdG = 8-hydroxydeoxyguanosine;
BAL = bronchoalveolar lavage; CHO =  Chinese hamster ovary; DNA = deoxyribonucleic acid; NT = not tested;
SHE = Syrain hamster embryo
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SILICA 180
3. HEALTH EFFECTS
Animal Studies. Evidence from a limited number of animal studies indicates that c-silica is a mutagenic 
and DNA damaging agent in vivo; however, the susceptibility appears to differ between species, with
effects observed in rats but not hamsters.
The number of mutations at the hprt locus was significantly increased (p<0.05) in alveolar type II
epithelial cells isolated from rat lungs following exposure to cristobalite via inhalation at concentrations 
of 3 mg/m3 for 6 hours/day, 5 days/week, for 13 weeks (Johnston et al. 2000). Similarly, the number of
gene mutations at the hprt locus was significantly increased (p<0.05) in a dose-related manner in alveolar
type II epithelial cells isolated from rat lungs 15 months after a single intratracheal instillation of 10 or
100 mg/kg of quartz, compared with controls (Driscoll et al. 1997).
DNA strand breaks were significantly increased (p<0.05) in lung epithelial cells isolated from rats 3 days 
after a single intratracheal instillation of 2 mg/rat (9 mg/kg, based on reported body weights) of quartz, 
compared with controls (Knaapen et al. 2002).  When the quartz samples were pretreated with the surface 
modifying compounds, polyvinylpyridine-N-oxide or aluminium lactate, DNA damage was inhibited, 
suggesting a critical role of the reactive particle surface in quartz-induced DNA damage in vivo. 
8-Hydroxydeoxyguanosine (8-OHdG) modified DNA was increased in a time- and dose-dependent
manner in alveolar cells isolated from rat lungs 3, 21, or 90 days after a single intratracheal instillation of
quartz at doses ≥1.2 mg/rat (6 mg/kg, based on reported body weights), indicating oxidative DNA
damage; modified DNA was not significantly elevated at doses ≤0.6 mg/rat (3 mg/kg, based on reported 
body weights) (Seiler et al. 2001a, 2001b, 2001c).  However, 8-OHdG modified DNA was not
significantly elevated in alveolar cells isolated from hamster lungs 90 days after a single intratracheal
instillation of quartz at doses up to 12 mg/kg (Seiler et al. 2001c).
In vitro Studies. Evidence from the numerous in vitro studies provides consistent evidence that c-silica is 
a DNA damaging agent.  Evidence also suggests that c-silica is mutagenic and clastogenic; however,
there are some inconsistencies in the results between different test systems.
The number of gene mutations at the hprt locus was significantly increased in rat alveolar epithelial cells 
incubated with bronchoalveolar lavage (BAL) cells collected from rat lungs 15 months after a single 
intratracheal instillation of quartz particles at a dose of 10 or 100 mg/kg; mutations were significantly
increased in a dose-related manner when the BAL cell:epithelial cell ratio was 50:1, but not 10:1 (Driscoll
et al. 1997).  However, cII and lacZ mutant frequencies were not elevated in MutaTMMouse lung epithelial
cells exposed to quartz particles in vitro (Jacobsen et al. 2007).
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DNA repair was not induced in the Rec-assay in Bacillus subtilis (Kada et al. 1980; Kanematsu et al.
1980).  However, DNA strand breaks and/or 8-OHdG modified DNA were consistently observed in 
various human, rat, and hamster lung cell lines exposed to quartz particles in vitro (Cakmak et al. 2004;
Fanizza et al. 2007; Li et al. 2007; Msiska et al. 2010; Schins et al. 2002a, 2002b; Zhang et al. 1999, 
2000; Zhong et al. 1997b). Oxidative DNA damage was reported as “marginally” increased (p=0.05) in 
MutaTMMouse lung epithelial cells exposed to quartz particles in vitro, compared with control; however,
the number of DNA strand breaks was not significantly increased following quartz exposure (Jacobsen et
al. 2007).  Generation of reactive oxygen species (ROS) following c-silica exposure was associated with
DNA damage in several of these studies (Li et al. 2007; Msiska et al. 2010; Schins et al. 2002a, 2002b; 
Zhang et al. 1999, 2000), and surface modifications of quartz that decrease hydroxyl-radical generation
and reduce cell uptake led to reductions in quartz-mediated DNA damage (Schins et al. 2002a).  In 
various isolated DNA samples, DNA damage was consistently observed following incubation with 
c-silica (quartz, tridymite, cristobalite) (Daniel et al. 1993, 1995; Shi et al. 1994) and DNA binding to 
c-silica particles was observed (Mao et al. 1994).
Available data indicate that c-silica can cause clastogenic effects; however, evidence is not conclusive.
Both chromosomal aberrations and cytotoxicity were significantly increased in Syrian hamster embryo
(SHE) cells following in vitro exposure to quartz and calcined diatomaceous earth (approximately 50%
crystallization) (Elias et al. 2006).  Chromosomal aberrations were not observed in SHE cells at lower,
non-cytotoxic concentrations of quartz (Oshimura et al. 1984).  Additionally, chromosomal aberrations
were not induced in human embryonic lung cells or Chinese hamster lung fibroblasts following in vitro 
exposure to quartz (Nagalakshmi et al. 1995; Price-Jones et al. 1980).  In contrast, several studies reported
micronuclei induction following exposure to quartz or calcined diatomaceous earth in various cell lines,
including human embryonic lung cells, Chinese hamster fibroblasts, and Chinese hamster ovary (CHO)
cells (Hart and Hesterberg 1998; Nagalakshmi et al. 1995; Zhong et al. 1997a).  Low concentrations of
quartz did not induce micronuclei in Chinese hamster fibroblasts or SHE cells (Oshimura et al. 1984;
Price-Jones et al. 1980). Sister chromatid exchanges were induced in mixed human peripheral
lymphocyte and monocyte cultures following exposure to tridymite at cytotoxic concentrations, but
results with quartz were inconclusive (only significant in 1/3 replicates at cytotoxic concentration);
neither tridymite nor quartz induced sister chromatid exchanges in purified human peripheral lymphocyte
cultures (Pairon et al. 1990).
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Quartz induced cell transformation in mouse embryo cells, and transformed cells showed significant
genomic instability compared with non-transformed cells (Keshava et al. 1999).  Cell transformation and
cytotoxicity were induced in a concentration-related manner in SHE cells following exposure to various
crystalline species, including quartz, cristobalite, and heated diatomaceous earth samples with some 
crystallization (Elias et al. 2000, 2006; Hesterberg and Barret 1984).  The extent of cytotoxicity of various
c-silica samples and the induction of cell transformation was not correlated; however, transforming
potency was well-correlated with the amount of hydroxyl radicals generated (Elias et al. 2000, 2006).
Cell transformation was not observed in SHE cells at lower, noncytotoxic concentrations of quartz
(Oshimura et al. 1984).
Amorphous Silica. a-Silica has been shown to cause DNA damage and chromosomal aberrations in 
vitro; however, concentrations producing these effects are approximately 2–4-fold higher than c-silica
under similar experimental conditions.  The in vivo database is too limited to draw conclusions. In vivo
and in vitro genotoxicity studies evaluating a-silica are summarized in Table 3-21.
Animal Studies. No significant increases in the number of mutations at the hprt locus were observed in
alveolar type II epithelial cells isolated from rat lungs following exposure to a-silica via inhalation at
concentrations of 50 mg/m3 for 6 hours/day, 5 days/week, for 13 weeks (Johnston et al. 2000).  As
discussed above, exposure to c-silica under the same conditions resulted in a significant increase in
mutations. The only other available in vivo study showed no induction of micronuclei in peripheral blood 
erythrocytes from mice following oral or intraperitoneal exposure to silicon dioxide at doses up to 
5,000 mg/kg (Morita et al. 1997).
In vitro Studies. Available evidence from in vitro studies show that a-silica is capable of causing DNA
and chromosomal damage at concentrations 2–4-fold higher than c-silica; however, findings are 
inconsistent between studies.  DNA strand breaks were significantly elevated in human embryonic lung
cells and Chinese hamster lung fibroblasts following exposure to a-silica in vitro; however, the 
concentration of a-silica required to induce micronuclei was 4-fold higher than the concentration of
c-silica (quartz) required to induce micronuclei under the same experimental conditions (Zhong et al. 
1997b).  Some evidence of DNA strand breaks was observed in human lung epithelial cells exposed to
a-silica at noncytotoxic concentrations up to 80 µg/mL; however, the results did not exhibit
concentration-dependence (Guidi et al. 2013).  In murine macrophage cells, DNA strand breaks were only
observed at a-silica particle concentrations that caused cytotoxicity (≥5 µg/mL) (Guidi et al. 2013).
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Table 3-21. Genotoxicity of a-Silica
Results
With Without




a-Silica Gene mutation at hprt
locus in alveolar type II
epithelial cells
– Johnston et al.
2000
Mouse Silicon dioxide Micronuclei in – Morita et al.
(oral) peripheral erythrocytes 1997
Mouse Silicon dioxide Micronuclei in – Morita et al.
(intraperitoneal) peripheral erythrocytes 1997
In vitro
Mammalian cells:
A549 human lung 
epithelial cells
a-Silica DNA strand breaks NT ± Guidi et al. 2013
Hel 299 human 
embryonic lung cells
a-Silica DNA strand breaks NT + Zhong et al.
1997b




a-Silica DNA strand breaks NT + Zhong et al.
1997b




SHE cells a-Silica Chromosomal NT + Elias et al. 2006
aberrations
A549 human lung 
epithelial cells
a-Silica Micronuclei NT – Guidi et al. 2013
RAW264.7 murine a-Silica Micronuclei NT + Guidi et al. 2013
macrophages
V79 Chinese hamster a-Silica Micronuclei NT + Liu et al. 1996b
lung fibroblasts





SHE cells Diatomaceous Cell transformation NT + Elias et al. 2000
earth (≤6%
c-silica) 
SHE cells Diatomaceous Cell transformation NT – Elias et al. 2006
earth (0%
c-silica)
SHE cells a-Silica Cell transformation NT – Elias et al. 2000
SHE cells a-Silica Cell transformation NT – Elias et al. 2006
+ = positive result; - = negative result; ± = inconclusive result; CHO =  Chinese hamster ovary;
DNA = deoxyribonucleic acid; NT = not tested; SHE = Syrain hamster embryo
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Both chromosomal aberrations and cytotoxicity were significantly increased in exposures to natural, non-
crystalline diatomaceous earth; however, exposure to vitreous a-silica did not induce chromosomal
aberrations (Elias et al. 2006).  a-Silica did not induce micronuclei in human lung epithelial cells;
however, a-silica and non-crystalline diatomaceous earth induced micronuclei in murine macrophage 
cells, Chinese hamster lung fibroblasts, and CHO cells (Guidi et al. 2013; Hart and Hesterberg 1998; Liu 
et al. 1996b).  The concentration of a-silica required to induce micronuclei was 2-fold higher than the
concentration of quartz required to induce micronuclei in Chinese hamster lung fibroblasts (Liu et al. 
1996b).
Both cell transformation and cytotoxicity were induced in a concentration-related manner in SHE cells 
exposed to natural diatomaceous earth samples with minimal (up to 6%) crystallization (Elias et al. 2000, 
2006).  However, neither cell transformation nor cytotoxicity was observed in SHE cells exposed to 
unheated diatomaceous earth samples (0% crystallization) or pyrogenic or vitreous a-silica samples (Elias 
et al. 2000, 2006).  
3.4  TOXICOKINETICS
Throughout this section, the term silica refers to all types of silica particles.  Information that is specific to
c-silica or a-silica is indicated as such.
3.4.1 Absorption 
3.4.1.1  Inhalation Exposure 
Inhaled silica particles that deposit in the respiratory tract are subject to three general distribution
processes:  (1) bronchial and tracheal mucociliary transport to the gastrointestinal tract; (2) transport to
thoracic lymph nodes (e.g., lung, tracheobronchial, mediastinal); or (3) absorption by blood and/or lymph 
and transfer to other tissues (e.g., peripheral lymph tissues, kidney).  The above processes apply to all
forms of deposited silica, although the relative contributions of each pathway and rates associated with 
each pathway vary with the physical characteristics (e.g., particle size) and biological reactivity
(e.g., macrophage recruitment, activation, and cytotoxicity).
Particles having diameters >5 µm deposit in the upper airways (extrathoracic, tracheobronchial regions)
and are cleared from the respiratory tract primarily by mucociliary transport to the gastrointestinal tract 
(Bailey et al. 2007; ICRP 1994).  Smaller particles (≤5 µm) are deposited primarily in the pulmonary
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region (terminal bronchioles and alveoli). Particles are cleared from the pulmonary region primarily by
lymph drainage, macrophage phagocytosis and migration, and upward mucociliary flow. Dissolution, 
which contributes to absorptive clearance of some types of particles, is negligible for c-silica because of
the low solubility of c-silica particles.  Dissolution may play a larger role in clearance of a-silica, and may
contribute to its faster pulmonary clearance compared to c-silica (Davis 1986; Kelly and Lee 1990;
Reuzel et al. 1991; Schepers 1981). 
The various processes that contribute to the clearance of silica from the respiratory tract give rise to multi-
phasic lung retention kinetics (Katsnelson e al. 1992; Stober et al. 1999; Vacek et al. 1991).  In most
studies of lung retention, at least two kinetic components are evident.  The faster phase is thought to be
contributed by relatively rapid mechanical clearance mechanisms (e.g., mucociliary transport) and, for 
more soluble forms (e.g., a-silica), absorption to blood of soluble or relatively rapidly dissolved insoluble
material deposited in the lung.  The slower phase is contributed by physical transformation and 
dissolution and/or mechanical clearance of highly insoluble particles by phagocytosis and macrophage 
migration.
Rates for slow-phase clearance vary with the type of silica particle inhaled, inhaled dosage, and animal
species (Kreyling 1990).  In humans, slow-phase clearance of highly insoluble particles occurs with half-
lives of several years (Bailey et al. 2007; ICRP 1994). The slow phase of clearance of silica particles 
explains the accumulation of particles in the human lung that can occur with repeated exposures to 
airborne silica as well as its detection in lung tissue years after cessation of exposure (Borm et al. 2002;
Case et al. 1995; Dobreva et al. 1975; Dufresne et al. 1998; Loosereewanich et al. 1995). 
Studies conducted in rodents found that clearance of c-silica (quartz) was >10 times slower than a-silica 
(Davis 1986; Kelly and Lee 1990; Reuzel et al. 1991; Schepers 1981). A contributing factor to the slower
clearance of c-silica may be its greater cytotoxic potency, related to its surface structure.  In rats,
clearance following inhalation of an aerosol of pure cristobalite was slower than following inhalation of
aerosols of quartz, and rats showed a more pronounced lung inflammatory response to cristobalite
compared to quartz (Hemenway et al. 1990).  Macrophages play an important role in the mechanical
clearance of silica particles (Absher et al. 1992; Brody et al.1982). A more intense inflammatory
response to macrophage cytotoxicity induced by c-silica results in slow particle clearance (Donaldson and 
Borm 1998; Fenoglio et al. 2000; Warheit et al. 2007).  In general, mechanical clearance of deposited 
particles appears to have a limited capacity.  Macrophage-mediated clearance of respirable particles is 
inhibited at high particle loads.  This phenomenon has been referred to as particle overload (Mauderly et
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al. 1990; Morrow 1992).  The inhaled dose required to achieve particle overload is not the same in all
animal species and may be lower in small mammals (Snipes 1996). Rats exhibit lower particle overload 
thresholds than hamsters (Saffiotti et al. 1993).  Above the particle overload threshold, differences in 
clearance between c-silica and a-silica become less pronounced (Pratt 1983).  Particle overload is an 
important consideration in low-dose extrapolation of dose-response relationships and in extrapolation 
across animal species because it may result in a nonlinear relationship between the inhaled dosages and
particle burden in the lung (Lippmann and Timbrell 1990; McClellan 1990).  Particle overload may also 
render the respiratory tract more vulnerable to other airborne particulates as a result of depressed particle 
clearance (Morrow 1992).
3.4.1.2  Oral Exposure
Little information regarding the gastrointestinal absorption of silica was identified.  In rats, six gavage
doses of 50 mg c-silica did not result in detectable silica particles in gastrointestinal submucosa or region
lymph nodes, suggesting little or no transfer out of the gastrointestinal tract lumen (Gonzalez Huergo 
1991). 
3.4.1.3  Dermal Exposure 
Studies of dermal absorption of silica have not been reported and, given the solubility of silica dusts,
dermal exposure is likely to be a minor pathway of absorption of silica. Skin samples collected from
patients with progressive systemic scleroderma (PSS) and who were also exposed to c-silica (quartz
dusts) showed evidence of quartz crystals in chorionic fibers, blood vessel walls, corneas, epidermal
keratinocytes, and collagen fiber, based on detection of birefringent particles (Mehlhorn et al. 1990). This
finding could indicate dermal absorption or dermal deposition of inhaled or ingested silica. Quartz 
crystals were not observed in skin tissue of patients who did not have PSS and were exposed to quartz
dust, including silicosis patients.
3.4.2 Distribution 
3.4.2.1  Inhalation Exposure 
Few studies of distribution of silica outside of the respiratory tract have been reported (Absher et al.
1992).  Evidence for associations between exposure to c-silica dusts and renal disease suggests that
c-silica particles may distribute to the kidney (see Section 3.2.1.3, Inhalation, Systemic Effects).  Silica 
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has been detected in kidney tissue and urine of workers who have been exposed to c-silica, suggesting 
that systemic distribution can occur in humans following inhalation exposure (Giles et al. 1978;
Hauglustaine et al. 1980; Ibrahim et al. 2011; Saldanha et al. 1975).  Inhalation exposure of rats to c-silica 
shows distribution primarily to mediastinal lymph nodes and thymus; silica particles were detected in 
negligible amounts in the blood, kidney, liver, and spleen (Absher et al. 1992). These studies suggest that
lymph may provide a mechanism for systemic distribution of silica particles (Vacek et al. 1991).
3.4.2.2  Oral Exposure
Studies of the systemic distribution of silica following oral exposures have not been reported. 
3.4.2.3  Dermal Exposure 
Studies of the systemic distribution of silica following dermal exposures have not been reported.  
3.4.3 Metabolism
Absorbed silica is not metabolized.  Although c-silica particles are highly insoluble, in vitro studies have 
found that silica particles dissolved from slate dust can bind to serum albumin (Singh et al. 1984).
3.4.4 Elimination and Excretion 
3.4.4.1  Inhalation Exposure 
Silica has been detected in urine of ceramic factory workers exposed to c-silica, suggesting that systemic 
distribution can occur in humans following inhalation exposure (Ibrahim et al. 2011).  Urine is an 
excretory pathway for silica absorbed from the respiratory tract.
3.4.4.2  Oral Exposure
Ingested silica is excreted in the feces.  Absorbed silica, if absorption were to occur, may be excreted in 
urine; however, no studies of excretion of silica following absorption from the gastrointestinal tract have
been reported.
***DRAFT FOR PUBLIC COMMENT***
   
 
















    
   
   
 
  
     
 
  
    
   
    
     
   
   
   
 
       
  
   
  
  
   
  





3.4.4.3  Dermal Exposure 
Studies of excretion of silica following dermal exposures have not been reported. 
3.4.5 Physiologically Based Pharmacokinetic (PBPK)/Pharmacodynamic (PD) Models 
Physiologically based pharmacokinetic (PBPK) models use mathematical descriptions of the uptake and
disposition of chemical substances to quantitatively describe the relationships among critical biological
processes (Krishnan et al. 1994).  PBPK models are also called biologically based tissue dosimetry
models.  PBPK models are increasingly used in risk assessments, primarily to predict the concentration of
potentially toxic moieties of a chemical that will be delivered to any given target tissue following various 
combinations of route, dose level, and test species (Clewell and Andersen 1985).  Physiologically based 
pharmacodynamic (PBPD) models use mathematical descriptions of the dose-response function to 
quantitatively describe the relationship between target tissue dose and toxic end points.
PBPK/PD models refine our understanding of complex quantitative dose behaviors by helping to 
delineate and characterize the relationships between: (1) the external/exposure concentration and target
tissue dose of the toxic moiety, and (2) the target tissue dose and observed responses (Andersen and
Krishnan 1994; Andersen et al. 1987). These models are biologically and mechanistically based and can
be used to extrapolate the pharmacokinetic behavior of chemical substances from high to low dose, from
route to route, between species, and between subpopulations within a species.  The biological basis of
PBPK models results in more meaningful extrapolations than those generated with the more conventional
use of uncertainty factors.
The PBPK model for a chemical substance is developed in four interconnected steps: (1) model
representation, (2) model parameterization, (3) model simulation, and (4) model validation (Krishnan and
Andersen 1994).  In the early 1990s, validated PBPK models were developed for a number of
toxicologically important chemical substances, both volatile and nonvolatile (Krishnan and Andersen 
1994; Leung 1993).  PBPK models for a particular substance require estimates of the chemical substance-
specific physicochemical parameters, and species-specific physiological and biological parameters. The 
numerical estimates of these model parameters are incorporated within a set of differential and algebraic 
equations that describe the pharmacokinetic processes.  Solving these differential and algebraic equations 
provides the predictions of tissue dose.  Computers then provide process simulations based on these 
solutions.  
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The structure and mathematical expressions used in PBPK models significantly simplify the true 
complexities of biological systems.  However, if the uptake and disposition of the chemical substance(s)
are adequately described, this simplification is desirable because data are often unavailable for many
biological processes.  A simplified scheme reduces the magnitude of cumulative uncertainty. The 
adequacy of the model is, therefore, of great importance, and model validation is essential to the use of
PBPK models in risk assessment.
PBPK models improve the pharmacokinetic extrapolations used in risk assessments that identify the
maximal (i.e., the safe) levels for human exposure to chemical substances (Andersen and Krishnan 1994).  
PBPK models provide a scientifically sound means to predict the target tissue dose of chemicals in
humans who are exposed to environmental levels (for example, levels that might occur at hazardous waste 
sites) based on the results of studies where doses were higher or were administered in different species.
Figure 3-5 shows a conceptualized representation of a PBPK model.
If PBPK models for silica exist, the overall results and individual models are discussed in this section in 
terms of their use in risk assessment, tissue dosimetry, and dose, route, and species extrapolations.
No PBPK models for c-silica or a-silica were identified.
3.5  MECHANISMS OF ACTION 
3.5.1 Pharmacokinetic Mechanisms
Absorption. Several mechanisms contribute to the absorption of inhaled particles: (1) physical
transformation of particles deposited in the lung, including fragmentation or surface modification; 
(2) dissolution of particles; and (3) phagocytosis of particles by macrophages (Bailey et al. 2007; ICRP
1994).  
The relative contributions of these mechanisms appear to depend on several factors, including:
(1) particle size of the inhaled aerosol; (2) water solubility; and (3) surface characteristics of the particles 
that affect macrophage activation and cytotoxicity.  Macrophage phagocytosis and migration is by far the 
dominant mechanism for absorption of silica particles from the pulmonary region of the respiratory tract.  
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Figure 3-5.  Conceptual Representation of a Physiologically Based
 

















































Note:  This is a conceptual representation of a physiologically based pharmacokinetic (PBPK) model for a 
hypothetical chemical substance.  The chemical substance is shown to be absorbed via the skin, by inhalation, or by
ingestion, metabolized in the liver, and excreted in the urine or by exhalation.
Source:  Krishnan and Andersen 1994
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Phagocytosis of silica particles is mediated by interactions with cell membrane receptors (Hamilton et al.
2008).  Following uptake, silica particles trigger cytotoxicity and apoptosis (Hamilton et al. 2008;
Hornung et al. 2008; Thibodeau et al. 2004), leading to impaired particle clearance (Donaldson and Borm
1998; Fenoglio et al. 2000).  Because of the effect of cytotoxicity on macrophage-mediated clearance,
physical characteristics of silica particles that affect cytotoxic potential may contribute to differences in
lung clearance of silica particles (Begin et al. 1987; Brown and Donaldson 1996; Fenoglio et al. 2000).
Dissolution, which contributes to absorptive clearance of some types of particles, is negligible for c-silica 
because of the low solubility of c-silica particles.  Dissolution may play a larger role in clearance of
a-silica, and may contribute to its faster clearance compared to c-silica (Davis 1986; Kelly and Lee 1990;
Reuzel et al. 1991; Schepers 1981).
Studies conducted in Caco-2 cell culture monolayers, a differentiated cell line derived from human small
intestine, have found that silica amorphous silica particles 50–200 nm in diameter agglomerate in
gastrointestinal fluids (Sakai-Kato et al. 2014).  Absorptive transfer across the monolayers was negligible
when the monolayers were exposed to silica particles >100 nm.
Distribution.  Based on observations of silica particles in mediastinal lymph nodes following
inhalation, lymph may provide a mechanism for system distribution of silica particles (Absher et al. 1992;
Vacek et al. 1991).
Metabolism. Absorbed silica is not metabolized.  Although silica particles are highly insoluble, in
vitro studies have found that silica particles dissolved from slate dust can bind to serum albumin (Singh et
al. 1984).
Excretion. Renal handling of silicon has been studied in clinical studies of healthy adults and in 
chronic renal failure patients (Alder and Berlyne 1986; Berlyne and Alder 1986).  In these studies, silicon
was measured in urine and plasma using atomic absorption spectrophotometry, which could not
distinguish chemical forms of silicon. The exposure source of the silicon in plasma and urine was not
known and exposure may have been to metallic silicon or silicate.  Urinary excretion of silicon was 
correlated with urinary calcium, suggesting that it may be excreted as an orthosilicate complex (Alder and 
Berlyne 1986; Berlyne and Alder 1986).  Clearance studies showed that mechanisms of urinary excretion 
of silicon involve glomerular filtration and renal tubular secretion (Alder and Berlyne 1986; Berlyne and 
Alder 1986).
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3.5.2 Mechanisms of Toxicity
The mechanisms of toxicity for the main health effects of concern, including silicosis, COPD, lung
cancer, autoimmune disease, and renal disease, for c-silica are discussed below.
Role of Crystalline Silica Surface and Structural Features. The ability of different c-silicas (tridymite,
cristobalite, and quartz) to induce fibrosis can vary.  In addition, c-silica is more fibrogenic than a-silica.
Although the underlying mechanism for this variability has not been firmly established, both surface and 
structural features of silica appear to play a critical role in the fibrogenic activity of silica (Altree-
Williams and Sprogis 1982; Cox 2011; Donaldson and Borm 1998; Erdogdu and Hasirci 1998; Fujimura
2000; Guthrie 1995; IARC 2012; Leung et al. 2012; Mossman and Churg 1998; Murashov et al. 2006;
Rimal et al. 2005; Shi et al. 2001). Freshly fractured c-silica particles (i.e., particles generated during
abrasive blasting) are much more cytotoxic than “aged” particles due to the abundance of free radicals on
the fresh surface (silanol groups, ionized silanol groups).  This increased redox potential leads to 
increased inflammatory reactions in the lungs.  Processing of particles (through heating, grinding, 
chemical treatment, etc.) can decrease surface reactivity of c-silica. c-Silica particles can readily adsorb
other dusts and minerals, which may alter biological activity. Furthermore, the surface density of silanol, 
which varies between polymorphs, affects in vitro biological activity of silica (Murashov et al. 2006). 
Particle size also is likely to affect toxicity, although the relationship between c-silica particle size and
biological activity is still unclear.  Studies have come to divergent conclusions, with some suggesting that
particles in the 1–2-µm size range are the most fibrogenic, while others indicate that larger particles 
(≥5 µm) have the greatest fibrogenic potential.  Therefore, exposure conditions, including differences in 
dust composition, surface reactivity, particle size, and particle age, can alter the exposure-response
relationship between c-silica and disease, particularly silicosis, and potentially trigger various response
mechanisms.
Silicosis. Lung injury is a well-known effect of c-silica exposure (see Respiratory Effects in
Section 3.2.1.2 Systemic Effects of Inhalation Exposure), and the general mechanisms of silicosis have 
been extensively investigated (reviewed by Chen and Shi 2002; Cox 2011; Ding et al. 2002; Fujimura
2000; Huaux 2007; IARC 2012; Leung et al. 2012; Mossman and Churg 1998; Mossman and Glen 2013;
Parks et al. 1999; Rimal et al. 2005; Shi et al. 2001; Weissman et al. 1996). The underlying mechanism
of silicosis is considered to be an inflammatory process resulting from c-silica-induced cell death and 
tissue damage, predominantly mediated through macrophage apoptosis. The general mechanisms 
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underlying the development of silicosis are fairly well established (see Figure 3-6).  In the lung, inhaled 
c-silica particles are phagocytized by alveolar macrophages.  c-Silica is cytotoxic, leading to cell death
and release of intracellular silica, which is taken up by other macrophages.  In addition to releasing
intracellular c-silica upon cell death, damaged macrophages release a wide array of inflammatory 
cytokines and chemokines (notably TNF-α and IL-1), ROS and reactive nitrogen species (RNS), and 
arachidonic acid metabolites. These chemicals damage nearby cells and the extracellular matrix and also
recruit additional macrophages to the site of damage. Additionally, various transcription factors, notably
the pro-inflammatory and oncogenic factors nuclear factor kappa-B (NFkB) and activator protein (AP-1), 
are upregulated during this inflammatory response, potentially via reactive species or proteolytic 
pathways. This recurring cycle of macrophage phagocytosis, death, and release of intracellular contents 
results in a chronic inflammatory process (alveolitis). Injury to other pulmonary cells (e.g., epithelial
cells and fibroblasts) resulting from interactions with c-silica particles may also contribute to alveolitis.
However, studies in animal models indicate that apoptosis of macrophages, and subsequent influx of
additional macrophages, is the predominant mediator of alveolitis. The inflammatory phase is followed
by a reparative phase, which leads to release of anti-inflammatory and fibrogenic factors (e.g., EGF, 
IGF-1, IL-10, TGF-β) to stimulate recruitment and proliferation of mesenchymal cells, leading to tissue
repair and remodeling.  Additionally, chronic inflammation damages alveolar type I epithelial cells, which
triggers hyperplasia and hypertrophy of type II epithelial cells, which also leads to tissue repair and
remodeling.  Persistent cycling between the inflammatory and reparative phases leads to excess 
extracellular matrix deposition, ultimately leading to fibrosis.  The inflammatory cytokines TNF-α and 
IL-1 appear to be critical in the fibrotic process, as these cytokines are required for the development of
c-silica-induced fibrosis in animal models, and individuals with certain TNF-α or IL-1 polymorphisms
show an increased risk of developing silicosis (see Section 3.10 Populations That Are Unusually
Susceptible for more details).
While the major biological processes underlying silicosis have been established and the role of surface 
and structural properties have been acknowledged, the molecular events mediating the inflammatory
response in alveolar macrophages have not been fully elucidated (reviewed by Chen and Shi 2002; Cox 
2011; Ding et al. 2002; Huaux 2007; Leung et al. 2012; Mossman and Glenn 2013; Shi et al. 2001).  A 
sequence of events that could potentially lead to the induction of inflammation after phagocytosis of
c-silica by macrophages includes: (1) cellular uptake of c-silica into a phagosome via the scavenger
receptor MARCO; (2) swelling of phagosome, followed by lysing of phagosome and release of contents
into cytosolic compartment; (3) activation of nucleotide-binding domain, leucine-rich repeat protein
NALP3; (4) association of NALP3 with intracellular adapter protein ASC and pro-caspase-1, forming the
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Figure 3-6.  Overview of the Major Biological Processes Proposed to Underlie the
 
Pathogenesis of Silicosis and Lung Cancer
 
Inhaled c-silica is phagocytized by alveolar macrophages.  The phagocytized c-silica causes cytotoxicity and 
apoptosis, leading to release of intracellular c-silica as well as several chemicals (inflammatory cytokines and
chemokines, ROS, and arachidonic acid metabolites).  These chemicals damage nearby cells and extracellular
matrix, activate transcription factors, and recruit additional macrophages to the site of damage.  This cycle repeats,
causing a chronic inflammatory process.  The inflammatory phase is followed by a reparative phase, which leads to 
release of anti-inflammatory and fibrogenic factors to stimulate tissue repair and remodeling.  Excessive cycling 
between the inflammatory and reparative phases leads to excess extracellular matrix deposition, ultimately leading to 
fibrosis.  The inflammatory process can also lead to release of proteolytic enzymes and oxidants that cause cellular
and DNA damage, resulting in genotoxic events that can trigger a carcinogenic process.  This secondary,
inflammation-driven genotoxicity pathway is the most likely mechanism underlying c-silica-induced cancer; however,
a direct genotoxic of c-silica particles cannot be ruled out (see dashed arrows).
DNA = deoxyribonucleic acid; RNS= reactive nitrogen species; ROS = reactive oxygen species
Sources: Borm et al. (2011); Chen and Shi (2002); Cox (2011); Ding et al. (2002); Fujimura (2000); Huaux (2007);
IARC (2012); Leung et al. (2012); Mossman and Chung (1998); Mossman and Glenn (2013); Rimal et al. (2005);
Schins (2002); Shi et al. (2001); Weissman et al. (1996)
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NALP3 inflammasome; (5) activation of caspase-1 by inflammasome, leading to activation of
proinflammatory interleukins (e.g., IL-1β, IL-18) that were upregulated by activation of NFkB via an
unknown mechanism; and (6) activation of downstream mediators of inflammation, such as tumor
necrosis factor alpha (TNF-α) and cyclooxygenase II (COX-2). The activation of the NALP3 
inflammasome also requires generation of ROS, which are produced following the stimulation of a
respiratory burst in phagocytic cells.  c-Silica can produce ROS either directly via chemical interactions 
on freshly cleaved surfaces (see above) or indirectly via ROS generation in macrophages (oxidative 
burst).  
Following macrophage activation, the innate immune system responds, causing the observed 
inflammatory responses in the lung.  However, the innate immune mechanisms underlying the observed 
inflammatory responses are complex and not fully understood (reviewed by Fujimura 2000; Huaux 2007;
Leung et al. 2012; Weissman et al. 1996).  T-lymphocyte responses have been implicated, as there is a 
predominance of CD4+ T cells (helper/inducer T cells) in both humans diagnosed with silicosis and 
animal models of silicosis.  However, several animal studies have shown that T-lymphocyte responses are 
not essential for the development of silicosis.  Furthermore, the underlying response may not be due to 
inflammation exclusively, as several studies in mice show a persistent anti-inflammation response
subsequent to an acute inflammation response. The anti-inflammatory response is coupled with a pro-
fibrogenic response.  Interleukin-10 (IL-10) is proposed to play a key role in this process.  IL-10 has been 
shown to increase profibrotic activity via induction of TNF-α expression in conjunction with suppression 
of the expression of the anti-fibrotic eicosanoid PGE2.  These events are consistent with the overview
shown in Figure 3-6, which proposes that persistent cycling between inflammation and repair processes 
(including anti-inflammatory processes) leads to pathological fibrogenesis.
Chronic Obstructive Pulmonary Disease (COPD).  COPD, characterized by airflow limitation due to 
chronic bronchitis or emphysema, is associated with exposure to c-silica dust even in the absence of
silicosis. Possible mechanisms involved in the development of c-silica-induced COPD include:
(1) cellular damage, generation of ROS, and subsequent release of proinflammatory and fibrogenic
factors, and (2) injury to epithelial cells, allowing c-silica to penetrate small airway walls and induce 
localized fibrosis (Hnizdo and Vallyathan 2003).
Lung Cancer. It is generally thought that lung cancer following c-silica exposure results from
inflammation-based mechanisms secondary to silicosis; however, a direct genotoxic effect of c-silica
particles cannot be ruled out (reviewed by Borm et al. 2011; Brown 2009; Checkoway and Franzblau 
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2000; Chen and Shi 2002; Cox 2011; Ding et al. 2002; Huaux 2007; IARC 2012; Leung et al. 2012;
Mossman and Glenn 2013; Schins 2002; Shi et al. 2001) (see Figure 3-6).
As discussed above, silicosis is associated with chronic inflammation, which triggers activation of tissue 
repair, proliferation, and hyperplasia of mesenchymal cells and alveolar epithelial cells. As indicated
above, oncogenic transcription factors are also activated during the inflammatory process (e.g., NFkB,
AP-1).  As in silicosis, it is proposed that TNF-α has a critical role in c-silica-induced lung cancer.  While
NFkB leads to TNF-α release, TNF-α in turn is capable of activating NFkB, which leads to increased 
survival of transformed epithelial cells. The increased survival, and subsequent division, could lead to
increased pools of preneoplastic cells and ultimately neoplastic transformation.  One proposed mechanism
for this progression, based on studies in rat models, is epigenetic silencing of the tumor suppressor gene
p16 through hypermethylation of the promotor region due to proliferative stress.  Additionally, chronic
inflammation results in the formation of ROS and RNS.  These reactive species are thought to play a 
major role in DNA and cell damage, resulting in secondary, inflammation-driven genotoxicity that can 
lead to neoplastic changes.  These inflammation-based mechanisms are proposed to have a threshold
effect, as chronic inflammation occurs only following c-silica overload in the lung.  This inflammation-
based mechanism of carcinogenicity is supported by epidemiological data indicating that the association
between c-silica and lung cancer is stronger in individuals with silicosis than in individuals without 
silicosis.  However, these findings could merely reflect that c-silica levels high enough to cause silicosis 
(and inflammation) are also capable of causing cancer, rather than indicating that silicosis is a necessary
precursor for cancer development.
As discussed in Section 3.3 Genotoxicity, c-silica is a mutagenic and genotoxic agent both in vitro and in 
vivo.  Phagocytized c-silica particles could cause DNA damage and cell transformation by directly
interacting with DNA, disrupting chromosome segregation during mitosis, generation of ROS on reactive 
particle surfaces or during oxidative burst by macrophage, and/or depleting antioxidant defenses.  This
mechanism is proposed to be non-threshold in nature, and therefore does not require c-silica overload in 
the lung.  As discussed above for silicosis, surface properties and particle size, shape, and crystallinity are 
also important mediators for the genotoxic potential of c-silica. For example, surface modification of
quartz (to block reactive surfaces) prevents ROS generation and oxidative DNA damage in vitro. This
mechanism of carcinogenicity is supported by epidemiological data indicating that lung cancer can occur
in individuals who were not diagnosed with silicosis.
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Autoimmune Disease. Information in this section is from the following reviews: Huaux (2007); Lee et
al. (2012); Maeda et al. (2010); Otsuki et al. (2007); Parks et al. (1999); Rimal et al. (2005); Rocha-Parise
et al. (2014); Steenland and Goldsmith (1995); and Stratta et al. (2001a).  c-Silica is a known immune
adjuvant that can nonspecifically enhance immune responses via increased antibody production.  The
inflammatory response induced by c-silica is thought to underlie its adjuvant effect, potentially through
IL-1 activation of T-helper cells, which facilitate B-cell production of antibodies.  Therefore, c-silica 
exposure alone may not cause autoimmune dysfunction; rather, c-silica exposure may act as an adjuvant
to promote or accelerate autoimmune disease development triggered by another factor (e.g., genetic 
susceptibility, pathogen or chemical exposure).  Thus, the severe inflammatory response following
exposure to c-silica is proposed as a common initiating step that could lead to a variety of autoimmune 
disorders.  
Autoimmune disorders following c-silica exposure may occur secondary to silicosis, as chronic immune
stimulation in the lungs is capable of causing systemic effects.  For example, pulmonary inflammation
can lead to release of elastase into systemic circulation, leading to thrombotic events that mildly damage 
vasculature.  Chronic mild damage to vasculature may, in turn, lead to chronic inflammation in blood
vessels, triggering vasculitis.  Alternatively, autoimmune disorders may occur independently of lung
disease due to deposition of c-silica particles in the lymphatic system (transported via macrophages).  In
this case, macrophage destruction and recruitment cycles would occur in the lymph system (as described
above in the lung), leading to stimulation of T-helper cells and B-cell production. Increased B-cell 
activation would explain elevated levels of autoantibodies observed in c-silica-exposed individuals, 
including:
•	 Rheumatoid factor, which is associated with rheumatoid arthritis;
•	 Anti-nuclear antigen, which is associated with systemic sclerosis;
•	 Anti-topoisomerase I (anti-Scl-70), which is associated with systemic sclerosis;
•	 ANCA, which is associated with ANCA-associated vasculitis;
•	 Anti-CD95/Fas autoantibody, which leads to increased survival of responder T-lymphocytes
(autoimmune lymphoproliferative syndrome) and increased immune reactivity with self/non-self
antigens, and
•	 Anti-caspase 8 autoantibody, which is associated with decreased Fas-mediated apoptosis in 
T-lymphocytes.
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Recent studies have shown that c-silica specifically alters the peripheral CD4+25+ T-cell fraction,
particularly the balance between T-responder and T-regulator cells mediated via Fas-dependent apoptosis
(see Figure 3-7).  This imbalance, in addition to excess autoantibodies produced by activated B-cells,
would lead to a dysregulation of autoimmunity.  The disruption would likely be subclinical; however, 
promotion of a pre-existing autoimmune disorder or triggering of an autoimmune disorder in a pre-
disposed individual could occur. 
Renal Disease. Evidence for elevated risk of renal disease has been observed in c-silica-exposed 
individuals, both in the presence and absence of silicosis (see Renal Effects in Section 3.2.1.2 Systemic 
Effects of Inhalation Exposure).  Renal damage in c-silica-exposed individuals has been associated with
two distinct mechanistic pathways:  (1) direct toxic effect of excessive c-silica accumulation in the kidney
and (2) indirect toxic effects secondary to autoimmune disease (as reviewed by Parks et al. 1999; Stratta
et al. 2001a).  In the first proposed pathway, deposition of c-silica particles in the kidney leads to chronic 
inflammation, which progresses to fibrosis in a process similar to that described above for silicosis. This 
type of renal damage is most often described in individuals diagnosed with silicosis, and c-silica overload
would directly lead to renal failure.  In the second proposed pathway, renal complications of autoimmune
diseases would occur via different mechanisms depending upon the specific autoimmune disease present.
For example, renal damage associated with ANCA-associated vasculitis and systemic sclerosis is 
associated with vascular pathology in the glomerulus, resulting in glomerulonephritis.  Renal pathology
associated with systemic lupus erythematosus appears to be due to deposition of autoantibodies in the
kidney.  It has also been proposed that protein adsorbed onto the surface of c-silica deposited in the 
kidney may denature, potentially acquiring antigenic properties.  Subsequently, excess antibody
production from chronic immune stimulation in the lung and/or lymphatic system could cross-react with
renal antigens.
3.5.3 Animal-to-Human Extrapolations 
Numerous animal studies examining effects of inhaled c-silica have been conducted, and have been
particularly useful in investigating pulmonary clearance of particles and mechanisms of toxicity (Cox 
2011; EPA 1996; NIOSH 2002).  However, results of animal studies may be difficult to extrapolate to 
humans due to species differences in macrophage overloading, which can affect pulmonary clearance and
toxicity (EPA 1996).  Rats appear to be more sensitive than hamsters to macrophage overload (Saffiotti et
al. 1993).  Furthermore, it has been proposed that overload of lung macrophages in rats may not be
relevant to humans (Snipes 1996).  Regarding use of animal models to investigate the carcinogenic effects 
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Figure 3-7.  Proposed Mechanistic Pathway Leading to Autoimmune
 
Dysregulation Following c-Silica Exposure
 
c-Silica exposure causes macrophage recruitment/destruction cycles in the lymphatic system, leading to chronic
stimulation of T-cells.  Helper T-cells stimulate production of B-cells, which leads to increased production of
autoantibodies.  Both T-responder and T-regulator cells are also stimulated; however, T-regulator cells are lost from
the fraction due to Fas-mediated apoptosis.  This causes an imbalance in the CD4+25+ cell fraction.  Together with 
increased production of autoantibodies, this imbalance leads to dysregulation of autoimmunity, promoting and/or
accelerating autoimmune disease development triggered by another factor (e.g., genetic predisposition or other
chemical exposure).
Sources:  Huaux (2007); Lee et al. (2012, 2014); Maeda et al. (2010); Otsuki et al. (2007); Parks et al. (1999); Rimal
et al. (2005); Steenland and Goldsmith (1995); Stratta et al. (2001a)
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of c-silica, c-silica is carcinogenic in rats exposed by inhalation or intratracheal instillation, but not in
mice or hamsters (IARC 2012).  Thus, not all experimental animals appear to be appropriate for use in 
extrapolation to humans.
3.6  TOXICITIES MEDIATED THROUGH THE NEUROENDOCRINE AXIS
Recently, attention has focused on the potential hazardous effects of certain chemicals on the endocrine
system because of the ability of these chemicals to mimic or block endogenous hormones.  Chemicals
with this type of activity are most commonly referred to as endocrine disruptors. However, appropriate
terminology to describe such effects remains controversial.  The terminology endocrine disruptors, 
initially used by Thomas and Colborn (1992), was also used in 1996 when Congress mandated the EPA to 
develop a screening program for “...certain substances [which] may have an effect produced by a 
naturally occurring estrogen, or other such endocrine effect[s]...”.  To meet this mandate, EPA convened a
panel called the Endocrine Disruptors Screening and Testing Advisory Committee (EDSTAC), and in 
1998, the EDSTAC completed its deliberations and made recommendations to EPA concerning endocrine
disruptors.  In 1999, the National Academy of Sciences released a report that referred to these same types 
of chemicals as hormonally active agents. The terminology endocrine modulators has also been used to
convey the fact that effects caused by such chemicals may not necessarily be adverse.  Many scientists 
agree that chemicals with the ability to disrupt or modulate the endocrine system are a potential threat to
the health of humans, aquatic animals, and wildlife.  However, others think that endocrine-active 
chemicals do not pose a significant health risk, particularly in view of the fact that hormone mimics exist
in the natural environment.  Examples of natural hormone mimics are the isoflavinoid phytoestrogens
(Adlercreutz 1995; Livingston 1978; Mayr et al. 1992).  These chemicals are derived from plants and are 
similar in structure and action to endogenous estrogen.  Although the public health significance and 
descriptive terminology of substances capable of affecting the endocrine system remains controversial,
scientists agree that these chemicals may affect the synthesis, secretion, transport, binding, action, or
elimination of natural hormones in the body responsible for maintaining homeostasis, reproduction, 
development, and/or behavior (EPA 1997).  Stated differently, such compounds may cause toxicities that
are mediated through the neuroendocrine axis.  As a result, these chemicals may play a role in altering, 
for example, metabolic, sexual, immune, and neurobehavioral function.  Such chemicals are also thought
to be involved in inducing breast, testicular, and prostate cancers, as well as endometriosis (Berger 1994;
Giwercman et al. 1993; Hoel et al. 1992).
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No studies were located regarding endocrine disruption in humans and/or animals after exposure to 
c-silica or a-silica.
3.7  CHILDREN’S SUSCEPTIBILITY
This section discusses potential health effects from exposures during the period from conception to 
maturity at 18 years of age in humans, when most biological systems will have fully developed.  Potential
effects on offspring resulting from exposures of parental germ cells are considered, as well as any indirect
effects on the fetus and neonate resulting from maternal exposure during gestation and lactation.  
Relevant animal and in vitro models are also discussed.
Children are not small adults.  They differ from adults in their exposures and may differ in their
susceptibility to hazardous chemicals.  Children’s unique physiology and behavior can influence the
extent of their exposure.  Exposures of children are discussed in Section 6.6, Exposures of Children.
Children sometimes differ from adults in their susceptibility to adverse health effects from exposure to
hazardous chemicals, but whether there is a difference depends on the chemical(s) (Guzelian et al. 1992;
NRC 1993).  Children may be more or less susceptible than adults to exposure-related health effects, and
the relationship may change with developmental age (Guzelian et al. 1992; NRC 1993).  Vulnerability
often depends on developmental stage.  There are critical periods of structural and functional 
development during both prenatal and postnatal life that are most sensitive to disruption from exposure to 
hazardous substances.  Damage from exposure in one stage may not be evident until a later stage of 
development. There are often differences in pharmacokinetics and metabolism between children and
adults.  For example, absorption may be different in neonates because of the immaturity of their
gastrointestinal tract and their larger skin surface area in proportion to body weight (Morselli et al. 1980;
NRC 1993); the gastrointestinal absorption of lead is greatest in infants and young children (Ziegler et al. 
1978).  Distribution of xenobiotics may be different; for example, infants have a larger proportion of their
bodies as extracellular water, and their brains and livers are proportionately larger (Altman and Dittmer
1974; Fomon 1966; Fomon et al. 1982; Owen and Brozek 1966; Widdowson and Dickerson 1964).  Past
literature has often described the fetus/infant as having an immature (developing) blood-brain barrier that 
is leaky and poorly intact (Costa et al. 2004).  However, current evidence suggests that the blood-brain 
barrier is anatomically and physically intact at this stage of development, and the restrictive intracellular
junctions that exist at the blood-CNS interface are fully formed, intact, and functionally effective 
(Saunders et al. 2008, 2012).
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However, during development of the brain, there are differences between fetuses/infants and adults that
are toxicologically important. These differences mainly involve variations in physiological transport
systems that form during development (Ek et al. 2012).  These transport mechanisms (influx and efflux)
play an important role in the movement of amino acids and other vital substances across the blood-brain 
barrier in the developing brain; these transport mechanisms are far more active in the developing brain
than in the adult.  Because many drugs or potential toxins may be transported into the brain using these
same transport mechanisms—the developing brain may be rendered more vulnerable than the adult.  
Thus, concern regarding possible involvement of the blood-brain barrier with enhanced susceptibility of
the developing brain to toxins is valid.  It is important to note however, that this potential selective
vulnerability of the developing brain is associated with essential normal physiological mechanisms; and
not because of an absence or deficiency of anatomical/physical barrier mechanisms.
The presence of these unique transport systems in the developing brain of the fetus/infant is intriguing;
whether these mechanisms provide protection for the developing brain or render it more vulnerable to 
toxic injury is an important toxicological question.  Chemical exposure should be assessed on a case-by-
case basis.  Research continues into the function and structure of the blood-brain barrier in early life
(Kearns et al. 2003; Saunders et al. 2012; Scheuplein et al. 2002).
Many xenobiotic metabolizing enzymes have distinctive developmental patterns. At various stages of
growth and development, levels of particular enzymes may be higher or lower than those of adults, and 
sometimes unique enzymes may exist at particular developmental stages (Komori et al. 1990; Leeder and
Kearns 1997; NRC 1993; Vieira et al. 1996).  Whether differences in xenobiotic metabolism make the
child more or less susceptible also depends on whether the relevant enzymes are involved in activation of
the parent compound to its toxic form or in detoxification.  There may also be differences in excretion, 
particularly in newborns given their low glomerular filtration rate and not having developed efficient
tubular secretion and resorption capacities (Altman and Dittmer 1974; NRC 1993; West et al. 1948).  
Children and adults may differ in their capacity to repair damage from chemical insults.  Children also
have a longer remaining lifetime in which to express damage from chemicals; this potential is particularly
relevant to cancer.
Certain characteristics of the developing human may increase exposure or susceptibility, whereas others 
may decrease susceptibility to the same chemical.  For example, although infants breathe more air per
kilogram of body weight than adults breathe, this difference might be somewhat counterbalanced by their
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SILICA 203
3. HEALTH EFFECTS
alveoli being less developed, which results in a disproportionately smaller surface area for alveolar
absorption (NRC 1993).
No information regarding susceptibility of children to c-silica or a-silica has been identified.  Silicosis is 
considered to be an occupational disease that typically occurs with prolonged (years) exposure.  The same 
adverse effects observed in adult workers would be expected to occur in children if sufficiently exposed.
However, non-occupational exposure of children to c-silica could occur in rare circumstances (Bhagia 
2012; Grobbelaar and Bateman 1991a, 1991b; Norboo et al. 1991a, 1991b; Ranavanya et al. 1992; Rees 
and Murphy 2007).  For example, a mixed-etiology pneumoconiosis (combined exposure to c-silica,
heavy dust, and heavy domestic smoke) has been reported in adults engaging in domestic maize hand-
grinding activities using quartz rocks in South Africa (Grobbelaar and Bateman 1991).  Unique
geographical locations and environmental conditions may also result in elevated exposure leading to
silicosis.  For example, radiographic evidence consistent with silicosis has been reported in older
individuals in agricultural villages in the northwest Himalayas in India (Norboo et al. 1991a, 1991b; 
Ranavanya et al. 1992).  This area has frequent dust storms, producing silicotingen rock dust with high 
c-silica content.  However, non-occupational exposure to elevated levels of c-silica that produce silicosis
is very rare.
3.8  BIOMARKERS OF EXPOSURE AND EFFECT
Biomarkers are broadly defined as indicators signaling events in biologic systems or samples. They have 
been classified as markers of exposure, markers of effect, and markers of susceptibility (NAS/NRC
1989).
A biomarker of exposure is a xenobiotic substance or its metabolite(s) or the product of an interaction
between a xenobiotic agent and some target molecule(s) or cell(s) that is measured within a compartment
of an organism (NAS/NRC 1989).  The preferred biomarkers of exposure are generally the substance
itself, substance-specific metabolites in readily obtainable body fluid(s), or excreta.  However, several
factors can confound the use and interpretation of biomarkers of exposure.  The body burden of a
substance may be the result of exposures from more than one source. The substance being measured may
be a metabolite of another xenobiotic substance (e.g., high urinary levels of phenol can result from
exposure to several different aromatic compounds).  Depending on the properties of the substance (e.g.,
biologic half-life) and environmental conditions (e.g., duration and route of exposure), the substance and 
all of its metabolites may have left the body by the time samples can be taken.  It may be difficult to
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identify individuals exposed to hazardous substances that are commonly found in body tissues and fluids
(e.g., essential mineral nutrients such as copper, zinc, and selenium).  Biomarkers of exposure to silica are
discussed in Section 3.8.1.
Biomarkers of effect are defined as any measurable biochemical, physiologic, or other alteration within an
organism that, depending on magnitude, can be recognized as an established or potential health 
impairment or disease (NAS/NRC 1989). This definition encompasses biochemical or cellular signals of
tissue dysfunction (e.g., increased liver enzyme activity or pathologic changes in female genital epithelial
cells), as well as physiologic signs of dysfunction such as increased blood pressure or decreased lung
capacity.  Note that these markers are not often substance specific. They also may not be directly
adverse, but can indicate potential health impairment (e.g., DNA adducts).  Biomarkers of effects caused
by silica are discussed in Section 3.8.2.
A biomarker of susceptibility is an indicator of an inherent or acquired limitation of an organism's ability
to respond to the challenge of exposure to a specific xenobiotic substance.  It can be an intrinsic genetic or
other characteristic or a preexisting disease that results in an increase in absorbed dose, a decrease in the 
biologically effective dose, or a target tissue response. If biomarkers of susceptibility exist, they are 
discussed in Section 3.10, Populations That Are Unusually Susceptible.
3.8.1 Biomarkers Used to Identify or Quantify Exposure to Silica
Crystalline Silica and Amorphous Silica. Silica has been detected in urine of ceramic factory workers
exposed to c-silica, indicating that systemic distribution occurs in humans following inhalation exposure
(Ibrahim et al. 2011). Thus, the presence of silica in the urine indicates that exposure has taken place. 
a-Silica is excreted in the feces. The source of fecal silica us most likely from unabsorbed particles of
inhaled silica that are deposited in the oral cavity and swallowed or are cleared from the airway by muco-
ciliary clearance and subsequently swallowed.  However, the quantitative relationship between urinary
silica and cumulative exposure is unknown.  Thus, no biomarkers of exposure to c- or a-silica have been
identified.
3.8.2 Biomarkers Used to Characterize Effects Caused by Silica
No biomarkers have been identified to characterize effects caused by c-silica or a-silica.  Several studies 
have examined the association between biomarkers of oxidative stress and inflammation in blood and 
urine in small numbers of silica-exposed workers and in laboratory animals.  Markers examined include
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lactate dehydrogenase, alkaline phosphatase, tumor necrosis factors, interleukins, Clara cell proteins, and 
numerous proinflammatory cytokines (Aggarwal 2014; Altindag et al. 2003; Braz et al. 2014; Deb et al. 
2012; Jiang et al. 2015; Sauni et al. 2012; Sellamuthu et al. 2011; Slavov et al. 2010; Wang et al. 2007).  
Although associations have been observed, the biomarkers examined are not specific for exposure to
silica or as markers of silicosis or pre-silicosis. Elevation of these markers also may be caused by
exposure to many other chemicals and by diseases involving inflammatory processes or oxidative stress.
Therefore, at this time, no biomarkers for silica effects or for early detection of silica exposure-induced 
toxicity have been established.
3.9  INTERACTIONS WITH OTHER CHEMICALS
Crystalline Silica. As discussed in Section 3.2.1.7 (Inhalation, Cancer), results of recent studies show
that the risk of lung cancer due to c-silica is higher in smokers than in nonsmokers.  Results of a 
retrospective study in China examining lung cancer risk in smoking and nonsmoking c-silica-exposed 
workers showed a consistent increase (2.75–4.38-fold) in lung cancer risk in smokers versus nonsmokers
over stratified exposure quartiles (Liu et al. 2013).  The study authors stated that ‘the joint effect of
[c-]silica and smoking was more than additive and close to multiplicative.”  In addition, different c-silica 
industries may involve co-exposures with other chemicals (e.g., radon, metals, trace elements, asbestos, 
formaldehyde, benz[a]pyrene) that could potentially increase the toxicity of inhaled c-silica.
Amorphous silica. No studies on interactions of a-silica with other chemicals were identified. 
3.10  POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE 
A susceptible population will exhibit a different or enhanced response to silica than will most persons
exposed to the same level of silica in the environment.  Factors involved with increased susceptibility
may include genetic makeup, age, health and nutritional status, and exposure to other toxic substances
(e.g., cigarette smoke).  These parameters result in reduced detoxification or excretion of silica, or
compromised function of organs affected by silica.  Populations who are at greater risk due to their
unusually high exposure to silica are discussed in Section 6.7, Populations with Potentially High 
Exposures.
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Underlying Diseases. Progression of silicosis can cause serious decrements in lung function that may
result in death due to respiratory failure (see Section 3.2.1.2, Inhalation, Systemic Effects, Respiratory).  
Thus, individuals with underlying lung disease (e.g., asthma, emphysema, tuberculosis, infection with 
human immunodeficiency virus) may be more susceptible to adverse respiratory effects of inhaled
c-silica. Workers with underlying renal diseases also may be more susceptible to adverse respiratory
effects of inhaled c-silica.
Smoking. As discussed in Section 3.2.1.7 (Inhalation, Cancer), results of recent studies show that the risk
of lung cancer due to c-silica is higher in smokers than in nonsmokers.  Results of a retrospective study in
China examining lung cancer risk in smoking and nonsmoking c-silica workers showed a consistent
increase (2.75–4.38-fold) in lung cancer risk in smokers versus nonsmokers over stratified exposure 
quartiles (Liu et al. 2013).  The study authors stated that ‘the joint effect of [c-]silica and smoking was 
more than additive and close to multiplicative.”
Polymorphisms. Information in this section is from the following reviews: Ding et al. 2002; Gomez-
Puerta et al. 2013; Iannello et al. 2002; IARC 2012; NIOSH 2002; Parks et al. 1999; Yucesoy et al. 2002.
Specific growth factors and cytokines have been identified as playing a crucial role in the pathogenesis of
silicosis, particularly TNF-α or IL-1 (see Section 3.5.2 Mechanisms of Toxicity for more details).
Evidence from human studies indicates that certain polymorphisms for TNF-α or IL-1 are associated with
increased incidence and/or severity of silicosis following occupational exposure to c-silica.  For example, 
in silicotic patients, the risk of developing severe fibrosis was associated with the HLA-Aw19-B18 
TNF-α haplotype in the Caucasian population and the HLA-Bw54 TNF-α haplotype in the Japanese
population.  In a case-control study, the TNF-α variant (-238) was significantly associated with severe 
silicosis and the TNF-α (-308), IL-1RA (+2018), and IL-1RA (-208) variants were significantly
associated with moderate and severe silicosis.
Allelic variants of TNF-α or IL-1 have also been associated to autoimmune and inflammatory diseases.
For example, individuals with the HLA-DR3 TNF-α haplotype or a minor variant of the IL-1RA VNTR
in linkage disequilibrium have a genetic predisposition to SLE.  Therefore, individuals with
polymorphisms in these genes may also have increased susceptibility to autoimmune effects associated
with occupational exposure to c-silica.  In addition, individuals with other known genetic predispositions
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to autoimmune disease may have an increased risk of autoimmune dysfunction with occupational
exposure to c-silica (e.g., genetic alterations in the major histocompatibility complex). For example, only
specific strains of mice (NZB and MRL/MpJ) develop autoimmune pathology resembling SLE following
exposure to c-silica dust.
Altitude. In a recent review, Vearrier and Greenberg (2011) concluded that workers at high altitude are at 
risk for more rapid development and progression of silicosis.
Amorphous silica. No information regarding susceptible populations for a-silica was identified.
3.11  METHODS FOR REDUCING TOXIC EFFECTS
This section will describe clinical practice and research concerning methods for reducing toxic effects of
exposure to silica.  Because some of the treatments discussed may be experimental and unproven, this
section should not be used as a guide for treatment of exposures to silica.  When specific exposures have 
occurred, poison control centers, board certified medical toxicologists, board-certified occupational
medicine physicians and/or other medical specialists with expertise and experience treating patients 
overexposed to silica can be consulted for medical advice.
Silicosis is an irreversible, progressive, fibrotic lung disease that can continue to progress even after
removal from exposure. No established treatments to reverse pulmonary fibrosis or stop its progression 
have been identified.  Supportive therapy may include supplemental oxygen, antibiotic treatment of
infections, and vaccinations for influenza and pneumococcal pneumonia.  Patients also should undergo 
periodic tuberculosis screening. Treatment with bronchodilators and corticosteroids may be useful if the 
patient has changes of COPD (Dart et al. 2002; Hoffman et al. 2014).
Additional relevant information can be found in the front section of this profile under QUICK
REFERENCE FOR HEALTH CARE PROVIDERS.
3.11.1 Reducing Peak Absorption Following Exposure 
No methods have been identified to reduce peak absorption following exposure to c-silica or a-silica.
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3.11.2 Reducing Body Burden
No methods have been identified to reduce body burden of c-silica or a-silica.
3.11.3 Interfering with the Mechanism of Action for Toxic Effects
No methods have been identified to interfere with the mechanisms for toxic action of c-silica or a-silica.
3.12  ADEQUACY OF THE DATABASE 
Section 104(I)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of silica is available. Where adequate information is not 
available, ATSDR, in conjunction with the National Toxicology Program (NTP), is required to assure the
initiation of a program of research designed to determine the adverse health effects (and techniques for
developing methods to determine such health effects) of c-silica and a-silica.
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA.  They are defined as substance-specific informational needs that if met would 
reduce the uncertainties of human health risk assessment.  This definition should not be interpreted to 
mean that all data needs discussed in this section must be filled.  In the future, the identified data needs
will be evaluated and prioritized, and a substance-specific research agenda will be proposed.
3.12.1 Existing Information on Health Effects of Silica
The existing data on health effects of inhalation, oral, and dermal exposure of humans and animals to
silica are summarized in Figures 3-8 and 3-9.  The purpose of this figure is to illustrate the existing
information concerning the health effects of silica.  Each dot in the figure indicates that one or more
studies provide information associated with that particular effect. The dot does not necessarily imply
anything about the quality of the study or studies, nor should missing information in this figure be
interpreted as a “data need”.  A data need, as defined in ATSDR’s Decision Guide for Identifying 
Substance-Specific Data Needs Related to Toxicological Profiles (Agency for Toxic Substances and 
Disease Registry 1989), is substance-specific information necessary to conduct comprehensive public 
health assessments.  Generally, ATSDR defines a data gap more broadly as any substance-specific 
information missing from the scientific literature.
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*For inhalation toxicity, the focus of this toxicological profile for crystalline silica is on health effects
associated with occupational exposure (silicosis, lung cancer, COPD, renal toxicity, tuberculosis, and 
autoimmune disorders).  Other effects in humans were not evaluated. Studies on effects of inhalation 
exposure of animals were not reviewed.
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Crystalline Silica. The focus of this toxicological profile for c-silica is on health effects associated with
inhalation exposure in occupational settings (silicosis, lung cancer, COPD, renal toxicity, tuberculosis,
and autoimmune disorders). Information regarding effects of inhalation exposure to c-silica is derived
from an extensive database of occupational exposure studies.  Effects of occupational exposure to c-silica 
typically occur after prolonged (chronic) exposure (years).  Intermediate-duration exposure typically is
not associated with adverse health effects, although intermediate-duration occupational exposure to high 
levels of respirable c-silica may cause acute silicosis. Exposure to respirable c-silica in ambient air has 
not been associated with adverse health effects.  Adverse health effects have not been associated with
c-silica following oral or dermal exposure.
Amorphous Silica. Few studies have evaluated the effects of exposure to a-silica in humans or animals, 
with most data obtained from animal studies.  Pulmonary fibrosis has been reported in a-silica workers,
although co-exposure to c-silica could not be ruled out.  Animal studies show that inhalation of a-silica
produces pulmonary inflammation and reversible fibrosis, but silicosis is not observed.  Other than 
pulmonary effects, no other effects associated with inhaled a-silica have been established.  Available data
for oral exposure are inadequate to establish adverse effects of a-silica in humans or animals.  Adverse 
health effects have not been associated with dermal exposure to a-silica.
3.12.2 Identification of Data Needs 
For c-silica, the focus of data needs is on the primary health effects associated with inhalation exposure in 
occupational settings (silicosis, lung cancer, COPD, kidney effects, tuberculosis, and autoimmune
disorders).  Thus, data needs for other health effect end points were not evaluated for inhaled c-silica.
Given the lack of data for oral c-silica and inhaled and oral a-silica, comprehensive evaluations of data
needs for these exposures were conducted. The effects of c-silica and a-silica have not been investigated
in humans or animals following dermal exposure.  As the dermal route is not considered a major route of
exposure for silica compounds, data needs for dermal exposure to c-silica and a-silica were not evaluated.
Acute-Duration Exposure.
Crystalline Silica. Adverse effects of occupational (inhalation) exposure to c-silica occur after
intermediate (>14 days to <1 year) or chronic exposure (years) and are not associated with exposure
durations of ≤14 days. 
***DRAFT FOR PUBLIC COMMENT***
   
 









     
  
    
   
  
     
    
   
 
     
  
    
  
    
    
 
     
      
 
 
    
   
  
    
 
     
 
      
   
       
    
    
   
SILICA 212
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The oral database for acute exposure to c-silica is limited to a single study in rats exposed to 50 mg
c-silica/kg/day in drinking water as sodium metasilicate for 8 days (Öner et al. 2005, 2006).  Effects in
tissues from exposed rats were altered responses of cardiac tissue to various contractile and dilatory
stimuli, and altered ammonia, γ-GT, and glutathione levels in cultured renal slices. The toxicological 
significance of these findings is not known.  No exposure-related changes were observed in glomerular
filtration rate.  No other end points were evaluated. Considering the limitations of the available data,
well-designed acute oral toxicity studies of c-silica may provide evidence to identify critical effects and
establish NOAEL and LOAEL values.
Amorphous Silica. The database is lacking studies evaluating the effects of acute-duration inhalation
exposure to a-silica in humans.  However, data are adequate to identify the critical effect following acute 
exposure to a-silica in animals.  Available data indicate that the primary target of acute toxicity is the
respiratory system, with transient pulmonary lesions and markers of inflammation after exposure to
concentrations as low as 5 mg/m3 for 3–14 days (Arts et al. 2007; Reuzel et al. 1991; Warheit et al. 1991,
1995).  At higher exposure levels (≥87 mg/m3) for 2 weeks, hematological effects (increased erythrocytes,
hemoglobin, and pack cell volume) and decreased body weight were observed (Reuzel et al. 1991).  
Additional acute inhalation studies evaluating dose- and duration-dependence would provide more
information on other potential effects and may identify critical effects and establish NOAEL and LOAEL
values.
With the exception of an oral LD50 study in Sprague-Dawley rats (Lewinson et al. 1994), studies
evaluating effects of acute oral exposure of humans or animals to a-silica were not identified.
Considering the lack of the available data, well-designed acute oral toxicity studies of a-silica may
provide evidence to identify critical effects and establish NOAEL and LOAEL values.
Intermediate-Duration Exposure.
Crystalline Silica. Intermediate-duration inhalation exposure typically is not associated with adverse health
effects in workers, although occupational exposure to high levels (not defined; also called ‘intense 
exposure”) of respirable c-silica, such as in sand blasting, may cause accelerated silicosis (Beckett 1997;
Leung et al. 2012). Accelerated silicosis may occur after weeks of intense exposure, but typically occurs
5–10 years after the start of exposure.  Results of available occupational studies do not provide
information on dose- or duration-dependence of intermediate-duration exposure associated with the 
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development of accelerated silicosis. Therefore, additional occupational exposure studies of workers with
accelerated silicosis that provide exposure-response and duration-response data may define the NOAEL
and LOAEL values for accelerated silicosis associated with intense exposure.
Studies evaluating the effects of intermediate-duration oral exposure of humans or animals to c-silica 
were not identified.  Given the lack of information, well-designed intermediate-duration oral toxicity
studies of c-silica would provide information about potential effects of exposure and possibly establish 
critical effects and NOAEL and LOAEL values.
Amorphous Silica. The database is lacking studies evaluating the effects of intermediate-duration 
inhalation exposure to a-silica in humans.  However, data are adequate to identify the critical effect
following intermediate exposure to a-silica in animals.  Available data indicate that the primary target of
acute toxicity is the respiratory system, with evidence of transient pulmonary lesions and markers of
inflammation after exposure to concentrations as low as 5 mg/m3 for 4–13 weeks (Johnston et al. 2000;
Lee and Kelly 1992; Reuzel et al. 1991; Warheit et al. 1991, 1995).  The only other systemic effect
reported in intermediate-duration inhalation studies in animals included hematological effects (increased
neutrophils, increased erythrocytes, hemoglobin, and pack cell volume) at 30 mg/m3 for 13 weeks (Reuzel
et al. 1991). Given the lack of information, well-designed intermediate-duration inhalation toxicity
studies of a-silica would provide information about potential effects of exposure and possibly establish
critical effects and NOAEL and LOAEL values.
A single study investigating the effects of intermediate-duration oral exposure of rats to a-silica was 
identified (Lewinson et al. 1994).  Results showed histological effects on the liver (atrophy of the hepatic
epithelium, condensation of the cytoplasm, loss of basophilic structure, and hyperchromatic and 
contracted nuclei) following an 8-week exposure to an escalating dosage regimen at doses up to
16,000 mg/kg/day.  However, no histopathological effects were observed in other organ systems.  Given 
the lack of information, well-designed intermediate-duration oral toxicity studies of a-silica would
provide information about potential effects of exposure and possibly establish critical effects and NOAEL
and LOAEL values.  
Chronic-Duration Exposure and Cancer.
Crystalline Silica. The available database for chronic-duration occupational exposure to c-silica is 
extensive and identifies silicosis, lung cancer, COPD, renal effects, tuberculosis, and autoimmune
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disorders as targets. For all health effects, comparison of exposure-response data across studies can be
challenging due to potential differences in toxicological potency of c-silica polymorphs and exposures to
co-contaminants.  Additional occupational exposure studies providing quantitative information of c-silica
polymorphs and co-contaminants may provide useful information to determine the basis of differences in
study results from different occupational cohorts.
Several occupational studies have demonstrated exposure-response relationships for silicosis and 
mortality due to silicosis (Checkoway et al. 1997; Chen et al. 2001, 2012; Churchyard et al. 2004;
Hedlund et al. 2008; Hnizdo and Sluis-Cremer 1993; Hughes et al. 1998, 2001; Kreiss and Zhen 1996;
Mannetje et al. 2002a, 2002b; McDonald et al. 2005; Muir et al. 1989a, 1989b; Mundt et al. 2011;
Steenland and Brown 1995a; Vacek et al. 2011).  However, the low end of the exposure-response curve is 
not well-defined, with silicosis and death due to silicosis observed for the lowest cumulative exposure 
ranges reported.  For the lowest cumulative exposure range of 0–0.2 mg/m3-year, silicosis was observed
in 5 of 3,330 gold miners (Steenland and Brown 1995a). For mortality due to silicosis, the lowest
cumulative exposure range of 0.1–1.23 mg/m3-year was associated with an increased risk of mortality
(hazard ratio: 1.89; 95% CI: 1.60, 2.24) (Chen et al. 2012). Additional occupational studies focused on 
lower c-silica exposures may provide information to identify no-effect levels or threshold levels for
silicosis or mortality due to silicosis.
c-Silica is classified as a human lung carcinogen (IARC 2012; NIOSH 2002; NTP 2014).  IARC (1997, 
2012) acknowledged that some occupational exposure studies did not show an association between 
c-silica exposure and lung cancer, possibly due to the characteristics of c-silica in different occupational
settings or other factors affecting its biological activity; in addition, other confounding factors and biases
may have influenced study results (e.g., errors in estimating c-silica exposure levels, absence of or
presence and severity of silicosis, adequate control of confounding from smoking, and unaccounted
occupational co-exposures that may have contributed to lung cancer risk).  (Brown 2009; Checkoway
2000; Checkoway and Franzblau 2000; Cox 2001; NIOSH 2002; Pelucchi et al. 2006; Smith et al. 1995;
Soutar et al. 2000; Steenland and Ward 2014).  Additional, well-controlled occupational exposure studies
would provide important information regarding the exposure-response relationship for c-silica-induced 
lung cancer and the relationship between silicosis and lung cancer. 
Occupational exposure to c-silica has been associated with increased risk of a wide-spectrum of renal
pathologies, including acute and chronic renal nephritis/nephrosis, end-stage renal failure,
glomerulonephritis, and renal damage associated with autoimmune disorders (Calvert et al. 1997; Rapiti 
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et al. 1999; Steenland 2005; Steenland et al. (2001b).  However, exposure-response relationships for these
effects are not well-defined.  Additional occupational exposure studies providing quantitative exposure
data may allow for identification of NOAEL and LOAEL values for renal toxicity. 
The oral database for chronic-duration exposure to c-silica is limited to a few epidemiological studies
evaluating potential noncancer effects of silica (form not reported, assumed to be c-silica) in drinking
water, including renal disease and cognitive effects.  Silicon dioxide levels in water were significantly
positively correlated with developing Balkan nephropathy (BN; an endemic chronic kidney disease of the
Balkan Peninsula); however, the study authors proposed that it is more likely that the silicon dioxide
content in drinking water is correlated with the substance or substances causing the disease, rather than
the underlying cause of BN (Radovanovic et al. 1991).  Additionally, lower silica content has been 
reported in wells from BN-endemic villages, compared with control villages (reviewed by Voice et al.
2006).  Therefore, additional studies evaluating renal disease and silica content in drinking water may not
be warranted.  Two French studies did not find an adverse association between silica levels in drinking
water and cognitive decline in an elderly population (Gillette-Guyonnet et al. 2005; Jacqmin-Gadda et al.
1996).  Given the lack of data on chronic-duration oral exposure in humans and animals, 
well-designed chronic-duration oral toxicity studies of c-silica would provide information about potential 
effects of exposure and possibly establish critical effects and NOAEL and LOAEL values.
Amorphous Silica. The available epidemiological studies in humans occupationally exposed to a-silica 
are inadequate to determine whether or not a-silica causes lung disease in humans, as workers often had
exposure to both amorphous and c-silica, as well as other inorganic dusts (Choudat et al. 1990; Gamsky et
al. 1992; Jorna et al. 1994). However, it is important to note that silicosis has generally not been observed
in epidemiological studies in workers with long-term exposure to a-silica with no known exposure to 
c-silica (reviewed by McLaughlin et al. 1997; Merget et al. 2002).  A limited number of human studies
have reported an increased risk of lung cancer or mesothelioma in industries with occupational exposure
to a-silica; however, the usefulness of these studies is limited due to potential co-exposure to c-silica and
lack of quantitative exposure data (Brooks et al. 1992; Checkoway et al. 1993; Le Blond et al. 2010;
Rothschild and Mulvey 1982; Sinks et al. 1994; reviewed by McLaughlin et al. 1997; Merget et al. 2002).  
Available occupational exposure studies do not identify targets other than the respiratory system. 
Additional occupational exposure studies that have quantitative data on a-silica exposure and account for
c-silica exposure would be helpful in defining the dose-response relationship between inhalation of
a-silica and respiratory system toxicity.  Additional studies also may identify other systemic targets for
occupational exposure to a-silica. Available data from two chronic animal studies indicate that chronic
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inhalation exposure to a-silica can lead to pulmonary inflammation in rats, guinea pigs, and rabbits and 
early nodular fibrosis and reduced lung function in monkeys (Groth et al. 1981; Schepers 1981). 
However, a near-complete reversal of adverse effects was observed during a recovery period of 3– 
9 months. Other effects observed in chronic inhalation studies included altered hematological parameters 
in rabbits (increased erythrocytes, hemoglobin, and pack cell volume), but not monkeys, rats, or guinea
pigs (Groth et al. 1981; Schepers 1981).  No other systemic targets were identified in these chronic animal
studies. Given the lack of data on chronic-duration oral exposure, well-designed chronic-duration 
inhalation toxicity studies of a-silica in animals would provide information about potential effects of
exposure and possibly establish critical effects and NOAEL and LOAEL values.
The oral database for chronic-duration exposure to a-silica is limited to a single 24-month study in rats
(Lewinson et al. 1994).  In this study, the only administered dose level of 100 mg/kg/day was identified as
a NOAEL for a lack of systemic effects. The reliability of this study is low due to small animal groups 
(20/sex), lack of concurrent control, and use of a single dose level that did not approach the MTD.  
Considering the limitations of the available data, well-designed chronic toxicity studies of a-silica may
provide evidence to establish a LOAEL and critical effects for long-term oral exposure.
Genotoxicity.
Crystalline Silica. Results of numerous studies indicate that c-silica is a genotoxic agent in mammalian
cells, with the ability to cause mutagenicity, clastogenicity, and DNA-damage.  Chromosomal and DNA
damage in peripheral lymphocytes and increased micronuclei formation in peripheral lymphocytes and 
nasal epithelial cells have been observed following occupational exposure to c-silica (Basaran et al. 2003;
Demircigil et al. 2010; Sobti and Bhardwaj 1991); however, data are insufficient to determine the
exposure-response relationship.  Additional occupational exposure studies providing quantitative
exposure data may allow for the determination of exposure-response relationships between inhaled
c-silica and genotoxicity.  In vivo studies in rodents exposed to c-silica by intratracheal instillation show
DNA damage to lung epithelial cells (Knaapen et al. 2002; Seiler et al. 2001a, 2001b, 2001c).  Results of
in vitro studies also indicate that c-silica causes DNA damage, mutagenicity, and clastogenicity (Cakmak
et al. 2004; Driscoll et al. 1997; Fanizza et al. 2007; Hart and Hesterberg 1998; Li et al. 2007; Msiska et
al. 2010; Nagalakshmi et al. 1995; Schins et al. 2002a, 2002b; Zhang et al. 1999, 2000; Zhong et al. 
1997b).  Additional occupational exposure studies providing quantitative exposure data may allow for the
determination of exposure-response relationships between inhaled c-silica and genotoxicity.
***DRAFT FOR PUBLIC COMMENT***
   
 








     
      
     
  
      
      
     
 
     
 
      
   
    
     
    
 
  
    
 
      
    
    
       
   
 
 
     
 
     
   
     
 




Amorphous Silica. Studies evaluating genotoxicity in humans following occupational exposure to 
a-silica were not identified.  The few in vivo studies in animals were negative for mutations and induction 
of micronuclei (Johnston et al. 2000; Morita et al. 1997).  However, results of in vitro studies show that
a-silica can cause DNA and chromosomal damage, although conflicting results have been observed (Elias 
et al. 2006; Guidi et al. 2013; Liu et al. 1996a; Zhong et al. 1997b).  Additional occupational exposure
studies, in vivo animal studies, and in vitro studies would provide important information to clarify
conflicting results and determine if a-silica is genotoxic under conditions of occupational exposure.
Reproductive Toxicity.
Crystalline Silica. Results of an environmental study of pregnant women to c-silica in drinking water
suggest that the risk of spontaneous abortion was increased in the highest exposure tertile (3.7– 
32.0 mg/L) (Aschengrau et al. 1989).  The form of silica was not specified, although the study authors
assumed that exposure was to c-silica.  Due to limitations in study design (lack of data on water
consumption, organic contaminants, and no controls for other environmental exposures), interpretation of
study results is difficult.  No studies evaluating reproductive effects in animals following oral exposure to
c-silica were identified.  Well-controlled reproductive studies in animals would provide information 
regarding the potential reproductive effects of oral c-silica.
Amorphous Silica. No studies evaluating reproductive effects in humans following inhalation exposure
to a-silica were identified.  No histopathological changes to reproductive organs or effects on
reproductive performance were observed in rats exposed to oral a-silica at a daily dose of 500 mg/kg/day
for 6 months (Lewinson et al. 1994). Results of this study indicate that reproductive effects of oral
a-silica are probably not of concern; therefore, additional developmental studies do not appear to be
critical.
Developmental Toxicity.
Crystalline Silica. No studies evaluating developmental effects in humans or animals following oral
exposure to c-silica were identified.  Well-controlled developmental studies in animals would provide
information regarding the potential reproductive effects of oral c-silica.
Amorphous Silica. No studies evaluating developmental effects in humans or animals following
inhalation exposure to a-silica were identified.  No developmental effects were observed in offspring of
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rats exposed to dietary a-silica for 6 months, based on results of two matings (Lewinson et al. 1994).  
Results of this study indicate that developmental effects of a-silica are probably not of concern; therefore,
additional developmental studies do not appear to be critical.
Immunotoxicity.
Crystalline Silica. Numerous retrospective cohort and case-control studies have evaluated potential
associations between c-silica exposure and a wide spectrum of autoimmune disorders, including systemic
sclerosis (scleroderma), rheumatoid arthritis, systemic lupus erythematosus, ANCA-associated vasculitis,
and sarcoidosis (Bartunkova et al. 2006; Beaudreuil et al. 2005; Bovenzi et al. 1995, 2004; Brown et al.
1997; Burns et al. 1996; Calvert et al. 2003; Conrad et al. 1996; Cooper et al. 2010; Cowie 1987; Diot et
al. 2002; Englert et al. 2000; Finckh et al. 2006; Gold et al. 2007; Gregorini et al. 1993; Hogan et al. 
2001; Klockars et al. 1987; Lacey et al. 1997; Koskela et al. 1987b; Makol et al. 2011; Maitre et al. 2004;
Marie et al. 2014; Nuyts et al. 1995; Rafnsson et al. 1998; Rihova et al. 2005; Rodnan et al. 1967;
Rosenman and Zhu 1995; Rosenman et al. 1999; Silman and Jones 1992; Sluis-Cremer et al. 1985, 1986;
Steenland and Brown 1995b; Steenland et al. 1992, 2001b; Stolt et al. 2005, 2010; Stratta et al. 2001b; 
Turner and Cherry 2000; Walsh 1999).  However, exposure-response relationships for these effects are 
not well-defined.  Additional occupational exposure studies providing quantitative exposure data may
allow for identification of NOAEL and LOAEL values for autoimmune disorders.  
Amorphous Silica. No studies evaluating immunological or lymphoreticular effects in humans following
inhalation or oral exposure to a-silica were identified. No immune system toxicity was observed in rats 
exposed by inhalation to a-silica at concentrations up to 30 mg/m3 for 6 hours/day, 5 days/week for
13 weeks (Reuzel et al. 1991) or in monkeys, rats, or guinea pigs following exposure to a-silica at up to
9.9 mg/m3 for 6 hours/day, 5 days/week for up to 18 months (Groth et al. 1981).  Similarly, no immune
system effects were observed in rats exposed to oral a-silica at doses of 500 mg/kg/day for 6 months or
100 mg/kg/day for 24 months (Lewinson et al. 1994).  Given the limited data on a-silica and the 
immunotoxicity associated with c-silica, additional well-controlled occupational and animal studies
would provide information regarding the potential for a-silica to produce autoimmune disorders.
Neurotoxicity.
Crystalline Silica. No associations were observed between oral exposure of humans to c-silica and
cognitive impairment or increased risk of Alzheimer’s disease (Gillette-Guyonnet et al. 2005; Jacqmin-
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Gadda et al. 1996).  No studies evaluating neurological effects in animals following oral exposure to 
c-silica were identified.  Given the low level of absorption following oral exposure to c-silica, additional 
studies on neurotoxicity of oral c-silica are not critical.
Amorphous Silica. No changes in brain weight or central or peripheral nervous tissue histology were
observed in rats exposed to inhaled a-silica at concentrations up to 30 mg/m3 for 6 hours/day, 5 days/week 
for 13 weeks (Reuzel et al. 1991).  No signs of neurotoxicity were observed in rats exposed to oral a-silica 
500 mg/kg/day for 6 months or 100 mg/kg/day for 24 months.  Given the low level of absorption 
following oral to a-silica, additional studies on neurotoxicity of a-silica are not critical.
Epidemiological and Human Dosimetry Studies. Numerous occupational exposure studies have been 
conducted on the effects of inhalation exposure to c-silica.  These are reviewed above (Chronic-Duration 
Exposure and Cancer). Of special value in any ongoing or future occupational exposure studies is reliable 
exposure data, including quantitative data on the level and duration of exposure for c-silica and a-silica 
polymorphs.
Biomarkers of Exposure and Effect.
Exposure. Silica has been detected in urine of ceramic factory workers exposed to c-silica, suggesting 
that systemic distribution occurs in humans following inhalation exposure (Ibrahim et al. 2011). This
suggests that urine may be an excretory pathway for c-silica absorbed from the respiratory tract.  
However, no studies examining the relationship between urinary silica and cumulative exposure were 
identified.  Research examining the link between urinary silica and cumulative exposure may provide
information that urinary silica serves as a biomarker for exposure.
Effect. Silicosis is a unique effect of exposure to c-silica.  However, other than the signs and symptoms 
associated with silicosis, no other markers of effect have been identified. Several studies have examined
the association between biomarkers of oxidative stress and inflammation in blood and urine in small
numbers of silica-exposed workers and in laboratory animals. Markers examined include lactate 
dehydrogenase, alkaline phosphatase, tumor necrosis factors, interleukins, Clara cell proteins, and 
numerous proinflammatory cytokines (Aggarwal 2014; Altindag et al. 2003; Braz et al. 2014; Deb et al. 
2012; Jiang et al. 2015; Sauni et al. 2012; Sellamuthu et al. 2011; Slavov et al. 2010; Wang et al. 2007).  
Additional research on the association between biomarkers and silica-exposed workers would be
important to determine if such biomarkers could be used for early detection of silica-induced toxicity.
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Absorption, Distribution, Metabolism, and Excretion.
Absorption. Quantitative estimates regarding absorption and pulmonary retention of c-silica and a-silica 
polymorphs are not available.  Silica has been detected in urine of ceramic factory workers exposed to 
c-silica, suggesting that absorption occurs in humans following inhalation exposure (Ibrahim et al. 2011).
Several studies have evaluated the pulmonary deposition and retention of c-silica and a-silica in the lung
of animals (Borm et al. 2002; Case et al. 1995; Davis 1986; Dobreva et al. 1975; Donaldson and Borm
1998; Dufresne et al. 1998; Kelly and Lee 1990; Loosereewanich et al. 1995; Reuzel et al. 1991; Schepers
1981). Additional studies to determine quantitative estimates of pulmonary retention and clearance of
c-silica and a-silica following inhalation exposure may provide important information regarding the toxic
pulmonary load of silica compounds.  Results of a single study evaluating the absorption of oral c-silica
in rats indicates that silica was not absorbed (Gonzalez et al. 1991). Given the lack of quantitative
information on pulmonary and oral absorption of c-silica and a-silica, well-controlled studies in humans
and animals would provide important information to more fully describe the absorption of silica
compounds.
Distribution. Little information is available regarding extrapulmonary distribution of silica compounds.  
Occupational exposure studies indicate that inhaled c-silica distributes to the kidney, although 
quantitative information regarding distribution was not identified (Giles et al. 1978; Hauglustaine et al.
1980; Ibrahim et al. 2011; Saldanha et al. 1975). Studies in rats show distribution to blood, lymph nodes, 
thymus, kidney, liver, and spleen (Absher et al. 1992). No studies of distribution of silica compounds
following oral exposure were identified.  Given the lack of qualitative and quantitative information on 
distribution, well-controlled studies in humans and animals would provide important information to more
fully describe the distribution of silica compounds.
Metabolism. Absorbed silica compounds are not metabolized.  Additional studies on metabolism are not
considered critical.
Excretion. Silica has been detected in urine of ceramic factory workers exposed to c-silica, suggesting
that urine may be an excretory pathway for silica absorbed from the respiratory tract (Ibrahim et al. 2011).
Ingested silica is excreted in the feces; however, there are no studies on urinary excretion of absorbed oral
silica. Studies on urinary excretion of silica in workers and animals would provide information on 
relative contribution of excretory pathways and quantitative estimates on retention and excretion of silica.
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Comparative Toxicokinetics. Very little is available on the post-absorptive kinetics of absorbed
silica compounds.  Silica is distributed to tissues outside of the respiratory tract.  Additional studies on 
distribution and mechanisms of excretion would be useful to gain a better understanding of non-
respiratory toxic effects.
Methods for Reducing Toxic Effects. Silicosis is an irreversible, progressive, fibrotic lung disease 
that can continue to progress even after removal from exposure. Other than supportive therapy, no 
established treatments to reverse pulmonary fibrosis or stop its progression have been identified.
Children’s Susceptibility. Data needs relating to both prenatal and childhood exposures, and
developmental effects expressed either prenatally or during childhood, are discussed in detail in the
Developmental Toxicity subsection above.
No information regarding susceptibility of children to c-silica or a-silica has been identified. Silicosis is 
strictly an occupational disease that occurs from prolonged (years) exposure.  As such, studies on 
children’s susceptibility are not considered critical.
Child health data needs relating to exposure are discussed in Section 6.8.1, Identification of Data Needs:
Exposures of Children.
3.12.3 Ongoing Studies 
Ongoing research identified in the National Institute of Health (NIH) RePORTER (2015) database is 
summarized in see Table 3-22).  
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Table 3-22. Ongoing Studies on Silica Compounds
Principal 
investigator Study topic Institution Sponsor







Fattman, CL Use of stem cells as therapy
for silicotic lung disease using 
mice as the animal model






Holian, A Mechanisms of c-silica-
induced fibrosis examining the 
role of activated lung 







Kelly, C Mechanism of tissue-specific 
fibrosis in autoimmune-prone 
mice
Integrated Laboratory
Systems, Inc., Research 





Larue, AC The potential of circulating 
fibroblast precursor as a 
biomarker of pulmonary
fibrosis using a silica mouse 
model





Laskin, DL Mechanism examining the role 
of caveolin-1 and TNFα in 
silica-induced toxicity
The State University of
New Jersey at Rutgers,
Rutgers, New Jersey
National Cancer Institute
Migliaccio, CT Mechanism of multiple cell




National Center for Research 
Resources
Ortiz, LA Role of tumor necrosis factor
receptor-1 phosphorylation on 
silica-induced lung injury






Ortiz, LA Mechanisms of bone marrow
derived mesenchymal stem
cells to employ microvesicles
as a means to deliver
University of Pittsburg at
Pittsburg, Pittsburg,
Pennsylvania
National Heart, Lung, and 
Blood Institute
peptides, miRNAs, and 
mitochondria to reprogram the 
innate immunity and 
ameliorate silicosis
Pollard, KM Characterization of silica-
induced immunological
responses leading to 
autoimmunity in mice
Scripps Research 





Source:  RePORTER 2015.
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4. CHEMICAL AND PHYSICAL INFORMATION
4.1 CHEMICAL IDENTITY
The synonyms, trade names, chemical formulas, and identification numbers of silica and selected forms 
of silica are provided in Table 4-1. 
4.2 PHYSICAL AND CHEMICAL PROPERTIES 
Information regarding the physical and chemical properties of silica and selected silica forms is provided
in Table 4-2. 
Silica occurs naturally in crystalline and amorphous (or non-crystalline) forms, herein referred to as 
c-silica and a-silica, respectively. Silica has one general Chemical Abstract Service registry number
(CASRN 7631-86-9) and more specific CASRNs for individual silica forms and preparations.  Both the
crystalline and amorphous forms of silica are composed of a 1:2 net ratio of silicon atoms to oxygen 
atoms, corresponding to an empirical formula of SiO2 and the chemical name silicon dioxide (IARC
1997).  All silica compounds are silicon dioxide. The internal chemical structure of most forms of silica 
consists of each silicon atom bonded to four oxygen atoms in a silicon and oxygen tetrahedral (SiO4) or 
pyramidal unit with four triangular sides.  Crystalline forms of silica have regular, repeating three-
dimensional patterns with internal oxygen atoms shared between two tetrahedral silicon atoms.  Terminal
oxygen atoms are negatively charged ions at environmentally relevant pH (OSHA 2013c).  Amorphous
forms of silica are composed of highly disordered, randomly linked silicon and oxygen tetrahedral units 
with no defined pattern.  X-ray diffraction patterns distinguish crystalline polymorphs from each other
and c-silica from a-silica (discussed in Section 7.2).
The surface properties of silica compounds, even the same polymorph, varies.  Both c- and a- forms of 
silica have surfaces composed of siloxane (covalently bonded silicon and oxygen; Si-O-Si) and silanol
groups (Si-OH) (Rimola et al. 2013; Zhuravlev 2000).  Exposure to water will break silicon-oxygen 
bonds on the surface of silica to form silanols.  In contrast, heating silica results in condensation of pairs 
of silanols to form siloxane bridges.  In general, c-silica surfaces tend to have more order, although some 
c-silica is found with an outer layer of a-silica.  a-Silica may contain a c-silica component from exposure
to high temperatures and pressures (e.g., flux calcination).  Grinding silica results in either heterolytic
cleavage or homolytic cleavage of silicon-oxygen bonds at the surface interfaces producing Si+ and SiO–
surface charges or surface radicals, respectively (Fubini et al. 1995). The total concentration and
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4. CHEMICAL AND PHYSICAL INFORMATION
Table 4-1.  Chemical Identity of Silica and Compoundsa 
Characteristic Information
Chemical name Silica Quartz Cristobalite Tridymite




































No data No data
Chemical formula SiO2 SiO2 SiO2 SiO2







CAS registry 7631-86-9 14808-60-7 14464-46-1 15468-32-3
NIOSH RTECSd,e VV7310000 VV7330000 VV7325000 VV7335000
EPA hazardous waste No data No data No data No data
OHM/TADS No data No data No data No data
DOT/UN/NA/IMDG
shipping
No data No data No data No data
HSDB 7168 and 682 7168c 7168c 682c 
NCI No data No data No data No data
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4. CHEMICAL AND PHYSICAL INFORMATION
Table 4-1.  Chemical Identity of Silica and Compoundsa 
Characteristic Information
Chemical name Kieselguhr Kieselguhr, soda 
ash flux-calcined
Vitreous silica Kieselguhr, calcined





























Chemical formula SiO2 SiO2 SiO2 SiO2
Chemical structure Not applicablef Not applicablef Not applicablef Not applicablef
Identification numbers:
CAS registry 61790-53-2 68855-54-9 60676-86-0 91053-39-3g 
NIOSH RTECSd,e HL8600000 No data VV7328000 No data
EPA hazardous No data No data No data No data
waste
OHM/TADS No data No data No data No data
DOT/UN/NA/IMDG
shipping
No data No data No data No data
HSDB 682c 682c 682c No data
NCI No data No data No data No data
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4. CHEMICAL AND PHYSICAL INFORMATION
Table 4-1.  Chemical Identity of Silica and Compoundsa 
Characteristic Information
Chemical name Fumed silica Precipitated silica Silica gel
Chemical formb Amorphous silica Amorphous silica Amorphous silica
















Chemical formula SiO2 SiO2 SiO2
Chemical structure Not applicablef Not applicablef Not applicablef 
Identification numbers:
CAS registry 112945-52-5 112926-00-8 63231-67-4
NIOSH RTECSd,e VV7310000 VV8850000 No data 
EPA hazardous No data No data No data
waste
OHM/TADS No data No data No data
DOT/UN/NA/IMDG
shipping
No data No data No data
HSDB 682c 682c 682c 
NCI No data No data No data
aAll information obtained from IARC (1997) except where noted.
 
ba-Silica may contain c-silica; c-silica content varies based on methods of preparation and purification (IARC 1997).
 




eIPCS 2001, 2016a, 2016b, 2016c.
 
fAmorphous, randomly linked silicon and oxygen tetrahedral units with no defined pattern.
 
gFlorke et al. 2008.
 
CAS = Chemical Abstracts Service; DOT/UN/NA/IMDG = Department of Transportation/United Nations/North 

America/International Maritime Dangerous Goods Code; EPA = Environmental Protection Agency;
 
HSDB = Hazardous Substances Data Bank; NCI = National Cancer Institute; NIOSH = National Institute for
 
Occupational Safety and Health; OHM/TADS = Oil and Hazardous Materials/Technical Assistance Data System;
 
RTECS = Registry of Toxic Effects of Chemical Substances
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4. CHEMICAL AND PHYSICAL INFORMATION
Table 4-2.  Physical and Chemical Properties of Silica and Compoundsa 
Property Information
Chemical name Quartz Cristobalite Tridymite Kieselguhr
Chemical formb Crystalline silica Crystalline silica Crystalline silica Amorphous silica
Molecular weight 60.1 60.1 60.1 60.1
Color Colorless, white, Colorless, white, or Colorless or white Colorless crystals 
black, purple, or yellowish solid solid or white powder
green solid
Physical state Solid Solid Solid Solid
Melting point (°C)c 573 (α-quartz 1,713 1,470 (tridymite 1,710





Boiling point (°C) 2,230 2,230 2,230 2,230
Density (g/cm3) at
20°Cd
2.648 (α-quartz) 2.334 2.265 2.2 at 25°C
Odor Odorless Odorless Odorless No data
Odor threshold:
Water Not applicable Not applicable Not applicable No data
Air Not applicable Not applicable Not applicable No data
Taste Tasteless Tasteless Tasteless No data 
Taste threshold Not applicable Not applicable Not applicable No data
Solubility:
Water at 20°C Insoluble Insoluble Insoluble Poorly to insoluble
Other solvents Dissolves in Dissolves in Dissolves in No data
hydrofluoric acid hydrofluoric acid hydrofluoric acid





Log Kow No data No data No data No data
Log Koc No data No data No data No data
Vapor pressure Negligible at 20°C No data No data Negligible at 20°C
(mmHg) at 20°C
Henry's law constant No data No data No data No data
at 25°C
Auto ignition No data No data No data No data
temperature
Flashpoint No data No data No data No data
Flammability limits No data No data No data No data
Conversion factors No data No data No data No data
(ppm to mg/m3)
Explosive limits No data No data No data No data
***DRAFT FOR PUBLIC COMMENT***
   
 














    







    
    
    
 
 
   
    
    
    
    
    
    
    
    
   
 
 
    
    
    
 
   
  
 
   
 
 
   
    
    
 
  
   
    
SILICA 228
4. CHEMICAL AND PHYSICAL INFORMATION
Table 4-2.  Physical and Chemical Properties of Silica and Compoundsa 
Property Information
Chemical name Kieselguhr, soda ash flux- Vitreous silica Kieselguhr, calcined
calcined
Chemical formb Amorphous silica Amorphous silica Amorphous silica
Molecular weight 60.1 60.1 60.1
Color Colorless crystals or white Colorless crystals or white Colorless crystals or white 
powder powder powder
Physical state Solid Solid Solid
Melting point (°C) 1,710 1,713c 1,710
Boiling point (°C) 2,230 2,230 2,230
Density (g/cm3) at 2.2 at 25°C 2.196c 2.2 at 25°C
20°C
Odor No data No data No data
Odor threshold:
Water No data No data No data
Air No data No data No data
Taste No data No data No data
Taste threshold No data No data No data
Solubility:
Water at 20°C Poorly to insoluble Poorly to insoluble Poorly to insoluble
Other solvents No data Dissolves in hydrofluoric No data
acid 
Partition coefficients:
Log Kow No data No data No data
Log Koc No data No data No data
Vapor pressure Negligible at 20°C Negligible at 20°C Negligible at 20°C
(mmHg) at 20°C
Henry's law constant No data No data No data
at 25°C
Auto ignition No data No data No data
temperature
Flashpoint No data No data No data
Flammability limits No data No data No data
Conversion factors No data No data No data
(ppm to mg/m3)
Explosive limits No data No data No data
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4. CHEMICAL AND PHYSICAL INFORMATION
Table 4-2.  Physical and Chemical Properties of Silica and Compoundsa 
Property Information
Chemical name Precipitated silica Fumed silica Silica gel
Chemical formb Amorphous silica Amorphous silica Amorphous silica
Molecular weight 60.1 60.1 60.1
Color Colorless crystals or white Colorless crystals or white Colorless crystals or white 
powder powder powder
Physical state Solid Solid Solid
Melting point (°C) 1,710 1,710 1,710
Boiling point (°C) 2,230 2,230 2,230
Density (g/cm3) at 2.2 at 25°C 2.2 at 25°C 2.2 at 25°C
20°C
Odor No data No data No data
Odor threshold:
Water No data No data No data
Air No data No data No data
Taste No data No data No data
Taste threshold No data No data No data
Solubility:




Other solvents No data No data No data
 
Partition coefficients:
Log Kow No data No data No data
Log Koc No data No data No data
Vapor pressure Negligible at 20°C Negligible at 20°C Negligible at 20°C
(mmHg) at 20°C
Henry's law constant No data No data No data
at 25°C
Auto ignition No data No data No data
temperature
Flashpoint No data No data No data
Flammability limits No data No data No data
Conversion factors No data No data No data
(ppm to mg/m3)
aAll information obtained from HSDB (2009, 2012) except where noted.









fThe solubility of silica is influenced by several factors including temperature and pH; it is affected by the presence of
 
trace metals and the rate of solubility is dependent on the particle size and presence of an external a-silica layer on 

the particle surface (IARC 1997).
 
***DRAFT FOR PUBLIC COMMENT***
   
 









     
  
    
  
 
    
  
   
 
























4. CHEMICAL AND PHYSICAL INFORMATION
arrangement of silanol on the surface of c- and a-silica can vary greatly.  Thus, for a single polymorph of
c- or a-silica, surface chemistry of the compound may vary, depending upon production method and 
degree of hydration.  As discussed in Sections 2.2 and 3.5.2, the biological activity of both c-silica and
a-silica polymorphs is affected by surface chemistry of the silica particle (Donaldson and Borm 1998;
Greenberg et al. 2007; Guthrie 1995; Mossman and Churg 1998; Mossman and Glenn 2013).
c-Silica is polymorphic, meaning that there are several distinctly different crystalline forms with the same 
chemical composition.  c-Silica polymorphs have regular, repeating three-dimensional patterns with long-
range order; however, discernable variations in tetrahedral orientation and crystal symmetry differentiate 
the polymorphs.  c-Silica is often referred to as quartz.  Quartz is the most common naturally occurring
form of silica and is the second most common mineral in the world (USGS 1992).  Other common forms
of c-silica are tridymite and cristobalite, and less common forms of c-silica are keatite, coesite, stishovite,
amethyst, and moganite (NIOSH 2002).  Interconversion of the silica polymorphs occurs upon heating or
cooling (see Section 6.3.2 for additional information).
The term ‘free silica’ refers to pure c-silica.  Major impurities in c-silica polymorphs include aluminum, 
iron, titanium, lithium, sodium, potassium, and calcium ions (IARC 1997).  The concentration of these
impurities varies depending on the sample source, but is generally <1.0% in weight as oxide.  Natural
quartz may contain elemental impurities that are substitutions for silicon.  Elemental impurities may also 
be present as internal or surface defects (Guthrie 1995).  c-Silica substances containing other elements,
such as sodium, potassium, calcium, magnesium, iron, and aluminum substituted into the crystalline
matrix, are referred to as silicates (EPA 1996; USGS 1992).
a-Silica is composed of a random network of tetrahedral silica, and does not display long-range order.  
a-Silica forms are classified as natural or synthetic a-silica based on their origin.  Synthetic a-silica forms 
are further classified by their preparation method; there are wet process silica forms, which include 
precipitated silica and silica gels, and thermal process silica forms, including pyrogenic (or fused) silica.
Surface-modified silica is physically or chemically treated a-silica (IARC 1997).
Silica is a stable oxide of silicon.  c-Silica does not readily react with most acids, but does react with
hydrofluoric acid to produce silicon tetrafluoride gas (IARC 2012; OSHA 2013c).  c-Silica also reacts
with alkaline aqueous solutions and catechol (IARC 2012).  a-Silica will react with mineral acids and
alkaline solutions (OSHA 2013c).
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4. CHEMICAL AND PHYSICAL INFORMATION
In general, silica is considered poorly water soluble and chemically unreactive in the environment (EPA
1991; IARC 1997).  The water solubility of silica has some variation due to differences in trace metal
impurities and hydration (OSHA 2013c).  Solubility is lower for c-silica polymorphs than for a-silica, and
anhydrous a-silica dissolves less rapidly than hydrated a-silica (IARC 1997).  a-Silica dissolves in water
to form monosilicic acid (Waddell 2006).  External conditions such as higher temperatures and pH
increase the water solubility of silica.  The hydrophilicity of c-silica particles increases in humid 
conditions because an external layer of hydroxylated silica (silanol; SiOH) forms on the surface of the 
particles.  Fresh surfaces of silica exposed by fracture are highly reactive and have a propensity to
produce surface radicals; however, the surface is inactivated once hydrated (Costa et al. 1991; Fubini et
al. 1995).  Aged quartz has an external amorphous layer, referred to as a Beilby layer.  The Beilby layer is 
more water soluble than the underlying c-silica (IARC 1997; OSHA 2013c). 
Particle size has also been found to influence the rate of solubility.  Silica particulate surface areas and
sizes are distinguishable based on their source.  Ground vitreous silica and c-silica particles have acute 
edges and heterogeneous particle sizes; surface areas range from 0.1 and 10 to 15 m2/g (IARC 1997).  
Diatomaceous earth and cristobalite particles from diatomaceous earth are found in a variety of shapes 
and surface areas.  Calcinated diatomaceous earth particles have surface areas that range from 2 to
20 m2/g.  Pyrogenic a-silica particles are nonporous, smooth, round aggregates with surface areas that
range from 50 to 400 m2/g.  Precipitated a-silica particles have sizes and porous structures that vary in
surface area from 50 to approximately 1,000 m2/g, depending on the procedure used in their preparation.  
Nanoscale forms of silica were not included in this assessment. 
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5. PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL
5.1 PRODUCTION
No information is available in the TRI database on facilities that manufacture or process silica because 
this chemical is not required to be reported under Section 313 of the Emergency Planning and Community
Right-to-Know Act (Title III of the Superfund Amendments and Reauthorization Act of 1986) (EPA
2005).
Silica exists in the natural environment and is produced in crystalline and amorphous forms (OSHA
2013c).  Sand and gravel, quartz crystals, and diatomite are the three predominant commercial silica 
product categories (IARC 2012).  c-Silica is a common component of igneous rocks such as granite, 
rhyolite, quartz diorite, quartz monzonite, and andesite.  Naturally occurring silica is mined from the
earth’s crust (USGS 1992).  Typically, silica is mined using open pit or dredging methods with standard 
mining equipment (USGS 2014b). The major component of sand and gravel is quartz.  The quartz
content of crushed stone varies from region to region. 
The U.S. Geological Survey (USGS 2015) reported sand and gravel in two mineral commodity
summaries, industrial sand and gravel or commercial sand and gravel.  An estimated 139 million metric
tons of silica, in the form of industrial sand and gravel, were produced throughout the world in 2012 
(USGS 2014b).  The United States (50.7 million metric tons), Italy (16.4 million metric tons), Germany
(7.5 million metric tons), Turkey (7 million metric tons), France (6.3 million metric tons), Australia
(5.3 million metric tons), Spain (5 million metric tons), the United Kingdom (3.8 million metric tons), and 
Japan (3.2 million metric tons) were the highest producing countries in 2012. The USGS performed a
voluntary survey in 2012 of U.S. industrial sand and gravel producers from 77 operations, which 
represented 75% of the U.S. total production (combined).  The survey data indicated that the Midwest
produced over half (56%) of the 50.7 metric tons of industrial sand and gravel produced in the United 
States, followed by the South at 36%, the West at 5%, and the Northeast at 3% (USGS 2014b).  Demand 
for hydraulic fracturing sand has resulted in increased industrial sand and gravel production capacity in
the United States through ongoing permitting and opening of new mines (USGS 2015).
In 2012, the United States produced 812 million metric tons of construction sand and gravel (USGS
2014c).  Construction sand and gravel were produced by 4,100 companies and government agencies in 
the United States (USGS 2015).  Texas, California, Minnesota, Washington, Michigan, Colorado, 
Arizona, North Dakota, Wisconsin, and Ohio accounted for about 55% of total U.S. output.
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5. PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL
Quartz crystal for electronics is predominantly from cultured, not natural, crystal.  Synthetic quartz
crystals are grown in specific shapes and sizes in heavy-duty autoclaves at 1,500–20,000 pounds/inch2 
and 250–450°C (USGS 1992).  No companies in the United States reported production of cultured quartz
crystal in a 2012 USGS voluntary survey (USGS 2014b).  Cultured quartz crystal is produced primarily in 
Asia.
Quartz has two forms, α-quartz and β-quartz.  The thermodynamically stable form of quartz under
ambient conditions is α-quartz; β-quartz forms at temperatures >573°C (USGS 1992).  Quartz has a range
of physical forms with different sizes, shapes, surface area, roughness, and sorption capacity.  Natural
quartz is collected from ore through a beneficiation process where raw material is milled and ground into 
particles and separated into desired mineral and waste.  Grinding of sand or gravel is sometimes required 
to achieve a desired silica material; these processes increase the levels of dust containing respirable 
c-silica (NTP 2014).  Idiomorphic quartz, lump quartz, quartz pebbles, granular quartz, quartz sand, 
quartz powder, and quartz rock are quartz raw material forms (Florke et al. 2008).  Silica flour is an 
extremely fine-grade silica sand product.  Tripoli (CASRN 1317-95-9) is a form of microcrystalline
quartz with an extremely small particle size (NIOSH 2011).
Cristobalite is a form of c-silica formed at temperatures >1,470°C (OSHA 2013c).  High-temperature 
calcined and high-temperature flux-calcined diatomaceous earth may contain cristobalite, formed during
the calcination process of diatomaceous earth (Mossman and Glenn 2013).  Cristobalite may be formed
from quartz during the pouring of metal in foundries where quartz is used to make molds and cores 
(IARC 1997).  Tridymite is a form of c-silica formed at temperatures >870°C (OSHA 2013c).  Both 
cristobalite and tridymite are found in volcanic rocks and glass (Mossman and Glenn 2013).
Flint, chalcedony, agate, chert, and novaculit are cryptocrystalline silica.  Cryptocrystalline silica is silica 
with submicrometer crystals formed by geological crystallization or compaction of a-silica (IARC 1997;
USGS 1992).  Forms of c-silica are gemstones (USGS 2014a, 2015).  The estimated values in 2012 of
U.S. natural quartz gemstone production were $383,000 and $261,000 for macrocrystalline and 
cryptocrystalline quartz, respectively (quantity in mass not reported). The macrocrystalline quartz
gemstones are amethyst, aventurine, blue quartz, citrine, hawk's eye, pasiolite, prase, quartz cat's eye,
rock crystal, rose quartz, smoky quartz, and tiger's eye; the cryptocrystalline quartz gemstones are agate,
carnelian, chalcedony, chrysoprase, fossilized wood, heliotrope, jasper, moss agate, onyx, and sard.
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5. PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL
Biogenic silica is a-silica from living matter, such as plants and diatoms, radiolarians, or silicoflagellates.
Certain species of plants and animals, known as diatoms and radiolarians, respectively, extract dissolved
silica from their aqueous environment to form structures and shells (USGS 1992).  Diatoms and 
radiolarians are biological sources of silica. The remains of diatoms and radiolarians in sediment can
harden into diatomite and radiolarite.  Diatomite or Kieselguhr, which is also known as diatomaceous
earth, is a loosely coherent, chalk-like sediment that contains up to 94% SiO2 (IARC 1987).  Kieselguhr is
obtained through open pit mining (HSDB 2009).  In 2014, an estimated 800,000 tons of diatomite was
produced at 11 mining areas and 9 processing facilities in California, Nevada, Oregon, and Washington 
(USGS 2015). The estimated world mine reserves of diatomite is large (>360 million metric tons).  In 
2014, total (world) mine production was 2.36 million metric tons, with 800,000 metric tons in the United 
States, 430,000 metric tons in China, and 325,000 metric tons in Denmark.  The largest diatomite deposits
in the world are located in Lompoc, California (Florke et al. 2008).  Diatomites are also mined in Georgia,
Mississippi, Nevada, Oregon, and Washington.
In general, synthetic a-silica forms have very high purity.  Diatomite (or Kieselguhr) is a sedimentary
rock that typically contains 86–94% silica (0.1 to 4.0% c-silica).  Aluminum oxide, iron (III) oxide, 
titanium dioxide, and calcium, magnesium, sodium, and potassium ions are common impurities in
diatomite (IARC 1997).  Flux-calcined diatomaceous earth is produced when diatomite is heated with
flux and typically contains between 40 and 60% cristobalite (OSHA 2013c).  The highest synthetic
a-silica production capacity in 2004 was in Europe (36%), followed by North America (26%), China
(25%; estimated), and Japan (13%) (Waddell 2006).
Pyrogenic (or fumed) silica is typically >99.8% silica (IARC 1997).  It is prepared by vaporizing silica at
2,000°C or oxidizing organic or inorganic silicon compounds (Waddell 2006).  Vitreous silica (or fused 
silica) is glassy silica formed by melting and rapidly cooling c-silica to avoid recrystallization (Florke et 
al. 2008; Smith 2006).  Vitreous silica is also formed by vapor-phase hydrolysis of silicon tetrachloride in
a methane oxygen flame. Transparent fused silica is formed from exposing 15 nm silica particles to
1,200°C and 13.8 MPa (2,000 psi) or by electric arc fusion of pure silica sand (Waddell 2006). 
Precipitated silica is a finely divided synthetic a-silica produced by precipitation from a vapor or solution
(EPA 1996).  Some precipitated silica and silica gels are prepared with washing steps, which reduce metal
oxide impurities to 100–1,000 ppm (IARC 1997).  Silica gel is a synthetic amorphous form of hydrous
silica containing an interconnected random array of spheroidal particles with 2–10-nm diameters and
surface areas of approximately 300–1,000 m2/g SiO2 (Florke et al. 2008).  Silica gel is produced when 
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SILICA 236
5. PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL
aqueous alkali metal silicate is neutralized under acidic conditions, initiating the polymerization of
a-silica into small spheroids. Silica gel has three variations referred to as hydrogel, aerogel, and xerogel
based on the production method used (Waddell 2006).
5.2 IMPORT/EXPORT
In 2012, 306,000 metric tons of industrial sand were imported into the United States and 4.36 million 
metric tons were exported. The largest quantities of industrial sand and gravel imported were from
Canada (226,000 metric tons) and Mexico (64,000 metric tons) (USGS 2014b).  The largest quantities of
industrial sand and gravel exported were from the United States to Canada (2.33 million metric tons), 
Mexico (807,000 metric tons), and Japan (632,000 metric tons).  In 2013, 160,000 metric tons of
industrial sand were imported into the United States and 2.96 million metric tons were exported.
In 2013, 3 million metric tons of construction sand were imported into the United States (USGS 2015).
The largest quantities of construction sand and gravel imported were from Canada (2.37 million metric
tons), Mexico (210,000 metric tons), The Bahamas (150,000 metric tons), and other (270,000 metric
tons).  In 2014, 3,000 tons of diatomite were imported for use and 87,000 tons were exported (USGS
2015).  Imports were from Mexico (1,080 metric tons), France (990 metric tons), China (300 metric tons), 
and others (630 metric tons).
5.3 USE 
Sand and gravel are used for road building and concrete construction (OSHA 2013c).  In the United
States, an estimated 44% of construction sand and gravel is used for concrete aggregates; the remainder is 
used for road base and coverings and road stabilization (25%), asphaltic concrete aggregates and other
bituminous mixtures (13%), construction fill (12%), concrete products (1%), plaster and gunite sands
(1%), snow and ice control (1%), and filtration, golf courses, railroad ballast, roofing granules, and other
miscellaneous uses (3% combined) (USGS 2015).
Heavy industry uses quartz sand to produce high-temperature or refractory silica brick, foundry molds, 
and cores for the production of metal castings (IARC 2012).  The oil and gas industry uses a water-sand 
mixture to fracture rock.  Silica sand is used as a proppant, to prop open fractures and promote
hydrocarbon flow and extraction.  Water and proppants make up 98–99.5% of typical fracturing fluids. 
Silica sand with a round spherical shape and commonly graded particle distribution is specifically
selected for hydraulic fracturing fluid production.  Resin-coated silica is also used as a proppant
***DRAFT FOR PUBLIC COMMENT***












   
       
 
    
    
     
    
 






   
     
  









   
  
    
 
SILICA 237
5. PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL
(Holloway and Rudd 2014).  In the United States, an estimated 72% was used as hydraulic fracturing sand 
and well-packing and cementing sand; the remainder was used for glassmaking sand (13%), foundry sand 
(6%), whole-grain fillers and building products (3%), other whole-grain silica (2%), ground and unground 
sand for chemicals (2%), and other uses (2%) (USGS 2015).  c-Silica is used as an asphalt filler and in
bricks, mortar, plaster, caulk, roofing granules, wallboard, concrete, and dimension stone in building
materials (IARC 2012).  Quartz is used as filler in plastics, rubber, and paint or as an abrasive
(e.g., blasting, scouring cleansers, sawing, and sanding).  Quartz sand is used in municipal water filter
beds and sewage treatment plants for filtering out impurities, sediment, and bacteria.  Sand and gravel
aggregates are used as abrasives on roads in winter (EC 2013).
c-Silica is used in products such as art clay, glazes, cleansers, cosmetics, pet litter, furniture foam,
personal care products, talcum powder, and Jeweler’s rouge (buffing agent) and as a gemstone
(e.g., amethyst, citrine, and quartz) (IARC 2012; USGS 1992).  Silica gemstones are used in jewelry, for
collections, decorative art objects, and exhibits (USGS 2014a).  Cristobalite sand, powder, and flour are
used in the production of plastics, adhesives, wall paint, texture coatings, and road paint (Florke et al. 
2008).
Quartz sand is used to manufacture glass and pure silicon for computer chips.  Sand with >98% silica
content is used for glass and ceramics.  Finely ground c-silica is used to make ceramics (e.g., pottery,
brick, and tile), porcelain, and fine china (IARC 2012; USGS 1992).  Windows and specialized devices 
such as lasers use optical-grade quartz, while electronic-grade quartz is required for electronic circuits.
Electronic-grade quartz crystal is used for accurate filters, frequency controls, and timers used in
electronic circuits (USGS 2014b).  Piezoelectric quartz crystals convert mechanical pressure into
electricity and are used in advanced communication systems (IARC 2012; USGS 1992). 
Silica stone, a type of c-silica, is produced to manufacture files, deburring-tumbling media, oilstones, and 
whetstones (USGS 2014b). Artificial, decorative stone products for bathroom and kitchen countertops
are manufactured with up to 93% silica content (Kramer et al. 2012).  Quartzite, tripoli, ganister, chert, 
and novaculite are commercially produced silica products (NTP 2014). 
Tripoli is extremely fine-grained c-silica, used as a functional filler and extender in adhesives, plastics,
rubber, and sealants, and in toothpaste, tooth polishing compounds, industrial soaps, metal- and jewelry-
polishing compounds, and buffing and polishing compounds for lacquer finishing in the automobile
industry (OSHA 2013c; USGS 2014b).  Silica flour (CASRN 14808-60-7) is a fine grade of silica with
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particles up to 100 µm in diameter used in toothpaste, scouring powders, metal polishes, paints, rubber, 
paper, plastics, wood fillers, cements, road surfacing materials, and foundry applications (NIOSH 1981;
NTP 2009).
Diatomite is used for removing microbial contaminants (e.g., bacteria, protozoa, and viruses) in public
water systems (USGS 2015).  In 2014, diatomite was used predominantly in filter aids (58%), absorbents
(14%), cement (14%), and fillers (13%), and for other specialized applications such as pharmaceutical
and biomedical uses (1%). Diatomaceous earth silica and silica gel are used as insecticides and
acaracides to control insects, mites, and ticks (EPA 1991). The particle size of diatomaceous earth
influences the insecticidal efficacy (Vajias et al. 2009).  These compounds act as pesticide carriers and
abrasive desiccants, which remove oily, protective films causing insects to dry out and die.  Diatomite is 
applied to stored grain, food stores, feed, and ornamental plants, as well as on pets and their living or
sleeping areas.
a-Silica is used at levels up to 2% by weight in food products (IARC 1997).  a-Silica is used as an anti-
caking agent and as an excipient in pharmaceuticals. a-Silica is used in cosmetics such as makeup
preparations, hair dyes and colors, hair bleaches, hair straighteners, permanent waves, hair preparations, 
personal cleanliness products, skin care preparations, bubble baths, bath oils, tablets, and salts, body and
hand preparations (excluding shaving preparations), moisturizing preparations, underarm deodorants, 
paste masks, perfumes, foot powders and sprays, cleansing products, and suntan gels, creams, and liquids
(HSDB 2009). 
Silica gel is used as a desiccant and adsorbent for water and other species, thickener in dentifrice, matting
agent in coatings, chromatographic media, and catalyst support.  Silica fume, a-silica formed as a 
byproduct of silicon metal or ferrosilicon alloy production, is used in cement, concrete, and mortars to 
improve strength and durability (Florke et al. 2008).
Transparent and nontransparent vitreous glass is used in tubing, rods, crucibles, dishes, boats, 
chromatographic substrate, precious-metal thermocouples protection, high temperature pyrometry prisms, 
lenses, cells, windows, other optical components, lasers, mercury vapor lamps, transducers, 
semiconductor technology, space shuttle windows, and optical fibers (Smith 2006).
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5.4 DISPOSAL
In the United States, approximately 34% of glass containers are recycled (USGS 2015).  Foundry sand 
and cullet or glass pieces are also recycled, but to a lesser extent.  Asphalt road surface layers, cement
concrete surface layers, and concrete structures are recycled; however, it is considered to be a small
percentage of aggregate (or total) amount used.  Approximately 13.7 kkg of Portland cement concrete was 
recycled in 2012 (USGS 2014c).
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6.1 OVERVIEW
Silica is ubiquitous and is widespread in the environment.  It is of particular concern in areas adjacent to 
crystalline silica mining, processing, and transporting facilities (Richards and Brozell 2015; Richards et
al. 2009).
Silicate minerals and quartz comprise approximately 80 and 12% by volume of the earth’s crust, 
respectively (IARC 1997).  Generally, silica deposits are quartz (or derived from quartz), formed by
metamorphism, sedimentation, or igneous activity.  Silica-containing deposits are found in every land 
mass and strata from every period of geological time (IARC 1987).  Sea sand is almost pure silica (HSDB
2012).  Silica is also present in air, water, and food.  Silica enters environmental media naturally through 
the weathering of rocks and minerals.  Anthropogenic releases of silica are primarily in the form of air
emissions.  Silica undergoes atmospheric transport as a fractional component of particulate emissions 
(EPA 1996).
The primary route of exposure for the general population is thought to be via inhalation of c-silica during
the use of commercial products containing quartz (IARC 2012).  Silica is an air contaminant and 
significant amounts of a-silica and c-silica may be found in fly ash from power stations and various
manufacturing facilities (IARC 1997).  Silica-containing dust is produced during rock cutting, drilling, 
crushing, grinding, mining, abrasion, pottery making, and diatomaceous earth processing (HSDB 2012).  
a-Silica fibers have been identified as smoke constituents in air samples collected near burning sugarcane 
fields and near rice farming operations (IARC 1997).
The major features of the biogeochemical cycle of silica include dissolution of terrestrial or lithogenic
silica in marine sediments, Aeolian dust settling on the ocean water surface, weathering of continental
rocks, and silica settling out of water into sediment from biogenic sources (Trėguer and De La Rocha
2013).  Bioavailable silicic acid, Si(OH)4, reaches concentrations up to 2 mM when dissolving in water
from minerals in near-neutral pH conditions (Lickiss 2006).  Some organisms in water, including diatoms
and radiolarian, build up exoskeletons of hydrated silica from silicic acid.  Rice, millet, sugarcane, and
wheat plants accumulate a-silica; dried sugarcane leaf has silica concentrations ranging between 0.45 and
1.8 weight % (LeBlond 2010; Rabovsky 1995).
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Background gravimetric airborne dust concentrations of remote continental air are 0.04 mg/m3, of which 
≥10% is c-silica (Moore 1999).  In urban areas across the United States, the measured mean 24-hour
average ambient c-silica concentration ranged from 0.0009 to 0.008 mg/m3 for particles in the size range 
of 2.5–15 µm (Davis et al. 1984).  Average ambient levels of silica in metropolitan areas of the United
States generally have ranged between 0.001 and 0.003 mg/m3 with <15 µm aerodynamic diameter (EPA
1996).  Typical silica concentrations in waters are 13 ppm for lakes, 3–15 ppm for major rivers, 1–10 ppm
for seawater, 2–60 ppm for wells, and 50–300 ppm for wells in volcanic and oil fields (Ning 2002).
Since silica is ubiquitous in the environment, the general population will be exposed to silica by
inhalation of ambient air and ingestion of food and water.  a-Silica compounds are used as pesticides that
are applied to crops and are used near food handling and preparation areas (EPA 1991).  Silica is used in 
food packaging; therefore, food is expected to be a source of exposure to silica for most people (FDA
2015a, 2015b). The use of other consumer items such as cosmetics, cleansers, and toothpaste that also 
contain silica will result in exposure to silica.
Occupational exposures to silica occur during the mining and processing of metals, nonmetals, and coal, 
and in many other industries because silica is extremely common, is widely used in materials and
products, and is naturally occurring.  Occupations in mines and mills (metal, nonmetal, and coal), gas and 
oil drilling with hydraulic fracturing, granite quarrying and processing, crushed-stone and related 
industries, foundries, the ceramics industry, manufacture and installation of kitchen countertops, 
construction, and sandblasting operations are most frequently found to have respirable quartz levels 
>0.1 mg/m3 (NTP 2014).  In agriculture operations, such as plowing, harvesting, using machinery, 
burning agricultural waste, and processing agricultural products, silica exposure from the soil may occur
(NIOSH 2002).  Individuals living in the vicinity of industrial emission sources, quarries, or sand and 
gravel operations may be exposed to elevated levels of respirable c-silica.  Local meteorological
conditions, such as wind and rain, especially in deserts and areas near recent volcanic eruptions and mine
dumps, are expected to influence the location and spread of silica-containing dust (IARC 1987).
6.2 RELEASES TO THE ENVIRONMENT
The Toxics Release Inventory (TRI) data should be used with caution because only certain types of
facilities are required to report (EPA 2005).  This is not an exhaustive list.  Manufacturing and processing
facilities are required to report information to the TRI only if they employ 10 or more full-time
employees; if their facility is included in Standard Industrial Classification (SIC) Codes 10 (except 1011, 
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1081, and 1094), 12 (except 1241), 20–39, 4911 (limited to facilities that combust coal and/or oil for the
purpose of generating electricity for distribution in commerce), 4931 (limited to facilities that combust
coal and/or oil for the purpose of generating electricity for distribution in commerce), 4939 (limited to
facilities that combust coal and/or oil for the purpose of generating electricity for distribution in
commerce), 4953 (limited to facilities regulated under RCRA Subtitle C, 42 U.S.C. section 6921 et seq.), 
5169, 5171, and 7389 (limited S.C. section 6921 et seq.), 5169, 5171, and 7389 (limited to facilities
primarily engaged in solvents recovery services on a contract or fee basis); and if their facility produces, 
imports, or processes ≥25,000 pounds of any TRI chemical or otherwise uses >10,000 pounds of a TRI
chemical in a calendar year (EPA 2005).
6.2.1 Air
There is no information on releases of silica to the atmosphere from manufacturing and processing 
facilities because these releases are not required to be reported (EPA 2005).
Silica may be released to air by natural and human processes.  c-Silica is emitted into the ambient
environment as a component of particulate emissions (EPA 1996).  Process-stream air emissions of
c-silica occur during activities, such as brick making, and fugitive emissions of c-silica occur ancillary to
activities.  For example, soil particles containing c-silica enter the atmosphere when vehicles travel on
unpaved roads as fugitive emissions.  Ambient dust containing silica by fugitive emissions include
agricultural tilling, burning (forest and non-forest fires), construction, mining, quarrying, hydraulic
fracturing, paved and unpaved roads, and wind erosion sources.  Soil geology factors are an important
source of variability in c-silica emissions by fugitive releases in construction.
There are multiple possible sources of ambient silica.  Industrial quarrying and mining are inherently
dusty and are expected to contribute to ambient c-silica emissions (EPA 1996).  c-Silica may be released
during metallurgic manufacturing, although this is dependent on the c-silica use and application of
particulate pollution control efforts.  Power plant emissions contain c-silica from spent ash and 
combustion (EPA 1996).  Sanding roads for deicing activities in winter may be a potential exposure route 
for silica as particulate emissions (EPA 1996).
Cristobalite dust may become released into the air by volcanic eruptions (OSHA 2013c). Forest fire and
crop burning may emit silica.  The original a-silica in vegetation can be released in an amorphous form
when combustion occurs at lower temperature, but may release cristobalite and quartz when burned at
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higher temperatures (EPA 1996). Wind erosion emissions of silica, where particulate aerosols are 
generated from air currents moving over soil, may spread c-silica particles in soils, and vary based on soil
parameters, climatic factors, geographic features, vegetation type, and farming practices (EPA 1974). 
In urban areas across the United States, the measured mean 24-hour average ambient c-silica 
concentration ranged from 0.0009 to 0.008 mg/m3 for particles in the size range of 2.5–5 µm, as presented 
in Table 6-1 (EPA 1996).  The mass median aerodynamic diameters (MMADs) of most c-silica particles
released into the environment were >2.5 µm.  Average ambient levels of silica with <15 µm aerodynamic 
diameter in metropolitan areas of the United States generally have ranged between 0.001 and
0.003 mg/m3 in most circumstances and are not expected to exceed an annual average of 0.008 mg/m3 
(EPA 1996).
Green et al. (1990) evaluated agricultural particulate emissions and background emissions using regional
historical data in Alberta, Canada.  Variability was associated with the farm and the crops raised.
Background total suspended particulate levels ranged from 0.040 to 0.080 mg/m3, with 0.85–17.5%
c-silica.
PM10 concentrations obtained 22–745 m downwind from a sand and gravel facility in California ranged 
from approximately 0.026 to 1.026 mg/m3 (Shiraki and Holmen 2002).  The airborne quartz mass
concentrations from the three downwind sites ranged from 0.0262 to 0.0972 mg/m3. Samples obtained at
one site 1,495 m upwind had mass concentrations of quartz ranging from 0.0041 to 0.0163 mg/m3.
In another study, the measured ambient concentrations of PM4 c-silica ranged from below the detectable 
limit (0.0003 mg/m3) to 0.0028 mg/m3 in samples collected upwind and downwind of quarry and 
processing equipment at Carroll Canyon and Vernalis plants in California (Richards et al. 2009).  The
8-hour working shift PM10 c-silica concentrations ranged from 0.001 to 0.0109 mg/m3. The study was
sponsored by the National Stone, Sand, & Gravel Association and samples were collected downwind of
four crushing plants processing high-quartz-content rock (Richards et al. 2009).
Recent air monitoring reports conducted by the Minnesota Air Pollution Authority evaluated c-silica in
PM10 and PM4 particles in ambient air near industrial sand mining, processing, and transport sites (MPCA 
2015a, 2015b).  For PM10 particles, almost all measurements were below the detectable limits 
(0.001 mg/m3), with all values <0.002 mg/m3 (MPCA 2015a).
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Siteb Nc Mean deviation Mean deviation Mean deviation Coarse Fine
Akron, OH 7 4.2 1.4 <0.1 0.1 71.2 16.1 5.9 <0.1
Boston, MA 1 8.0 – 0 – 140.8 – 5.7 0
Braidwood, IL 1 4.4 – 0 – 57.2 – 7.7 0
Buffalo, NY 14 2.3 1.4 0.1 0.3 83.6 26.6 2.8 0.1
Cincinnati, OH 2 2.6 1.5 0 – 63.2 1.0 4.1 0
Dallas, TX 4 2.6 1.0 0.3 0.3 62.7 22.9 4.2 0.5
El Paso, TX 10 2.2 1.1 0.1 0.1 76.5 43.2 2.9 0.1
Five Points, CA 3 6.6 3.2 1.0 1.2 124.8 84.1 5.3 0.8
Hartford, CT 2 3.0 2.1 0 – 54.8 6.2 5.5 0
Honolulu, HI 1 1.2 – 1.2 – 47.1 – 2.6 2.6
Inglenook, ALd 8 5.2 1.7 0.3 0.2 72.6 14.0 7.2 0.4
Kansas City, KS 8 4.7 2.6 0.4 0.4 69.2 28.3 6.8 0.6
Kansas City, MO 3 4.2 3.0 0.1 0.1 58.6 21.6 7.2 0.2
Minneapolis, MN 6 3.7 2.3 0.1 0.1 46.5 7.9 8.0 0.2
Portland, OR 7 1.4 0.6 <0.1 0.1 133.9 122.2 1.0 <0.1
Research Triangle 3 0.9 0.5 0.4 0.1 37.0 3.5 2.4 0.1
Park, NC
Riverside, CA 4 3.0 1.1 0 – 106.6 42.2 2.8 0
St. Louis, MO 5 4.4 2.6 0.1 0.1 57.0 11.5 7.7 0.2
San Jose, CA 6 1.9 0.9 <0.1 0.1 67.0 27.3 2.8 <0.2
Seattle, WA 1 1.0 – 0.1 – 36.1 – 2.8 0.3
Tarrant, ALd 6 4.3 2.3 1.9 1.0 101.9 57.7 4.2 1.9
Winnemucca, NV 5 5.9 4.3 0.8 0.7 65.7 47.4 9.0 1.2
aTotal dichotomous mass.
bPost office state abbreviations used.
cNumber of filters analyzed.
dNorth Birmingham.
Source: EPA 1996
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For PM4 particles, almost all measurements were below the detectable limits (0.0012 mg/m3), with all 
concentrations <0.007 mg/m3 (MPCA 2015b).  Air monitoring in downtown Winona, Minnesota showed 
that the c-silica concentration was <0.0005 mg/m3 in all samples (MPCA 2015c). 
6.2.2 Water
There is no information on releases of silica to the water from manufacturing and processing facilities 
because these releases are not required to be reported (EPA 2005).
c-Silica is virtually insoluble in water at standard atmospheric temperatures and pressures; however, it has 
a strong affinity for water and may form hydrogen-bonds with water (Moore 1999).  On the surface of
c-silica, Si(O)4 tetrahedron may contain (OH)2 groups instead of oxygen.  Within the c-silica crystal
structures, (OH)4 may replace Si(O)4 groups.  The term ‘dissolved silica’ (dSi) corresponds to silicic acid,
which is formed from inorganic silicon dissolving from lithogenic sources, such as silicate minerals, as 
part of the weathering process.  c-Silica is virtually insoluble in water; however, dissolved silica flows 
from rivers and groundwater into the ocean where it may settle into marine sediments or be taken up by
organisms as part of the biogeochemical silica cycle (Trėguer and De La Rocha 2013).  The
transformation and degradation of silica in water is further discussed in Section 6.3.2.2.
Quartz sand is used in municipal water filter beds and sewage treatment plants for filtering out impurities, 
sediment, and bacteria.
6.2.3 Soil 
There is no information on releases of silica to the soil from manufacturing and processing facilities 
because these releases are not required to be reported (EPA 2005).
Silica is a component of sediments, soils, and rock-forming minerals in magmatic and metamorphic rocks 
(Florke et al. 2008). Quartz is present in trace to major amounts in sedimentary (e.g., sandstones and 
conglomerates) and metamorphic rock types (IARC 2012).  Silicon dioxide and silica gel are released to
soil as registered pesticides for use on food and nonfood crops (EPA 1991).
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6.3 ENVIRONMENTAL FATE
6.3.1 Transport and Partitioning 
Quartz, cristobalite, and tridymite are found in rocks and soil and can be released to the environment
through natural processes, such as weathering or volcanic eruptions, and from anthropogenic sources, 
such as foundry processes, brick and ceramics manufacturing, silicon carbide production, burning of
agricultural waste or products, or calcining of diatomaceous earth (IARC 2012).  At least a trace amount
of c-silica, in the form of quartz, is present in all soils (USGS 1992).  Quartz is the major component of
sand and dust particulate matter in air.
Silica particles may be transported by wind or water currents as part of the biogeochemical silica cycle.
Dissolved silica is transported by river and groundwater sources into the ocean.  Ocean water also
contains silica from dissolution of terrestrial lithogenic silica in marine sediments, Aeolian dust settling
on the ocean water surface, and weathering of continental rocks (Trėguer and De La Rocha 2013).  Silica
deposits may settle out of water into sediment from biogenic sources.  c-Silica may undergo atmospheric 
transport as a fractional component of particulate emissions (EPA 1996). 
6.3.2 Transformation and Degradation
Natural or synthetic changes in temperature and pressure may cause the crystalline structure of silica to
change (IARC 2002).  At elevated temperatures, the silica tetrahedron linkages break and reform into new
crystalline structures (OSHA 2013c).  Quartz, the most common form of c-silica, converts to cristobalite 
at 1,470°C, and cristobalite loses its crystalline structure and becomes amorphous fused silica at 1,723°C.  
The temperature-dependent transitions reverse at extremely slow rates.  Different forms of silica co-exist
after the heated silica crystal cools.  At lower temperatures, the silica-oxygen bonds in the silica
tetrahedron rotate or stretch, causing alpha and beta transitions that are readily and rapidly reversed upon 
cooling.  Cristobalite and tridymite are formed when quartz or a-silica is subjected to extremely high
temperatures (Leung et al. 2012; Mossman and Glenn 2013).  Biogenic silicas are converted into 
cristobalite at approximately 800°C (IARC 1997). Cristobalite is produced (40–60% cristobalite in
finished product) when diatomaceous earth (diatomite) is heated with flux (OSHA 2013c). 
Natural activities may cause silica polymorph transformations.  For example, lightning strikes or
meteorite impacts can change alpha quartz into keatite or coesite (IARC 2002).  Cristobalite may be 
produced by combustion metamorphism of naturally occurring substances (e.g., bituminous rocks, coal, 
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or oil) (Clark and Peacor 1992).  Anthropogenic activities may also cause transformation of silica from
one polymorph into another (IARC 2012).  Quartz in furnace bricks may convert to cristobalite when 
subjected to prolonged high temperatures.  Burning of agricultural wastes, such as rice hulls, or forest
fires may also cause a-silica to convert to cristobalite.
6.3.2.1 Air
Little information is available on the atmospheric reaction of silica.  The silica forms found in air as dusts
are stable and not subject to photochemical reactions.
6.3.2.2 Water
Silicon dissolves from minerals in water forming bioavailable silicic acid (Si(OH)4) reaching
concentrations <2 mM at near neutral pH (Lickiss 2006).  Silicic acid polymerization rate is dependent on 
temperature, ionic strength of the solution, pH, and silica saturation.  Polymerization is fast in neutral and 
slightly alkaline solutions, and slow at pH values of 2–3 (Icopini 2005; Ning 2002).  For example, silica
polymerization rates were evaluated at 25°C in a series of controlled experiments.  The reported fourth-
order rate constants for the 0.01 molal ionic strength experiment with an initial concentration of
20.8 mmolal were 1.17x10-9 millimolal-3·second-1 at pH 3 and 3.53x10-10 millimolal-3·second-1 at pH 11
(Icopini 2005).  Soluble silica half-lives were reported to be approximately 355 minutes at pH 6.5, 
55 minutes at pH 8, and 95 minutes at pH 8.75 (Zuhl and Amjad 2013).
6.3.2.3 Sediment and Soil
Quartz is extremely resistant to physical and chemical breakdown by the weathering process (USGS
1992).  The weathering rate of a square meter of catchment area from different geographic areas using
field measurements is 10-2–10-1 moles·m-2·year-1 (Ning 2002). 
6.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT
Reliable evaluation of the potential for human exposure to silica depends in part on the reliability of
supporting analytical data from environmental samples and biological specimens.  Concentrations of
silica in unpolluted atmospheres and in pristine surface waters are often so low as to be near the limits of
current analytical methods.  In reviewing data on silica levels monitored or estimated in the environment, 
it should also be noted that the amount of chemical identified analytically is not necessarily equivalent to
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6. POTENTIAL FOR HUMAN EXPOSURE
the amount that is bioavailable. The analytical methods available for monitoring silica in a variety of
environmental media are detailed in Chapter 7.
6.4.1 Air
Widespread occurrence and use of silica-containing materials result in silica-containing airborne dusts
being present in the environment (Moore 1999).  Silica particles suspended in the air create non-explosive
dusts (OSHA 2013c).  Silica from unconsolidated material on the earth’s surface in the form of soils, 
deserts and beaches, volcanic ash, and extraterrestrial dust are natural sources of silica in air (Moore 
1999).  Remote continental air contains a background gravimetric airborne dust concentration of
0.04 mg/m3, of which ≥10% is c-silica.  Desert dust consists of fine particles (<10 µm) of quartz (IARC
1997). 
Samples collected from an urban area in Rome, Italy between September 2004 and October 2005 were
analyzed to determine the concentration of silica particles in the inhalable particulate fraction (De 
Berardis et al. 2007).  The total PM10 particulate in the samples contained 1.6±0.6–10.4±1.4% silica or
0.00025–0.00287 mg c-silica/m3 air. The silica particles in the samples had a mean diameter range of
0.3–10.5 µm, and >87% had a diameter of <2.5 µm.  The authors hypothesized that Southern winds from
the Sahara Desert carry silica particles into Mediterranean Europe.  Corresponding data on the intensity
and direction of the wind, humidity, and rain on and near sampling days demonstrated a strong
relationship between the concentration of c-silica in the samples and meteorological-climate conditions.
The weight percent of c-silica in particles was higher between April and June than the winter months.
The concentration of quartz was reported to be ≤0.034 mg/m3 in air samples from Tokyo in 1965.  The
concentration of cristobalite and potential sources of airborne silica were not reported (NTP 2009).  Dust
samples collected from two communes in a sandy area of Gansu Province, China during the windy season 
ranged from 8.35 to 22 mg/m3. The dust consisted of fine particles (<5 µm) with a free silica content of
15–26% (IARC 1997). 
Volcanic ash collected at 34–36 km altitude from El Chichón (Mexico) were composed of 35%
cristobalite and keatite. Volcanic ash collected from Mount St. Helens in Washington State contained 3–
7% c-silica (IARC 1997).
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Air monitoring was performed using PM10 high volume samplers at two locations near an industrial slate 
pencil site and at one control site 5 km away (Bhagia 2009).  The quartz concentrations were
0.04107±0.02125–0.05722±0.02205 mg/m3 near the slate industrial site and 0.00351±0.00145 mg/m3 at
the control site.  In another study, PM10, PM4, and PM2.5 ambient air samples were obtained for indoor air
in two villages neighboring stone crushing sites in India (Mukhopadhyay et al. 2011).  The silica content
in the samples was between 7 and 24%. The average ambient PM10 values in the two neighboring
communities were 0.77 and 0.46 mg/m3. The indoor air average PM4 values were 0.5 and 0.65 mg/m3, 
respectively, and the PM2.5 values were 0.13 and 0.28 mg/m3, respectively.  The workers' average 
exposure to respirable particulates (PM4) in three stone crushing units ranged from 4.51 to 8.15 mg/m3 
(Mukhopadhyay et al. 2011).
In California, 1 of 11 samples obtained upwind of rice farming operations and half of the downwind 
samples contained a-silica at a concentration of 0.02 fibers/mL; the overall mean concentration of all
downwind samples was 0.004 fibers/mL.  Silica fibers (fiber length in the respirable dust fraction: >5 µm, 
with 90% of fibers <5 µm in length; range of fiber width: 0.2–75 µm), measured by polycarbonate
membrane filter, were detected in 4 of 14 samples in neighboring towns on days when there was rice
burning at a mean concentration of <0.004 fibers/mL (Lawson et al. 1995).  a-Silica fibers were identified
in three of seven smoke samples collected near burning sugarcane fields in Hawaii (IARC 1997).
6.4.2 Water
Silicon dissolves from minerals in water, forming bioavailable silicic acid, Si(OH)4, reaching
concentrations up to 2 mM at near neutral pH (Lickiss 2006).  Organisms, such as diatoms and 
radiolarian, build up exoskeletons of hydrated silica from silicic acid in water.  Plants use silicic acid to
make silica materials for strengthened stems and leaves or protective spikes. Typical concentrations of
silica in natural waters are 13 ppm for lakes, 3–15 ppm for major rivers, 1–10 ppm for seawater, 2– 
60 ppm for wells, and 50–300 ppm for wells in volcanic and oil fields (Ning 2002).  The concentration of
silica is low at the surface, increases with increasing depth, and is nearly exclusively in the monosilicic 
acid form.
Median seasonal concentrations of silica were reported for 12 sites in the Hudson River Basin in New
York State (Wall et al. 1998). The samples taken between December and March had silica concentrations 
ranging from 2.8 to 10.0 mg/L.  The samples collected between April and November had silica 
concentrations ranging from 0.72 to 9.1 mg/L.  George et al. (2000) measured the total silica content in 
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springs and wells in Southern Nevada. Total silica concentrations were detected for the low molecular
weight silica that were not colloidal. The authors suggested that decreases in the silica concentration was 
due to biological causes, such as phytoplankton uptake, based on silica concentrations correlating to the
nitrate concentration trend. 
6.4.3 Sediment and Soil
Silica is ubiquitous in the environment; over 95% of the earth’s crust is made of silica-containing
minerals and c-silica (Uhrlandt 2006).  c-Silica has been found in samples from every geologic era and
from every location around the globe (USGS 1992).  Alpha quartz is most common in nature, accounting
for almost 12% by volume of the earth’s crust (OSHA 2013c).  At least a trace amount of c-silica, in the 
form of quartz, is present in all soils.  Quartz is found as crystals, aggregates, or discrete particles (IARC
1997).  The silica polymorphs, cristobalite and tridymite, are found in rocks, soil, and volcanic rocks.  
Volcanic rocks in California and Colorado are a major source of cristobalite and tridymite in the United 
States (NIOSH 1986).  The c-silica polymorphs keatite, coesite, stishovite, and moganite are rarely found 
in nature (IARC 2012). 
Quartz is an important component of many igneous and sedimentary rocks (IARC 1997).  The
sedimentary rocks sandstones, greywackes, and shales contain 82, 37, and 20% quartz by weight, 
respectively.  Some of the igneous rocks that contain quartz are rhyolites, alkali granites, alkali rhyolites,
and granites in 33.2, 32.2, 31.1, and 29.2% quartz by weight, respectively.  Typically, silica sand deposits
have a silica content of 95%, although impurities may reach up to 25% (NTP 2014).
Soils from North Carolina were analyzed for quartz content (Stopford and Stopford 1995).  Sandy-loam 
soils with particles in the 4.25 µm fraction had an average quartz content of 15.2%, clay soils had 2.2%, 
and sandy soils had 31.6%.  Quartz was detected in dust samples collected from indoor and outdoor
locations in Oman (Abdul-Wahab et al. 2005).  Samples obtained inside and outside a residential house in 
Al-Suwayq (Oman) contained quartz and quartz, dolomite, and gypsum.  Calcite, quartz, dolomite, and 
goethite were detected in the samples obtained in the residential house near the cement plant.
Settled dust collected from five family farms located in Lublin, Jastków, Konopnica, and Niemce, Poland 
contained 0.7–65.2% silica (Molocznik 2002).  Average free silica content in bituminous coal was 
174,000 ppm (standard deviation 94,000) from Xuan Wei, China and 18,000 ppm (standard deviation 
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17,000) from the United States (Large et al. 2009).  Grainsize analysis of coal from Xuan Wei, China
indicates that 35–55% of the total quartz had a particle size <10 µm. 
a-Silica mean concentrations were 5.2, 4.7, and 3.9 mg Si/g in cultivated soil, meadow, and forest, 
respectively, from the Seine River watershed.  Suspended matter from the winter and summer had a-silica
average concentrations of 5.7±0.9 and 18.4 mg Si/g (Sferratore et al. 2006).
Ash from the Eyjafjallajökull Volcano eruption in 2010 and from the eruption of Grímsvötn, Iceland in 
2011 was studied and compared to ash from Soufrière Hills Volcano, Montserrat that has been studied 
since eruptive activity began in 1995 (Horwell et al. 2013).  Ash from Eyjafjallajökull had a c-silica 
abundance of 1.4–3.2 weight % and ash from Grímsvötn did not have detectable c-silica content.  Ash 
samples from Soufrière Hills contained 5.2–15.2 weight % cristobalite and 1.2–1.6 weight % quartz
(Horwell et al. 2010).  c-Silica is formed in volcanic environments by lava dome eruptions with viscous, 
silicic magma extruded from the volcano at approximately 800°C, forming a dome of rock in the crater
(Horwell et al. 2012).
6.4.4 Other Environmental Media 
a-Silica accumulates in rice, millet, sugarcane, and wheat plants (Rabovsky 1995).  Liu et al. (1996a) 
measured free silica content of rice husk ash to be 91.4% (25.5% cristobalite and 3.6% tridymite) when 
the rice husk was burned at 1,100°C; however, the silica content was dependent on the temperature of
burning.  When the rick husk was burned at 350°C, the ash contained 23% free silica, of which 1.1% was
quartz, 3.4% was cristobalite, and 0.5% was tridymite.  Tridymite is rarely reported in the workplace or
found in nature (Smith 1998). 
Le Blond et al. (2010) reported raw air dried sugarcane leaf silica concentrations ranging between
0.45 and 1.8 weight %.  Sugarcane trash ash burned at temperatures up to 1,056°C had silica
concentrations ranging from 10.38 to 24.77 weight %. Bagasse, the fibrous remains left after sucrose 
extraction, is often burned as an energy source. The bagasse ash contained between 39.2 and 40.0 weight 
% silica content.  No c-silica was found in the ash burned at temperatures <800°C; however, cristobalite
and quartz formed when the sugarcane burned at higher temperatures. 
High-purity, mesoporous a-silica was found in a study of the freshwater sponge, Cauxi.  The study
evaluated the skeleton and spicules of a sample made of glassy silica with a length of 305±18 and a width
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6. POTENTIAL FOR HUMAN EXPOSURE
of 15.6±1.5 µm (Jensen et al. 2009).  An axial filament that is known to contain the silica catalyst protein,
silicatein α, was also evaluated. 
6.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE
Silica is ubiquitous in the environment. Over 95% of the earth’s crust is made of silica-containing
minerals and c-silica (Uhrlandt 2006).  Silica exposure is expected in both occupational and general
settings from the natural environment and consumer use of products containing silica (NTP 2014; USGS
1992).  As silica is part of the natural environment and widely distributed in soils and rocks, exposure to 
silica is unavoidable.  It is important to consider the form and availability of silica when discussing silica 
exposure because silica has multiple forms, particle sizes, surface areas, and surface chemistry (OSHA 
2013c).  Inhalation is expected to be the primary route of exposure to c-silica for the general population 
from the use of commercial products containing quartz (IARC 2012). Occupational exposure is further
discussed in Section 6.7, Populations with Potentially High Exposures.
Silica is an established air contaminant. Local meteorological conditions can give rise to silica-containing
dust, most notably in areas around recent volcanic eruptions, mine dumps, and deserts (IARC 1987).  
People who live near quarries, sand or gravel operations, or hydraulic fracturing operations may be
exposed to respirable c-silica. Consumer exposure to respirable c-silica is possible from the use of
abrasives, sand paper, detergent, grouts, and concrete (IARC 1997).  Diatomaceous earth is used as a
filler in reconstituted tobacco sheets and may be converted to cristobalite at high temperatures when 
passing through the burning tip of tobacco products (IARC 1987). 
Dermal and oral exposure to quartz may occur through the use of consumer and commercial products, 
including cleansers, skin care products and soaps, art clays and glazes, pet litter, talcum powder, caulk, 
pharmaceuticals, putty, paint, and mortar (NTP 2009).  A homeopathic remedy called silicea, prepared 
from flint, quartz, sandstone, and other rocks, is another potential source of dermal silica exposure.
Exposure to a-silica may occur through dietary intake based on the widespread use of a-silica in the food, 
cosmetics, and pharmaceutical industries as anticaking agents or carriers.  Although quantitative data are 
not available, diatomite fragments are present in drinking water worldwide, and ingestion of potable water
containing quartz particles is a potential source of exposure for the general population (IARC 2012).
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6.6 EXPOSURES OF CHILDREN 
This section focuses on exposures from conception to maturity at 18 years in humans.  Differences from
adults in susceptibility to hazardous substances are discussed in Section 3.7, Children’s Susceptibility.
Children are not small adults.  A child’s exposure may differ from an adult’s exposure in many ways.  
Children drink more fluids, eat more food, breathe more air per kilogram of body weight, and have a
larger skin surface in proportion to their body volume than adults.  A child’s diet often differs from that of
adults.  The developing human’s source of nutrition changes with age: from placental nourishment to 
breast milk or formula to the diet of older children who eat more of certain types of foods than adults.  A
child’s behavior and lifestyle also influence exposure.  Children crawl on the floor, put things in their
mouths, sometimes eat inappropriate things (such as dirt or paint chips), and may spend more time
outdoors.  Children also are generally closer to the ground and have not yet developed the adult capacity
to judge and take actions to avoid hazards (NRC 1993).
As with adults, exposures of children to silica from breathing air, drinking water, and eating food is
expected.  As silica is part of the natural environment and found widely in soils, rocks, water, and foods, 
exposure to silica is unavoidable.  Children are likely to ingest dirt from their unwashed hands or when 
playing with soils, and may be exposed to silica in this manner.  Children living in proximity to mines, 
quarry sites, or industries that release silica particulates to the environment may be exposed to higher
levels of silica than are found in the natural environment via inhalation of silica from dust that is entrained
in air.  Silica is a major component of sand and dirt and may be in many forms; some of these forms may
be embedded in minerals. 
Dermal and oral exposure may occur through the use of consumer and commercial products that contain 
silica, including cleansers, skin care products and soaps, art clays and glazes, talcum powder, and 
pharmaceuticals (NTP 2009).  Both silicon dioxide and diatomaceous earth may be found in food and are
listed on the Everything Added to Food in the United States (EAFUS) report of items added directly to 
food that the FDA has either approved as food additives or listed or affirmed as Generally Recognized As 
Safe (GRAS) (FDA 2013).  However, average daily intakes and exposure information for children were 
not available.
In one study, respirable c-silica measurements ranged from <0.008 to 0.074 mg/m3 in 11 high school
ceramics classrooms located in Salt Lake County, Utah, with up to 88% quartz found in one sample
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(Fechser et al. 2014).  The respirable c-silica measurements ranged from 0.005 to 0.039 mg/m3 in the kiln.  
Inside control samples all had respirable c-silica concentrations <0.012 mg/m3 with 55% quartz and 
outside control samples had respirable c-silica concentrations of 0.012 mg/m3 with ≤65% quartz. 
6.7 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES 
Respirable c-silica is extremely common, is widely used in materials and products, and is naturally
occurring; therefore, occupational exposures occur in a variety of industries and occupations (NIOSH
2002).  Metal, nonmetal, and coal mines and mills, granite quarrying and processing sites, hydraulic
fracturing operations, crushed-stone industries, foundries, ceramics, construction, and sandblasting
operations are most frequently found to have respirable quartz levels >0.1 mg/m3 (NTP 2014).  Main 
industries where c-silica exposure is likely are those that require job activities involving the movement of
earth, disturbing products containing silica, and handling or use of sand and other silica-containing
products (IARC 1997, 2012).  Workers in other industries also have reported exposure to silica, including
shipbuilding and repair, rubber and plastics, paint, soap and cosmetics, roofing asphalt and felt, 
agricultural chemicals, jewelry, arts, crafts, sculpture, counter manufacture and installation, dental
material, boiler scaling, and automobile repair (NIOSH 2002).
A total of 81,221 workers had the potential to be exposed to quartz at 4,077 facilities in 59 industries in 
1972–1974 based on data from a National Occupational Hazard Survey conducted from 1972 to 1974 
(NIOSH 1976).  The survey for 1981–1983 reported that 944,731 workers (112,888 women) were
potentially exposed to quartz and 31,369 workers (2,228 were women) were potentially exposed to 
cristobalite (NIOSH 1990).  NIOSH estimated that approximately 1.7 million workers had the potential to
be exposed to respirable c-silica based on data from 1986, of which 722,708 workers were in mining
industries and 522,748 workers were in non-mining industries (NIOSH 2002). 
Yassin et al. (2005) estimated that 119,381 workers in the United States are potentially exposed to high 
levels of c-silica based on data from 7,209 personal sample measurements collected from 1988 to 2003 
stored in the OSHA Integrated Management Information System (IMIS) database.  Geometric mean
airborne silica exposure levels among workers were 0.070 mg/m3 from 1988 to 1991, 0.068 mg/m3 from
1992 to 1995, 0.080 mg/m3 from 1996 to 1999, and 0.073 mg/m3 from 2000 to 2003.  Freeman and 
Grossman (1995) evaluated data for measured respirable quartz in 1,655 inspections from 255 industries
collected by OSHA.  The most severe 8-hour TWA exposures were in the fabricated structural metal and 
painting and paper hanging industries.
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Radnoff et al. (2014) evaluated the occupational exposure of workers in Alberta, Canada to respirable
quartz.  Workers in the oil and gas industry had the highest maximum exposure of 8.6 mg/m3; however, 
workers in the sand and mineral processing industry had the highest geometric mean exposure to quartz at
0.09 mg/m3.  Bricklayer and concrete job activities (coring, cutting, or finishing) had a geometric mean 
exposure concentration of 0.105 mg/m3 respirable quartz exposure, which was the highest among the
occupations in the study.  In Italy, geometric mean occupational exposure respirable c-silica 
concentrations ranged from 0.007 mg/m3 for workers in the manufacture of basic metals to 0.045 mg/m3 
for construction workers (Scarselli et al. 2014).
Agricultural workers in the United States may be exposed to dust containing a significant percentage of
respirable c-silica (Linch et al. 1998).  In agriculture operations, plowing, harvesting, using machinery, 
burning agricultural waste, and processing agricultural products are possible routes of silica exposure
from the soil (NIOSH 2002).  Farmers may be exposed to biogenic a-silica during harvesting and may be
exposed to a-silica and cristobalite during crop burning or incineration (Rabovsky 1995).  Agricultural
workers from 10 farms in Yolo and Solano counties in California wore personal sampling equipment to 
measure exposure to inhalable and respirable dust levels (Nieuwenhuijsen et al. 1999).  The geometric
mean concentration of respirable dust ranged from 0.05 to 2.83 mg/m3 (the dust contained 18.6%
c-silica).  Inhalable dust concentrations ranged from 0.30 to 45.14 mg/m3 and contained 7.4% c-silica 
overall.  Respirable silica concentrations were measured for farm workers in eastern North Carolina 
(Archer et al. 2002). The mean silica concentrations ranged from below the level of detection
(0.005 mg/m3 quartz) to 3.91±2.31 mg/m3 for sweet potato planting in Wayne County. 
Respirable quartz concentrations were measured at three South African farms with either sandy, sandy
loam, or clay soil (Swanepoel 2011). The geometric mean respirable quartz concentrations were 0.0317, 
0.0316, and 0.031 mg/m3 for the sandy soil, sandy loam soil, and clay soil farms, respectively.  The level
of silica in air collected from five family farms located in Lublin, Jastków, Konopnica, and Niemce,
Poland contained 1.1–22% silica (Molocznik 2002).
Industrial hygiene practices such as engineering controls, tailored work practices, respirators, and worker
training can be used to minimize potential silica health hazards.  In the construction industry, wet cutting
using water to control airborne dust levels and vacuum dust collection are used to reduce silica dust
exposure (OSHA 2009).  Construction workers may become exposed to silica from sand, concrete, rock, 
soil, mortar, plaster, and shingles (NIOSH 2002).  In ‘new’ construction, concentrations of respirable 
c-silica range from 0.013 to 1 mg/m3 (Radnoff et al. 2014).  In the United States, a study evaluated silica
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6. POTENTIAL FOR HUMAN EXPOSURE
exposure at 36 construction sites (Rappaport et al. 2003).  The highest exposures, with a median silica
concentration of 1.28 mg/m3, were from painters, followed by laborers at 0.350 mg/m3, bricklayers at
0.320 mg/m3, and operating engineers at 0.075 mg/m3.  Quartz dust geometric mean concentrations
ranged from 0.01 mg/m3 (geometric standard deviation of 2.6) to 0.61 mg/m3 (geometric standard
deviation of 5.4) for the tuck point grinder job in a personal silica exposure monitoring data study of the
construction industry (Flanagan et al. 2006).
Abrasive blasting is considered to be one of the more hazardous operations involving silica, and it is
important for workers performing this task to use proper respiratory protection (Madl et al. 2008).  A
study was performed to evaluate 11,845 measurements obtained for exposure to respirable c-silica in the 
construction industry (Beaudry et al. 2013).  The majority of the measurements (92%) were obtained with 
personal measurement devices from 1974 to 2009.  The highest geometric mean concentration of c-silica 
that workers were exposed to was 1.59 mg/m3 for the abrasive blasting task.  In New Jersey, occupational
exposure monitoring was performed for a footbridge repainting project using a substitute abrasive with no 
to low abrasive content in 2002 (Meeker et al. 2005). The workers’ exposures to respirable silica were 
still high, most likely because a high level of silica contaminant, ranging from 0.52 to 25.66 mg/m3, was 
found in the surface paint.  Personal samples for exposure to quartz were collected on heavy and highway
construction workers (Woskie et al. 2002).  The geometric mean concentration for respirable quartz
ranged from 0.007 to 0.026 mg/m3 for the job tasks of operating engineers and laborers, respectively.
Personal breathing zone air samples were collected to analyze home construction roof workers’ exposure 
to c-silica (Hall et al. 2013).  The 8-hour respirable dust concentration ranged from 0.2 to 3.6 mg/m3. The
respirable silica 8-hour exposures ranged from 0.04 to 0.44 mg/m3.  The geometric mean concentrations 
of respirable silica were 0.12, 0.14, 0.16, and 0.14 mg/m3 for four companies. 
Granite and marble countertop workers had 8-hour TWA exposures as high as 3.07 mg/m3 (14% quartz)
in a 1999 OSHA inspection and 7.4 mg/m3 (0.7% quartz) based on personal monitoring data (Fairfax and
Oberbeck 2008).  Akbar-Khanzadeh et al. (2007) measured the concentration of c-silica dust and
respirable particulate matter encountered during indoor concrete grinding, wet grinding, and ventilated 
grinding and uncontrolled conventional grinding.  The mean TWA c-silica dust concentrations with no 
general ventilation were 86.0 mg/m3 for uncontrolled grinding, 1.40 mg/m3 for wet grinding, and 
0.161 mg/m3 for local exhaust ventilation grinding; when general ventilation was used, the dust
concentrations were 25.4 mg/m3 for uncontrolled grinding, 0.521 mg/m3 for wet grinding, and 
0.148 mg/m3 for local exhaust ventilation grinding.  c-Silica dust mean concentrations during surface 
concrete grinding with a 100–125 mm grinding cup were 0.17 and 0.11 mg/m3 with a HEPA-cyclone and 
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HEPA tank, 0.54 and 0.12 mg/m3 with a shop vacuum, 0.96 and 0.27 mg/m3 with wet grinding, and 
23.6 and 5.78 mg/m3 with and without general ventilation, respectively (Akbar-Khanzadeh 2010).  When 
a 180-mm cup was used, the silica dust concentrations were 0.54 and 0.20 mg/m3 with a HEPA-cyclone
and HEPA tank, 1.90 and 0.14 mg/m3 with a shop vacuum, 8.83 and 2.08 mg/m3 with wet grinding, and 
55.3 and 15.1 mg/m3 with and without general ventilation, respectively. 
The mean exposure to respirable dust and quartz was reported for the Dutch construction industry (van 
Deurssen et al. 2014).  The overall mean concentrations were 0.88 mg/m3 for respirable dust and 
0.10 mg/m3 for quartz.  The concentrations ranged from 0.02 to 33.76 mg/m3 for respirable dust and from
0.01 to 1.36 mg/m3 for quartz.
Workers in the nonmetal mining operations (i.e., sandstone, clay, shale, and miscellaneous nonmetallic
mineral mills) had higher exposure to silica dust than those in metal mining operations.  Baggers, general
laborers, and personnel involved in the crushing, grinding, and sizing operations had the highest exposure
within the mills (IARC 1987).  In samples obtained from metal and nonmetal mines from 2005 to 2010, 
the respirable dust geometric mean concentrations were highest in underground nonmetal and limestone 
mining samples at 0.88 and 0.73 mg/m3, with quartz present in 0.029 and 0.024 mg/m3, respectively
(Watts et al. 2012).  The highest geometric mean quartz concentration was found in underground sand and
gravel mines at 0.068 mg/m3.
In a cohort mortality study of North American industrial sand workers, the overall geometric mean 
exposure to respirable c-silica was calculated to be 0.042 mg/m3 based on 14,249 measurements taken 
between 1974 and 1998 (Rando et al. 2001).  Granite shed workers in Elberton, Georgia were exposed to 
respirable c-silica at a mean exposure concentration of 0.052 mg/m3 (Wickman and Middendorf 2002).  
Exposure surveys were conducted in a granite quarry with side-by-side arrays of four closed-face 
cassettes, four cyclones, four personal environmental monitors, and a real-time particle counter (Sirianni
et al. 2008).  c-Silica concentrations ranged from 0.41 mg/m3 from a personal exposure monitor to 
12.38 mg/m3 for a closed-face cassette.  Differences were reported related to the size and silica content of
airborne particles depending on the tools being used and the granite activity level at the time of sampling.
In a c-silica occupational exposure study performed in the United States, a geometric mean of
0.065 mg/m3 was reported for all occupations in the stonework masonry based on data collected between 
1988 and 2003 (Yassin et al. 2005).  A study evaluating the occupational exposure for workers at 18 silica
sand plants from 1974 to 1996 from 4,269 respirable dust samples, reported a geometric mean quartz
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concentration of 25.9 mg/m3 (geometric standard deviation of 10.9), and samples ranged from <1 to 
11,700 mg/m3 (Sanderson 2000).
An average concentration of 0.22 mg/m3 was reported for 148 carvers at a stone-carving company in
Thailand (Yingratanasuk et al. 2002).  Pestle makers and mortar makers had exposure to c-silica at
concentrations of 0.05 and 0.88 mg/m3, respectively.  Personal sampling by workers in a small-scale 
mining operation reported 15.5 mg/m3 respirable dust, 2.4 mg/m3 respirable c-silica, 1.5 mg/m3 respirable 
combustible dust, and 28.4 mg/m3 ‘total’ dust during activities such as drilling, blasting, and shoveling
(Bratveit et al. 2003).  Respirable dust and respirable c-silica were 4.3 and 1.1 mg/m3, respectively, during
shoveling and loading of sacks.  An overall geometric mean of 0.09 mg/m3 of respirable c-silica was 
reported from samples collected at seven U.K. quarries between 1978 and 2000 (Brown and Rushton 
2005). 
Occupational exposure of coal miners to respirable coal mine dust in the United States was evaluated
using data collected from 1995 to 2008 (Joy 2012).  Quartz content in airborne dust was variable, and 
>5% quartz content was found in 20,193 samples (21.6%) below the 0.100 mg/m3 respirable dust
standard.  Average respirable quartz concentrations exposure for miners at surface coal mines in the 
United States ranged from 0.08 mg/m3 in 1986 to 0.15 mg/m3 in 1982 based on data from the Mine Safety
and Health Administration (MSHA) inspectors (Piacitelli et al. 1990).
Average exposure was calculated using MSHA compliance data from 16,578 measurements at
4,726 mines obtained from 1998 to 2002 (Weeks and Rose 2006).  Continuous miner operators were
exposed to a mean concentration range of 0.0061–0.2717 mg/m3. Workers in underground mines had the
highest geometric mean concentration of 0.050 mg/m3. Workers in strip and open pit mines and mills or
preparation plants had slightly lower mean concentrations of 0.047 and 0.045 mg/m3, respectively.
The overall geometric mean concentration of respirable c-silica was 0.027 mg/m3 for underground coal
mining in the United Republic of Tanzania (Mamuya et al. 2006).  Employees for the development team, 
mine team, transport team, and maintenance team reported geometric mean concentrations of 0.073, 
0.013, 0.006, and 0.016 mg/m3, respectively.  A study evaluating respirable samples for silica exposure 
from two copper mines in Mufulira and Nkana, Zambia reported concentrations of 0.143±0.2 and 
0.060±0.06 mg/m3 of respirable quartz, respectively (Hayumbu 2008).  The mean respirable quartz
concentration reported in Ontario gold mines ranged from 0.02 mg/m3 for the task operations designated
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as other to 0.17 mg/m3 for the conveying and transporting operations (Verma et al. 2014).  The highest (or
maximum) concentration reported was 0.85 mg/m3 for the Conveying and Transporting task. 
Personal respirable dust exposures were collected at crushed stone facilities in the United States (Kullman
et al. 1995).  Workers with limestone were exposed to dust with an 11% mean α-quartz content or a
geometric mean concentration of 0.04 mg/m3 (standard deviation 1.88).  Workers with granite were
exposed to dust with 37% mean α-quartz content or a geometric mean concentration of 0.06 mg/m3 
(standard deviation 1.94).  Workers with Traprock were exposed to dust with 15% mean α-quartz content
or a geometric mean concentration of 0.04 mg/m3 (standard deviation 1.62).  Silica flour is made by
drying and milling mined quartz into fine particles, many of which are respirable (MMWR 1989). The 
MSHA measured respirable quartz exposures at 28 plants using personal breathing-zone air samplers and
found free silica levels above the MSHA permissible exposure limit (PEL) of 0.1 mg/m3 in 52% of the
samples.
Exposure levels to airborne respirable dust with quartz powder sizes of 1.52–3.04 or 3.04–6.08 mm in 
quartz manufacturing units in India were studied (Fulekar 1999).  The mean respirable dust exposure level
was 2.93 mg/m3 and exposures ranged from 0.11 to 11.2 mg/m3 with a high silica content, ranging from
86 to 98%.  The TWA exposure of stone crushing laborers in India for PM2.5 c-silica was 2.29 mg/m3 
(Semple et al. 2008).  Occupational exposure to silica was evaluated at slate pencil manufacturing units in 
India (Fulekar and Khan 1995).  Total and respirable dust was present at concentrations up to 380.50 and 
31.44 mg/m3, respectively, based on data from the study performed in 1977.  Total and respirable dust
was present at concentrations as low as 4.04 and 0.61 mg/m3, respectively, in a study performed in 1991. 
The free silica content was 35–40, 42–47, and 35–47% in three studies performed in 1977, 1982, and 
1991 respectively.
Quartz exposure levels were measured in the Alta, Northern Norway slate industry (Bang and Suhr 1998).  
The slate factory had respirable quartz average concentrations of 0.12 mg/m3 inside and 0.13 mg/m3 
outside.  c-Silica exposure was measured in the Norwegian silicon carbide industry using 720 fiber
samples, 720 respirable dust samples, and 1,400 total dust samples (Foreland et al. 2008).  Respirable
cristobalite geometric mean levels ranged from below the limit of detection to 0.038 mg/m3 (geometric 
standard deviation of 2.0). Respirable quartz geometric mean levels ranged from below the limit of
detection to 0.020 mg/m3 (geometric standard deviation of 2.1).  Personal airborne geometric mean
concentrations of quartz and cristobalite were 0.013 mg/m3 (geometric standard deviation of 4.58) and 
0.010 mg/m3 (geometric standard deviation of 2.10) for workers performing the carboselector job (Dion et
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6. POTENTIAL FOR HUMAN EXPOSURE
al. 2005).  The workers with the job title, Attendant in Acheson furnace maintenance, had a geometric
mean quartz exposure of 0.079 mg/m3 (geometric standard deviation of 1.49).
During the hydraulic fracturing process, large quantities of silica sand, with up to 99% silica, are used for
pumping into wells at high pressure (Chalupka 2012).  Data from 111 personal breathing zone samples at
11 sites in five states were evaluated by NIOSH to determine worker exposures to respirable c-silica 
during hydraulic fracturing (Esswein et al. 2013).  The median percentage of quartz in 111 personal
breathing zone samples was 53%. Total geometric mean concentrations of respirable quartz were 
0.122 mg/m3 for all samples and the geometric standard deviation was 1.152.  Workers with the job titles, 
T-belt Operator and Sand Mover Operator, had the highest geometric mean concentrations of respirable 
c-silica of 0.327 and 0.259 mg/m3, respectively, compared to other job titles.
Operations in the ceramic, brick, and clay industries result in c-silica emissions through kiln drying of
clay and brick objects, crystalline sand processing, glass manufacturing, calcining of diatomaceous earth,
and pottery manufacturing (EPA 1996).  Birk et al. (2010) evaluated respirable c-silica measurements 
obtained from 1955 to 2006 for worker exposure in the ceramics industry.  Typically, the highest
exposure occurred in the historic samples obtained in 1955–1959 for all job task activities. The highest 
exposure geometric mean concentration of respirable c-silica in the 2000–2006 data set was from the
preparation task at 0.03 mg/m3. A heavy clay industry exposure study was performed with 18 factories
from England and Scotland and 1,400 personal dust samples (Love et al. 1999). Mean quartz
concentrations ranged from 0.04 to 0.62 mg/m3 for non-process workers and kiln demolition workers,
respectively. Respirable α-quartz concentrations were measured for workers in the refractory material
manufacturing industries (Chen et al. 2007).  A minimum variance unbiased estimate of the arithmetic 
mean respirable α-quartz content ranged from 0.0298 mg/m3 in the crushing area to 0.0681 mg/m3 in the
mixing area.
OSHA sampling on the melt deck and sprue line of a ductile and malleable iron foundry detected c-silica 
at 0.21 mg/m3 based on the TWA; however, employees engaged in the furnace cleaning and scrapping
were exposed to 7.92 and 0.54 mg/m3, respectively (Strelec 2010).  Personal monitors were used to 
collect 158 measurements of respirable quartz from jobs conducted from 1993 to 1998 (Maxim et al. 
1999). Most of the respirable c-silica concentrations, 91.14%, were less than the limit of detection; the
remainder ranged from 0.010 to 0.100 mg/m3.  Occupational silica exposures were evaluated for workers 
at a grey and ductile iron foundry that manufactures heavy industrial castings, such as transmission
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6. POTENTIAL FOR HUMAN EXPOSURE
housings for large trucks (Lee 2009).  The 8-hour TWA c-silica concentrations ranged from 0.988 mg/m3 
for a molder to 4.38 mg/m3 for a grinder based on the results obtained from personal sampling devices.
Andersson et al. (2012) performed an exposure assessment of quartz in Swedish iron foundries using both 
historical and current data.  The job title with the highest mean quartz exposure was the furnace and ladle
repair, with a total concentration of 0.42 mg/m3, and the lowest was the core maker, with a total
concentration of 0.024 mg/m3.  The arithmetic mean minimum variance unbiased estimate of respirable 
quartz exposure profiles for workers during a municipal waste incinerator relining ranged from 0.040 to 
0.578 mg/m3 (Shih et al. 2008).  In Khaf, Iran, occupational exposure to respirable quartz was evaluated 
for workers at an iron ore mine (Naghizadeh et al. 2011).  The maximum mean concentration of total
quartz was at the crusher machine station at 26 mg/m3 with a standard deviation of 7, and the minimum
concentration was 0.012 mg/m3 with a standard deviation of 0.002.
At a flat outdoor firing range in 2004, quartz levels were found to exceed 0.030 mg/m3 (Mancuso et al.
2008); the likely source of the quartz was the sand on the floor of the range.  In 2006, after the sand was
changed, barrier curtains were added, and lava rock was added to the floor for silica exposure control, the
quartz levels were below 0.018 mg/m3. At a tunnel type outdoor firing range, personal sampling devices 
found quartz silica levels ranging from 0.15 to 0.21 mg/m3. After Hurricane Sandy in 2012, clean-up 
workers were monitored for silica exposure (Freund et al. 2014).  One measurement of 0.015 mg/m3 taken
at Rockaway, New York in the vicinity of sand was above the detection limit. 
Occupational exposure to a-silica may occur in the use or manufacture of a-silica and a-silica-containing
products, such as synthetic resins, plastics, lacquers, vinyl coatings, varnishes, pharmaceuticals,
cosmetics, adhesives, paints, and foods (IARC 1997).  Workers in other industries, such as glass, 
ceramics, cement, refractory brick, paper, paint, and rubber, may be exposed to various forms of a-silica 
when used as fillers, filters, or other purposes (NIOSH 2002). 
Diatomaceous earth mining, processing, and production reported respirable dust levels ranging from
0.1 to 28.2 mg/m3 with a c-silica content ranging from <1 to 75% (IARC 1997).  Diatomaceous earth
workers have the potential for inhalation exposure to high levels of respirable cristobalite and quartz that
may be present as impurities or from heating silica (IARC 1997; Rabovsky 1995).  In industries where
silica products are heated, such as refractory brick and diatomaceous earth plants and ceramic and pottery
manufacturing plants, occupational exposure to cristobalite may occur (IARC 1997). 
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At a diatomaceous earth mining and milling facility in California, respirable c-silica average cumulative 
exposure was 0.29 mg/m3 per years of employment.  The c-silica content of the diatomaceous earth dusts 
varied from 1 to 25% from 1942 to 1994 (Park et al. 2002).  Final cumulative exposures to total respirable
dust and respirable c-silica dust were 7.31 mg/m3·years (average; 168.84 maximum) and
2.16 mg/m3·years (average; 62.52 maximum), respectively (Checkoway et al. 1997).
In an occupational exposure study, 1,375 inhalable synthetic a-silica dust concentration measurements 
were performed from five German synthetic a-silica plants producing pyrogenic and precipitated forms of
silica (Morfeld et al. 2014).  Mean aerodynamic diameters of the a-silica were 200 µm.  Exposures were
grouped into categories of low (<1 mg/m3), medium (1–4 mg/m3), high (4–10 mg/m3), and peak
(>10 mg/m3).
a-Silica fume is a byproduct of the ferrosilicon industrial process (IARC 1997).  Total dust containing
synthetic-precipitated a-silica was measured at three chemical plants at concentrations of 0–10.5 mg/m3. 
Total dust and respirable dust from personal samples obtained from synthetic pyrogenic fumed 
manufacturing plants was found at median concentrations of 0.61–6.5 and 0.2–2.1 mg/m3, respectively.
One ferrosilicon industry exposure study reported 22.3% silica content (amorphous and crystalline) in 
total dust found at concentrations of 7.3 mg/m3. In another ferrosilicon industry exposure study, 
maintenance workers had respirable dust containing a-silica exposures ranging from 0.27 to 2.24 mg/m3. 
6.8 ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of silica is available. Where adequate information is not
available, ATSDR, in conjunction with NTP, is required to assure the initiation of a program of research 
designed to determine the health effects (and techniques for developing methods to determine such health 
effects) of silica.
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA.  They are defined as substance-specific informational needs that if met would 
reduce the uncertainties of human health assessment.  This definition should not be interpreted to mean 
that all data needs discussed in this section must be filled.  In the future, the identified data needs will be 
evaluated and prioritized, and a substance-specific research agenda will be proposed.
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6.8.1 Identification of Data Needs
Physical and Chemical Properties. The physical and chemical properties of the forms of silica are
sufficiently well defined to allow an assessment of the environmental fate of these compounds (CRC
2014; HSDB 2009, 2012; IARC 1997).  No additional data are needed at this time.
Production, Import/Export, Use, Release, and Disposal. According to the Emergency
Planning and Community Right-to-Know Act of 1986, 42 U.S.C. Section 11023, industries are required 
to submit substance release and off-site transfer information to the EPA.  The TRI, which contains this
information for 2013, became available in October of 2014.  This database is updated yearly and should 
provide a list of industrial production facilities and emissions.
Because many forms of silica occur naturally (IARC 1997) and are widely used in industry, in the
manufacture of household products, and in processing, packaging, and preserving food (IARC 2012), the
potential for human exposure to silica through ingestion of food and water and inhalation of airborne
particulates is substantial. Recent data on production, import/export, and use are available (USGS 2015).  
Information on disposal of silica is limited.  In the United States, about 34% of silica glass containers
were recycled in 2014 (USGS 2015).  Additional information on disposal would be useful in assessing the
potential for the release of and exposure to silica.
Environmental Fate. Silica is a solid that partitions to air as dust, water, soil, and plant material.
Silica in the environment can undergo various weathering dissolutions or precipitations.  Partitioning to 
various media is determined by the physical and chemical properties of the form of silica and the
characteristics of the environmental matrix affecting its solubility (IARC 1997; Ning 2002).  Silica is
transported through the atmosphere primarily as a constituent of soil and other particulate matter (EPA
1996).  Transformations are not expected to occur during transport of silica through the atmosphere.  
Information on the environmental fate of silica is sufficient to permit a general understanding of transport
and transformation in all environmental media. No additional information is needed at this time.
Bioavailability from Environmental Media. Very limited information is available regarding
absorption following oral or dermal exposure; however, these pathways of exposure are not expected to
be significant.  No additional information is needed at this time.
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6. POTENTIAL FOR HUMAN EXPOSURE
Food Chain Bioaccumulation. Diatoms are photosynthetic protists that take up dissolved silica
from the water and precipitate opaline silica to form their cell wall (IARC 1997).  a-Silica levels in
diatoms ranges from <1% to approximately 50% by weight.  Radiolarians and sponges also extract silica
dissolved in water to form their shells.  a-Silica has been found to accumulate in rice, millet, sugarcane, 
and wheat plants (Rabovsky 1995).  No additional information is needed at this time.
Exposure Levels in Environmental Media. Reliable monitoring data for the levels of silica in
contaminated media at hazardous waste sites are needed so that the information obtained on levels of
silica in the environment can be used in combination with the known body burden of silica to assess the
potential risk of adverse health effects in populations living in the vicinity of hazardous waste sites. Silica 
is ubiquitous in the environment.  c-Silica has been found in samples from every geologic era and from
every location around the globe (USGS 1992).  Typical concentrations of silica in natural waters is 
13 ppm for lakes, 3–15 ppm for major rivers, 1–10 ppm for seawater, 2–60 ppm for wells, and 50– 
300 ppm for wells in volcanic and oil fields (Ning 2002).  Average ambient levels of silica with <15 µm
aerodynamic diameter in metropolitan areas of the United States generally have ranged between
0.001 and 0.003 mg/m3 in most circumstances and are not expected to exceed 0.008 mg/m3 annual
average (EPA 1996).  More recent studies on the ambient levels of silica are needed.
Exposure Levels in Humans. Data on nonoccupational exposures to all forms of silica are 
extremely limited.  Limited analytical methods reported the analysis of silica in biological materials.  All 
forms of silica are considered to be poorly soluble particles.  Inhaled silica particles, not cleared by
mucociliary escalators or coughing, are embedded and remain in the lung (Cox 2011).  Additional
information is necessary for assessing the need to conduct health studies on these populations.
Exposures of Children. Limited analytical methods reported the analysis of silica in biological
materials. More recent studies on the ambient levels of silica are needed. Data were not available on the 
intake of silica in food eaten by children and from their diet.  Current information on whether children are
different in their weight-adjusted intake of silica via oral, inhalation, and dermal exposures was not
located.  A study to determine this information would be useful.
Child health data needs relating to susceptibility are discussed in Section 3.12.2, Identification of Data
Needs: Children’s Susceptibility.
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Exposure Registries. The information amassed in the National Exposure Registry facilitates the 
epidemiological research needed to assess adverse health outcomes that may be related to exposure to this 
substance; however, no exposure registries for silica were located.  Silica is not currently one of the 
compounds for which a sub-registry has been established in the National Exposure Registry.  Silica will 
be considered in the future when chemical selection is made for sub-registries to be established.
6.8.2 Ongoing Studies 
The NIH RePORTER (2015) database provides additional information obtainable from a few ongoing
studies that may fill in some of the data needs identified in Section 6.8.1.  These studies are summarized 
in Table 6-2.
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6. POTENTIAL FOR HUMAN EXPOSURE
Table 6-2.  Ongoing Studies on Silica
Investigator Affiliation Research description Sponsor
Chugh, Yoginder P Southern Illinois The USBM and NIOSH have done extensive NIOSH
University research on coal and quartz dusts with an emphasis
Carbondale on eastern U.S. coal mines.  The goals of this
research are to develop physical and chemical
characteristics of different particle size coal and 
quartz dusts from different unit operations.  The 
sampling data from the Interior Coal Basin mines
from MSHA and company dust data will also be 
utilized to identify occupations and locations most
exposed.  Surface and wettability characteristics for
different size fractions of coal and silica dusts
generated during mining, haulage, and roof support
operations will evaluated.
Miller, Frederick NIEHS Evaluation of exposures to items including silica to NIEHS
assess relationships and the development of
systemic autoimmune diseases.
MSHA = Mine Safety and Health Administration; NIEHS = National Institute of Environmental Health Sciences;
 
NIH = National Institutes of Health; NIOSH = National Institute for Occupational Safety and Health;
 
USBM = U.S. Bureau of Mines
 
Source: NIH RePORTER 2015
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7. ANALYTICAL METHODS
The purpose of this chapter is to describe the analytical methods that are available for detecting,
measuring, and/or monitoring silica, its metabolites, and other biomarkers of exposure and effect to silica.
The intent is not to provide an exhaustive list of analytical methods.  Rather, the intention is to identify
well-established methods that are used as the standard methods of analysis. Many of the analytical
methods used for environmental samples are the methods approved by federal agencies and organizations 
such as EPA and the National Institute for Occupational Safety and Health (NIOSH).  Other methods
presented in this chapter are those that are approved by groups such as the Association of Official
Analytical Chemists (AOAC) and the American Public Health Association (APHA).  Additionally,
analytical methods are included that modify previously used methods to obtain lower detection limits
and/or to improve accuracy and precision.
7.1 BIOLOGICAL MATERIALS
Limited analytical methods reported the analysis of c-silica or a-silica in biological materials.  All forms 
of silica are considered to be poorly soluble particles.  Inhaled silica particles, not cleared by mucociliary
escalators or coughing, are embedded and remain in the lung (Cox 2011).
OSHA method PV2121 characterizes the term ‘respirable dust’ as dust particle sizes with a median 
diameter of 3.5 µm; however, NIOSH Method 0600 lists a diameter size of 4 µm (NIOSH 1998; OSHA 
2015).  The European standard PN-EN 481:1998 and international standard PN-ISO 7708:2001 describe
the term ‘respirable dust’ as a cumulated log-normal distribution, with the median diameter of 4.25 µm
and geometric standard deviation of 1.5 (Maciejewska 2008). 
NIOSH (2003b) Analytical Method 7601 is a standardized method used to determine the concentration of
c-silica by x-ray diffraction (XRD) with filter redeposition in respirable or total dust, settled dust, and 
biological samples, although studies describing the use of this method with biological samples were not
identified.
7.2 ENVIRONMENTAL SAMPLES 
Table 7-1 lists the methods used for determining silica in environmental samples. Silica is a common
material in the environment with many distinct forms.  Determination of the form of silica present and
concentration of each form of silica in a sample may be achieved through several different analytical
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Air (dust) Collection with 10-mm










Air (dust) Collection with PVC
membrane filter
P-2; XRD 20 µg quartz ±20%
(accuracy)
MHSA 2013b
Air (dust) Collection with 25 mm,
5-µm PVC membrane 















Air (dust) Collection with 10-mm
nylon cyclone and 










Air (dust) Collection with 10-mm
nylon cyclone and 




5 µg quartz Not
reported
NIOSH 2003c









Air (dust) Collection with 10-mm
nylon cyclone and 











Air (dust) Collection with membrane 
filter
P-7; IR 20 µg quartz ±13%
(accuracy)
MHSA 2013


















Air (dust) Collection with membrane 
filter







Air (dust) Collection with 10-mm
nylon cyclone and 












48% HBF4 at 70°C, filter,
dissolve in 1:1 KHCO3
and KCl, boiling water, 
add 0.1 mL 10%
Spectro-
photometer
8 µg quartz 99.8% Stopford 1994
ammonium molybdate,
adjust pH to 2.1 
Air (dust) Collection with 37 mm,
5-µm PVC membrane
LIBS 0.16 µg/cm2 10%
(relative
errors)
Stipe et al. 2012
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Table 7-1. Analytical Methods for Determining Silica in Environmental Samples
Sample Analytical Sample Percent
matrix Preparation method method detection limit recovery Reference








acidic solution to filtrate;
the color complex is
measured 
Water Add molybdate ion in Spectro- 0.1 mg silica/L Not USGS 1989
(dissolved ascorbic acid solution to photometer/ reported
silica) filtrate; the color complex USGS 
is measured NWQL
I-2700-85
Water Filtered, acid preserved ICP-AES/ 26 µg/L 96–104% EPA 1994b
(dissolved sample is mixed with 1% EPA 200.7 (estimated) (in tap
silica) v/v HNO3 water)
Water Samples are solubilized ICP-AES/ 0.017 mg/L Not EPA 2000
(dissolved or digested prior to EPA 6010c (estimated) reported
silica) analysis
Water Sample undergoes a ICP-AES/ 0.01 mg/L Not USGS 1987
(dissolved direct-reading, no USGS (estimated) reported
silica) preparation NWQL
I-1472-87
Water Acidify sample with HNO3 AVICP- 0.01 mg silica/L Not EPA 2003
(dissolved to pH <2 AES/EPA reported
silica) 200.5
Water Acidify sample with HNO3 ICP-OES/ Not reported Not USGS 1998
(dissolved to pH <2 USGS reported
silica) NWQL
I-4471-97
Soil LiCO3 /H3BO3 flux and AAS Not reported 99.7% Barredo and Diez
stabilization with fluoride 1980
Soil Sample weighed Thermal <1% Not Sheffield 1994
analysis reported
AAS = atomic absorption spectroscopy; AVICP-AES = axially viewed inductively coupled plasma-atomic emission
spectrometry; EPA = Environmental Protection Agency; FT-IR = Fourier transform infrared spectrometry;
ICP-AES = inductively coupled plasma-atomic emission spectrometry; ICP-OES = inductively coupled plasma-optical
emission spectrometry; IR = infrared spectrometry; MCE = mixed cellulose ester; MSHA = Mine Safety and Health 
Administration; NIOSH = National Institute for Occupational Safety and Health; NPDES = National Pollutant
Discharge Elimination System; NWQL = National Water Quality Laboratory; OSHA = Occupational Safety and Health 
Administration; PVC = polyvinyl chloride; RSD = relative standard deviation; USGS = U.S. Geological Survey;
VIS = visible absorption spectrophotometry; XRD = x-ray diffraction
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techniques. The use of XRD and infrared spectroscopy (IR) allows for the separate determination of
quartz, cristobalite, and tridymite (Maciejewska 2008).  The total content of all crystalline forms of silica 
is obtained with visible absorption spectrophotometry.  Optical microscopy, electron microscopy, thermal
analysis, selective dissolution, and density separation may also be used to analyze silica.  Several
analytical methods have been reported by regulatory agencies including NIOSH, OSHA, USGS, and
MSHA.
Mineral interferences may be reduced prior to analysis with sample preparation techniques; for example, 
a phosphoric acid digestion is used if there is a presence of a-silica (Talvitie 1951).  a-Silica and some 
smaller c-silica particles dissolve in phosphoric acid (Eller 1999).  c-Silica particles <3 µm dissolve in hot
phosphoric acid; therefore, the amount of free silica may be underestimated when using this method 
(Yabuta and Ohta 2003).  Hydrochloric acid is used to remove calcite, magnetite, and hematite.  Air
samples collected with filters are ashed or dissolved in tetrahydrofuran (NIOSH 2003f). The ashed 
sample is suspended in a solvent and deposited onto an analytical filter.  Another preparation method used 
to obtain the free silica in respirable dust samples uses pyrophosphoric acid and a closed vessel
dissolution technique with microwave heating (Shinohara 1993).
Particle-size distribution of silica samples is measured by laser scattering or air-jet screening (Florke et al.
2008).  Cyclone air samples, filter cassette, and filter media are used to retain the respirable dust fraction
without non-respirable particles.  Criteria for collecting particles of the appropriate size with cyclone air
samplers are established by the International Organization for Standardization (ISO), the European 
Committee for Standardization (CEN), and ACGIH (NIOSH 2003f).  The XRD, IR, and colorimetric
analytical methods are subject to different particle size effects, and each cyclone exhibits its own unique
particle collection characteristics (NIOSH 2003f).
XRD patterns are able to distinguish c-silica polymorphs from each other and from other a-silica forms.
XRD patterns are produced specific to the c-silica crystalline structure (IARC 1997). The polymorph 
α-quartz has a primary diffraction line at 26.66 °2θ (3.343 Å).  NIOSH (2003a) Analytical Method 7500 
is a standardized method used to determine the concentration of c-silica by XRD with filter redeposition 
in dust.  NIOSH (2003c) Analytical Method 7501 is a standardized method used specifically for a-silica
in crystalline (e.g., quartz) matrices with XRD analysis. The Department of Labor’s MSHA has method
MDHS 101 (replaces MDHS 51/2), an XRD method for the determination of quartz in dust.
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c-Silica polymorphs have distinct infrared absorption patterns.  α-Quartz has a doublet at 798–790 and 
779–780 cm-1, with secondary peaks at 694, 512, 460, 397, and 370 cm-1 (NIOSH 2003f).  Cristobalite
peaks are found at 798, 623, 490, 385, 297, and 274 cm-1 and tridymite peaks are found at 793, 617, and 
476 cm-1 . NIOSH (2003d) Analytical Method 7602 is a standardized method used to determine the
concentration of c-silica by IR analysis in air dust samples.  NIOSH (2003e) Analytical Method 7603 is a 
standardized method used to determine the concentration of c-silica in coal dust by Fourier transform
infrared spectroscopy (FT-IR) or IR analysis. The Department of Labor’s MSHA also has an IR method
for the determination of quartz in respirable coal mine dust (MSHA 2013).  MDHS 37 and MDHS 38 are
other standardized methods used to determine the silica content of a sample by IR (NIOSH 2003f). 
The combination of XRD and IR has been used to quantify the a-silica and c-silica content of samples to
obtain the c-silica and total silica content, respectively (Bye et al. 1980).  A direct differential scanning IR
method has been described to determine the c-silica content in respirable atmospheric dust samples 
(Foster and Walker 1984).  A difference spectrum method may be used to correct for interfering spectra 
when determining the c-silica content of dust samples with IR (Ojima 2003). Kaolinite is a commonly
found mineral in coal mine dust that interferes with IR analysis of quartz, and corrections with a standard 
reference material have been suggested (Lee et al. 2013; NIOSH 2003f).  Field-portable IR spectrometers 
are used to provide more timely estimates of silica exposure (Miller et al. 2012). A direct-on-filter 
method using partial least squares regression to the infrared transmission spectra of samples deposited on
porous polymeric filters was developed to allow for the use of field-portable infrared spectrometers
(Weakley et al. 2014).
NIOSH (2003b) Analytical Method 7601 is a standardized method used to determine the concentration of
c-silica by visible absorption spectrophotometry (VIS) in respirable or total dust, settled dust, and
biological samples.  Colorimetric methods require preparation steps and color development methods
(citric acid and tartaric acid); absorbance is measured at 785 nm (Stopford 1994).  Colorimetric methods
for c-silica are less precise than XRD or IR (NIOSH 2003f).
Laser-induced breakdown spectroscopy quantifies quartz in coal dust samples collected on filter media
with extremely low (0.16 µg/cm2) limit of detection levels for silica (Stipe et al. 2012).
Dissolved silica concentrations are used to determine the silicon content of water (USGS 1998).
Molybdate ion in acidic solution, when added to a water sample containing dissolved silica, forms a 
greenish-yellow color complex proportional to the dissolved silica and is measured spectrophoto-
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metrically.  Dissolved silica in drinking, surface, and saline waters and domestic and industrial wastes is 
measured using EPA Method 370.1 or USGS NWQL I-2700-85 with a spectrophotometer (NPDES 1978;
USGS 1989).  Silica in solution is also measureable using inductively coupled plasma-atomic emission
spectrometry (ICP-AES) according to EPA Method 200.7 or 6010.C or USGS NWQL I-1472-87 (EPA
1994b, 2000; USGS 1987), axially viewed inductively coupled plasma-atomic emission spectrometry
(AVICP-AES) by EPA Method 200.5 (EPA 2003) and inductively coupled plasma/optical emission 
spectrometry by USGS NWQL I-4471-97 (USGS 1998).  Samples prepared by EPA Method 200.2 are
acidified, mixed, and held at a pH <2 (EPA 1994a).
The silica content of rock samples may be obtained by decomposing the sample in LiCO3/H3BO3 flux 
followed by stabilization in fluoride (Barredo and Diez 1980).  An atomic absorption spectrophotometer
(AAS) and EEL lamp are used to detect the major elements of the rock samples.  Thermal analysis of
c-silica, to measure the energy associated with phase changes based on changes in temperatures of
samples, has also been developed (Sheffield 1994).  An analytical procedure detects the a-silica content of
a sample by converting to cristobalite with heating (Lange et al. 1981).
Scanning electron microscopy (SEM) identifies minerals by energy dispersive techniques and sometimes 
by morphology, but does not enable differentiation between the polymorphs of c-silica, a-silica, glasses,
and opal (Miles 1999).  The transmission electron microscope (TEM), when combined with energy
dispersive X-ray spectroscopy and electron diffraction, is used to distinguish grains of c-silica.
Differentiation of the forms of a-silica involves investigation into the chemical composition, physical 
properties, and characteristics of the particles (Waddell 2006).  The amount of silica, percentage of
associated water, total solids content of nonoxidizable materials, presence of stabilizers and carbon 
content, level of soluble salts, metal impurities, and silanol group density are important chemical
composition information.  The pH, density and tamped density, viscosity, turbidity, refractive index, and
light-scattering properties are important physical characteristics.  Specific surface area, average particle 
size and size distribution, sieve residue, porosity (including average pore diameter and pore volume), 
degree of aggregation, and oil absorption information is used to characterize the silica particles.  Although 
analytical techniques exist to distinguish between a-silica polymorphs, most are too sophisticated for
routine measurements (IARC 1997).  Therefore, environmental exposures are typically reported for
a-silica, rather than for specific polymorphs. 
***DRAFT FOR PUBLIC COMMENT***
   
 












    
   
  










   
     






   




Particle-size measurement is important in silica-gel characterization.  Granular gel standardized sieve 
screening uses method ASTM D 4513.  Static light scattering and conductivity methods are preferred for
particle size analysis of particles roughly 1–1,000 mm.  Dynamic light scattering, electron microscopy, 
and small-angle X-ray scattering are used for particle sizes of roughly 10–1,000 nm (Florke et al. 2008). 
Porosity of silica gels is described by pore diameter as microporous (<2 nm), mesoporous (approximately
2–50 nm), or macroporous (>50 nm) (Florke et al. 2008).  Thermogravimetric analysis, vibrational
spectroscopy, and nuclear magnetic resonance are used to study hydroxyl concentration, hydrogen bond 
interaction between hydroxyl groups, and distribution of silica-oxygen species on the surface of silica gel
(Florke et al. 2008).
Density separation uses heavy liquids to separate particles and is based on differences in density of the
forms of silica and silicates (Miles 1999), although it is usually impossible to fully liberate c-silica from
other phases. This technique works best with (mono-mineral) mineral grains ≥0.1 mm. 
7.3 ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of silica is available. Where adequate information is not
available, ATSDR, in conjunction with NTP, is required to assure the initiation of a program of research
designed to determine the health effects (and techniques for developing methods to determine such health 
effects) of silica.
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA.  They are defined as substance-specific informational needs that if met would 
reduce the uncertainties of human health assessment.  This definition should not be interpreted to mean 
that all data needs discussed in this section must be filled.  In the future, the identified data needs will be
evaluated and prioritized, and a substance-specific research agenda will be proposed.
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7.3.1 Identification of Data Needs 
Methods for Determining Biomarkers of Exposure and Effect.
Exposure. As discussed in Section 3.12.2, no biomarkers of exposure have been identified for silica.
c-Silica has been detected in the urine of ceramic factory workers (Ibrahim et al. 2011) and development
of sensitive analytical methods may be useful in the assessment of whether urinary silica could be used as
a biomarker of exposure.
Effect. Sensitive biomarkers of effect have not been identified.
Methods for Determining Parent Compounds and Degradation Products in Environmental
Media. Silica is ubiquitous in the environment and does not degrade.  It is found in air, water, soil, 
sediments, and food.  Analytical methods exist for the analysis of silica in all of these environmental
media, and these methods have the sensitivity to measure background levels and detect elevated
concentrations due to anthropogenic sources (NIOSH 2002).  Additional research to reduce chemical and 
matrix interferences is needed to improve the speed and accuracy of the analyses.
7.3.2 Ongoing Studies 
No ongoing studies regarding analytical methods for measuring silica in biological materials or
environmental media were located.
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8. REGULATIONS, ADVISORIES, AND GUIDELINES
 
MRLs are substance specific estimates that are intended to serve as screening levels. They are used by
ATSDR health assessors and other responders to identify contaminants and potential health effects that
may be of concern at hazardous waste sites.
The international and national regulations, advisories, and guidelines regarding silica in air, water, and 
other media are summarized in Table 8-1.  
Silica polymorphs may have separate regulations, advisories, and guidelines.  For example, general
industry PELs for cristobalite and tridymite are lower than general industry PEL for quartz (OSHA
2013a).
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SILICA 278
8.  REGULATIONS, ADVISORIES, AND GUIDELINES
Table 8-1.  Regulations, Advisories, and Guidelines Applicable to Silica
Agency Description Information Reference
INTERNATIONAL
Guidelines:
IARC Carcinogenicity classification IARC 2015
Silica, amorphous Group 3a 
Silica dust, crystalline, in the form
of quartz or cristobalite
Group 1b 
WHO Air quality guidelines No data WHO 2010





ACGIH TLV (8-hour TWA) ACGIH 2015
Silica, crystalline—α-quartz (1317-
95-9; 14808-60-7) and cristobalite 
(14464-46-1)











silica and silica gel (112926-00-8)
Withdrawne 
AIHA ERPGs No data AIHA 2014
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8.  REGULATIONS, ADVISORIES, AND GUIDELINES
Table 8-1.  Regulations, Advisories, and Guidelines Applicable to Silica
Agency Description Information Reference
NATIONAL (cont.)
DOE PACs DOE 2012a
PAC-1f 




Cristobalite 0.075 mg/m3 
Silica, amorphous fumed 6 mg/m3 














Cristobalite 0.41 mg/m3 
Silica, amorphous fumed 6 mg/m3 














Cristobalite 41 mg/m3 
Silica, amorphous fumed 630 mg/m3 






calcinated; filter agent, celite;
amorphous silica)
59 mg/m3 
EPA AEGLs No data EPA 2015a
Hazardous air pollutant No data EPA 2013a
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SILICA	 280
8.  REGULATIONS, ADVISORIES, AND GUIDELINES
Table 8-1.  Regulations, Advisories, and Guidelines Applicable to Silica
Agency Description	 Information Reference
NATIONAL (cont.)
NIOSH REL (10-hour TWA) NIOSH 2015a,
2015bSilica, amorphous 6 mg/m3 
Silica, crystalline (as respirable 0.05 mg/m3 
dust)
IDLH
Silica, amorphous 3000 mg/m3 
Silica, crystalline (as respirable 25 mg/m3 
dust - cristobalite, tridymite)
Silica, crystalline (as respirable 50 mg/m3 
dust - quartz, tripoli)
OSHA PEL (8-hour TWA)g 0.05 mg/m3 OSHA 2016…
Silica, respirable crystalline for
general industry and maritime 
PEL (8-hour TWA)h 0.025 mg/m3 OSHA 2016
Silica, respirable crystalline for
construction industry
PEL (8-hour TWA) 80 mg/m3/%SiO2 OSHA 2013a
29 CFR 1910.1000,Silica, amorphous, including 
Table Z-3natural diatomaceous earth
b. Water
EPA Designated as hazardous substances No data EPA 2013b
in accordance with Section 40 CFR 116.4
311(b)(2)(A) of the Clean Water Act
Drinking water standards and health No data EPA 2012
advisories
National primary drinking water No data EPA 2009
standards
National recommended water quality No data EPA 2015b
criteria: human health for the 
consumption of
Reportable quantities of hazardous No data EPA 2013c
substances designated pursuant to 40 CFR 117.3
Section 311 of the Clean Water Act
c. Food




Diatomaceous earth Yesj,k 
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SILICA 281
8.  REGULATIONS, ADVISORIES, AND GUIDELINES
Table 8-1.  Regulations, Advisories, and Guidelines Applicable to Silica
Agency Description Information Reference
NATIONAL (cont.)
d. Other
ACGIH Carcinogenicity classification ACGIH 2015
Silica, crystalline—α-quartz (1317- A2l 
95-9; 14808-60-7) and cristobalite 
(14464-46-1)
Silica, amorphous—diatomaceous Withdrawnd 
earth (61790-53-2)
Silica, amorphous—fume (69012- Withdrawne 
64-2)
Silica, amorphous—fused (60676- Withdrawne 
86-0)
Silica, amorphous—precipitated Withdrawne 
silica and silica gel (112926-00-8)
NIOSH REL and IDLH NIOSH 2015b
Silica, crystalline (as respirable Cam 
dust)
EPA Carcinogenicity classification No data IRIS 2015
Superfund, emergency planning, and No data EPA 2014a
community right-to-know 40 CFR 302.4
TSCA chemical lists and reporting No data EPA 2014b
periods 40 CFR 712.30
NATIONAL (cont.)
DHHS Carcinogenicity classification NTP 2014
Silica, crystalline (respirable size; Known to be a human 
no CAS No.) carcinogen
aGroup 3: not classifiable as to its carcinogenicity to humans.





dWithdrawn due to insufficient data on single-substance exposure; most are co-exposures with crystalline silica.
 
eWithdrawn due to insufficient data.
 
fDefinitions of PAC terminology are available from U.S. Department of Energy (DOE 2012b).
 
gCompliance schedule for general industry and maritime is June 23, 2018 (2 years after the effective rule date).
 
hCompliance schedule for construction industry is June 23, 2017 (1 year after the effective rule date).
 




jThe EAFUS list of substances contains ingredients added directly to food that FDA has either approved as food 

additives or listed or affirmed as GRAS.
 
kAlthough listed as added to food, there is no current reported use of the substance.
 
lA2: suspected human carcinogen
 
mCa = potential occupational carcinogen
 
ACGIH = American Conference of Governmental Industrial Hygienists; AEGL = acute exposure guideline levels;
 
AIHA = American Industrial Hygiene Association; CERCLA = Comprehensive Environmental Response,
 
Compensation, and Liability Act; CFR = Code of Federal Regulations; DHHS = Department of Health and Human 

Services; DOE = Department of Energy; DWEL = drinking water equivalent level; EAFUS = Everything Added to 

Food in the United States; EPA = Environmental Protection Agency; ERPG = emergency response planning 

guidelines; FDA = Food and Drug Administration; GRAS = Generally Recognized As Safe; IARC = International
 
Agency for Research on Cancer; IDLH = immediately dangerous to life or health; IRIS = Integrated Risk Information 
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8.  REGULATIONS, ADVISORIES, AND GUIDELINES
Table 8-1.  Regulations, Advisories, and Guidelines Applicable to Silica
Agency Description Information Reference
System; MCL = maximum contaminant level; NAS = The National Academies of Sciences; NIOSH = National Institute
for Occupational Safety and Health; NTP = National Toxicology Program; OSHA = Occupational Safety and Health 
Administration; PAC = Protective Action Criteria; PEL = permissible exposure limit; RCRA = Resource Conservation
and Recovery Act; REL = recommended exposure limit; RfC = inhalation reference concentration; RfD = oral
reference dose; TLV = threshold limit values; TSCA = Toxic Substances Control Act; TWA = time-weighted average; 
WHO = World Health Organization
***DRAFT FOR PUBLIC COMMENT***
















    
   
 
    
   
 
 




































*Abdul-Wahab SA, Worthing MA, Al-Maamari S.  2005.  Mineralogy of atmospheric suspended dust in 
three indoor and one outdoor location in Oman.  Environ Monit Assess 107(1-3):313-327.  
10.1007/s10661-005-3112-4.
*Absher MP, Hemenway DR, Leslie KO, et al.  1992.  Intrathoracic distribution and transport of
aerosolized silica in the rat.  Exp Lung Res 18(5):743-757.  10.3109/01902149209031705.  
*ACGIH.  2015. Silica.  In: TLVs and BEIs based on the documentation of the threshold limit values for
chemical substances and physical agents and biological exposure indices.  Cincinnati, OH:  American
Conference of Governmental Industrial Hygienists, 52, 89, 90.  
*Adler AJ, Berlyne GM.  1986.  Silicon metabolism. II.  Renal handling in chronic renal failure patients.
Nephron 44(1):36-39.  
*Adlercreutz H.  1995.  Phytoestrogens:  Epidemiology and a possible role in cancer protection.  Environ 
Health Perspect 103(7):103-112.  
*Aggarwal BD.  2014.  Lactate dehydrogenase as a biomarker for silica exposure-induced toxicity in 
agate workers.  Occup Environ Med 71(8):578-582.  10.1136/oemed-2014-102190.  
*AIHA.  2014. Current ERPG Values (2014).  Fairfax, VA:  American Industrial Hygiene Association.  
https://www.aiha.org/get-
involved/AIHAGuidelineFoundation/EmergencyResponsePlanningGuidelines/Documents/2014%20ERP 
G%20Values.pdf.  March 4, 2015.  
*Akbar-Khanzadeh F, Milz S, Ames A, et al.  2007. Crystalline silica dust and respirable particulate
matter during indoor concrete grinding - wet grinding and ventilated grinding compared with uncontrolled 
conventional grinding.  J Occup Environ Hyg 4(10):770-779.  10.1080/15459620701569708.
*Akbar-Khanzadeh F, Milz SA, Wagner CD, et al.  2010.  Effectiveness of dust control methods for
crystalline silica and respirable suspended particulate matter exposure during manual concrete surface 
grinding.  J Occup Environ Hyg 7(12):700-711.  10.1080/15459624.2010.527552.
*Altindag ZZ, Baydar T, Isimer A, et al.  2003.  Neopterin as a new biomarker for the evaluation of
occupational exposure to silica.  Int Arch Occup Environ Health 76(4):318-322.  10.1007/s00420-003-
0434-9.  
*Altman PL, Dittmer DS.  1974. 2nd ed.  Bethesda, MD:  Federation of American Societies of
Experimental Biology.  
*Altree-Williams S, Sprogis I.  1982. Quartz:  Correlation between crystallinity index and fibrogenicity?
Ann Occup Hyg 25(4):455-458.  
*Amandus H, Costello J.  1991.  Silicosis and lung cancer in US metal miners.  Arch Environ Health 
46(2):82-89.  (As cited in Erren et al. 2009a, 2009b; Lacrasse et al. 2005)
* Cited in text
+ Cited in supplemental document
***DRAFT FOR PUBLIC COMMENT***













    
 
    
 
  
     
 
    
   
  
 
   










   
   
 
    
   
 
 









     
 
 







*Amandus HE, Castellan RM, Shy C, et al.  1992.  Reevaluation of silicosis and lung cancer in North 
Carolina dusty trades workers.  Am J Ind Med 22(2):147-153.  (As cited in Kurihara and Wada 2004)
*Amandus HE, Shy C, Castellan RM, et al.  1995.  Silicosis and lung cancer among workers in North 
Carolina dusty trades.  Scand J Work Environ Health 21(2):81-83.  (As cited in Kurihara and Wada 2004)
*Amandus HE, Shy C, Wing S, et al.  1991. Silicosis and lung cancer in North Carolina dusty trades
workers.  Am J Ind Med 20(1):57-70.  (As cited in Erren et al. 2009a, 2009b; Lacrasse et al. 2005)
*Andersen ME, Krishnan K.  1994.  Relating in vitro to in vivo exposures with physiologically based
tissue dosimetry and tissue response models.  In:  Salem H, ed.  Animal test alternatives:  Refinement,
reduction, and replacement.  New York, NY:  Marcel Dekker, Inc., 9-25.  
*Andersen ME, Clewell HJ, Gargas ML, et al.  1987.  Physiologically based pharmacokinetics and the
risk assessment process for methylene chloride. Toxicol Appl Pharmacol 87(2):185-205.  
*Andersson L, Burdorf A, Bryngelsson IL, et al.  2012.  Estimating trends in quartz exposure in Swedish 
iron foundries--predicting past and present exposures.  Ann Occup Hyg 56(3):362-372.  
10.1093/annhyg/mer106.
*Archer JD, Cooper GS, Reist PC, et al.  2002.  Exposure to respirable crystalline silica in eastern North 
Carolina farm workers.  AIHA J 63(6):750-755.  
*Armstrong BK, McNulty JC, Levitt LJ, et al.  1979.  Mortality in gold and coal miners in Western 
Australia with special reference to lung cancer.  Br J Ind Med 36(3):199-205.  (As cited in Erren et al.
2009a, 2009b)
+*Arts JH, Muijser H, Duistermaat E, et al.  2007. Five-day inhalation toxicity study of three types of
synthetic amorphous silicas in Wistar rats and post-exposure evaluations for up to 3 months.  Food Chem
Toxicol 45(10):1856-1867.  10.1016/j.fct.2007.04.001.
+*Aschengrau A, Zierler S, Cohen A.  1989.  Quality of community drinking water and the occurrence of
spontaneous abortion.  Arch Environ Health 44(5):283-290.  10.1080/00039896.1989.9935895.
*ATSDR.  1989.  Decision guide for identifying substance-specific data needs related to toxicological
profiles; Notice.  Agency for Toxic Substances and Disease Registry.  Fed Regist 54(174):37618-37634.  
*Bailey MR, Ansoborlo E, Guilmette RA, et al.  2007.  Updating the ICRP human respiratory tract
model.  Radiat Prot Dosimetry 127(1-4):331-334.  
*Bakke B, Ulvestad B, Stewart P, et al. 2004.  Cumulative exposure to dust and gasses as determinants 
of lung function in tunnel construction workers.  Occup Environ Med 61:262-269.  
*Bang BE, Suhr H.  1998. Quartz exposure in the slate industry in northern Norway.  Ann Occup Hyg
42(8):557-563.  
*Bang KM, Attfield MD, Wood JM, et al.  2008.  National trends in silicosis mortality in the United 
States, 1981-2004.  Am J Ind Med 51(9):633-639.  10.1002/ajim.20607.
***DRAFT FOR PUBLIC COMMENT***
























   
 
    
 
 































*Bang KM, Mazurek JM, Wood JM, et al.  2015.  Silicosis mortality trends and new exposures to 
respirable crystalline silica - United States, 2001-2010.  MMWR Morb Mortal Wkly Rep 64(5):117-120.  
*Barredo BF, Polo Diez L.  1980. Routine accurate determination of silica in silicate materials by
atomic-absorption spectrophotometry and subsequent computation.  Talanta 27:69-70.  
*Bartunkova J, Pelclova D, Fenclova Z, et al.  2006.  Exposure to silica and risk of ANCA-associated 
vasculitis.  Am J Ind Med 49(7):569-576.  10.1002/ajim.20327.
*Basaran N, Shubair M, Undeger U, et al.  2003.  Monitoring of DNA damage in foundry and pottery
workers exposed to silica by the alkaline comet assay.  Am J Ind Med 43(6):602-610.  
10.1002/ajim.10222.
*Beaudreuil S, Lasfargues G, Laueriere L, et al.  2005.  Occupational exposure in ANCA-positive
patients:  A case-control study.  Kidney Int 67(5):1961-1966.  10.1111/j.1523-1755.2005.00295.x.
*Beaudry C, Lavoue J, Sauve JF, et al.  2013.  Occupational exposure to silica in construction workers:
A literature-based exposure database.  J Occup Environ Hyg 10(2):71-77.  
10.1080/15459624.2012.747399.
*Beckett W, Abraham J, Becklake M, et al.  1997.  Adverse effects of crystalline silica exposure.  Am J
Respir Crit Care Med 155(2):761-768.  
*Begin R, Filion R, Ostiguy G.  1995. Emphysema in silica and asbestos-exposed workers seeking
compensation.  A CT scan study.  Chest 108(3):647-655.  
*Begin R, Masse S, Sebastien P, et al.  1987.  Sustained efficacy of aluminum to reduce quartz toxicity in 
the lung.  Exp Lung Res 13(2):205-222.  
*Berger GS, ed. 1994. Epidemiology of endometriosis.  In:  Endometriosis:  Modern surgical
management of endometriosis.  New York, NY:  Springer-Verlag, 3-7.
*Berlyne GM, Adler AJ, Ferran N, et al.  1986.  Silicon metabolism.  I.  Some aspects of renal silicon 
handling in normal man.  Nephron 43(1):5-9.  
*Berry G, Rogers A, Yeung P.  2004. Silicosis and lung cancer:  A mortality study of compensated men 
with silicosis in New South Wales, Australia.  Occup Med 54(6):387-394.  10.1093/occmed/kqh029.
*Beskow R.  1978. Silicosis in diatomaceous earth factory workers in Sweden.  Scand J Respir Dis
59(4):216-221.  
*Bhagia LJ.  2009.  Non-occupational exposure to silica dust in vicinity of slate pencil industry, India.
Environ Monit Assess 151(1-4):477-482.  10.1007/s10661-008-0290-x.
*Birk T, Guldner K, Mundt KA, et al.  2010.  Quantitative crystalline silica exposure assessment for a 
historical cohort epidemiologic study in the German porcelain industry.  J Occup Environ Hyg 7(9):516-
528. 10.1080/15459624.2010.487789.
*Birk T, Mundt KA, Guldner K, et al.  2009.  Mortality in the German porcelain industry 1985-2005:
First results of an epidemiological cohort study.  J Occup Environ Med 51(3):373-385.  
10.1097/JOM.0b013e3181973e19.
***DRAFT FOR PUBLIC COMMENT***




















   




   
 
































*Borm PJ, Tran L.  2002.  From quartz hazard to quartz risk: The coal mines revisited.  Ann Occup Hyg
46(1):25-32.  
*Borm PJ, Tran L, Donaldson K.  2011. The carcinogenic action of crystalline silica:  A review of the 
evidence supporting secondary inflammation-driven genotoxicity as a principal mechanism.  Crit Rev
Toxicol 41(9):756-770.  10.3109/10408444.2011.576008.
*Boujemaa W, Lauwerys R, Bernard A.  1994.  Early indicators of renal dysfunction in silicotic workers.  
Scand J Work Environ Health 20(3):180-183.  
*Bovenzi M, Barbone F, Betta A, et al.  1995.  Scleroderma and occupational exposure.  Scand J Work
Environ Health 21(4):289-292.  (As cited in McCormic et al. 2010)
*Bovenzi M, Barbone F, Pisa FE, et al.  2004.  A case-control study of occupational exposures and 
systemic sclerosis.  Int Arch Occup Environ Health 77(1):10-16.  10.1007/s00420-003-0462-5.  (As cited
in McCormic et al. 2010)
*Bratveit M, Moen BE, Mashalla YJ, et al. 2003. Dust exposure during small-scale mining in Tanzania:
A pilot study.  Ann Occup Hyg 47(3):235-240.  
*Braz NF, Carneiro AP, Amorim MR, et al.  2014.  Association between inflammatory biomarkers in 
plasma, radiological severity, and duration of exposure in patients with silicosis.  J Occup Environ Med 
56(5):493-497.  10.1097/jom.0000000000000164.
*Brody AR, Roe MW, Evans JN, et al.  1982.  Deposition and translocation of inhaled silica in rats.  
Quantification of particle distribution, macrophage participation, and function.  Lab Invest 47(6):533-542.  
*Brooks SM, Stockwell HG, Pinkham PA, et al.  1992.  Sugarcane exposure and the risk of lung cancer
and mesothelioma.  Environ Res 58:195-203.  
*Brown T.  2009.  Silica exposure, smoking, silicosis and lung cancer--complex interactions.  Occup Med
59(2):89-95.  10.1093/occmed/kqn171.
*Brown GM, Donaldson K.  1996. Modulation of quartz toxicity by aluminum.  In:  Castranova V, 
Vallyathan V, Wallace WE, eds.  Silica and silica-induced lung diseases.  Boca Raton, FL:  CRC Press, 
299-304.  
*Brown TP, Rushton L.  2005.  Mortality in the UK industrial silica sand industry:  2. A retrospective
cohort study.  Occup Environ Med 62(7):446-452.  10.1136/oem.2004.017731.  (As cited in Lacasse et al.
2009; Pelucci et al. 2006)
*Brown DP, Kaplan SD, Zumwalde RD, et al.  1986.  Retrospective cohort mortality study of
underground gold mine workers.  In:  Silica, silicosis, and cancer:  Controversy in occupational medicine
Vol. 2, 335-350.  (As cited in Mannetje et al. 2002b)
*Brown LM, Gridley G, Olsen JH, et al.  1997.  Cancer risk and mortality patterns among silicotic men in
Sweden and Denmark.  J Occup Environ Med 39(7):633-638.  (As cited in Kurihara and Wada 2004;
Lacrasse et al. 2005; McCormic et al. 2010; Pelucci et al. 2006)
***DRAFT FOR PUBLIC COMMENT***












      
 
    
 
 
    
  
   
 
   
 
 







     
    
    
 
  
   
    
 
 
    
      
 






    
 
 
    
 
 





*Bruske-Hohlfeld I, Mohner M, Pohlabeln H, et al.  2000.  Occupational lung cancer risk for men in 
Germany:  Results from a pooled case-control study.  Am J Epidemiol 151(4):384-395.  (As cited in 
Kurihara and Wada 2004; Lacasse et al. 2009; Pelucci et al. 2006)
*Bruske I, Thiering E, Heinrich J, et al.  2014.  Respirable quartz dust exposure and airway obstruction:
A systematic review and meta-analysis.  Occup Environ Med 71(8):583-589.  10.1136/oemed-2013-
101796. 
*Burns CJ, Laing TJ, Gillespie BW, et al.  1996.  The epidemiology of scleroderma among women:
Assessment of risk from exposure to silicone and silica.  J Rheumatol 23(11):1904-1911.  (As cited in 
McCormic et al. 2010)
*Bye E, Edholm G, Gylseth B, et al.  1980.  On the determination of crystalline silica in the presence of
amorphous silica.  Ann Occup Hyg 23(4):329-334.  
*Cakmak GD, Schins RP, Shi T, et al.  2004.  In vitro genotoxicity assessment of commercial quartz
flours in comparison to standard DQ12 quartz.  Int J Hyg Environ Health 207(2):105-113.  10.1078/1438-
4639-00276.
*Caldwell DM.  1958.  The coalescent lesion of diatomaceous earth pneumoconiosis.  Am Rev Tuberc
77:644-661. 
*Calvert GM, Rice FL, Boiano JM, et al. 2003.  Occupational silica exposure and risk of various
diseases:  An analysis using death certificates from 27 states of the United States.  Occup Environ Med
60(2):122-129.  (As cited in McCormic et al. 2010; Pelucci et al. 2006)
*Calvert GM, Steenland K, Palu S.  1997. End-stage renal disease among silica-exposed gold miners.  A
new method for assessing incidence among epidemiologic cohorts. J Am Med Assoc 277(15):1219-1223.  
(As cited in McCormic et al. 2010)
*Carta P, Aru G, Manca P. 2001. Mortality from lung cancer among silicotic patients in Sardinia:  An
update study with 10 more years of follow up.  Occup Environ Med 58(12):786-793. (As cited in Erren et
al. 2009a, 2009b; Lacrasse et al. 2005; Pelucci et al. 2006)
*Case BW, Dufresne A, Richardson L, et al.  1995.  Lung-retained dose following occupational exposure
to silica.  Appl Occup Environ Hyg 10(12):1031-1036.  
*Castranova V, Vallyathan V.  2000.  Silicosis and coal workers' pneumoconiosis.  Environ Health 
Perspect 108(4):675-684.  
*CDC.  1998a.  Silicosis deaths among young adults- United States, 1968-1994.  Morb Mortal Wkly Rep 
47(16):331-335.  
*CDC.  1998b. Silicosis deaths among young adults- United States, 1968-1994.  J Am Med Assoc
280(1):13-15.  
*Chalupka S.  2012. Occupational silica exposure in hydraulic fracturing.  Workplace Health Saf
60(10):460.  10.3928/21650799-20120926-70.
***DRAFT FOR PUBLIC COMMENT***











      
   
 
    
 
 
   
 
 




      
 
    
 
   
 
 





    
 
  
   
 
     
 
 


















*Chan CK, Leung CC, Tam CM, et al.  2000.  Lung cancer mortality among a cohort of men in a silicotic
register. J Occup Environ Med 42(1):69-75. (As cited in Kurihara and Wada 2004; Erren et al. 2009a, 
2009b; Lacrasse et al. 2005; Pelucci et al. 2006)
*Checkoway H.  2000. Epidemiological evidence on the carcinogenicity of silica:  Factors in scientific
judgement.  Ann Occup Hyg 44(6):483-484.  
*Checkoway H, Franzblau A.  2000. Is silicosis required for silica-associated lung cancer?  Am J Ind
Med 37(3):252-259.  
*Checkoway H, Heyer NJ, Demers PA, et al.  1993. Mortality among workers in the diatomaceous earth
industry.  Br J Ind Med 50(7):586-597.  
*Checkoway H, Heyer NJ, Demers PA.  1996a.  An updated mortality follow-up study of Florida
phosphate industry workers.  Am J Ind Med 30(4):452-460.  (As cited in Pelucci et al. 2006)
*Checkoway H, Heyer NJ, Demers PA, et al.  1996b. Reanalysis of mortality from lung cancer among
diatomaceous earth industry workers, with consideration of potential confounding by asbestos exposure.  
Occup Environ Med 53(9):645-647.  (As cited in Mannetje et al. 2002b)
*Checkoway H, Heyer NJ, Seixas NS, et al.  1997.  Dose-response associations of silica with
nonmalignant respiratory disease and lung cancer mortality in the diatomaceous earth industry.  Am J
Epidemiol 145(8):680-688.  
*Checkoway H, Hughes JM, Weill H, et al.  1999.  Crystalline silica exposure, radiological silicosis, and 
lung cancer mortality in diatomaceous earth industry workers.  Thorax 54(1):56-59.  (As cited in Erren et
al. 2009a, 2009b; Kurihara and Wada 2004; Lacrasse et al. 2005; Pelucci et al. 2006)
*Chen W, Chen J. 2002. Nested case-control study of lung cancer in four Chinese tin mines.  Occup 
Environ Med 59(2):113-118.  (As cited in Pelucci et al. 2006)
*Chen F, Shi X.  2002.  NF-κB, a pivotal transcription factor in silica-induced diseases.  Mol Cell
Biochem 234-235(1):169-176.  
*Chen M, Tse LA.  2012. Laryngeal cancer and silica dust exposure:  A systematic review and meta-
analysis.  Am J Ind Med 55(8):669-676.  10.1002/ajim.22037.
*Chen J, McLaughlin JK, Zhang JY, et al.  1992.  Mortality among dust-exposed Chinese mine and 
pottery workers.  J Occup Med 34(3):311-316.  
*Chen W, Bochmann F, Sun Y.  2007. Effects of work related confounders on the association between
silica exposure and lung cancer:  A nested case-control study among Chinese miners and pottery workers.  
Int Arch Occup Environ Health 80(4):320-326.  10.1007/s00420-006-0137-0.  (As cited in Lacasse et al.
2009)
*Chen W, Liu Y, Wang H, et al.  2012.  Long-term exposure to silica dust and risk of total and cause-
specific mortality in Chinese workers:  A cohort study.  PLoS Med 9(4):e1001206.
10.1371/journal.pmed.1001206.
*Chen W, Zhuang Z, Attfield MD, et al.  2001.  Exposure to silica and silicosis among tin miners in 
China:  Exposure-response analyses and risk assessment.  Occup Environ Med 58(1):31-37.  
***DRAFT FOR PUBLIC COMMENT***





















   
    









   
  
 










   
  







    
 
    
    
 




*Cherry N, Harris J, McDonald C, et al.  2013.  Mortality in a cohort of Staffordshire pottery workers:

Follow-up to December 2008.  Occup Environ Med 70(3):149-155.  10.1136/oemed-2012-100782.
 
*Cherry NM, Burgess GL, Turner S, et al.  1998.  Crystalline silica and risk of lung cancer in the
 




*Chia KS, Ng TP, Jeyaratnam J.  1992.  Small airways function of silica-exposed workers.  Am J Ind 

Med 22(2):155-162.  

*Chia SE, Chia KS, Phoon WH, et al.  1991. Silicosis and lung cancer among Chinese granite workers.  





*Chiazze L, Jr., Watkins DK, Fryar C. 1997. Historical cohort mortality study of a continuous filament
 
fiberglass manufacturing plant.  I.  White Men.  J Occup Environ Med 39(5):432-441. (As cited in 

Pelucci et al. 2006)

*Chiyotani K, Saito K, Okubo T, et al.  1990.  Lung cancer risk among pneumoconiosis patients in Japan, 

with special reference to silicotics.  IARC Sci Publ (97):95-104. 

*Choudat D, Frisch C, Barrat G, et al.  1990.  Occupational exposure to amorphous silica dust and 

pulmonary function.  Br J Ind Med 47(11):763-766.  

*Churchyard GJ, Ehrlich R, teWaterNaude JM, et al.  2004. Silicosis prevalence and exposure-response
 
relations in South African goldminers.  Occup Environ Med 61(10):811-816.  10.1136/oem.2003.010967.
 
*Clark BH, Peacor DR.  1992.  Occupational silica exposure in hydraulic fracturing.  Contrib Mineral
 
Petrol 112:558-568.  

*Clewell HJ, Andersen ME.  1985.  Risk assessment extrapolations and physiological modeling.  Toxicol
 
Ind Health 1(4):111-131.  

*Cocco PL, Carta P, Bario P, et al.  1990.  Case-controlled study on silicosis and lung cancer.  In:

Sakurai H, Okazaki I, Omae K, eds.  Occupational medicine:  Proceedings of the 7th international
 




*Cocco PL, Carta P, Belli S, et al.  1994.  Mortality of Sardinian lead and zinc miners: 1960-88.  Occup 

Environ Med 51(10):674-682.  

*Cocco P, Rice CH, Chen JQ, et al.  2001.  Lung cancer risk, silica exposure, and silicosis in Chinese
 
mines and pottery factories:  The modifying role of other workplace lung carcinogens.  Am J Ind Med 

40(6):674-682. (As cited in Erren et al. 2009a, 2009b; Lacasse et al. 2009; Pelucci et al. 2006)

*Coggiola M, Bosio D, Pira E, et al. 2003. An update of a mortality study of talc miners and millers in
 
Italy.  Am J Ind Med 44(1):63-69. 10.1002/ajim.10240.  (As cited in Pelucci et al. 2006)

*Collins JF, Salmon AG, Brown JP, et al.  2005.  Development of a chronic inhalation reference level for
 
respirable crystalline silica.  Regul Toxicol Pharmacol 43(3):292-300.  10.1016/j.yrtph.2005.08.003.
 
***DRAFT FOR PUBLIC COMMENT***











   
   
 
    
 
 






     
  
 



































*Conrad K, Mehlhorn J, Luthke K, et al.  1996.  Systemic lupus erythematosus after heavy exposure to
quartz dust in uranium mines:  Clinical and serological characteristics.  Lupus 5(1):62-69.  
*Cooper WC, Jacobson G. 1977. A 21-year radiographic follow-up of workers in the diatomite industry.  
J Occup Med 19(8):563-566.  
*Cooper WC, Sargent EN. 1984. A 26-year radiographic follow-up of workers in a diatomite mine and 
mill.  J Occup Med 26(6):456-460.  
*Cooper GS, Wither J, Bernatsky S, et al.  2010.  Occupational and environmental exposures and risk of
systemic lupus erythematosus:  Silica, sunlight, solvents.  Rheumatology 49(11):2172-2180.  
10.1093/rheumatology/keq214.
*Costa D, Fubini B, Giamello E, et al.  1991. A novel type of active site at the surface of crystalline Si02 
(α-quartz) and its possible impact on pathogenicity.  Can J Chem 69(9):1427-1434.  
*Costa LG, Aschner M, Vitalone A, et al. 2004. Developmental neuropathology of environmental
agents.  Annu Rev Pharmacol Toxicol 44:87-110.  
*Costello J, Graham WGB. 1988. Vermont granite workers' mortality study.  Am J Ind Med 13(4):483-
497. 
*Costello J, Castellan RM, Swecker GS, et al.  1995. Mortality of a cohort of U.S. workers employed in 
the crushed stone industry, 1940-1980.  Am J Ind Med 27(5):625-640.  
*Cowie RL.  1987.  Silica-dust-exposed mine workers with scleroderma (systemic sclerosis).  Chest
92(2):260-262.  
*Cowie RL.  1994.  The epidemiology of tuberculosis in gold miners with silicosis.  Am J Respir Crit
Care Med 150(5 Pt 1):1460-1462.  10.1164/ajrccm.150.5.7952577.  
*Cowie RL, Hay M, Thomas RG.  1993.  Association of silicosis, lung dysfunction, and emphysema in 
gold miners.  Thorax 48(7):746-749.  
*Cox LA.  2011. An exposure-response threshold for lung diseases and lung cancer caused by crystalline 
silica.  Risk Anal 31(10):1543-1560.  10.1111/j.1539-6924.2011.01610.x.
*Daniel LN, Mao Y, Saffiotti U.  1993.  Oxidative DNA damage by crystalline silica.  Free Radic Biol
Med 14(5):463-472.  
*Daniel LN, Mao Y, Wang TC, et al.  1995.  DNA strand breakage, thymine glycol production, and 
hydroxyl radical generation induced by different samples of crystalline silica in vitro. Environ Res
71(1):60-73.  
*Dart RC, ed., Cavarvati EM, McGuigan MA, et al.  2004.  Silica-related diseases and silicosis.  In:
Medical toxicology.  3rd ed.  Philadelphia, PA:  Lippincott Williams & Wilkins, 1192-1193.  
*Das PB, Fletcher AG, Dordhare SG.  1976. Mesothelioma in an agricultural community of India:  A
clinicopathological study.  Aust N Z J Med 46:218-226.  
***DRAFT FOR PUBLIC COMMENT***















   











   
  
 







     









    
  
 
   
  
 
   





*Davis GS.  1986. Pathogenesis of silicosis:  Current concepts and hypotheses.  Lung 164(3):139-154.  
*Davis BL, Johnson LR, Stevens RK, et al.  1984.  The quartz content and elemental composition of
aerosols from selected sites of the EPA inhalable particulate network.  Atmos Environ 18(4):771-782.  
*Davis LK, Wegman DH, Monson RR, et al.  1983. Mortality experience of Vermont granite workers.
Am J Ind Med 4(6):705-723.  (As cited in Mannetje et al. 2002b)
*Deane KD, El-Gabalawy H.  2014. Pathogenesis and prevention of rheumatic disease:  Focus on
preclinical RA and SLE.  Nat Rev Rheumatol 10(4):212-228.  
*Deb U, Lomash V, Raghuvanshi S, et al.  2012.  Effects of 28 days silicon dioxide aerosol exposure on 
respiratory parameters, blood biochemical variables and lung histopathology in rats.  Environ Toxicol
Pharmacol 34(3):977-984.  10.1016/j.etap.2012.07.009.  
*de Klerk NH, Musk AW.  1998. Silica, compensated silicosis, and lung cancer in Western Australian 
goldminers.  Occup Environ Med 55(4):243-248.  
*de Klerk NH, Musk AW, Tetlow S, et al.  1995. Preliminary study of lung cancer mortality among
Western Australian gold miners exposed to silica.  Scand J Work Environ Health 21 Suppl 2:66-68.  
*Demircigil GC, Coskun E, Vidinli N, et al.  2010. Increased micronucleus frequencies in surrogate and 
target cells from workers exposed to crystalline silica-containing dust.  Mutagenesis 25(2):163-169.  
10.1093/mutage/gep057.
*Demoruelle MK, Deane KD, Holers VM.  2014.  When and where does inflammation begin in 
rheumatoid arthritis?  Curr Opin Rheumatol 26(1):64-71.  
*De Stefani E, Kogevinas M, Boffetta P, et al. 1996.  Occupation and the risk of lung cancer in Uruguay.  
Scand J Work Environ Health 22(5):346-352.  (As cited in Kurihara and Wada 2004; Pelucci et al. 2006)
*Ding M, Chen F, Shi X, et al.  2002.  Diseases caused by silica:  Mechanisms of injury and disease 
development.  Int Immunopharmacol 2(2-3):173-182.  
*Dion C, Dufresne A, Jacob M, et al.  2005.  Assessment of exposure to quartz, cristobalite and silicon 
carbide fibres (whiskers) in a silicon carbide plant.  Ann Occup Hyg 49(4):335-343.  
10.1093/annhyg/meh099.
*Diot E, Lesire V, Guilmot JL, et al. 2002. Systemic sclerosis and occupational risk factors:  A case-
control study.  Occup Environ Med 59(8):545-549.  
*Dobbie JW, Smith MJ.  1982.  Silicate nephrotoxicity in the experimental animal: The missing factor in 
analgesic nephropathy.  Scott Med J 27(1):10-16.
*Dobreva M, Burilkov T, Kolev K, et al.  1975.  Characteristics of lung dusts and their relation to dust
exposure and pathological findings in the lungs.  In: Inhaled Particles IV.  Proceedings of an
International Symposium organized by The British Occupational Hygiene Society, Edinburgh, 22-26 
September 1975.  Vol. 4 Pt 2.  Oxford:  Pregamon Press, 717-725. 
***DRAFT FOR PUBLIC COMMENT***










   













   
 
   
    
   
 
    
   
 









   
     




   
 
     
  
 
    
    




*DOE.  2012a.  Table 3:  PACs by CASRN (pdf).  PAC Rev 27 Tables - PAC data and chemical
properties presented in pdf and excel tables.  Protective Action Criteria (PAC) with AEGLs, ERPGs, &
TEELs:  Rev. 27 for Chemicals of Concern - March 2012.  Oak Ridge, TN:  U.S. Department of Energy.  
http://energy.gov/ehss/protective-action-criteria-pac-aegls-erpgs-teels-rev-27-chemicals-concern-march-
2012. March 4, 2015.  
*DOE.  2012b. Protective action criteria (PAC):  Chemicals with AEGLs, ERPGs, & TEELs.  Definition
of PACs (AEGLs, ERPGs or TEELs).  Protective Action Criteria (PAC) with AEGLs, ERPGs, & TEELs:
Rev. 27 for Chemicals of Concern - March 2012.  Oak Ridge, TN:  U.S. Department of Energy.  
http://energy.gov/ehss/protective-action-criteria-pac-aegls-erpgs-teels-rev-27-chemicals-concern-march-
2012. March 24, 2015.  
*Donaldson K, Borm PJ.  1998.  The quartz hazard:  A variable entity.  Ann Occup Hyg 42(5):287-294.  
*Dong D, Xu G, Sun Y, et al.  1995.  Lung cancer among workers exposed to silica dust in Chinese
refractory plants.  Scand J Work Environ Health 21(2):69-72.  (As cited in Erren et al. 2009a, 2009b;
Kurihara and Wada 2004; Lacrasse et al. 2005)
*Dosemeci M, Chen JQ, Hearl F, et al.  1993.  Estimating historical exposure to silica among mine and 
pottery workers in the People's Republic of China.  Am J Ind Med 24(1):55-66.  (As cited in Mannetje et
al. 2002b)
*Driscoll KE, Deyo LC, Carter JM, et al.  1997.  Effects of particle exposure and particle-elicited
inflammatory cells on mutation in rat alveolar epithelial cells.  Carcinogenesis 18(2):423-430.  
*Driscoll T, Nelson DI, Steenland K, et al.  2005. The global burden of non-malignant respiratory disease
due to occupational airborne exposures.  Am J Ind Med 48(6):432-445.  
*Dufresne A, Begin R, Dion C, et al.  1998.  Angular and fibrous particles in lung in relation to silica-
induced diseases.  Int Arch Occup Environ Health 71(4):263-269.  
*Dutra FR.  1965.  Diatomaceous earth pneumoconiosis.  Arch Environ Health 11:613-619.  
*Ebihara I, Kawami M.  1998.  Lung cancer and immunopathologic diseases among copper miners in a
small copper mine, stone masons and pneumoconiotic patients in Japan.  In:  Chiyotani K, Honda Y, 
Aizawa Y, eds.  Advances in the prevention of occupational respiratory disease. Amsterdam:  Elsevier
Science. (As cited in Kurihara and Wada 2004)
*Ebihara I, Shinokawa E, Kawami M, et al.  1990.  A retrospective cohort mortality study of
pneumoconiotics.  J Sci Labour 66(9):399-407.  (As cited in Kurihara and Wada 2004; Lacrasse et al. 
2005)
*Ehrlich RI, Myers JE, te Water Naude JM, et al.  2011.  Lung function loss in relation to silica dust
exposure in South African gold miners.  Occup Environ Med 68(2):96-101.  10.1136/oem.2009.048827.
*Eisen EA, Smith TJ, Wegman DH, et al.  1984.  Estimation of long term dust exposures in the Vermont
granite sheds.  Am Ind Hyg Assoc J 45(2):89-94.  10.1080/15298668491399424.  (As cited in Mannetje
et al. 2002b)
***DRAFT FOR PUBLIC COMMENT***

























   
 




   
  
 
   
   
 
 
      


















*Eisen EA, Wegman DH, Louis TA, et al.  1995.  Healthy worker effect in a longitudinal study of one-
second forced expiratory volume (FEV1) and chronic exposure to granite dust.  Int J Epidemiol
24(6):1154-1161.  
*Ek CJ, Dziegielewska KM, Habgood MD, et al.  2012.  Barriers in the developing brain and
neurotoxicology.  Neurotoxicology 33(3):586-604.  10.1016/j.neuro.2011.12.009.
*Elias Z, Poirot O, Daniere MC, et al.  2000. Cytotoxic and transforming effects of silica particles with 
different surface properties in Syrian hamster embryo (SHE) cells. Toxicol in Vitro 14(5):409-422.  
*Elias Z, Poirot O, Fenoglio I, et al.  2006.  Surface reactivity, cytotoxic, and morphological transforming
effects of diatomaceous earth products in Syrian hamster embryo cells. Toxicol Sci 91(2):510-520.  
10.1093/toxsci/kfj177.
*Eller PM, Feng HA, Song RS, et al.  1999.  Proficiency analytical testing (PAT) silica variability, 1990-
1998. Am Ind Hyg Assoc J 60:533-539.  
*El-Safty IAM, Gadallah M, Shouman AE, et al.  2003.  Subclinical nephrotoxicity caused by smoking
and occupational silica exposure among Egyptian industrial workers.  Arch Med Res 34(5):415-421.  
10.1016/s0188-4409(03)00077-8.
*Englert H, Small-McMahon J, Davis K, et al.  2000. Male systemic sclerosis and occupational silica 
exposure-a population-based study.  Aust N Z J Med 30(2):215-220.  
*Environment Canada.  2013.  Quartz chemical abstracts service registry number 14808-60-7 cristobalite
chemical abstracts service registry number 14464-46-1.  Environment Canada, Health Canada.
https://www.ec.gc.ca/ese-ees/1EB4F4EF-88EE-4679-9A6C-008F0CBC191C/FSAR_B12%20-
%2014464-46-1%20%26%2014808-60-7%20%28QC%29_EN.pdf.  October 6, 2015.  
*EPA.  1974. Development of emission factors for fugitive dust sources.  Research Triangle Park, NC:
U.S. Environmental Protection Agency, Office of Air and Waste Management.
*EPA.  1983. Silica, dissolved.  Method 3701.  In:  Methods for chemical analysis of water and wastes.  
U.S. Environmental Protection Agency.  http://nepis.epa.gov/Exe/ZyPURL.cgi?Dockey=30000Q10.txt. 
September 24, 2015.  
*EPA.  1991. R.E.D. facts.  Silicon dioxide and silica gel.  U.S. Environmental Protection Agency.  
738F91107.  http://www.epa.gov/pesticides/chem_search/reg_actions/reregistration/fs_G-74_1-Sep-
91.pdf.  October 6, 2015.
*EPA.  1994a.  Method 200.2.  Sample preparation procedure for spectrochemical determination of total




*EPA.  1994b. Method 200.7.  Determination of metals and trace elements in water and wastes by
inductively coupled plasma-atomic emission spectrometry.  Cincinnati, OH:  U.S. Environmental
Protection Agency, Office of Research and Development.
http://water.epa.gov/scitech/methods/cwa/bioindicators/upload/2007_07_10_methods_method_200_7.pdf
October 6, 2015.
***DRAFT FOR PUBLIC COMMENT***
























   
  

















    
 
 
      








*EPA.  1996. Ambient levels and noncancer health effects of inhaled crystalline and amorphous silica:
Health issue assessment.  Research Triangle Park, NC:  U.S. Environmental Protection Agency, Office of
Research and Development.  EPA600R95115.  
http://ofmpub.epa.gov/eims/eimscomm.getfile?p_download_id=4608. October 6, 2015.
*EPA.  1997. Special report on environmental endocrine disruption:  An effects assessment and analysis.  
Washington, DC:  U.S. Environmental Protection Agency, Office of Pollution Prevention and Toxics.  
*EPA. 2000. Inductively coupled plasma-atomic emission spectrometry.  Method 6010C.  U.S. 
Environmental Protection Agency.  
*EPA.  2003. Method 200.5.  Determination of trace elements in drinking water by axially viewed 
inductively coupled plasma-atomic emission spectrometry.  U.S. Environmental Protection agency, Office
of Research and Development.  EPA600R06115.  
http://water.epa.gov/scitech/methods/cwa/upload/Determination-of-Trace-Elements-in-Drinking-Water-
by-Axially-Viewed-Inductively-Coupled-Plasma-Atomic-Emission-Spectrometry.pdf.  October 6, 2015.
*EPA.  2005. Toxic chemical release inventory reporting forms and instructions:  Revised 2004 version.  
Section 313 of the Emergency Planning and Community Right-to-Know Act (Title III of the Superfund
Amendments and Reauthorization Act of 1986).  U.S. Environmental Protection Agency, Office of
Environmental Information.  
*EPA.  2009. National primary drinking water regulations.  Washington, DC:  U.S. Environmental
Protection Agency, Office of Ground Water and Drinking Water.  
http://water.epa.gov/drink/contaminants/upload/mcl-2.pdf. March 4, 2015.  
*EPA.  2011. Exposure Factors Handbook 2011 Edition (Final).  U.S. Environmental Protection Agency.  
http://cfpub.epa.gov/ncea/risk/recordisplay.cfm?deid=236252. September 22, 2015.  
*EPA.  2012. 2012 Edition of the drinking water standards and health advisories.  Washington, DC:  U.S.
Environmental Protection Agency, Office of Water.  
http://water.epa.gov/action/advisories/drinking/upload/dwstandards2012.pdf. March 4, 2015.  
*EPA.  2013a.  The Clean Air Act amendments of 1990 list of hazardous air pollutants.  Washington, DC:
U.S. Environmental Protection Agency.  http://www.epa.gov/ttn/atw/orig189.html. March 4, 2015.  
*EPA.  2013b. Subchapter D-water programs.  Designation of hazardous substances.  U.S. 
Environmental Protection Agency.  Code of Federal Regulations 40 CFR 116.4.
http://www.gpo.gov/fdsys/pkg/CFR-2014-title40-vol22/pdf/CFR-2014-title40-vol22-sec116-4.pdf. 
March 4, 2015.  
*EPA. 2013c.  Subpart A - general provisions.  Determination of reportable quantities.  U.S. 
Environmental Protection Agency.  Code of Federal Regulations 40 CFR 117.3.
http://www.gpo.gov/fdsys/pkg/CFR-2014-title40-vol22/pdf/CFR-2014-title40-vol22-sec117-3.pdf. 
March 4, 2015.  
*EPA.  2014a.  Subchapter J-Superfund, emergency planning, and community right-to-know programs.  
Designation of hazardous substances.  U.S. Environmental Protection Agency.  Code of Federal
Regulations 40 CFR 302.4.  http://www.gpo.gov/fdsys/pkg/CFR-2014-title40-vol28/pdf/CFR-2014-
title40-vol28-sec302-4.pdf.  March 4, 2015.  
***DRAFT FOR PUBLIC COMMENT***















































    
 
    
   
 
    





*EPA.  2014b. Subpart B - Manufacturers reporting - preliminary assessment information.  Chemical
lists and reporting periods.  U.S. Environmental Protection Agency.  Code of Federal Regulations 40 CFR
712.30. http://www.gpo.gov/fdsys/pkg/CFR-2014-title40-vol31/pdf/CFR-2014-title40-vol31-sec712-
30.pdf.  April 9, 2015.  
*EPA.  2015a.  Final AEGLs (176).  Washington, DC:  U.S. Environmental Protection Agency, Office of
Pollution Prevention and Toxics.  
http://www.epa.gov/oppt/aegl/pubs/compiled_aegl_update09jun2015.pdf. July 23, 2015.  
*EPA.  2015b. National recommended water quality criteria.  Washington, DC: U.S. Environmental
Protection Agency, Office of Water, Office of Science and Technology.  
http://water.epa.gov/scitech/swguidance/standards/criteria/current/index.cfm. July 23, 2015.  
*Erren TC, Glende CB, Morfeld P, et al.  2009a.  Is exposure to silica associated with lung cancer in the
absence of silicosis?  A meta-analytical approach to an important public health question.  Int Arch Occup 
Environ Health 82(8):997-1004.  10.1007/s00420-008-0387-0.
*Erren TC, Glende CB, Morfeld P, et al.  2009b.  Electronic supplemental materials.  Is exposure to silica 
associated with lung cancer in the absence of silicosis?  A meta-analytical approach to an important
public health question.  Int Arch Occup Environ Health 10.1007/s00420-008-0387-0.
*Esswein EJ, Breitenstein M, Snawder J, et al. 2013. Occupational exposures to respirable crystalline 
silica during hydraulic fracturing.  J Occup Environ Hyg 10(7):347-356.  
10.1080/15459624.2013.788352.
*Fairfax R, Oberbeck B.  2008.  OSHA compliance issues.  Exposure to crystalline silica in a countertop 
manufacturing operation. J Occup Environ Hyg 5(8):D81-85.  10.1080/15459620802161934.  
*Fanizza C, Ursini CL, Paba E, et al. 2007. Cytotoxicity and DNA-damage in human lung epithelial
cells exposed to respirable α-quartz.  Toxicol in Vitro 21(4):586-594.  
*FDA.  2013. Everything added to food in the United States (EAFUS).  Washington, DC:  U.S. Food and 
Drug Administration.  http://www.accessdata.fda.gov/scripts/fcn/fcnnavigation.cfm?rpt=eafuslisting.
January 8, 2014.  
*FDA.  2015a.  Silica aerogel.  Subpart B-multiple purpose GRAS food substances.  Food and Drug
Administration.  Code of Federal Regulations 21 CFR 182.1711.  http://www.gpo.gov/fdsys/pkg/CFR-
2015-title21-vol3/pdf/CFR-2015-title21-vol3-sec182-1711.pdf.  September 23, 2015.  
*FDA.  2015b. Substances migrating to food from paper and paperboard products.  Subpart A.  Food and 
Drug Administration.  Code of Federal Regulations 21 CFR 182.90.  http://www.gpo.gov/fdsys/pkg/CFR-
2015-title21-vol3/pdf/CFR-2015-title21-vol3-sec182-90.pdf.  September 23, 2015.
*Fechser M, Alaves V, Larson R, et al.  2014.  Evaluation of respirable crystalline silica in high school
ceramics classrooms.  Int J Environ Res Public Health 11(2):1250-1260.  
*Fenoglio I, Croce A, DiRenzo F, et al.  2000.  Pure silica zeolites (porosils) as model solids for the
evaluation of the physiochemical features determining silica toxicity to macrophages.  Chem Res Toxicol
13:489-500.  
***DRAFT FOR PUBLIC COMMENT***










   
 
 
       
  
 






   
     
   
 
    




   
   
 
    
   
 
  
    
 




     






   
 
   
      
 
 
   
SILICA 296
9.  REFERENCES
*Fenwick S, Main J.  2000.  Increased prevalence of renal disease in silica-exposed workers.  Lancet
356(9233):913-914.  
*Filios MS, Mazurek JM, Schleiff PL, et al.  2015.  Surveillance for silicosis- Michigan and New Jersey
2003-2010.  Morbidity and Mortality Weekly Report 62(54):81-85.  
*Finckh A, Cooper GS, Chibnik LB, et al.  2006.  Occupational silica and solvent exposures and risk of
systemic lupus erythematosus in urban women.  Arthritis Rheum 54(11):3648-3654.  
*Finkelstein MM.  1994.  Silicosis surveillance in Ontario:  Detection rates, modifying factors, and
screening intervals.  Am J Ind Med 25(2):257-266.  
*Finkelstein MM.  1995.  Radiographic abnormalities and the risk of lung cancer among workers exposed 
to silica dust in Ontario.  Can Med Assoc J 152(1):37-43. (Erren et al. 2009a, 2009b; Kurihara and Wada
2004; Lacrasse et al. 2005)
*Finkelstein MM.  1998.  Radiographic silicosis and lung cancer risk among workers in Ontario.  Am J
Ind Med 34(3):244-251.  (As cited in Erren et al. 2009a, 2009b; Pelucci et al. 2006)
*Finkelstein MM.  2000.  Silica, silicosis, and lung cancer:  A risk assessment.  Am J Ind Med 38(1):8-
18. 
*Finkelstein MM, Verma DK.  2005.  Mortality among Ontario members of the International Union of
Bricklayers and Allied Craftworkers.  Am J Ind Med 47(1):4-9.  (As cited in Pelucci et al. 2006)
*Finkelstein M, Liss GM, Krammer F, et al.  1987.  Mortality among workers receiving compensation 
awards for silicosis in Ontario 1940-85.  Br J Ind Med 44(9):588-594.  (As cited in Erren et al. 2009a, 
2009b; Lacrasse et al. 2005)
*Flanagan ME, Seixas N, Becker P, et al.  2006.  Silica exposure on construction sites:  Results of an 
exposure monitoring data compilation project. J Occup Environ Hyg 3(3):144-152.  
*Florke OW, Graetsch HA, Brunk F, et al.  2012.  Silica.  In:  Ullmann's encyclopedia of industrial
chemistry.  Wiley-VCH Verlag GmbH & Co.
http://onlinelibrary.wiley.com/doi/10.1002/14356007.a23_583.pub3/abstract. September 22, 2015.  
*Fomon SJ.  1966.  Body composition of the infant:  Part 1: The male reference infant.  In:  Faulkner F, 
ed.  Human development.  Philadelphia, PA: WB Saunders, 239-246.  
*Fomon SJ, Haschke F, Ziegler EE, et al.  1982.  Body composition of reference children from birth to 
age 10 years.  Am J Clin Nutr 35(Suppl 5):1169-1175.  
*Forastiere F, Lagorio S, Michelozzi P, et al.  1986.  Silica, silicosis and lung cancer among ceramic
workers:  A case-referent study.  Am J Ind Med 10(4):363-370.  (As cited in Erren et al. 2009a, 2009b;
Kurihara and Wada 2004; Lacrasse et al. 2005)
*Forastiere F, Lagorio S, Michelozzi P, et al.  1989.  Mortality pattern of silicotic subjects in the Latium
region, Italy.  Br J Ind Med 46(12):877-880.  (As cited in Erren et al. 2009a, 2009b)
*Foreland S, Bye E, Bakke B, et al.  2008.  Exposure to fibres, crystalline silica, silicon carbide and 
sulphur dioxide in the Norwegian silicon carbide industry.  Ann Occup Hyg 52(5):317-336.  
***DRAFT FOR PUBLIC COMMENT***











   
  
 
   
  
 
   
 
 
    
   
 









    
 
 
    
   
 
 




    
 
 
   












   
SILICA 297
9.  REFERENCES
*Foster RD, Walker RF.  1984.  Quantitative determination of crystalline silica in respirable-size dust
samples by infrared spectrophotometry.  Analyst 109(97):1117-1127.  
*Freeman CS, Grossman EA.  1995. Silica exposures in workplaces in the United States between 1980 
and 1992.  Scand J Work Environ Health 21(2):47-49.  
*Freund A, Zuckerman N, Luo H, et al.  2014. Diesel and silica monitoring at two sites following
hurricane Sandy.  J Occup Environ Hyg 11(9):D131-143.  
*Fu H, Gu X, Jin X, et al.  1994. Lung cancer among tin miners in southeast China:  Silica exposure, 
silicosis, and cigarette smoking.  Am J Ind Med 26(3):373-381.  (As cited in Lacrasse et al. 2005)
*Fubini B, Bolis V, Cavenago A, et al.  1995. Physicochemical properties of crystalline silica dusts and 
their possible implication in various biological responses.  Scand J Work Environ Health 21(SUPPL. 
2):9-14.  
*Fujimura N.  2000.  Pathology and pathophysiology of pneumoconiosis.  Curr Opin Pulm Med 6(2):140-
144. 
*Fulekar MH.  1999.  Occupational exposure to dust in quartz manufacturing industry.  The Ann Occup 
Hyg 43(4):269-273.  
*Fulekar MH, Khan MMA.  1995. Occupational exposure to dust in slate pencil manufacture.  Ann 
Occup Hyg 39(1):107-114.  
*Gamble JF.  2011.  Crystalline silica and lung cancer:  A critical review of the occupational
epidemiology literature of exposure-response studies testing this hypothesis.  Crit Rev Toxicol 41(5):404-
465. 
*Gamsky TE, McCurdy SA, Samuels SJ, et al.  1992.  Reduced FVC among California grape workers.
Am Rev Respir Dis 145(2):257-262.  
*GBD.  2015. Global, regional, and national age-sex specific all-cause and cause-specific mortality of
240 causes of death, 1990-2013:  A systematic analysis for the Global Burden of Disease Study 2013.  
GBD 2013 Mortality and Causes of Death Collaborators.  Lancet 385:117-171.  
*George S, Steinberg SM, Hodge V.  2000. The concentration, apparent molecular weight and chemical
reactivity of silica from groundwater in southern Nevada.  Chemosphere 40:57-63.  
*Ghahramani N.  2010.  Silica nephropathy.  Int J Occup Environ Med 1(3):108-115.  
*Gibelin A, Maldini C, Mahr A.  2011.  Epidemiology and etiology of Wegener granulomatosis,
microscopic polyangiitis, Churg-Strauss syndrome and Goodpasture syndrome: Vasculitides with 
frequent lung involvement.  Semin Respir Crit Care Med 32(3):264-273.  
*Giles RD, Sturgill BC, Suratt PM, et al.  1978. Massive proteinuria and acute renal failure in a patient
with acute silicoproteinosis.  Am J Med 64(2):336-342.  
+*Gillette-Guyonnet S, Andrieu S, Nourhashemi F, et al.  2005.  Cognitive impairment and composition 
of drinking water in women:  Findings of the EPIDOS Study.  Am J Clin Nutr 81(4):897-902.  
***DRAFT FOR PUBLIC COMMENT***





















   
 




   






















   










*Giwercman A, Carlsen E, Keiding N, et al.  1993.  Evidence for increasing incidence of abnormalities of
the human testis:  A review.  Environ Health Perspect 101(Supp 2):65-71.  
*Gold LS, Ward MH, Dosemeci M, et al.  2007. Systemic autoimmune disease mortality and 
occupational exposures.  Arthritis Rheum 56(10):3189-3201.  
*Goldsmith DF, Beaumont JJ, Morrin LA, et al.  1995.  Respiratory cancer and other chronic disease
mortality among silicotics in California.  Am J Ind Med 28(4):459-467.  
*Goldsmith JR, Goldsmith DF.  1993. Fiberglass or silica exposure and increased nephritis or ESRD
(end-stage renal disease). Am J Ind Med 23(6):873-881.  
*Gomez-Puerta JA, Gedmintas L, Costenbader KH.  2013.  The association between silica exposure and
development of ANCA-associated vasculitis:  Systematic review and meta-analysis.  Autoimmun Rev
12(12):1129-1135.  10.1016/j.autrev.2013.06.016.
*Gonzalez Huergo D, Rojo Ortega D.  1991.  [Experimental study of silica absorption through the
digestive tract as a cause of extrapulmonary silicosis]. Rev Esp Enferm Dig 80(2):95-98.  
*Grobbelaar JP, Bateman ED.  1991a.  Correction:  Hot lung:  A domestically acquired pneumoconiosis
of mixed aetiology.  (Thorax 46:334-340).  Thorax 46:544.  
*Grobbelaar JP, Bateman ED.  1991b. Hut lung:  A domestically acquired pneumoconiosis of mixed 
aetiology in rural women.  Thorax 46:334-340.  
*Graham WG, Costello J, Vacek PM.  2004.  Vermont granite mortality study:  An update with an 
emphasis on lung cancer. J Occup Environ Med 46(5):459-466.  (As cited in Pelucci et al. 2006)
*Greaves IA.  2000. Not-so-simple silicosis:  A case for public health action.  Am J Ind Med 37(3):245-
251. 
*Green FHY, Yoshida K, Fick G, et al.  1990.  Characterization of airborne mineral dusts associated with 
farming activities in rural Alberta, Canada.  Int Arch Occup Environ Health 62(6):423-430.  
*Greenberg MI, Waksman J, Curtis J.  2007.  Silicosis:  A review.  Disease-a-month 53(8):394-416.  
10.1016/j.disamonth.2007.09.020.
*Gregorini G, Ferioli A, Donato F, et al.  1993. Association between silica exposure and necrotizing
crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies:  A hospital-based case-control
study.  Adv Exp Med Biol 336:435-440.  
+*Groth DH, Moorman WJ, Lynch DW, et al.  1981. Chronic effects of inhaled amorphous silicas in 
animals.  In:  Dunnom DD, ed.  Health effects of synthetic silica particulates. (ASTM STP 732).
Philadelphia, PA:  American Society for Testing and Materials, 118-143.
*Guenel P, Hojberg G, Lynge E.  1989. Cancer incidence among Danish stone workers.  Scand J Work, 
Environ Health 15(4):265-270.  (As cited in Kurihara and Wada 2004)
*Guidi P, Nigro M, Bernardeschi M, et al.  2013.  Genotoxicity of amorphous silica particles with 
different structure and dimension in human and murine cell lines.  Mutagenesis 28(2):171-180.  
***DRAFT FOR PUBLIC COMMENT***











   
 
 
   
   
 
   
  
 
   
 
 
    
  
 







   
 





   








    
 
 
   
  
   
 
     




*Guthrie GD.  1995.  Mineralogical factors affect the biological activity of crystalline silica.  Appl Occup
Environ Hyg 10(12):1126-1131.  
*Guzelian PS, Henry CJ, Olin SS. 1992. Similarities and differences between children and adults:
Implications for risk assessment.  Washington, DC:  International Life Sciences and Press Institute Press.
*Hall RM, Achutan C, Sollberger R, et al.  2013.  Exposure assessment for roofers exposed to silica
during installation of roof tiles.  J Occup Environ Hyg 10(1):D6-D10.  10.1080/15459624.2012.739439.
*Hamilton RF, Jr., Thakur SA, Holian A.  2008. Silica binding and toxicity in alveolar macrophages.
Free Radic Biol Med 44(7):1246-1258.  10.1016/j.freeradbiomed.2007.12.027.  
*Hart GA, Hesterberg TW. 1998. In vitro toxicity of respirable-size particles of diatomaceous earth and
crystalline silica compared with asbestos and titanium dioxide.  J Occup Environ Med 40(1):29-42.  
*Hauglustaine D, Van Damme B, Daenens P, et al.  1980.  Silicon nephropathy: A possible occupational
hazard.  Nephron 26(5):219-224.  
*Haynes WM, Lide DR, Bruno TJ, et al.  2014.  In:  CRC handbook of chemistry and physics.  95th ed.  
Boca Raton, FL:  CRC Press, 4-88.  
*Hayumbu P, Robins TG, Key-Schwartz R.  2008. Cross-sectional silica exposure measurements at two
Zambian copper mines of Nkana and Mufulira.  Int J Environ Res Public Health 5(2):86-90.  
*HazDat.  2007.  Silica.  HazDat Database:  ATSDR’s Hazardous Substance Release and Health Effects 
Database.  Atlanta, GA:  Agency for Toxic Substances and Disease Registry.
*Hedlund U, Jonsson H, Eriksson K, et al.  2008.  Exposure-response of silicosis mortality in Swedish
iron ore miners.  Ann Occup Hyg 52(1):3-7.  10.1093/annhyg/mem057. 
*Hemenway DR, Absher MP, Trombley L, et al.  1990.  Comparative clearance of quartz and cristobalite
from the lung.  Am Ind Hyg Assoc J 51(7):363-369.  10.1080/15298669091369790.  
*Hemlick CG, Felson DT, Lawrence RC, et al.  2008.  Estimates of the prevalence of arthritis and other
rheumatic conditions in the United States.  Arthritis Rheum 58(1):15-25.  
*Hertzberg VS, Rosenman KD, Reilly MJ, et al.  2002.  Effect of occupational silica exposure on 
pulmonary function.  Chest 122(2):721-728.  
*Hessel PA, Gamble JF, Gee JB, et al.  2000.  Silica, silicosis, and lung cancer:  A response to a recent
working group report.  J Occup Environ Med 42(7):704-720.  
*Hessel PA, Sluis-Cremer GK, Hnizdo E.  1986.  Case-control study of silicosis, silica exposure, and
lung cancer in white South African gold miners.  Am J Ind Med 10(1):57-62.  (As cited in Lacrasse et al.
2005)
*Hesterberg TW, Barrett JC. 1984. Dependence of asbestos- and mineral dust-induced transformation of
mammalian cells in culture on fiber dimension.  Cancer Res 44(5):2170-2180.  
***DRAFT FOR PUBLIC COMMENT***










   
   





    
  
   
 
     
 






    
 
   
 
      
   
 
   
  
 







   
 
 













*Hewson GS.  1993.  Estimates of silica exposure among metalliferous miners in Western Australia 
(1925–1993).  Perth:  Department of Minerals and Energy Western Australia.  (As cited in Mannetje et al.
2002b)
*Hinchcliff M, Varga J.  2008.  Systemic sclerosis/scleroderma:  A treatable multisystem disease.  Am
Fam Physician 78(8):961-968.  
*Hnizdo E, Murray J.  1998.  Risk of pulmonary tuberculosis relative to silicosis and exposure to silica
dust in South African gold miners.  Occup Environ Med 55(7):496-502.  (As cited in Mannetje et al. 
2002b)
*Hnizdo E, Sluis-Cremer GK.  1991.  Silica exposure, silicosis, and lung cancer: A mortality study of
South African gold miners.  Br J Ind Med 48(1):53-60.  (As cited in Finkelstein 2000; Mannetje et al. 
2002b)
*Hnizdo E, Sluis-Cremer GK.  1993.  Risk of silicosis in a cohort of white South African gold miners.  
Am J Ind Med 24(4):447-457.  
*Hnizdo E, Vallyathan V.  2003. Chronic obstructive pulmonary disease due to occupational exposure to 
silica dust:  A review of epidemiological and pathological evidence.  Occup Environ Med 60(4):237-243.  
*Hnizdo E, Murray J, Klempman S.  1997. Lung cancer in relation to exposure to silica dust, silicosis
and uranium production in South African gold miners.  Thorax 52(3):271-275.  (As cited in Erren et al.
2009a, 2009b; Finkelstein 2000; Kurihara and Wada 2004; Mannetje et al. 2002b; Pelucci et al. 2006;
Steenland et al. 2001a)
*Hnizdo E, Murray J, Sluis-Cremer GK, et al.  1993. Correlation between radiological and pathological
diagnosis of silicosis:  An autopsy population based study.  Am J Ind Med 24(4):427-445.  
*Hoel DG, Davis DL, Miller AB, et al.  1992. Trends in cancer mortality in 15 industrialized countries,
1969-1986.  J Natl Cancer Inst 84(5):313-320.  
*Hoffman RS, Howland MA, Lewin NA, et al.  2014. Inorganic dust exposure.  In:  Goldfrank's
toxicologic emergencies.  10th ed.  New York, NY:  McGraw Hill, 1575.  
*Hogan SL, Cooper GS, Savitz DA, et al.  2007. Association of silica exposure with anti-neutrophil
cytoplasmic autoantibody small-vessel vasculitis:  A population-based, case-control study.  Clin J Am
Soc Nephrol 2(2):290-299.  10.2215/cjn.03501006.  
*Hogan SL, Satterly KK, Dooley MA, et al.  2001.  Silica exposure in anti-neutrophil cytoplasmic
autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol 12(1):134-142.  
*Holloway MD, Rudd O.  2014. Fracking operations.  In:  Kirk-Othmer encyclopedia of chemical
technology.  John Wiley & Sons, 10.1002/0471238961.fracholl.a01.
*Hornung V, Bauernfeind F, Halle A, et al.  2008.  Silica crystals and aluminum salts activate the NALP3
inflammasome through phagosomal destabilization.  Nat Immunol 9(8):847-856.  10.1038/ni.1631.  
*Horwell CJ, Baxter PJ, Hillman SE, et al.  2013. Physicochemical and toxicological profiling of ash 
from the 2010 and 2011 eruptions of Eyjafjallajokull and Grimsvotn volcanoes, Iceland using a rapid 
respiratory hazard assessment protocol.  Environ Res 127:63-73.  10.1016/j.envres.2013.08.011.
***DRAFT FOR PUBLIC COMMENT***











   




















   
 
    




    
 
 














   
  




*Horwell CJ, Williamson BJ, Donaldson K, et al.  2012.  The structure of volcanic cristobalite in relation
to its toxicity; relevance for the variable crystalline silica hazard.  Part Fibre Toxicol 9:44.  10.1186/1743-
8977-9-44.
*Hotz P, Gonzalez-Lorenzo J, Siles E, et al.  1995.  Subclinical signs of kidney dysfunction following
short exposure to silica in the absence of silicosis.  Nephron 70(4):438-442.  
*HSDB.  2009. Amorphous silica.  CASRN:  No CAS RN.  Hazardous Substances Data Bank.  National
Library of Medicine.  http://toxnet.nlm.nih.gov. September 23, 2015.  
*HSDB.  2012. Crystalline silica.  CASRN:  No CAS RN.  Hazardous Substances Data Bank.  National
Library of Medicine.  http://toxnet.nlm.nih.gov. September 23, 2015.  
*Huaux F.  2007.  New developments in the understanding of immunology in silicosis.  Curr Opin 
Allergy Clin Immunol 7(2):168-173.  10.1097/ACI.0b013e32802bf8a5.
*Hughes JM, Weill H, Checkoway H, et al.  1998.  Radiographic evidence of silicosis risk in the
diatomaceous earth industry.  Am J Respir Crit Care Med 158(3):807-814.  
10.1164/ajrccm.158.3.9709103.
*Hughes JM, Weill H, Rando RJ, et al.  2001.  Cohort mortality study of North American industrial sand 
workers.  II.  Case-referent analysis of lung cancer and silicosis deaths.  Ann Occup Hyg 45(3):201-207.  
*Iannello S, Camuto M, Cantarella S, et al.  2002. Rheumatoid syndrome associated with lung interstitial
disorder in a dental technician exposed to ceramic silica dust.  A case report and critical literature review.
Clin Rheumatol 21(1):76-81.  
*IARC.  1987. Silica and some silicates.  In:  IARC monographs of the evaluation of the carcinogenic 
risk of chemicals to humans.  Vol. 42.  Lyon, France: World Health Organization, International Agency
for Research on Cancer.  
*IARC.  1997. Silica.  IARC monographs on the evaluation of carcinogenic risks to humans.  Vol. 68. 
Lyon, France:  World Health Organization, International Agency for Research on Cancer. 
*IARC.  2012. Silica dust, crystalline, in the form of quartz or cristobalite.  Arsenic, metals, fibres, and 
dusts.  IARC monographs on the evaluation of carcinogenic risks to humans.  Vol. 100C.  A review of
human carcinogens.  Lyon, France: World Health Organization, International Agency for Research on 
Cancer.
*IARC.  2015. Agents classified by the IARC monographs.  Volumes 1–113.  Lyon, France:  World
Health Organization, International Agency for Research on Cancer.  
http://monographs.iarc.fr/ENG/Classification/List_of_Classifications_Vol1-113.pdf. July 29, 2015. 
*Ibrahim KS, Ahmed SB, Amer NM.  2011.  Study of kidney dysfunction in non-silicotic Egyptian
workers.  Int J Hyg Environ Health 214(1):53-58.  10.1016/j.ijheh.2010.08.012.
*ICRP.  1994. Annex D.  Deposition of inhaled particles, Annex E.  Clearance of particles from the
respiratory tract.  In:  Human respiratory tract model for radiological protection.  ICRP Publication 66.  
Tarrytown, NY:  International Commission on Radiological Protection.  Elsevier Science, Inc., 231-413.  
***DRAFT FOR PUBLIC COMMENT***











   























     
 
 
   









   
 





*Infante-Rivard C, Armstrong B, Petitclerc M, et al.  1989.  Lung cancer mortality and silicosis in 
Quebec, 1938-85.  Lancet 2(8678-8679):1504-1507.  (As cited in Erren et al. 2009a, 2009b; Kurihara and 
Wada 2004)
*Iocopini GA, Brantley SL, Heaney PJ.  2005.  Kinetics of silica oligomerization and nanocolloid 
formation as a function of pH and ionic strength at 25 degrees C.  Geochim Cosmochim Acta 69(2):293-
303. 
*IPCS.  2001. International Chemical Safety Cards (ICSC).  Diatomaceous earth (uncalcined).  ICSC:
0248. International Programme on Chemical Safety and the European Commission.  
http://www.ilo.org/dyn/icsc/showcard.display?p_lang=en&p_card_id=0248&p_version=1. April 20, 
2017. 
*IPCS.  2016a.  International Chemical Safety Cards (ICSC).  Cristobalite.  ICSC:  0809. International
Programme on Chemical Safety and the European Commission.
http://www.ilo.org/dyn/icsc/showcard.display?p_lang=en&p_card_id=0809&p_version=1. April 20, 
2017. 
*IPCS.  2016b. International Chemical Safety Cards (ICSC).  Quartz.  ICSC:  0808.  International
Programme on Chemical Safety and the European Commission.
http://www.ilo.org/dyn/icsc/showcard.display?p_lang=en&p_card_id=0808&p_version=1. April 20, 
2017. 
*IPCS.  2016c.  International Chemical Safety Cards (ICSC).  Tridymite.  ICSC:  0807. International
Programme on Chemical Safety and the European Commission.  
http://www.ilo.org/dyn/icsc/showcard.display?p_lang=en&p_card_id=0807&p_version=1. April 20, 
2017. 
*IRIS.  2015. Integrated Risk Information System.  Washington, DC:  U.S. Environmental Protection 
Agency.  http://cfpub.epa.gov/ncea/iris/index.cfm?fuseaction=iris.showSubstanceList.  August 4, 2015.  
*Jacobsen NR, Saber AT, White P, et al.  2007.  Increased mutant frequency by carbon black, but not
quartz, in the lacZ and cII transgenes of MutaTM mouse lung epithelial cells.  Environ Mol Mutagen
48(6):451-461.  10.1002/em.20300.
+*Jacqmin-Gadda H, Commenges D, Letenneur L, et al.  1996.  Silica and aluminum in drinking water
and cognitive impairment in the elderly.  Epidemiology 7(3):281-285.  
*Jensen M, Keding R, Hoche T, et al.  2009.  Biologically formed mesoporous amorphous silica.  J Am
Chem Soc 131(7):2717-2721.  10.1021/ja808847y.
*Jiang PR, Cao Z, Qiu ZL, et al.  2015.  Plasma levels of TNF-alpha and MMP-9 in patients with 
silicosis.  Eur Rev Med Pharmacol Sci 19:1716-1720.  
+*Johnston CJ, Driscoll KE, Finkelstein JN, et al.  2000.  Pulmonary chemokine and mutagenic responses
in rats after subchronic inhalation of amorphous and crystalline silica.  Toxicol Sci 56(2):405-413.  
*Jorna T, Borm PJA, Koiter KD, et al.  1994.  Respiratory effects and serum type III procollagen in 
potato sorters exposed to diatomaceous earth.  Int Arch Occup Environ Health 66(4):217-222.  
***DRAFT FOR PUBLIC COMMENT***













    
  
 


















     
 
 











    
   
 
    










*Joy GJ.  2012.  Evaluation of the approach to respirable quartz exposure control in U.S. coal mines.  J
Occup Environ Hyg 9(2):65-68.  10.1080/15459624.2011.639232.
*Kada T, Hirano K, Shirasu Y.  1980. Screening of environmental chemical mutagens by the Rec-assay
system with Bacillus subtilis. Chem Mutagens 6:149-173.  
*Kanematsu N, Hara M, Kada T.  1980.  Rec assay and mutagenicity studies on metal compounds.  Mutat
Res 77:109-116.  
*Katsnelson BA, Konysheva LK, Privalova LI, et al.  1992.  Development of a multicompartmental
model of the kinetics of quartz dust in the pulmonary region of the lung during chronic inhalation 
exposure of rats.  Br J Ind Med 49(3):172-181.  
*Kauppinen T, Heikkila P, Partanen T, et al. 2003. Mortality and cancer incidence of workers in Finnish 
road paving companies.  Am J Ind Med 43:49-57.  (As cited in Pelucci et al. 2006)
*Kearns GL, Abdel-Rahman SM, Alander SW, et al.  2003.  Developmental pharmacology--drug
disposition, action, and therapy in infants and children.  N Engl J Med 349(12):1157-1167.  
10.1056/NEJMra035092.
*Kelly DP, Lee KP.  1990.  Pulmonary response to Ludox colloidal silica inhalation exposure in rats.  
Toxicologist 90:202.  
*Keshava C, Keshava N, Zhou G, et al. 1999. Genomic instability in silica- and cadmium chloride-
transformed BALB/c-3T3 and tumor cell lines by random amplified polymorphic DNA analysis. Mutat
Res 425(1):117-123.  
*Klockars M, Koskela RS, Jarvinen E, et al.  1987.  Silica exposure and rheumatoid arthritis:  A follow
up study of granite workers 1940-81.  Br Med J 294(6578):997-1000.  
*Knaapen AM, Albrecht C, Becker A, et al. 2002. DNA damage in lung epithelial cells isolated from
rats exposed to quartz:  Role of surface reactivity and neutrophilic inflammation.  Carcinogenesis
23(7):1111-1120.  
*Komori M, Nishio K, Kitada M, et al.  1990.  Fetus-specific expression of a form of cytochrome P-450 
in human livers.  Biochemistry 29(18):4430-4433.  
*Koskela RS.  1995.  Association of silica dust exposure with lung cancer and other diseases.  Acta 
Universitatis Tamperensis, Ser A, Vol. 460.  Academic dissertation, University of Tampere, Finland.  (As
cited in Mannetje et al. 2002b)
*Koskela RS, Klockars M, Jarvinen E, et al.  1987a.  Cancer mortality of granite workers.  Scand J Work
Environ Health 13(1):26-31.  (As cited in Mannetje et al. 2002b)
*Koskela RS, Klockars M, Jarvinen E, et al.  1987b.  Mortality and disability among granite workers.  
Scand J Work Environ Health 13(1):18-25.  
*Koskela RS, Klockars M, Laurent H, et al.  1994.  Silica dust exposure and lung cancer.  Scand J Work
Environ Health 20(6):407-416.  
***DRAFT FOR PUBLIC COMMENT***






















   
 
 
      
 
 
   









    
  
 
   
  
 


















*Kramer MR, Blanc PD, Fireman E, et al.  2012.  Artificial stone silicosis:  Disease resurgence among
artificial stone workers.  Chest 142(2):419-424.  10.1378/chest.11-1321.
*Kreiss K, Zhen B.  1996.  Risk of silicosis in a Colorado mining community.  Am J Ind Med 30(5):529-
539. 
*Kreyling WG.  1990.  Interspecies comparison of lung clearance of "insoluble" particles. J Aerosol Med 
3(1):S-93 to S-110.  
*Kullman GJ, Greife AL, Costello J, et al.  1995.  Occupational exposures to fibers and quartz at 19 
crushed stone mining and milling operations.  Am J Ind Med 27(5):641-660.  
*Kurihara N, Wada O.  2004.  Silicosis and smoking strongly increase lung cancer risk in silica-exposed 
workers.  Ind Health 42(3):303-314.  
*Lacasse Y, Martin S, Gagne D, et al.  2009.  Dose-response meta-analysis of silica and lung cancer.
Cancer Causes Control 20(6):925-933.  10.1007/s10552-009-9296-0.
*Lacey JV, Laing TJ, Gillespie BW, et al.  1997.  Mr. Lacey, et al. reply.  [Reply to "Epidemiology of
scleroderma among women:  Assessment of risk from exposure to silicone and silica"]. J Rheumatol
24(9):1853-1855.  
*Lagorio S, Forastiere F, Michelozzi P, et al.  1990.  A case-referent study on lung cancer mortality
among ceramic workers.  IARC Sci Publ (97):21-28.  (As cited in Erren et al. 2009a, 2009b)
*Lane SE, Watts RA, Bentham G, et al.  2003.  Are environmental factors important in primary systemic
vasculitis?  Arthritis Rheum 48(3):8114-8823.  
*Lange BA, Haartz JC, Hornung RW.  1981. Determination of synthetic amorphous silica in industrial
air samples.  Anal Chem 53(9):1479-1484.  
*Large DJ, Kelly S, Spiro B, et al.  2009.  Silica-volatile interaction and the geological cause of the Xuan
Wei lung cancer epidemic.  Environ Sci Technol 43(23):9016-9021.  10.1021/es902033j.
*Lawson RJ, Schenker MB, McCurdy SA, et al.  1995.  Exposure to amorphous silica fibers and other
particulate matter during rice farming operations.  Appl Occup Environ Hyg 10(8):677-684.  
*Le Blond JS, Horwell CJ, Williamson BJ, et al.  2010.  Generation of crystalline silica from sugarcane 
burning.  J Environ Monit 12(7):1459-1470.  10.1039/c0em00020e.
*Lee K.  2009.  OSHA compliance issues benzene and crystalline silica exposures in a grey iron foundry.  
J Occup Environ Hyg 6(5):D15-D17.  10.1080/15459620902754380.
+*Lee KP, Kelly DP.  1992.  The pulmonary response and clearance of Ludox colloidal silica after a 4-
week inhalation exposure in rats.  Fundam Appl Toxicol 19(3):399-410.  
*Lee S, Hayashi H, Maeda M, et al.  2012.  Environmental factors producing autoimmune dysregulation--
chronic activation of T cells caused by silica exposure.  Immunobiology 217(7):743-748.  
10.1016/j.imbio.2011.12.009.
***DRAFT FOR PUBLIC COMMENT***







































   













   





*Lee S, Matsuzaki H, Kumagai-Takei N, et al.  2014.  Silica exposure and altered regulation of 
autoimmunity.  Environ Health Prev Med 19(5):322-329.  10.1007/s12199-014-0403-9.
*Lee T, Chisholm WP, Kashon M, et al.  2013.  Consideration of kaolinite interference correction for
quartz measurements in coal mine dust.  J Occup Environ Hyg 10(8):425-434.  
10.1080/15459624.2013.801819.
*Leeder JS, Kearns GL.  1997.  Pharmacogenetics in pediatrics:  Implications for practice.  Pediatr Clin 
North Am 44(1):55-77.  
*Legge RT, Rosencrantz E.  1932. Observations and studies on silicosis by diatomaceous silica.  Arch
Environ Health 1:125-128.  
*Leung H.  1993. Physiologically-based pharmacokinetic modelling.  In:  Ballantyne B, Marrs T, Turner
P, eds.  General and applied toxicology.  Vol. 1.  New York, NY:  Stockton Press, 153-164.  
*Leung CC, Yu IT, Chen W.  2012.  Silicosis.  Lancet 379(9830):2008-2018.  10.1016/s0140-
6736(12)60235-9.
+*Lewinson J, Mayr W, Wagner H.  1994. Characterization and toxicological behavior of synthetic
amorphous hydrophobic silica.  Regul Toxicol Pharmacol 20(1):37-57.  10.1006/rtph.1994.1035.
*Li H, Haberzettl P, Albrecht C, et al.  2007.  Inhibition of the mitochondrial respiratory chain function 
abrogates quartz induced DNA damage in lung epithelial cells.  Mutat Res 617(1-2):46-57.  
10.1016/j.mrfmmm.2006.12.001.
*Lickiss PD.  2006. Silicon:  Inorganic chemistry.  In:  Encyclopedia of inorganic chemistry.  John Wiley
& Sons, Ltd.  http://onlinelibrary.wiley.com/doi/10.1002/0470862106.ia219/abstract.  September 22, 
2015. 
*Linch KD, Miller WE, Althouse RB, et al.  1998.  Surveillance of respirable crystalline silica dust using
OSHA compliance data (1979-1995).  Am J Ind Med 34(6):547-558.  
*Lippmann M, Timbrell V.  1990. Particle loading in the human lung- human experience and 
implications for exposure limits. J Aerosol Med 3:155-168.  
*Liu H, Patel DJ, Welch AM, et al.  2016.  Association between occulpational exposures and sarcoidosis. 
Chest Surg Clin N Am 150(2):289-298.  
*Liu S, Liu N, Li J.  1996a.  Silicosis caused by rice husk ashes. J Occup Health 38(2):57-62.  
*Liu X, Keane MJ, Zhong BZ, et al.  1996b.  Micronucleus formation in V79 cells treated with respirable
silica dispersed in medium and in simulated pulmonary surfactant.  Mutat Res 2(3):89-94.  
*Liu Y, Rong Y, Steenland K, et al.  2014.  Long-term exposure to crystalline silica and risk of heart
disease mortality.  Epidemiology 25(5):689-696.  10.1097/ede.0000000000000143.  
*Liu Y, Steenland K, Rong Y, et al.  2013.  Exposure-response analysis and risk assessment for lung
cancer in relationship to silica exposure:  A 44-year cohort study of 34,018 workers.  Am J Epidemiol
178(9):1424-1433.  10.1093/aje/kwt139.
***DRAFT FOR PUBLIC COMMENT***














    
  
 




   















    
  
 
   
     
 
  
   
 
 














*Livingston AL.  1978.  Forage plant estrogens.  J Toxicol Environ Health 4(2-3):301-324.  
*Loosereewanich P, Ritchie AC, Armstrong B, et al.  1995. Pulmonary dust retention in silicotics with 
and without lung cancer.  Appl Occup Environ Hyg 10(12):1104-1106.
*Love RG, Waclawski ER, Maclaren WM, et al.  1999.  Risks of respiratory disease in the heavy clay
industry.  Occup Environ Med 56(2):124-133.  
*Maciejewska A.  2008.  Occupational exposure assessment for crystalline silica dust:  Approach in
Poland and worldwide.  Int J Occup Med Environ Health 21(1):1-23.  10.2478/v10001-008-0010-3.
*Madl AK, Donovan EP, Gaffney SH, et al.  2008.  State-of-the-science review of the occupational health
hazards of crystalline silica in abrasive blasting operations and related requirements for respiratory
protection. J Toxicol Environ Health B Crit Rev 11(7):548-608.  10.1080/10937400801909135.
*Maeda M, Nishimura Y, Kumagai N, et al.  2010.  Dysregulation of the immune system caused by silica 
and asbestos.  J Immunotoxicol 7(4):268-278.  10.3109/1547691x.2010.512579.
*Maitre A, Hours M, Bonneterre V, et al.  2004. Systemic sclerosis and occupational risk factors:  Role
of solvents and cleaning products.  J Rheumatol 31:2395-2401.  
*Makol A, Reilly MJ, Rosenman KD.  2011.  Prevalence of connective tissue disease in silicosis (1985-
2006)-a report from the state of Michigan surveillance system for silicosis.  Am J Ind Med 54(4):255-262.  
10.1002/ajim.20917.
*Malmberg P, Hedenstrom H, Sundblad BM.  1993.  Changes in lung function of granite crushers
exposed to moderately high silica concentrations:  A 12 year follow up.  Br J Ind Med 50(8):726-731.  
*Mamuya SH, Bratveit M, Mwaiselage J, et al.  2006. High exposure to respirable dust and quartz in a
labour-intensive coal mine in Tanzania.  Ann Occup Hyg 50(2):197-204.  10.1093/annhyg/mei052.
*Mancuso JD, McCoy J, Pelka B, et al. 2008.  The challenge of controlling lead and silica exposures
from firing ranges in a special operations force.  Mil Med 173(2):182-186.  
*Mannetje A, Steenland K, Attfield M, et al.  2002a.  Exposure-response analysis and risk assessment for
silica and silicosis mortality in a pooled analysis of six cohorts.  Occup Environ Med 59(11):723-728.  
*Mannetje A, Steenland K, Checkoway H, et al.  2002b.  Development of quantitative exposure data for a 
pooled exposure-response analysis of 10 silica cohorts.  Am J Ind Med 42(2):73-86.  10.1002/ajim.10097.
*Manson JJ, Rahman A.  2006. Systemic lupus erythematosus.  Orphanet J Rare Dis 10.1186/1750-1172-
1-6.
*Mao Y, Daniel LN, Whittaker N, et al.  1994.  DNA binding to crystalline silica characterized by
Fourier-transform infrared spectroscopy.  Environ Health Perspect 102(Suppl 10):165-171.  
*Marie I, Gehanno JF, Bubenheim M, et al.  2014.  Prospective study to evaluate the association between 
systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 13(2):151-
156. 10.1016/j.autrev.2013.10.002.
***DRAFT FOR PUBLIC COMMENT***












   
   
     
 
 
   
      
 










   
 
 
     
 
 
    
 
 
    
    
 




      
   
   
 









*Marinaccio A, Scarselli A, Gorini G, et al.  2006.  Retrospective mortality cohort study of Italian 
workers compensated for silicosis.  Occup Environ Med 63(11):762-765.  10.1136/oem.2006.027854.
*Martin JC, Imbernon E, Goldberg M, et al.  2000.  Occupational risk factors for lung cancer in the
French electricity and gas industry:  A case-control survey nested in a cohort of active employees.  Am J
Epidemiol 151(9):902-912.  (As cited in Kurihara and Wada 2004; Pelucci et al. 2006)
*Mastrangelo G, Zambon P, Simonato L, et al.  1988.  A case-referent study investigating the relationship 
between exposure to silica dust and lung cancer.  Int Arch Occup Environ Health 60(4):299-302.  (As
cited in Erren et al. 2009a, 2009b; Kurihara and Wada 2004; Lacrasse et al. 2005)
*Mauderly JL, Cheng YS, Snipes MB.  1990.  Particle overload in toxicology studies:  Friend or foe? J
Aerosol Med 3(Suppl 1):S169-S187.  
*Maxim DL, Venturin D, Allshouse JN.  1999.  Respirable crystalline silica exposure associated with the 
installation and removal of RCF and conventional silica-containing refractories in industrial furnaces. 
Regul Toxicol Pharmacol 29(1):44-63.  10.1006/rtph.1998.1268.
*Mayr U, Butsch A, Schneider S.  1992.  Validation of two in vitro test systems for estrogenic activities 
with zearalenone, phytoestrogens and cereal extracts.  Toxicology 74(2-3):135-149.  
*Mazurek JM, Attfield MD.  2008. Silicosis mortality among young adults in the United States, 1968-
2004. Am J Ind Med 51(8):568-578.  10.1002/ajim.20597.
*McClellan RO.  1990.  Particle overload in the lung: Approaches to improving our knowledge.  J
Aerosol Med 3:197-207.  
*McCormic ZD, Khuder SS, Aryal BK, et al.  2010. Occupational silica exposure as a risk factor for
scleroderma:  A meta-analysis.  Int Arch Occup Environ Health 83(7):763-769.  10.1007/s00420-009-
0505-7.
*McDonald AD, McDonald JC, Rando RJ, et al.  2001.  Cohort mortality study of North American 
industrial sand workers.  I.  Mortality from lung cancer, silicosis and other causes. Ann Occup Hyg
45(3):193-199.  (As cited in Kurihara and Wada 2004)
*McDonald JC, McDonald AD, Hughes JM, et al.  2005.  Mortality from lung and kidney disease in a
cohort of North American industrial sand workers:  An update.  Ann Occup Hyg 49(5):367-373.  
10.1093/annhyg/mei001. 
*McLaughlin JK, Chen JQ, Dosemeci M, et al.  1992. A nested case-control study of lung cancer among
silica exposed workers in China.  Br J Ind Med 49(3):167-171.  (As cited in Kurihara and Wada 2004;
Mannetje et al. 2002b)
*McLaughlin JK, Chow WH, Levy LS.  1997. Amorphous silica:  A review of health effects from
inhalation exposure with particular reference to cancer.  J Toxicol Environ Health 50(6):553-566.  
10.1080/15287399709532054.
*Meeker JD, Susi P, Pellegrino A.  2005. Exposure to silica and metals among painters using specular
hematite abrasive.  J Occup Environ Hyg 2(8):D60-D64.  
***DRAFT FOR PUBLIC COMMENT***













     
   
   
 
  
   





    
 
   
 
    





   




    
 
       
   
 

















*Mehlhorn J, Ziegler V, Keyn J, et al.  1990.  [Quartz crystals in the skin as cause of progressive systemic 
scleroderma].  Zeitschrift fuer die Gesamte Innere Medizin und Ihre Grenzgebiete 45(6):149-154.
*Mehlorn J, Enderlein G, Conrad K, et al.  1999.  [Analysis for the association between progressive
systemic scleroderma, exposure to quartz dust, and silicosis in East Germany uranium mining].  Zbl
Arbeitsmed 49:134-147.  (As cited in McCormic et al. 2010)
*Mehnert WH, Staneczek W, Mohner M, et al.  1990.  A mortality study of a cohort of slate quarry
workers in the German Democratic Republic.  IARC Sci Publ (97):55-64.  (As cited in Erren et al. 2009a, 
2009b; Kurihara and Wada 2004; Lacrasse et al. 2005)
*Meijer E, Kromhout H, Heederik D.  2001. Respiratory effects of exposure to low levels of concrete
dust containing crystalline silica.  Am J Ind Med 40(2):133-140.  
*Meijers JM, Swaen GM, Slangen JJ.  1996.  Mortality and lung cancer in ceramic workers in The
Netherlands:  Preliminary results.  Am J Ind Med 30(1):26-30.  (As cited in Erren et al. 2009a, 2009b;
Kurihara and Wada 2004)
*Menvielle G, Luce D, Fevotte J, et al.  2003.  Occupational exposures and lung cancer in New
Caledonia.  Occup Environ Med 60(8):584-589.  (As cited in Pelucci et al. 2006)
*Merget R, Bauer T, Kupper HU, et al.  2002.  Health hazards due to the inhalation of amorphous silica.  
Arch Toxicol 75(11-12):625-634.  
*Merlo DF, Garattini S, Gelatti U, et al.  2004. A mortality cohort study among workers in a graphite
electrode production plant in Italy.  Occup Environ Med 61(2):e9.  (As cited in Pelucci et al. 2006)
*Merlo F, Costantini M, Reggiardo G, et al.  1991.  Lung cancer risk among refractory brick workers
exposed to crystalline silica:  A retrospective cohort study.  Epidemiology 2(4):299-305.  (As cited in
Kurihara and Wada 2004)
*Miles WJ. 1999.  Issues and controversy: The measurement of crystalline silica; review papers on
analytical methods.  Am Ind Hyg Assoc J 60:396-402.  
*Miller AL, Drake PL, Murphy NC, et al.  2012. Evaluating portable infrared spectrometers for 
measuring the silica content of coal dust.  J Environ Monit 14(1):48-55.  10.1039/c1em10678c.  
*Millerick-May ML, Schrauben S, Reilly MJ, et al.  2015.  Silicosis and chronic renal disease.  Am J Ind 
Med 58:730-736.  10.1002/ajim.22465.  
*MMWR.  1989.  Exposure trends in silica flour plants--United States, 1975-1986.  MMWR Morb Mortal
Wkly Rep 38(21):380-383.  
*Mohner M, Kersten N, Gellissen J.  2013a.  Chronic obstructive pulmonary disease and longitudinal
changes in pulmonary function due to occupational exposure to respirable quartz.  Occup Environ Med 
70(1):9-14.  10.1136/oemed-2012-100775.
*Mohner M, Kersten N, Gellissen J.  2013b. Re:  Clinically significant lung function impairment due to 
current levels of respirable quartz? (authors' response).  Occup Environ Med 70(12):893-894.  
10.1136/oemed-2013-101808.
***DRAFT FOR PUBLIC COMMENT***













   
 
  
    
 
 
      
  
   
 
    
    




      
 
 
   
     
 
  
   










    
 
  
   
 
 










*Molocznik A.  2002. Qualitative and quantitative analysis of agricultural dust in working environment.  
Ann Agric Environ Med 9(1):71-78.  
*Moore M. 1999. Crystalline silica: Occurrence and use.  Indoor Built Environ 8:82-88.  
*Morfeld P, Taeger D, Mitura H, et al.  2014.  Cross-sectional study on respiratory morbidity in workers
after exposure to synthetic amorphous silica at five German production plants:  Exposure assessment and 
exposure estimates.  J Occup Environ Med 56(1):72-78.  10.1097/jom.0000000000000055.
*Morinaga K, Sakatani M, Yokoyama K, et al.  1991.  Silicosis and lung cancer - A retrospective cohort
study of compensated patients with silicosis in Osaka.  Jpn J of Traumatol Occup Med39(3):192-197.  
(As cited in Lacrasse et al. 2005)
*Morita T, Asano N, Awogi T, et al.  1997.  Evaluation of the rodent micronucleus assay in the screening
of IARC carcinogens (groups 1, 2A and 2B) the summary report of the 6th collaborative study by 
CSGMT/JEMS MMS.  Collaborative study of the micronucleus group test. Mammalian Mutagenicity
Study Group [published erratum appears in Mutat Res 1997 Jul 14;391(3):259-67].  Mutat Res 389(1):3-
122. 
*Morrow PE.  1992.  Dust overloading of the lungs: Update and appraisal.  Toxicol Appl Pharmacol
113:1-12.  
*Morselli PL, Franco-Morselli R, Bossi L. 1980. Clinical pharmacokinetics in newborns and infants:
Age-related differences and therapeutic implications. Clin Pharmacokinet 5(6):485-527.  
*Moshammer H, Neuberger M.  2004.  Lung cancer and dust exposure:  Results of a prospective cohort
study following 3260 workers for 50 years.  Occup Environ Med 61(2):157-162.  (As cited in Pelucci et
al. 2006)
*Mossman BT, Churg A.  1998.  Mechanisms in the pathogenesis of asbestosis and silicosis.  Am J
Respir Crit Care Med 157(5 Pt 1):1666-1680.  10.1164/ajrccm.157.5.9707141.
*Mossman BT, Glenn RE.  2013. Bioreactivity of the crystalline silica polymorphs, quartz and 
cristobalite, and implications for occupational exposure limits (OELs).  Crit Rev Toxicol 43(8):632-660.  
10.3109/10408444.2013.818617.
*Moulin JJ, Clavel T, Roy D, et al.  2000.  Risk of lung cancer in workers producing stainless steel and 
metallic alloys.  Int Arch Occup Environ Health 73(3):171-180.  (As cited in Pelucci et al. 2006)
*MPCA.  2015a.  Shakopee Sand (previously Great Plains Sand) ambient air monitoring Jordan, 
Minnesota July 2012–June 2015.  Saint Paul, MN:  Minnesota Pollution Control Agency.  g-70-03.  
https://www.pca.state.mn.us/sites/default/files/g-70-03.pdf. January 18, 2017. 
*MPCA.  2015b. Titan Lansing Transload ambient air monitoring data report North Branch, Minnesota
November 2012–September 2015.  Saint Paul, MN: Minnesota Pollution Control Agency.  g-13-03.  
https://www.pca.state.mn.us/sites/default/files/g-13-03.pdf. January 17, 2017. 
*MPCA.  2015c.  Winona - Community ambient air monitoring Winona, Minnesota January 2014– 
December 2014.  Saint Paul, MN:  Minnesota Pollution Control Agency.  g-85-03.  
https://www.pca.state.mn.us/sites/default/files/g-85-03.pdf. January 17, 2017.
***DRAFT FOR PUBLIC COMMENT***























   
 




    
   
 
   
 
 
   
   
 
 
   
 
 
    















*MSHA.  2013. Infrared determination of quartz in respirable coal mine dust.  Method No.:  P-7.  Mine
Safety and Health Administration, Department of Labor.  
http://www.msha.gov/Techsupp/pshtcweb/MSHA%20P7.pdf. September 25, 2015.
*Msiska Z, Pacurari M, Mishra A, et al.  2010.  DNA double-strand breaks by asbestos, silica, and
titanium dioxide:  Possible biomarker of carcinogenic potential?  Am J Respir Cell Mol Biol 43(2):210-
219. 10.1165/rcmb.2009-0062OC.
*Muir DC, Julian JA, Shannon HS, et al. 1989b.  Silica exposure and silicosis among Ontario hardrock
miners:  III.  Analysis and risk estimates.  Am J Ind Med 16(1):29-43.  
*Muir DC, Shannon HS, Julian JA, et al.  1989a.  Silica exposure and silicosis among Ontario hardrock
miners:  I.  Methodology.  Am J Ind Med 16(1):5-11.  
*Mukhopadhyay K, Ramalingam A, Ramani R, et al.  2011.  Exposure to respirable particulates and silica
in and around the stone crushing units in central India.  Ind Health 49(2):221-227.  
*Mundt KA, Birk T, Parsons W, et al.  2011.  Respirable crystalline silica exposure-response evaluation 
of silicosis morbidity and lung cancer mortality in the German porcelain industry cohort.  J Occup 
Environ Med 53(3):282-289.  10.1097/JOM.0b013e31820c2bff.
*Murashov V, Harper M, Demchuk E.  2006. Impact of silanol surface density on the toxicity of silica
aerosols measured by erythrocyte haemolysis. J Occup Environ Hyg 3(12):718-723.
*Nagalakshmi R, Nath J, Ong T, et al. 1995. Silica-induced micronuclei and chromosomal aberrations in
Chinese hamster lung (V79) and human lung (Hel 299) cells.  Mutat Res 335(1):27-33.  
*Naghizadeh A, Mahvi AH, Jabbari H, et al.  2011. Exposure assessment to dust and free silica for
workers of Sangan iron ore mine in Khaf, Iran.  Bull Environ Contam Toxicol 87(5):531-538.  
10.1007/s00128-011-0375-z.
*NAS/NRC.  1989. Report of the oversight committee.  Biologic markers in reproductive toxicology.  
Washington, DC: 15-35.  
*Neuberger M, Kundi M, Westphal G, et al.  1986.  The Viennese dusty worker study.  In:  Silica, 
silicosis, and cancer:  Controversy in occupational medicine. Vol. 2.  415-422.  (As cited in Erren et al.
2009a, 2009b)
*Ng T, Chan S.  1994.  Quantitative relations between silica exposure and development of radiological
small opacities in granite workers.  Ann Occup Hyg 38:857-863.  
*Ng TP, Chan SL, Lee J.  1990.  Mortality of a cohort of men in a silicosis register:  Further evidence of
an association with lung cancer.  Am J Ind Med 17(2):163-171.  
*Ng TP, Lee HS, Phoon WH.  1993. Further evidence of human silica nephrotoxicity in occupationally
exposed workers.  Br J Ind Med 50(10):907-912.  
*Ng TP, Ng YL, Lee HS, et al.  1992.  A study of silica nephrotoxicity in exposed silicotic and non-
silicotic workers.  Br J Ind Med 49(1):35-37.  
***DRAFT FOR PUBLIC COMMENT***














    
 
 




















   
 
 




    
 
 









*Nieuwenhuijsen MJ, Noderer KS, Schenker MB, et al.  1999.  Personal exposure to dust, endotoxin and 
crystalline silica in California agriculture.  Ann Occup Hyg 43(1):35-42.  
*Ning RY.  2002. Discussion of silica speciation, fouling, control and maximum reduction.  Desalination 
151:67-73.  
*NIOSH.  1981.  Silica flour:  Silicosis (crystalline silica).  National Institute for Occupational Safety and
Health, 81-137.  http://www.cdc.gov/niosh/docs/81-137/.  September 23, 2015.
*NIOSH.  1986a.  Acute silicosis.  In:  Occupational respiratory diseases.  National Institute for
Occupational Safety and Health, U.S. Department of Health and Human Services, 239-241.  
PB87205662.  
*NIOSH.  1986b. Silicosis.  In:  Occupational respiratory diseases.  National Institute for Occupational
Safety and Health, U.S. Department of Health and Human Services, 219-237.  PB87205662.  
*NIOSH.  2002. NIOSH hazard review.  Health effects of occupational exposure to respirable crystalline 
silica.  Department of Health and Human Services, Centers for Disease Control and Prevention, National
Institute for Occupational Safety and Health.  DHHS (NIOSH) publication number 2002-129.  
http://www.cdc.gov/niosh/docs/2002-129/pdfs/2002-129.pdf. October 6, 2015.
*NIOSH.  2003a.  Silica, crystalline, by XRD (filter redeposition).  Method 7500, Issue 4.  NIOSH
Manual of Analytical Methods (NMAM), fourth edition.  National Institute for Occupational Safety and 
Health.  http://www.cdc.gov/niosh/docs/2003-154/pdfs/7500.pdf.  October 6, 2015.
*NIOSH.  2003b. Silica, crystalline, by VIS  Method 7601, issue 3.  NIOSH Manual of Analytical
Methods (NMAM), fourth edition.  National Institute for Occupational Safety and Health.  
http://www.cdc.gov/niosh/docs/2003-154/pdfs/7601.pdf. October 6, 2015.
*NIOSH.  2003c.  Silica, amorphous.  Method 7501, Issue 3.  NIOSH Manual of Analytical Methods
(NMAM).  National Institute for Occupational Safety and Health, U.S. Department of Health and Human 
Services.  http://www.cdc.gov/niosh/docs/2003-154/pdfs/7501.pdf. October 6, 2015.
*NIOSH.  2003d. Silica, crystalline by IR (KBr pellet).  Method 7602.  NIOSH Manual of Analytical
Methods (NMAM), fourth edition.  National Institute for Occupational Safety and Health.  
http://www.cdc.gov/niosh/docs/2003-154/pdfs/7602.pdf. October 6, 2015.
*NIOSH.  2003e.  Quartz in coal mine dust, by IR (redeposition).  Method 7603.  NIOSH Manual of
Analytical Methods (NMAM), fourth edition.  National Institute for Occupational Safety and Health.  
http://www.cdc.gov/niosh/docs/2003-154/pdfs/7603.pdf. October 6, 2015.
*NIOSH.  2003f.  Determination of airborne crystalline silica.  NIOSH Manual of Analytical Methods
(NMAM).  National Institute for Occupational Safety and Health.  http://www.cdc.gov/niosh/docs/2003-
154/pdfs/chapter-r.pdf.  October 6, 2015.  
*NIOSH.  2011. 1988 OSHA PEL project documentation.  Silica, crystal.  National Institute for
Occupational Safety and Health, U.S. Department of Health and Human Services.  
http://www.cdc.gov/niosh/pel88/1317-95.html. August 06, 2015.  
***DRAFT FOR PUBLIC COMMENT***


















    
   
 


















      
 
    
  
 
   
  
     
 
     










*NIOSH.  2015a.  Silica, amorphous.  NIOSH pocket guide to chemical hazards.  Atlanta, GA:  National
Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.  
http://www.cdc.gov/niosh/npg/npgd0552.html. July 30, 2015.  
*NIOSH.  2015b. Silica, crystalline (as respirable dust).  NIOSH pocket guide to chemical hazards. 
Atlanta, GA:  National Institute for Occupational Safety and Health, Centers for Disease Control and
Prevention.  http://www.cdc.gov/niosh/npg/npgd0684.html. July 30, 2015.  
*Norboo T, Angchuk PT, Yahya M, et al.  1991a.  Correction:  Silicosis in a Himalayan village
population:  Role of environmental dust.  (Thorax 46:341-343).  Thorax 46:544.  
*Norboo T, Angchuk PT, Yahya M, et al.  1991b.  Silicosis in a Himalayan village population:  Role of
environmental dust.  Thorax 46:341-343.  
*NRC.  1993. Pesticides in the diets of infants and children.  Washington, DC:  National Research 
Council.  National Academy Press.  
*NTP.  2009.  Chemical information review document for silica flour (micronized α-quartz).  Research 
Triangle Park, NC:  National Toxicology Program, U.S. Department of Health and Human Services.
https://ntp.niehs.nih.gov/ntp/noms/support_docs/silica%20flour_oct2009.pdf. October 6, 2015.
*NTP.  2014.  Silica, crystalline (respirable size).  Report on carcinogens.  Thirteenth edition.  Research 
Triangle Park, NC:  National Toxicology Program.  U.S. Department of Health and Human Services, 
Public Health Service.  http://ntp.niehs.nih.gov/ntp/roc/content/profiles/silica.pdf. July 30, 2015.
*Nuyts GD, Van Vlem E, De Vos A, et al. 1995. Wegener granulomatosis is associated to exposure to 
silicon compounds:  A case-control study.  Nephrol Dial Transplant 10(7):1162-1165.  
*Ogawa S, Imai H, Ikeda M.  2003.  Mortality due to silico-tuberculosis and lung cancer among 200 
whetstone cutters.  Ind Health 41(3):231-235.  (As cited in Pelucci et al. 2006)
*Ojima J.  2003.  Determining of crystalline silica in respirable dust samples by infrared
spectrophotometry in the presence of interferences.  J Occup Health 45(2):94-103.  
*Oksa P, Pukkala E, Karjalainen A, et al. 1997. Cancer incidence and mortality among Finnish asbestos
sprayers and in asbestosis and silicosis patients.  Am J Ind Med 31(6):693-698.  (As cited in Erren et al. 
2009a, 2009b; Kurihara and Wada 2004; Lacrasse et al. 2005)
+*Oner G, Cirrik S, Bakan O.  2005. Effects of silica on mitochondrial functions of the proximal tubule
cells in rats. Kidney Blood Press Res 28(4):203-210.  10.1159/000086006.
+*Oner G, Cirrik S, Bulbul M, et al.  2006.  Dietary silica modifies the characteristics of endothelial
dilation in rat aorta.  Endothelium 13(1):17-23.  10.1080/10623320600660045.
*OSHA.  1996. Quartz and cristobalite in workplace atmospheres.  Method number:  ID-142.  
Occupational Safety and Health Administration.  
https://www.osha.gov/dts/sltc/methods/inorganic/id142/id142.pdf. September 23, 2016.
*OSHA.  1997. Occupational exposure to methylene chloride.  29 CFR Parts 1910, 1915 and 1926.  
Occupational Safety and Health Administration.  Fed Regist 62(7):1494-1619.  
***DRAFT FOR PUBLIC COMMENT***



















     
   
 
 




      



















   
 
     
   
 
 





chloride.  June 28, 2016.
*OSHA.  2009. Controlling silica exposures in construction.  Occupational Safety and Health Standards.  
https://www.osha.gov/Publications/3362silica-exposures.pdf. October 24, 2016.
*OSHA.  2013a.  Subpart Z - Toxic and hazardous substances.  Air contaminants.  Occupational Safety
and Health Standards.  Code of Federal Regulations 29 CFR 1910.1000. 
http://www.gpo.gov/fdsys/pkg/CFR-2014-title29-vol6/pdf/CFR-2014-title29-vol6-sec1910-1000.pdf. 
March 4, 2015.  
OSHA.  2013b. Subpart Z - Toxic and hazardous substances.  Air contaminants. Table Z - Shipyards.  
Occupational Safety and Health Standards.  Code of Federal Regulations 29 CFR 1915.1000.
http://www.gpo.gov/fdsys/pkg/CFR-2013-title29-vol7/pdf/CFR-2013-title29-vol7-sec1915-1000.pdf. 
March 4, 2015.  
*OSHA.  2013c.  Occupational exposure to respirable crystalline silica.  Occupational Safety and Health
Administration.  78(177):56274-56504.  http://www.gpo.gov/fdsys/pkg/FR-2013-09-12/pdf/2013-
20997.pdf.  October 6, 2015.
*OSHA.  2014. Appendix A to Part 1926.55-1970 American Conference of Governmental Industrial
Hygienists’ threshold limit values of airborne contaminants.  Threshold limit values of airborne
contaminants for construction.  Occupational Safety and Health Standards.  Code of Federal Regulations
29 CFR 1926.55.  http://www.gpo.gov/fdsys/pkg/CFR-2014-title29-vol8/pdf/CFR-2014-title29-vol8-
sec1926-55.pdf.  March 4, 2015.  
*OSHA.  2015. Gravimetric determination.  Method No.  PV2121.  Occupational Safety and Health 
Standards.  https://www.osha.gov/dts/sltc/methods/partial/pv2121/pv2121.html. September 13, 2016. 
*OSHA.  2016. Occupational exposure to respirable crystalline silica; final rule.  Occupational Safety
and Health Standards.  Fed Regist 81(58):16285-16890.  https://www.gpo.gov/fdsys/pkg/FR-2016-03-
25/pdf/2016-04800.pdf.  October 24, 2016.
*Oshimura M, Hesterberg TW, Tsutsui T, et al.  1984.  Correlation of asbestos-induced cytogenetic 
effects with cell transformation of Syrian hamster embryo cells in culture.  Cancer Res 44(11):5017-5022.  
*Otsuki T, Maeda M, Murakami S, et al.  2007.  Immunological effects of silica and asbestos.  Cell Mol
Immunol 4(4):261-268.  
*Owen GM, Brozek J.  1966.  Influence of age, sex and nutrition on body composition during childhood 
and adolescence.  In:  Falkner F, ed.  Human development.  Philadelphia, PA:  WB Saunders, 222-238.  
*Page-Shipp RJ, Harris E.  1972. A study of the dust exposure of South African white gold miners.  J
South Afri Instit Mining Metal August:10-22.  (As cited in Mannetje et al. 2002b)
*Pairon JC, Jaurand MC, Kheuang L, et al.  1990. Sister chromatid exchanges in human lymphocytes
treated with silica.  Br J Ind Med 47(2):110-115.  
*Park R, Rice F, Stayner L, et al.  2002.  Exposure to crystalline silica, silicosis, and lung disease other
than cancer in diatomaceous earth industry workers:  A quantitative risk assessment.  Occup Environ Med
59(1):36-43.  
***DRAFT FOR PUBLIC COMMENT***














    
   
   
 
   
   
 








   
 
 
   
     









   
 
 















*Parks CG, Conrad K, Cooper GS.  1999.  Occupational exposure to crystalline silica and autoimmune
disease.  Environ Health Perspect 107(5):793-802.  
*Partanen T, Pukkala E, Vainio H, et al.  1994. Increased incidence of lung and skin cancer in Finnish 
silicotic patients.  J Occup Med 36(6):616-622. (As cited in Erren et al. 2009a, 2009b; Lacrasse et al. 
2005)
*Pelucchi C, Pira E, Piolatto G, et al.  2006.  Occupational silica exposure and lung cancer risk:  A review
of epidemiological studies 1996-2005. Ann Oncol 17(7):1039-1050.  10.1093/annonc/mdj125.
*Piacitelli GM, Amandus HE, Diefenbach A.  1990. Respirable dust exposures in USA surface coal
mines (1982-1986).  Arch Environ Health 45(4):202-209.  
*Plunkett ER, Dewitt BJ.  1962.  Occupational exposure to Hi-Sil and Silene.  Report of an 18-year study.  
Arch Environ Health 5:469-472.  
*Pratt PC.  1983.  Lung dust content and response in guinea pigs inhaling three forms of silica.  Arch 
Environ Health 38(4):197-204.  
*Price-Jones MJ, Gubbings G, Chamberlain M.  1980.  The genetic effects of crocidolite asbestos:
Comparison of chromosome abnormalities and sister-chromatid exchanges.  Mutat Res 79(4):331-336.  
*Pukkala E, Guo J, Kyyronen P, et al.  2005.  National job-exposure matrix in analyses of census-based
estimates of occupational cancer risk.  Scand J Work Environ Health 31:97-107.  (As cited in Lacasse et
al. 2009; Pelucci et al. 2006)
*Qaseem A, Wilt TJ, Weinberger SE, et al.  2011.  Diagnosis and management of stable chronic 
obstructive pulmonary disease:  A clinical practice guideline update from the American College of
Physicians, American College of Chest Physicians, American Thoracic Society, and European
Respiratory Society.  Ann Intern Med 155(3):179-191.  10.7326/0003-4819-155-3-201108020-00008.  
*Rabovsky J.  1995.  Biogenic amorphous silica.  Scand J Work Environ Health 21(2):108-110.  
*Radnoff D, Todor MS, Beach J.  2014. Occupational exposure to crystalline silica at Alberta work sites.  
J Occup Environ Hyg 11(9):557-570.  10.1080/15459624.2014.887205.
*Radovanovic Z, Markovic-Denic L, Marinkovic J, et al.  1991.  Well water characteristics and the
Balkan nephropathy.  Nephron 57(1):52-54.  
*Rafnsson V, Gunnarsdottir H.  1997. Lung cancer incidence among an Icelandic cohort exposed to 
diatomaceous earth and cristobalite.  Scand J Work Environ Health 23(3):187-192.  (As cited in Kurihara
and Wada 2004; Pelucci et al. 2006)
*Rafnsson V, Ingimarsson O, Hjalmarsson I, et al.  1998.  Association between exposure to crystalline
silica and risk of sarcoidosis.  Occup Environ Med 55(10):657-660.  
*Ranavaya MI, Reger RB, Battigelli MC.  1992. Non-occupational pneumoconiosis at high altitude
villages in central Ladakh.  Br J Ind Med 49(6):452-453.  
***DRAFT FOR PUBLIC COMMENT***















   
       
 
 
     
 
 




   
  
 
     
   
 
      


















    
  






*Rapiti E, Sperati A, Miceli M, et al.  1999.  End stage renal disease among ceramic workers exposed to
silica.  Occup Environ Med 56(8):559-561.  
*Rappaport SM, Goldberg M, Susi P, et al.  2003.  Excessive exposure to silica in the US construction 
industry.  Ann Occup Hyg 47(2):111-122.  
*Rasch EK, Hirsch R, Paulose-Ram R, et al.  2003.  Prevalence of rheumatoid arthritis in persons
60 years of age and older in the United States.  Effects of different methods of case classification.
Arthritis Rheum 48(4):917-926.  
*Rees D, Murray J.  2007. Silica, silicosis and tuberculosis.  Int J Tuberc Lung Dis 11(5):474-484.  
*Reid PJ, Sluis-Cremer GK.  1996. Mortality of white South African gold miners.  Occup Environ Med 
53(1):11-16.  (As cited in Mannetje et al. 2002b)
*RePORTER.  2015.  Silica.  National Institutes of Health, Research Portfolio Online Reporting Tools.  
http://projectreporter.nih.gov/reporter.cfm. September 18, 2015.  
+*Reuzel PG, Bruijntjes JP, Feron VJ, et al.  1991.  Subchronic inhalation toxicity of amorphous silicas
and quartz dust in rats.  Food Chem Toxicol 29(5):341-354.  
*Richards J, Brozell T.  2015.  Assessment of community exposure to ambient respirable crystalline silica
near frac sand processing facilities. Atmosphere 6(8):960.   
*Richards JR, Brozell TT, Rea C, et al.  2009. PM4 crystalline silica emission factors and ambient
concentrations at aggregate-producing sources in California.  J Air Waste Manage Assoc 59:1287-1295.  
*Rihova Z, Maixnerova D, Jancova E, et al.  2005.  Silica and asbestos exposure in ANCA-associated
vasculitis with pulmonary involvement.  Ren Fail 27(5):605-608.  
*Rimal B, Greenberg AK, Rom WN.  2005. Basic pathogenetic mechanisms in silicosis:  Current
understanding.  Curr Opin Pulm Med 11(2):169-173.  
*Rimola A, Costa D, Sodupe M, et al.  2013.  Silica surface features and their role in the adsorption of
biomolecules:  Computational modeling and experiments.  Chem Rev 113(6):4216-4313.  
10.1021/cr3003054.  http://dx.doi.org/10.1021/cr3003054. 
*Rocha-Parise M, Santos LM, Damoiseaux JG, et al.  2014. Lymphocyte activation in silica-exposed 
workers.  Int J Hyg Environ Health 217(4-5):586-591.  10.1016/j.ijheh.2013.11.002.  
*Rodnan GP, Benedek TG, Medsger TA, Jr., et al.  1967.  The association of progressive systemic 
sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis.  Ann Intern Med 
66(2):323-334.  
*Rodriguez V, Tardon A, Kogevinas M, et al.  2000. Lung cancer risk in iron and steel foundry workers:
A nested case-control study in Asturias, Spain.  Am J Ind Med 38(6):644-650.  (As cited in Pelucci et al. 
2006)
*Rosenman KD, Zhu Z.  1995. Pneumoconiosis and associated medical conditions.  Am J Ind Med 
27(1):107-113.  
***DRAFT FOR PUBLIC COMMENT***





















     
   












     
 
 





    






    
 









*Rosenman KD, Moore-Fuller M, Reilly MJ.  1999. Connective tissue disease and silicosis.  Am J Ind
Med 35(4):375-381.  
*Rosenman KD, Moore-Fuller M, Reilly MJ.  2000. Kidney disease and silicosis.  Nephron 85(1):14-19.  
*Rosenman KD, Reilly MJ, Henneberger PK.  2003.  Estimating the total number of newly-recognized 
silicosis cases in the United States.  Am J Ind Med 44(2):141-147.  10.1002/ajim.10243.
*Rothschild H, Mulvey JJ. 1982. An increased risk for lung cancer mortality associated with sugarcane
farming.  J Natl Cancer Inst 68:755-750.  
*Saffiotti U, Daniel LH, Mao Y, et al. 1993. Biological studies on the carcinogenic effects of quartz.  In:
Reviews in Mineralogy.  Health effects of mineral dusts.  Proceedings of a short course endorsed by the 
American College of Chest Physicians and the U.S. Geological Survey.  Vol. 28. Washington, DC:
Mineralogical Society of America, 523-544. 
*Sakai-Kato K, Hidaka M, Un K, et al.  2014.  Physicochemical properties and in vitro intestinal 
permeability properties and intestinal cell toxicity of silica particles, performed in simulated 
gastrointestinal fluids.  Biochim Biophys Acta 1840(3):1171-1180.  10.1016/j.bbagen.2013.12.014.
*Saldanha LF, Rosen VJ, Gonnick HC.  1975. Silicon nephropathy.  Am J Med 59:95-103.  
*Sanderson WT, Steenland K, Deddens JA.  2000.  Historical respirable quartz exposures of industrial
sand workers: 1946-1996.  Am J Ind Med 38(4):389-398.  
*Saunders NR, Ek CJ, Habgood MD, et al.  2008.  Barriers in the brain:  A renaissance? Trends Neurosci
31(6):279-286.  10.1016/j.tins.2008.03.003.
*Saunders NR, Liddelow SA, Dziegielewska KM.  2012.  Barrier mechanisms in the developing brain.  
Front Pharmacol 3:Article 46.  10.3389/fphar.2012.00046. 
*Sauni R, Oksa P, Lehtimaki L, et al.  2012.  Increased alveolar nitric oxide and systemic inflammation
markers in silica-exposed workers.  Occup Environ Med 69(4):256-260.  10.1136/oemed-2011-100347.  
*Scarselli A, Corfiati M, Marzio DD, et al.  2014.  Evaluation of workplace exposure to respirable
crystalline silica in Italy. Int J Occup Environ Health 20(4):301-307.  
10.1179/2049396714y.0000000078.
+*Schepers GWH.  1981.  Biological action of precipitation-process submicron α-silica (HI-SIL 233).  In:
Dunnom DD, ed.  Health effects of synthetic silica particulates:  A symposium sponsored by ASTM
Committee E-34 on occupational health and safety and the Industrial Health Foundation.  ASTM special
technical publication 732. Philadelphia, PA:  American Society for Testing and Materials, 144-171. 
*Scheuplein R, Charnley G, Dourson M.  2002.  Differential sensitivity of children and adults to chemical
toxicity.  I.  Biological basis.  Regul Toxicol Pharmacol 35(3):429-447.  
*Schiller A, Gusbeth-Tatomir P, Pavlovic N, et al.  2008.  Balkan endemic nephropathy:  A still unsolved 
puzzle.  J Nephrol 21:673-680.  
*Schins RP.  2002.  Mechanisms of genotoxicity of particles and fibers.  Inhal Toxicol 14(1):57-78.  
10.1080/089583701753338631.
***DRAFT FOR PUBLIC COMMENT***














   
 
   
     
 
    
    
 




   
   
 
  








      





















*Schins RPF, Duffin R, Hohr D, et al.  2002a.  Surface modification of quartz inhibits toxicity, particle
uptake, and oxidative DNA damage in human lung epithelial cells.  Chem Res Toxicol 15(9):1166-1173.  
*Schins RPF, Knaapen AM, Cakmak GD, et al.  2002b.  Oxidant-induced DNA damage by quartz in 
alveolar epithelial cells. Mutat Res 517(1-2):77-86.  
*Schuler G, Ruttner JR.  1986.  Silicosis and lung cancer in Switzerland.  In:  Silica, silicosis, and cancer:
Controversy in occupational medicine.  Vol. 2.  357-366. (As cited in Erren et al. 2009a, 2009b)
*Seiler F, Rehn B, Rehn S, et al. 2001a.  Evidence of a no-effect level in silica-induced rat lung
mutagenicity but not in fibrogenicity. Arch Toxicol 74(11):716-719.  
*Seiler F, Rehn B, Rehn S, et al.  2001b.  Quartz exposure of the rat lung leads to a linear dose response
in inflammation but not in oxidative DNA damage and mutagenicity.  Am J Respir Cell Mol Biol 
24(4):492-498.  10.1165/ajrcmb.24.4.4181.
*Seiler F, Rehn B, Rehn S, et al.  2001c.  Significant differences in the cellular and molecular reactions of
rat and hamster lung after quartz exposure.  Toxicol Lett 119(1):11-19.  
*Seixas NS, Heyer NJ, Welp EAE, et al.  1997.  Quantification of historical dust exposures in the
diatomaceous earth industry.  Ann Occup Hyg 41(5):591-604.  (As cited in Mannetje et al. 2002b)
*Sellamuthu R, Umbright C, Roberts JR, et al.  2011.  Blood gene expression profiling detects silica
exposure and toxicity.  Toxicol Sci 122(2):253-264.  10.1093/toxsci/kfr125.  
*Semple S, Green DA, McAlpine G, et al. 2008. Exposure to particulate matter on an Indian stone-
crushing site.  Occup Environ Med 65(5):300-305.  10.1136/oem.2007.032805.
*Sferratore A, Garnier J, Billen G, et al.  2006. Diffuse and point sources of silica in the Seine River
watershed.  Environ Sci Technol 40(21):6630-6635.  
*Sheffield GS.  1994.  Quantitative measurement of crystalline silica by thermal analysis.  Anal Chim
Acta 286(1):125-128.  
*Sherson D, Svane O, Lynge E.  1991. Cancer incidence among foundry workers in Denmark.  Arch 
Environ Health 46(2):75-81.  10.1080/00039896.1991.9937432.  (As cited in Erren et al. 2009a, 2009b;
Kurihara and Wada 2004)
*Shi X, Ding M, Chen F, et al.  2001.  Reactive oxygen species and molecular mechanism of silica-
induced lung injury.  J Environ Pathol Toxicol Oncol 20 (Suppl 1):85-93.  
*Shi X, Mao Y, Daniel LN, et al.  1994.  Silica radical-induced DNA damage and lipid peroxidation.  
Environ Health Perspect 102(10):149-154.  
*Shih TS, Lu PY, Chen CH, et al.  2008.  Exposure profiles and source identifications for workers
exposed to crystalline silica during a municipal waste incinerator relining period.  J Hazard Mater 154(1-
3):469-475.  10.1016/j.jhazmat.2007.10.047.
***DRAFT FOR PUBLIC COMMENT***











   
   
 
  
   
 
   
   
 
 
   
 
 




   
 







   
 
 
       
  
 
   
   
 
   
 
 
    
 
 








*Shima S, Arakawa T, Kato Y, et al.  1991.  Epidemiological studies on the risk of pulmonary
tuberculosis or lung cancer in ceramic workers with pneumoconiosis.  J Science of Labour 67:565-573.  
(As cited in Lacrasse et al. 2005)
*Shinohara Y.  1993. Application of the microwave acid digestion technique to the pyrophosphoric acid 
method for quantitative analysis of free silica in dust.  Ind Health 31(3):91-100.  
*Shiraki R, Holmen BA.  2002. Airborne respirable silica near a sand and gravel facility in central
California: XRD and elemental analysis to distinguish source and background quartz.  Environ Sci
Technol 36(23):4956-4961.  
*Silman AJ, Jones S.  1992.  What is the contribution of occupational environmental factors to the
occurrence of scleroderma in men?  Ann Rheum Dis 51(12):1322-1324.  
*Singh SV, Das B, Khan MF, et al.  1984.  The binding of silica to proteins from plasma and lungs of rat:
In vitro. Chem Biol Interact 49(1-2):155-164.  
*Sinks T, Goodman MT, Kolonel LN, et al.  1994.  A case-control study of mesothelioma and 
employment in the Hawaii sugarcane industry.  Epidemiology 5:466-468. 
*Sirianni G, Hosgood HD, 3rd, Slade MD, et al.  2008.  Particle size distribution and particle size-related
crystalline silica content in granite quarry dust.  J Occup Environ Hyg 5(5):279-285.  
10.1080/15459620801947259.
*Slavov E, Miteva L, Prakova G, et al.  2010.  Correlation between TNF-alpha and IL-12p40-containing
cytokines in silicosis.  Toxicol Ind Health 26(8):479-486.  10.1177/0748233710373082.  
*Sluis-Cremer GK, Hessel PA, Hnizdo E, et al.  1986.  Relationship between silicosis and rheumatoid 
arthritis.  Thorax 41(8):596-601.  
*Sluis-Cremer GK, Hessel PA, Hnizdo E, et al. 1985.  Silica, silicosis, and progressive systemic 
sclerosis.  Br J Ind Med 42(12):838-843.  
*Smailyte G, Kurtinaitis J, Andersen A.  2004.  Mortality and cancer incidence among Lithuanian cement
producing workers.  Occup Environ Med 61(6):529-534.  (As cited in Pelucci et al. 2006)
*Smart RH, Andersen WM.  1952. Pneumoconiosis due to diatomaceous earth: Clinical and x-ray 
aspects.  Ind Med Surg 21:509-518.
*Smith AH, Lopipero PA, Barroga VR.  1995.  Meta-analysis of studies of lung cancer among silicotics.
Epidemiology 6(6):617-624.  
*Smith CM.  2006.  Silica, vitreous.  In:  Kirk-Othmer encyclopedia of chemical technology.  Vol. 22.
John Wiley & Sons, Inc.  
http://onlinelibrary.wiley.com/doi/10.1002/0471238961.2209201819051316.a01.pub2/abstract. 
September 22, 2015.  
*Snipes MB.  1996. Current information on lung overload in non-rodent mammals:  Contrast with rats.
Inhal Toxicol 8:91-109.  
***DRAFT FOR PUBLIC COMMENT***














   
 
  
     
 















      













    
  
 
   
 
 





*Sobti RC, Bhardwaj DK.  1991. Cytogenetic damage and occupational exposure.  I.  Exposure to stone
dust.  Environ Res 56(1):25-30.  
*Soutar CA, Robertson A, Miller BG, et al.  2000.  Epidemiological evidence on the carcinogenicity of
silica: Factors in scientific judgement.  Ann Occup Hyg 44(1):3-14.  
*Starzynski Z, Marek K, Kujawska A, et al.  1996.  Mortality among different occupational groups of
workers with pneumoconiosis:  Results from a register-based cohort study.  Am J Ind Med 30(6):718-725.  
(As cited in Erren et al. 2009a, 2009b; Pelucci et al. 2006)
*Steenland K.  2005.  One agent, many diseases:  Exposure-response data and comparative risks of
different outcomes following silica exposure.  Am J Ind Med 48(1):16-23.  10.1002/ajim.20181.
*Steenland K, Beaumont J.  1986. A proportionate mortality study of granite cutters.  Am J Ind Med 
9(2):189-202.  
*Steenland K, Brown D.  1995a.  Silicosis among gold miners:  Exposure-response analyses and risk
assessment.  Am J Public Health 85(10):1372-1377.  
*Steenland K, Brown D.  1995b.  Mortality study of gold miners exposed to silica and nonasbestiform
amphibole minerals:  An uptake with 14 more years of follow-up.  Am J Ind Med 27(2):217-229.  
*Steenland K, Goldsmith DF.  1995. Silica exposure and autoimmune diseases.  Am J Ind Med 
28(5):603-608.  
*Steenland K, Greenland S.  2004. Monte Carlo sensitivity analysis and Bayesian analysis of smoking as 
an unmeasured confounder in a study of silica and lung cancer.  Am J Epidemiol 160(4):384-392.  
10.1093/aje/kwh211.
*Steenland K, Sanderson W.  2001.  Lung cancer among industrial sand workers exposed to crystalline
silica.  Am J Epidemiol 153(7):695-703.  
*Steenland K, Ward E.  2014.  Silica:  A lung carcinogen.  CA Cancer J Clin 64(1):63-69.  
http://onlinelibrary.wiley.com/store/10.3322/caac.21214/asset/caac21214.pdf?v=1&t=i7rvk2d3&s=673e1 
12917be9498955f32a802b64741e805bf01.  
*Steenland K, Attfield M, Mannejte A.  2002a.  Pooled analyses of renal disease mortality and crystalline 
silica exposure in three cohorts.  Ann Occup Hyg 46(Suppl 1):4-9.  
*Steenland K, Mannetje A, Boffetta P, et al.  2001a.  Pooled exposure-response analyses and risk
assessment for lung cancer in 10 cohorts of silica-exposed workers:  An IARC multicentre study.  Cancer
Causes Control 12(9):773-784.  
*Steenland K, Nowlin S, Ryan BM, et al.  1992.  Use of multiple-cause mortality data in epidemiologic
analyses:  U.S. rate and proportion files developed by the National Institute for Occupational Safety and 
Health and the National Cancer Institute.  Am J Epidemiol 136(7):855-862.  
*Steenland K, Rosenman K, Socie E, et al.  2002b.  Silicosis and end-stage renal disease.  Scand J Work
Environ Health 28(6):439-442.  
***DRAFT FOR PUBLIC COMMENT***










   






























     
 
 
     
    
 






     
 
 
   
    




*Steenland K, Sanderson W, Calvert GM.  2001b. Kidney disease and arthritis in a cohort study of
workers exposed to silica.  Epidemiology 12(4):405-412.  
*Steenland NK, Thun MJ, Ferguson CW, et al. 1990. Occupational and other exposures associated with 
male end-stage renal disease:  A case/control study.  Am J Public Health 80(2):153-157.  
*Stern F, Lehman E, Ruder A.  2001. Mortality among unionized construction plasterers and cement
masons.  Am J Ind Med 39(4):373-388.  (As cited in Kurihara and Wada 2004)
*Stipe CB, Miller AL, Brown J, et al. 2012. Evaluation of laser-induced breakdown spectroscopy
(LIBS) for measurement of silica on filter samples of coal dust.  Appl Spectrosc 66(11):1286-1293.  
10.1366/12-06671.
*Stober W.  1999.  POCK model simulations of pulmonary quartz dust retention data in extended 
inhalation exposures of rats.  Inhal Toxicol 11(4):269-292. 
*Stolt P, Kallberg H, Lundberg I, et al.  2005.  Silica exposure is associated with increased risk of
developing rheumatoid arthritis:  Results from the Swedish EIRA study.  Ann Rheum Dis 64(4):582-586.  
*Stolt P, Yahya A, Bengtsson C, et al.  2010. Silica exposure among male current smokers is associated 
with a high risk of developing ACPA-positive rheumatoid arthritis.  Ann Rheum Dis 69(6):1072-1076.  
10.1136/ard.2004.022053.
*Stone RA, Youk AO, Marsh GM, et al.  2004.  Historical cohort study of U.S. man-made vitreous fiber
production workers IX:  Summary of 1992 mortality follow up and analysis of respiratory system cancer
among female workers.  J Occup Environ Med 46(1):55-67.  10.1097/01.jom.0000105905.60844.e1. (As
cited in Pelucci et al. 2006)
*Stopford W.  1994.  Carbonate fusion to determine quartz in respirable and bulk earth samples.  Anal
Chim Acta 286(1):67-73.  
*Stopford CM, Stopford W.  1995. Potential for respirable quartz exposure from North Carolina farm
soils.  Scand J Work Environ Health 21(Suppl 2):44-46.  
*Stratta P, Canavese C, Messuerotti A, et al. 2001a.  Silica and renal diseases:  No longer a problem in
the 21st century? J Nephrol 14(4):228-247.  
*Stratta P, Messuerotti A, Canavese C, et al.  2001b.  The role of metals in autoimmune vasculitis:
Epidemiological and pathogenic study.  Sci Total Environ 270(1-3):179-190.  
*Strelec F.  2008.  Control of silica exposures in cement mixer drum cleaning operations.  J Occup 
Environ Hyg 5(12):D121-D123.  10.1080/15459620802432509.
*Swanepoel AJ, Kromhout H, Jinnah ZA, et al.  2011. Respirable dust and quartz exposure from three
South African farms with sandy, sandy loam, and clay soils.  Ann Occup Hyg 55(6):634-643.  
10.1093/annhyg/mer025.
*Szadkowska-Stanczyk I, Szymczak W.  2001. Nested case-control study of lung cancer among pulp and 
paper workers in relation to exposure to dusts.  Am J Ind Med 39(6):547-556. (As cited in Kurihara and 
Wada 2004; Pelucci et al. 2006)
***DRAFT FOR PUBLIC COMMENT***










   














   






   
   
 
 






    
 
 
      
  





     
 
 






*Takizawa Y, Hirasawa F, Noritomi E, et al.  1988.  Oral ingestion of SYLOID to mice and rats and its
chronic toxicity and carcinogenicity.  Acta Med Biol 36:27-56.  
*Talvitie NA.  1951.  Determination of quartz in presence of silicates using phosphoric acid.  Anal Chem
23(4).
*teWaternaude JM, Ehrlich RI, Churchyard GJ, et al.  2006. Tuberculosis and silica exposure in South 
African gold miners.  Occup Environ Med 63(3):187-192.  10.1136/oem.2004.018614.  
*Theriault GP, Burgess WA, DiBerardinis LJ, et al.  1974.  Dust exposure in the Vermont granite sheds.  
Arch Environ Health 28(1):12-17.  (As cited in Mannetje et al. 2002b)
*Thibodeau MS, Giardina C, Knecht DA, et al.  2004.  Silica-induced apoptosis in mouse alveolar
macrophages is initiated by lysosomal enzyme activity.  Toxicol Sci 80(1):34-48.  10.1093/toxsci/kfh121.  
*Thomas K, Colborn T.  1992.  Organochlorine endocrine disruptors in human tissue.  In:  Colborn T, 
Clement C, eds.  Chemically induced alterations in sexual and functional development:  The
wildlife/human connection.  Princeton, NJ:  Princeton Scientific Publishing, 365-394.  
*Thomas TL, Stewart PA.  1987. Mortality from lung cancer and respiratory disease among pottery
workers exposed to silica and talc.  Am J Epidemiol 125(1):35-43.  
*Thomeer M, Demedts M, Wuyts W.  2005. Epidemiology of sarcoidosis.  In:  European Respiratory
Monograph.  ERS Journals Ltd.  Volume 32. 
*Tornling G, Hogstedt C, Westerholm P.  1990. Lung cancer incidence among Swedish ceramic workers 
with silicosis.  IARC Sci Publ (97):113-119.  (As cited in Erren et al. 2009a, 2009b)
*Treguer PJ, De La Rocha CL.  2013. The world ocean silica cycle.  Ann Rev Mar Sci 5:477-501.  
10.1146/annurev-marine-121211-172346.
*Tse LA, Yu ITS, Leung CC, et al.  2007.  Mortality from non-malignant respiratory diseases among
people with silicosis in Hong Kong:  Exposure-response analyses for exposure to silica dust.  Occup
Environ Med 64(2):87-92.  
*Tsuda T, Mino Y, Babazono A, et al.  2002. A case-control study of lung cancer in relation to silica
exposure and silicosis in a rural area in Japan.  Ann Epidemiol 12(5):288-294.  (As cited in Erren et al. 
2009a, 2009b; Pelucci et al. 2006)
*Turner S, Cherry N.  2000.  Rheumatoid arthritis in workers exposed to silica in the pottery industry.  
Occup Environ Med 57(7):443-447.  
*Uhrlandt S.  2006.  Silica.  In:  Kirk-Othmer encyclopedia of chemical technology.  Vol. 22. John Wiley
& Sons, Inc., 1-17.  
*Ulm K, Gerein P, Eigenthaler J, et al.  2004. Silica, silicosis and lung-cancer:  Results from a cohort
study in the stone and quarry industry.  Int Arch Occup Environ Health 77(5):313-318.  10.1007/s00420-
004-0513-6.  
***DRAFT FOR PUBLIC COMMENT***













































   
 









*Ulm K, Waschulzik B, Ehnes H, et al.  1999.  Silica dust and lung cancer in the German stone, 
quarrying, and ceramics industries:  Results of a case-control study.  Thorax 54(4):347-351.  (As cited in 
Kurihara and Wada 2004; Lacasse et al. 2009; Pelucci et al. 2006)
*Ulvestad B, Bakke B, Eduard W, et al.  2001.  Cumulative exposure to dust causes accelerated decline in
lung function in tunnel workers.  Occup Environ Med 58(10):663-669.  
*USGS.  1987. Metals, atomic emission spectrometry, inductively coupled plasma (ICP).  U.S. 
Geological Survey, U.S. Department of the Interior.  
*USGS.  1989. Silica, colorimetric, molybdate blue, automated-segmented flow.  Techniques of water-
resource investigations of the United States Geological Survey.  Chapter A1.  Methods for determination 
of inorganic substances in water and fluvial sediments.  U.S. Geological Survey, U.S. Department of the
Interior. 417-419.  http://pubs.usgs.gov/twri/05a01/report.pdf. October 6, 2015.
*USGS.  1992. Crystalline silica primer.  U.S. Geological Survey, U.S. Department of the Interior, U.S. 
Bureau of Mines.  http://minerals.usgs.gov/minerals/pubs/commodity/silica/780292.pdf. October 6, 2015.
*USGS.  1998. Methods of analysis by the U.S. Geological Survey National Water Quality Laboratory-
Determination of elements in whole-water digests using inductively coupled plasma-optical emission
spectrometry and inductively coupled plasma-mass spectrometry.  U.S. Geological Survey, U.S. 
Department of the Interior.  http://nwql.usgs.gov/pubs/OFR/OFR-98-165.pdf.  October 6, 2015.
*USGS.  2014a.  2012 Minerals yearbook.  Gemstones [advance release].  U.S. Geological Survey, U.S. 
Department of the Interior.  http://minerals.usgs.gov/minerals/pubs/commodity/gemstones/myb1-2012-
gemst.pdf.  October 7, 2015.
*USGS.  2014b. 2012 Minerals yearbook.  Silica [advance release].  U.S. Geological Survey, U.S. 
Department of the Interior.  http://minerals.usgs.gov/minerals/pubs/commodity/silica/myb1-2012-
silic.pdf.  October 7, 2015.
*USGS.  2014c.  2012 Minerals yearbook.  Sand and gravel, construction [advance release]. U.S. 
Geological Survey, U.S. Department of the Interior.  
http://minerals.usgs.gov/minerals/pubs/commodity/sand_&_gravel_construction/myb1-2012-sandc.pdf. 
October 7, 2015.
*USGS.  2015. Mineral commodity summaries 2015.  U.S. Geological Survey, U.S. Department of the
Interior.  http://minerals.usgs.gov/minerals/pubs/mcs/2015/mcs2015.pdf. October 6, 2015.
*Vacek PM, Hemenway DR, Absher MP, et al.  1991.  The translocation of inhaled silicon dioxide:  An 
empirically derived compartmental model.  Fundam Appl Toxicol 17(3):614-626.  
*Vacek PM, Verma DK, Graham WG, et al.  2011. Mortality in Vermont granite workers and its
association with silica exposure.  Occup Environ Med 68(5):312-318.  10.1136/oem.2009.054452.
*van Deurssen E, Pronk A, Spaan S, et al.  2014.  Quartz and respirable dust in the Dutch construction 
industry:  A baseline exposure assessment as part of a multidimensional intervention approach.  Ann
Occup Hyg 58(6):724-738.  10.1093/annhyg/meu021.
***DRAFT FOR PUBLIC COMMENT***





















   




    
 
 






















   
       
 
 





*Vayias BJ, Athanassiou CG, Korunic Z, et al.  2009.  Evaluation of natural diatomaceous earth deposits
from south-eastern Europe for stored-grain protection:  The effect of particle size.  Pest Manage Sci
65:1118-1123.  
*Vearrier D, Greenberg MI.  2011. Occupational health of miners at altitude:  Adverse health effects,
toxic exposures, pre-placement screening, acclimatization, and worker surveillance.  Clin Toxicol (Phila)
49(7):629-640.  10.3109/15563650.2011.607169.  
*Verma DK, Rajhans GS, Malik OP, et al.  2014.  Respirable dust and respirable silica exposure in
Ontario gold mines.  J Occup Environ Hyg 11(2):111-116.  10.1080/15459624.2013.843784.
*Vieira I, Sonnier M, Cresteil T.  1996.  Developmental expression of CYP2E1 in the human liver:
Hypermethylation control of gene expression during the neonatal period.  Eur J Biochem 238(2):476-483.  
*Vigliani EC, Mottura G.  1948. Diatomaceous earth silicosis.  Br J Ind Med 5(3):148-160.  
*Vitums VC, Edwards MJ, Niles NR, et al.  1977. Pulmonary fibrosis from amorphous silica dust, a
product of silica vapor.  Arch Environ Health 32(2):62-68.  
*Voice TC, Long DT, Radovanovic Z, et al.  2006.  Critical evaluation of environmental exposure agents
suspected in the etiology of Balkan endemic nephropathy.  Int J Occup Environ Health 12:369-376.  
*Volk H.  1960. The health of workers in a plant making highly dispersed silica.  Arch Environ Health 
1:125-128.  
*Vupputuri S, Parks CG, Nylander-French LA, et al.  2012.  Occupational silica exposure and chronic
kidney disease.  Ren Fail 34(1):40-46.  10.3109/0886022x.2011.623496.
*Waddell WH.  2006.  Silica, amorphous.  In:  Kirk-Othmer encyclopedia of chemical technology.  Vol.
22. John Wiley & Sons, Inc.  
http://onlinelibrary.wiley.com/doi/10.1002/0471238961.0113151823010404.a01.pub2/abstract. 
September 22, 2015.  
*Wall GR, Phillips PJ, Riva-Murray K.  1998.  Seasonal and spatial patterns of nitrate and silica 
concentrations in Canajoharie Creek, New York.  J Environ Qual 27(2):381-389.  
*Walsh SJ.  1999.  Effects of non-mining occupational silica exposure on proportional mortality from
silicosis and systemic sclerosis. J Rheumatol 26(10):2179-2185.  (As cited in McCormic et al. 2010)
*Wang SX, Liu P, Wei MT, et al.  2007.  Roles of serum Clara cell protein 16 and surfactant protein-D in
the early diagnosis and progression of silicosis.  J Occup Environ Med 49(8):834-839.  
10.1097/JOM.0b013e318124a927.  
*Wang Z, Dong D, Liang X, et al.  1996.  Cancer mortality among silicotics in China's metallurgical
industry.  Int J Epidemiol 25(5):913-917. (As cited in Erren et al. 2009a, 2009b; Lacrasse et al. 2005)
*Ward MM.  2004.  Prevalence of physician-diagnosed systemic lupus erythematosus in the United
States:  Results from the Third National Health and Nutrition Examination Survey.  J Women's Health
13(6):713-718.  
***DRAFT FOR PUBLIC COMMENT***











    
 
  
   
 
 




      
 
   
 
 















       
 
      
  














+*Warheit DB, Carakostas MC, Kelly DP, et al.  1991.  Four-week inhalation toxicity study with Ludox 
colloidal silica in rats:  Pulmonary cellular responses.  Fundam Appl Toxicol 16(3):590-601.  
+*Warheit DB, McHugh TA, Hartsky MA.  1995. Differential pulmonary responses in rats inhaling
crystalline, colloidal or amorphous silica dusts.  Scand J Work Environ Health 21:2:19-21.  
*Warheit DB, Webb TR, Colvin VL, et al.  2007. Pulmonary bioassay studies with nanoscale and fine-
quartz particles in rats: Toxicity is not dependent upon particle size but on surface characteristics.  
Toxicol Sci 95(1):270-280.  10.1093/toxsci/kfl128.  
*Watkins DK, Chiazze L, Jr., Fryar CD, et al.  2002.  A case control study of lung cancer and non-
malignant respiratory disease among employees in asphalt roofing manufacturing and asphalt production.  
J Occup Environ Med 44(6):551-558.  (As cited in Pelucci et al. 2006)
*Watts WF, Jr., Huynh TB, Ramachandran G.  2012. Quartz concentration trends in metal and nonmetal
mining.  J Occup Environ Hyg 9(12):720-732.  10.1080/15459624.2012.733566.
*Weakley AT, Miller AL, Griffiths PR, et al. 2014.  Quantifying silica in filter-deposited mine dusts
using infrared spectra and partial least squares regression.  Anal Bioanal Chem 406(19):4715-4724.  
10.1007/s00216-014-7856-y.
*Weeks JL, Rose C.  2006.  Metal and non-metal miners' exposure to crystalline silica, 1998-2002.  Am J
Ind Med 49(7):523-534.  10.1002/ajim.20323.
*Weissman DN, Ma JKH, Rojanasakul Y, et al.  1996.  Immune dysfunction in silicosis:  A hypothesis.  
Appl Occup Environ Hyg 11(7):962-965.  
*West JR, Smith HW, Chasis H.  1948.  Glomerular filtration rate, effective renal blood flow, and 
maximal tubular excretory capacity in infancy.  J Pediatr 32:10-18.  
*Westberg HB, Bellander T.  2003.  Epidemiological adaptation of quartz exposure modeling in Swedish 
aluminum foundries:  Nested case-control study on lung cancer.  Appl Occup Environ Hyg 18(12):1006-
1013. 10.1080/10473220390244676.  (As cited in Lacasse et al. 2009; Pelucci et al. 2006)
*Westerholm P, Ahlmark A, Maasing R, et al.  1986.  Silicosis and lung cancer a cohort study.  In:
Silica, silicosis, and cancer:  Controversy in occupational medicine.  Vol. 2.  327-333.  (As cited in Erren
et al. 2009a, 2009b)
*WHO.  2010. WHO guidelines for indoor air quality:  Selected pollutants.  Geneva, Switzerland:  World 
Health Organization.  http://www.euro.who.int/__data/assets/pdf_file/0009/128169/e94535.pdf. 
September 9, 2014.  
*WHO.  2011. Guidelines for drinking-water quality.  Geneva, Switzerland: World Health Organization.
4th ed.  http://whqlibdoc.who.int/publications/2011/9789241548151_eng.pdf?ua=1.  September 9, 2014.  
*Wickman AR, Middendorf PJ.  2002.  An evaluation of compliance with occupational exposure limits
for crystalline silica (quartz) in ten Georgia granite sheds.  Appl Occup Environ Hyg 17(6):424-429.  
10.1080/10473220290035444.
***DRAFT FOR PUBLIC COMMENT***










    





    
















    
   
 
























*Widdowson EM, Dickerson JWT.  1964. Chemical composition of the body. In:  Comar, CL, Bronner
F, eds. Mineral metabolism:  An advance treatise. Volume II:  The elements Part A.  New York, NY:
Academic Press, 1-247.  
*Wilson MJ, Jones D, McHardy WJ.  1981.  The weathering of serpentinite by Lecanora atra.  
Lichenologist (Oxf) 13(2):167-176.  
*Wilson RK, Stevens PM, Lovejoy HB, et al.  1979. Effects of chronic amorphous silica exposure on 
sequential pulmonary function.  J Occup Med 21(6):399-402.  
*Woskie SR, Kalil A, Bello D, et al.  2002.  Exposures to quartz, diesel, dust, and welding fumes during
heavy and highway construction.  AIHA J 63(4):447-457.  
*Wu JJ, Schiff KR.  2004. Sarcoidosis.  Am Fam Physician 70:312-322.  
*Wyndham CH, Bezuidenhout BN, Greenacre MJ, et al.  1986.  Mortality of middle aged white South 
African gold miners.  Br J Ind Med 43:677-684.  
*Yabuta J, Ohta H.  2003.  Determination of free silica in dust particles:  Effect of particle size for the X-
ray diffraction and phosphoric acid methods.  Ind Health 41(3):249-259.  
*Yassin A, Yebesi F, Tingle R.  2005. Occupational exposure to crystalline silica dust in the United 
States, 1988-2003.  Environ Health Perspect 113(3):255-260.  
*Yingratanasuk T, Seixas N, Barnhart S, et al. 2002.  Respiratory health and silica exposure of stone
carvers in Thailand.  Int J Occup Environ Health 8(4):301-308.  10.1179/107735202800338722.  
*Yucesoy B, Vallyathan V, Landsittel DP, et al. 2002.  Cytokine polymorphisms in silicosis and other
pneumoconioses.  Mol Cell Biochem 234-235(1):219-224.  
*Zambon P, Simonato L, Mastrangelo G, et al.  1987.  Mortality of workers compensated for silicosis
during the period 1959-1963 in the Veneto region of Italy.  Scand J Work Environ Health 13(2):118-123.  
*Zhang Z, Shen HM, Zhang QF, et al.  1999.  Critical role of GSH in silica-induced oxidative stress, 
cytotoxicity, and genotoxicity in alveolar macrophages.  Am J Physiol 277(4 Pt 1):L743-748.  
*Zhang Z, Shen HM, Zhang QF, et al.  2000.  Involvement of oxidative stress in crystalline silica-induced 
cytotoxicity and genotoxicity in rat alveolar macrophages.  Environ Res 82(3):245-252.  
10.1006/enrs.1999.4025.
*Zhong BZ, Ong T, Whong WZ.  1997a.  Studies on the relationship between treatment condition and 
micronucleus induction in V79 cells exposed to silica and glass fibers.  Mutat Res 391(1-2):111-116.  
*Zhong BZ, Whong WZ, Ong TM.  1997b.  Detection of mineral-dust-induced DNA damage in two 
mammalian cell lines using the alkaline single cell gel/comet assay.  Mutat Res 393(3):181-187.  
*Zhuravlev LT.  2000.  The surface chemistry of amorphous silica.  Zhuravlev model.  Colloids Surf A
Physicochem Eng Asp 173(1–3):1-38.  10.1016/S0927-7757(00)00556-2.  
*Ziegler EE, Edwards BB, Jensen RL, et al.  1978.  Absorption and retention of lead by infants.  Pediatr 
Res 12(1):29-34.  
***DRAFT FOR PUBLIC COMMENT***











   
 
   
 
  
   
 
   




*Ziegler V, Enderlein G, Mehlorn J, et al. 1997.  [Retrospective epidemiological analysis of the relation 
between progressive systemic scleroderma and the exposure to quartz dust not from uranium ore mining
in East Germany].  Zbl Arbeitsmed 47:7-13.  (As cited in McCormic et al. 2010)
*Zuhl RW, Amjad Z.  2013.  Solution chemistry impact on silica polymerization by inhibitors.  In:
Amjad Z, ed.  Mineral scales in biological and industrial systems.  Boca Raton, FL:  CRC Press, 173-200.
*Zumwalde R, Ludwig H, Dement J.  1981. Industrial hygiene report, Homestake Mining Company, 
Lead, South Dakota [USA].  Industry-wide studies branch, DSHEFS, NIOSH, Cincinnati, Ohio.  (As
cited in Mannetje et al. 2002b)
***DRAFT FOR PUBLIC COMMENT***













   
 
   
 
 
   
  
 
    
   
 
   
    
   
 
 
    
     
   
   
    
 
   
  
 
   




   
 
   







   
  
 
   
   
 
   
     
SILICA 327
10.  GLOSSARY
Absorption—The taking up of liquids by solids, or of gases by solids or liquids.
Acute Exposure—Exposure to a chemical for a duration of 14 days or less, as specified in the
Toxicological Profiles.
Adsorption—The adhesion in an extremely thin layer of molecules (as of gases, solutes, or liquids) to the 
surfaces of solid bodies or liquids with which they are in contact.
Adsorption Coefficient (Koc)—The ratio of the amount of a chemical adsorbed per unit weight of
organic carbon in the soil or sediment to the concentration of the chemical in solution at equilibrium.
Adsorption Ratio (Kd)—The amount of a chemical adsorbed by sediment or soil (i.e., the solid phase)
divided by the amount of chemical in the solution phase, which is in equilibrium with the solid phase, at a
fixed solid/solution ratio.  It is generally expressed in micrograms of chemical sorbed per gram of soil or
sediment.
Benchmark Dose (BMD)—Usually defined as the lower confidence limit on the dose that produces a 
specified magnitude of changes in a specified adverse response.  For example, a BMD10 would be the
dose at the 95% lower confidence limit on a 10% response, and the benchmark response (BMR) would be
10%.  The BMD is determined by modeling the dose response curve in the region of the dose response 
relationship where biologically observable data are feasible.
Benchmark Dose Model—A statistical dose-response model applied to either experimental toxicological
or epidemiological data to calculate a BMD.
Bioconcentration Factor (BCF)—The quotient of the concentration of a chemical in aquatic organisms
at a specific time or during a discrete time period of exposure divided by the concentration in the
surrounding water at the same time or during the same period.
Biomarkers—Broadly defined as indicators signaling events in biologic systems or samples. They have 
been classified as markers of exposure, markers of effect, and markers of susceptibility.
Cancer Effect Level (CEL)—The lowest dose of chemical in a study, or group of studies, that produces
significant increases in the incidence of cancer (or tumors) between the exposed population and its
appropriate control.
Carcinogen—A chemical capable of inducing cancer.
Case-Control Study— A type of epidemiological study that examines the relationship between a
particular outcome (disease or condition) and a variety of potential causative agents (such as toxic 
chemicals).  In a case-control study, a group of people with a specified and well-defined outcome is 
identified and compared to a similar group of people without the outcome.
Case Report—Describes a single individual with a particular disease or exposure.  These may suggest
some potential topics for scientific research, but are not actual research studies.
Case Series—Describes the experience of a small number of individuals with the same disease or
exposure. These may suggest potential topics for scientific research, but are not actual research studies.
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Ceiling Value—A concentration that must not be exceeded. 
Chronic Exposure—Exposure to a chemical for 365 days or more, as specified in the Toxicological
Profiles.
Cohort Study—A type of epidemiological study of a specific group or groups of people who have had a
common insult (e.g., exposure to an agent suspected of causing disease or a common disease) and are 
followed forward from exposure to outcome.  At least one exposed group is compared to one unexposed 
group.
Cross-sectional Study—A type of epidemiological study of a group or groups of people that examines 
the relationship between exposure and outcome to a chemical or to chemicals at one point in time.
Data Needs—Substance-specific informational needs that, if met, would reduce the uncertainties of
human health risk assessment.
Developmental Toxicity—The occurrence of adverse effects on the developing organism that may result
from exposure to a chemical prior to conception (either parent), during prenatal development, or
postnatally to the time of sexual maturation.  Adverse developmental effects may be detected at any point
in the life span of the organism.
Dose-Response Relationship—The quantitative relationship between the amount of exposure to a
toxicant and the incidence of the adverse effects.
Embryotoxicity and Fetotoxicity—Any toxic effect on the conceptus as a result of prenatal exposure to
a chemical; the distinguishing feature between the two terms is the stage of development during which the 
insult occurs. The terms, as used here, include malformations and variations, altered growth, and in utero
death.
Environmental Protection Agency (EPA) Health Advisory—An estimate of acceptable drinking water
levels for a chemical substance based on health effects information.  A health advisory is not a legally
enforceable federal standard, but serves as technical guidance to assist federal, state, and local officials.
Epidemiology—Refers to the investigation of factors that determine the frequency and distribution of
disease or other health-related conditions within a defined human population during a specified period.  
Genotoxicity—A specific adverse effect on the genome of living cells that, upon the duplication of
affected cells, can be expressed as a mutagenic, clastogenic, or carcinogenic event because of specific 
alteration of the molecular structure of the genome.
Half-life—A measure of rate for the time required to eliminate one half of a quantity of a chemical from
the body or environmental media.
Immediately Dangerous to Life or Health (IDLH)—A condition that poses a threat of life or health, or
conditions that pose an immediate threat of severe exposure to contaminants that are likely to have 
adverse cumulative or delayed effects on health.  
Immunologic Toxicity—The occurrence of adverse effects on the immune system that may result from
exposure to environmental agents such as chemicals.
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Immunological Effects—Functional changes in the immune response.
Incidence—The ratio of new cases of individuals in a population who develop a specified condition to 
the total number of individuals in that population who could have developed that condition in a specified 
time period.
Intermediate Exposure—Exposure to a chemical for a duration of 15–364 days, as specified in the 
Toxicological Profiles.
In Vitro—Isolated from the living organism and artificially maintained, as in a test tube.
In Vivo—Occurring within the living organism.
Lethal Concentration(LO) (LCLO)—The lowest concentration of a chemical in air that has been reported
to have caused death in humans or animals.
Lethal Concentration(50) (LC50)—A calculated concentration of a chemical in air to which exposure for
a specific length of time is expected to cause death in 50% of a defined experimental animal population.
Lethal Dose(LO) (LDLo)—The lowest dose of a chemical introduced by a route other than inhalation that
has been reported to have caused death in humans or animals.
Lethal Dose(50) (LD50)—The dose of a chemical that has been calculated to cause death in 50% of a 
defined experimental animal population.
Lethal Time(50) (LT50)—A calculated period of time within which a specific concentration of a chemical
is expected to cause death in 50% of a defined experimental animal population.
Lowest-Observed-Adverse-Effect Level (LOAEL)—The lowest exposure level of chemical in a study, 
or group of studies, that produces statistically or biologically significant increases in frequency or severity
of adverse effects between the exposed population and its appropriate control.
Lymphoreticular Effects—Represent morphological effects involving lymphatic tissues such as the 
lymph nodes, spleen, and thymus.
Malformations—Permanent structural changes that may adversely affect survival, development, or
function.
Minimal Risk Level (MRL)—An estimate of daily human exposure to a hazardous substance that is 
likely to be without an appreciable risk of adverse noncancer health effects over a specified route and 
duration of exposure.
Modifying Factor (MF)—A value (greater than zero) that is applied to the derivation of a Minimal Risk
Level (MRL) to reflect additional concerns about the database that are not covered by the uncertainty
factors. The default value for a MF is 1.
Morbidity—State of being diseased; morbidity rate is the incidence or prevalence of disease in a specific 
population.
Mortality—Death; mortality rate is a measure of the number of deaths in a population during a specified 
interval of time.
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Mutagen—A substance that causes mutations.  A mutation is a change in the DNA sequence of a cell’s 
DNA.  Mutations can lead to birth defects, miscarriages, or cancer.
Necropsy—The gross examination of the organs and tissues of a dead body to determine the cause of
death or pathological conditions.
Neurotoxicity—The occurrence of adverse effects on the nervous system following exposure to a
hazardous substance.
No-Observed-Adverse-Effect Level (NOAEL)—The dose of a chemical at which there were no
statistically or biologically significant increases in frequency or severity of adverse effects seen between
the exposed population and its appropriate control.  Effects may be produced at this dose, but they are not
considered to be adverse.
Octanol-Water Partition Coefficient (Kow)—The equilibrium ratio of the concentrations of a chemical
in n-octanol and water, in dilute solution.
Odds Ratio (OR)—A means of measuring the association between an exposure (such as toxic substances 
and a disease or condition) that represents the best estimate of relative risk (risk as a ratio of the incidence
among subjects exposed to a particular risk factor divided by the incidence among subjects who were not
exposed to the risk factor).  An OR of greater than 1 is considered to indicate greater risk of disease in the 
exposed group compared to the unexposed group.
Organophosphate or Organophosphorus Compound—A phosphorus-containing organic compound 
and especially a pesticide that acts by inhibiting cholinesterase.
Permissible Exposure Limit (PEL)—An Occupational Safety and Health Administration (OSHA)
regulatory limit on the amount or concentration of a substance not to be exceeded in workplace air
averaged over any 8-hour work shift of a 40-hour workweek.
Pesticide—General classification of chemicals specifically developed and produced for use in the control
of agricultural and public health pests (insects or other organisms harmful to cultivated plants or animals).
Pharmacokinetics—The dynamic behavior of a material in the body, used to predict the fate
(disposition) of an exogenous substance in an organism.  Utilizing computational techniques, it provides
the means of studying the absorption, distribution, metabolism, and excretion of chemicals by the body.
Pharmacokinetic Model—A set of equations that can be used to describe the time course of a parent
chemical or metabolite in an animal system.  There are two types of pharmacokinetic models:  data-based
and physiologically-based.  A data-based model divides the animal system into a series of compartments,
which, in general, do not represent real, identifiable anatomic regions of the body, whereas the
physiologically-based model compartments represent real anatomic regions of the body.
Physiologically Based Pharmacodynamic (PBPD) Model—A type of physiologically based dose-
response model that quantitatively describes the relationship between target tissue dose and toxic end 
points.  These models advance the importance of physiologically based models in that they clearly
describe the biological effect (response) produced by the system following exposure to an exogenous
substance. 
***DRAFT FOR PUBLIC COMMENT***











    
      
  
    
 
 
    
 
 




     
  
 





   
    
   
  
 
   
       
 
    
    
    
 
 
   
  




    






      
   
    
SILICA 331
10.  GLOSSARY
Physiologically Based Pharmacokinetic (PBPK) Model—Comprised of a series of compartments
representing organs or tissue groups with realistic weights and blood flows. These models require a
variety of physiological information: tissue volumes, blood flow rates to tissues, cardiac output, alveolar
ventilation rates, and possibly membrane permeabilities.  The models also utilize biochemical
information, such as blood:air partition coefficients, and metabolic parameters.  PBPK models are also
called biologically based tissue dosimetry models.
Prevalence—The number of cases of a disease or condition in a population at one point in time. 
Prospective Study—A type of cohort study in which the pertinent observations are made on events
occurring after the start of the study.  A group is followed over time.
q1*—The upper-bound estimate of the low-dose slope of the dose-response curve as determined by the
multistage procedure.  The q1* can be used to calculate an estimate of carcinogenic potency, the 
incremental excess cancer risk per unit of exposure (usually μg/L for water, mg/kg/day for food, and 
μg/m3 for air).
Recommended Exposure Limit (REL)—A National Institute for Occupational Safety and Health
(NIOSH) time-weighted average (TWA) concentration for up to a 10-hour workday during a 40-hour
workweek.
Reference Concentration (RfC)—An estimate (with uncertainty spanning perhaps an order of
magnitude) of a continuous inhalation exposure to the human population (including sensitive subgroups)
that is likely to be without an appreciable risk of deleterious noncancer health effects during a lifetime.
The inhalation reference concentration is for continuous inhalation exposures and is appropriately
expressed in units of mg/m3 or ppm.
Reference Dose (RfD)—An estimate (with uncertainty spanning perhaps an order of magnitude) of the
daily exposure of the human population to a potential hazard that is likely to be without risk of deleterious
effects during a lifetime.  The RfD is operationally derived from the no-observed-adverse-effect level
(NOAEL, from animal and human studies) by a consistent application of uncertainty factors that reflect
various types of data used to estimate RfDs and an additional modifying factor, which is based on a
professional judgment of the entire database on the chemical. The RfDs are not applicable to
nonthreshold effects such as cancer.
Reportable Quantity (RQ)—The quantity of a hazardous substance that is considered reportable under
the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA).  Reportable
quantities are (1) 1 pound or greater or (2) for selected substances, an amount established by regulation 
either under CERCLA or under Section 311 of the Clean Water Act.  Quantities are measured over a 
24-hour period.
Reproductive Toxicity—The occurrence of adverse effects on the reproductive system that may result
from exposure to a hazardous substance.  The toxicity may be directed to the reproductive organs and/or
the related endocrine system.  The manifestation of such toxicity may be noted as alterations in sexual
behavior, fertility, pregnancy outcomes, or modifications in other functions that are dependent on the
integrity of this system.
Retrospective Study—A type of cohort study based on a group of persons known to have been exposed 
at some time in the past.  Data are collected from routinely recorded events, up to the time the study is
undertaken.  Retrospective studies are limited to causal factors that can be ascertained from existing
records and/or examining survivors of the cohort.
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SILICA 332
10.  GLOSSARY
Risk—The possibility or chance that some adverse effect will result from a given exposure to a hazardous 
substance.
Risk Factor—An aspect of personal behavior or lifestyle, an environmental exposure, existing health 
condition, or an inborn or inherited characteristic that is associated with an increased occurrence of
disease or other health-related event or condition.
Risk Ratio—The ratio of the risk among persons with specific risk factors compared to the risk among
persons without risk factors.  A risk ratio greater than 1 indicates greater risk of disease in the exposed
group compared to the unexposed group.
Short-Term Exposure Limit (STEL)—A STEL is a 15-minute TWA exposure that should not be
exceeded at any time during a workday.  
Standardized Mortality Ratio (SMR)—A ratio of the observed number of deaths and the expected 
number of deaths in a specific standard population.
Target Organ Toxicity—This term covers a broad range of adverse effects on target organs or
physiological systems (e.g., renal, cardiovascular) extending from those arising through a single limited 
exposure to those assumed over a lifetime of exposure to a chemical.
Teratogen—A chemical that causes structural defects that affect the development of an organism.
Threshold Limit Value (TLV)—An American Conference of Governmental Industrial Hygienists 
(ACGIH) concentration of a substance  to which it is believed that nearly all workers may be repeatedly
exposed, day after day, for a working lifetime without adverse effect. The TLV may be expressed as a 
Time Weighted Average (TLV-TWA), as a Short-Term Exposure Limit (TLV-STEL), or as a ceiling
limit (TLV-C).
Time-Weighted Average (TWA)—An average exposure within a given time period.  
Toxic Dose(50) (TD50)—A calculated dose of a chemical, introduced by a route other than inhalation, 
which is expected to cause a specific toxic effect in 50% of a defined experimental animal population.
Toxicokinetic—The absorption, distribution, and elimination of toxic compounds in the living organism.
Uncertainty Factor (UF)—A factor used in operationally deriving the Minimal Risk Level (MRL) or
Reference Dose (RfD) or Reference Concentration (RfC) from experimental data.  UFs are intended to
account for (1) the variation in sensitivity among the members of the human population, (2) the
uncertainty in extrapolating animal data to the case of human, (3) the uncertainty in extrapolating from
data obtained in a study that is of less than lifetime exposure, and (4) the uncertainty in using lowest-
observed-adverse-effect level (LOAEL) data rather than no-observed-adverse-effect level (NOAEL) data.
A default for each individual UF is 10; if complete certainty in data exists, a value of 1 can be used;
however, a reduced UF of 3 may be used on a case-by-case basis, 3 being the approximate logarithmic
average of 10 and 1.
Xenobiotic—Any substance that is foreign to the biological system.
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SILICA A-1
APPENDIX A.  ATSDR MINIMAL RISK LEVELS AND WORKSHEETS
The Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) [42 U.S.C. 
9601 et seq.], as amended by the Superfund Amendments and Reauthorization Act (SARA) [Pub. L. 99– 
499], requires that the Agency for Toxic Substances and Disease Registry (ATSDR) develop jointly with 
the U.S. Environmental Protection Agency (EPA), in order of priority, a list of hazardous substances most
commonly found at facilities on the CERCLA National Priorities List (NPL); prepare toxicological 
profiles for each substance included on the priority list of hazardous substances; and assure the initiation
of a research program to fill identified data needs associated with the substances.
The toxicological profiles include an examination, summary, and interpretation of available toxicological
information and epidemiologic evaluations of a hazardous substance.  During the development of
toxicological profiles, Minimal Risk Levels (MRLs) are derived when reliable and sufficient data exist to
identify the target organ(s) of effect or the most sensitive health effect(s) for a specific duration for a 
given route of exposure.  An MRL is an estimate of the daily human exposure to a hazardous substance
that is likely to be without appreciable risk of adverse noncancer health effects over a specified route and
duration of exposure.  MRLs are based on noncancer health effects only and are not based on a
consideration of cancer effects. These substance-specific estimates, which are intended to serve as 
screening levels, are used by ATSDR health assessors to identify contaminants and potential health 
effects that may be of concern at hazardous waste sites.  It is important to note that MRLs are not
intended to define clean-up or action levels.
MRLs are derived for hazardous substances using the no-observed-adverse-effect level/uncertainty factor
approach. They are below levels that might cause adverse health effects in the people most sensitive to
such chemical-induced effects. MRLs are derived for acute (1–14 days), intermediate (15–364 days), and 
chronic (365 days and longer) durations and for the oral and inhalation routes of exposure.  Currently, 
MRLs for the dermal route of exposure are not derived because ATSDR has not yet identified a method
suitable for this route of exposure.  MRLs are generally based on the most sensitive substance-induced
endpoint considered to be of relevance to humans.  Serious health effects (such as irreparable damage to 
the liver or kidneys, or birth defects) are not used as a basis for establishing MRLs.  Exposure to a level
above the MRL does not mean that adverse health effects will occur.
MRLs are intended only to serve as a screening tool to help public health professionals decide where to
look more closely.  They may also be viewed as a mechanism to identify those hazardous waste sites that
***DRAFT FOR PUBLIC COMMENT***










    
  
   
   
    
   
  
   
  
 
   
   
    
   









are not expected to cause adverse health effects.  Most MRLs contain a degree of uncertainty because of
the lack of precise toxicological information on the people who might be most sensitive (e.g., infants,
elderly, nutritionally or immunologically compromised) to the effects of hazardous substances.  ATSDR
uses a conservative (i.e., protective) approach to address this uncertainty consistent with the public health
principle of prevention.  Although human data are preferred, MRLs often must be based on animal studies 
because relevant human studies are lacking. In the absence of evidence to the contrary, ATSDR assumes 
that humans are more sensitive to the effects of hazardous substance than animals and that certain persons 
may be particularly sensitive.  Thus, the resulting MRL may be as much as 100-fold below levels that 
have been shown to be nontoxic in laboratory animals.
Proposed MRLs undergo a rigorous review process:  Health Effects/MRL Workgroup reviews within the
Division of Toxicology and Human Health Sciences, expert panel peer reviews, and agency-wide MRL
Workgroup reviews, with participation from other federal agencies and comments from the public.  They
are subject to change as new information becomes available concomitant with updating the toxicological
profiles. Thus, MRLs in the most recent toxicological profiles supersede previously published levels.
For additional information regarding MRLs, please contact the Division of Toxicology and Human 
Health Sciences, Agency for Toxic Substances and Disease Registry, 1600 Clifton Road NE, Mailstop 
F-57, Atlanta, Georgia 30329-4027.
MRLs were not derived for c-silica or a-silica, as discussed in Section 2.3.
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SILICA	 B-1
APPENDIX B.  USER'S GUIDE
Chapter 1
Public Health Statement
This chapter of the profile is a health effects summary written in non-technical language. Its intended
audience is the general public, especially people living in the vicinity of a hazardous waste site or
chemical release. If the Public Health Statement were removed from the rest of the document, it would 
still communicate to the lay public essential information about the chemical.
The major headings in the Public Health Statement are useful to find specific topics of concern.  The
topics are written in a question and answer format. The answer to each question includes a sentence that
will direct the reader to chapters in the profile that will provide more information on the given topic.
Chapter 2
Relevance to Public Health
This chapter provides a health effects summary based on evaluations of existing toxicologic,
epidemiologic, and toxicokinetic information.  This summary is designed to present interpretive, weight-
of-evidence discussions for human health end points by addressing the following questions:
1.	 What effects are known to occur in humans?
2.	 What effects observed in animals are likely to be of concern to humans?
3.	 What exposure conditions are likely to be of concern to humans, especially around hazardous
waste sites?
The chapter covers end points in the same order that they appear within the Discussion of Health Effects
by Route of Exposure section, by route (inhalation, oral, and dermal) and within route by effect.  Human 
data are presented first, then animal data.  Both are organized by duration (acute, intermediate, chronic).  
In vitro data and data from parenteral routes (intramuscular, intravenous, subcutaneous, etc.) are also 
considered in this chapter. 
The carcinogenic potential of the profiled substance is qualitatively evaluated, when appropriate, using
existing toxicokinetic, genotoxic, and carcinogenic data.  ATSDR does not currently assess cancer
potency or perform cancer risk assessments. Minimal Risk Levels (MRLs) for noncancer end points (if
derived) and the end points from which they were derived are indicated and discussed.
Limitations to existing scientific literature that prevent a satisfactory evaluation of the relevance to public 
health are identified in the Chapter 3 Data Needs section.
Interpretation of Minimal Risk Levels
Where sufficient toxicologic information is available, ATSDR has derived MRLs for inhalation and oral
routes of entry at each duration of exposure (acute, intermediate, and chronic). These MRLs are not
meant to support regulatory action, but to acquaint health professionals with exposure levels at which 
adverse health effects are not expected to occur in humans.
***DRAFT FOR PUBLIC COMMENT***










   
      
    
 
 
    
     
     
 
 
   
     
     
 
  
     
  
  
    
    
    
    
    
 
   
    









   
     
  
    
  





   





MRLs should help physicians and public health officials determine the safety of a community living near
a hazardous substance emission, given the concentration of a contaminant in air or the estimated daily
dose in water. MRLs are based largely on toxicological studies in animals and on reports of human
occupational exposure.
MRL users should be familiar with the toxicologic information on which the number is based.  Chapter 2, 
"Relevance to Public Health," contains basic information known about the substance.  Other sections such 
as Chapter 3 Section 3.9, "Interactions with Other Substances,” and Section 3.10, "Populations that are
Unusually Susceptible" provide important supplemental information.
MRL users should also understand the MRL derivation methodology.  MRLs are derived using a
modified version of the risk assessment methodology that the Environmental Protection Agency (EPA)
provides (Barnes and Dourson 1988) to determine reference doses (RfDs) for lifetime exposure.  
To derive an MRL, ATSDR generally selects the most sensitive end point which, in its best judgement,
represents the most sensitive human health effect for a given exposure route and duration.  ATSDR
cannot make this judgement or derive an MRL unless information (quantitative or qualitative) is available 
for all potential systemic, neurological, and developmental effects.  If this information and reliable
quantitative data on the chosen end point are available, ATSDR derives an MRL using the most sensitive 
species (when information from multiple species is available) with the highest no-observed-adverse-effect
level (NOAEL) that does not exceed any adverse effect levels.  When a NOAEL is not available, a 
lowest-observed-adverse-effect level (LOAEL) can be used to derive an MRL, and an uncertainty factor
(UF) of 10 must be employed.  Additional uncertainty factors of 10 must be used both for human 
variability to protect sensitive subpopulations (people who are most susceptible to the health effects 
caused by the substance) and for interspecies variability (extrapolation from animals to humans).  In 
deriving an MRL, these individual uncertainty factors are multiplied together.  The product is then 
divided into the inhalation concentration or oral dosage selected from the study. Uncertainty factors used




Tables and Figures for Levels of Significant Exposure (LSE)
Tables and figures are used to summarize health effects and illustrate graphically levels of exposure 
associated with those effects. These levels cover health effects observed at increasing dose 
concentrations and durations, differences in response by species, MRLs to humans for noncancer end
points, and EPA's estimated range associated with an upper- bound individual lifetime cancer risk of 1 in
10,000 to 1 in 10,000,000.  Use the LSE tables and figures for a quick review of the health effects and to 
locate data for a specific exposure scenario. The LSE tables and figures should always be used in
conjunction with the text.  All entries in these tables and figures represent studies that provide reliable,
quantitative estimates of NOAELs, LOAELs, or Cancer Effect Levels (CELs).
The legends presented below demonstrate the application of these tables and figures.  Representative 
examples of LSE Table 3-1 and Figure 3-1 are shown.  The numbers in the left column of the legends
correspond to the numbers in the example table and figure.
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See Sample LSE Table 3-1 (page B-6)
(1)	 Route of Exposure.  One of the first considerations when reviewing the toxicity of a substance 
using these tables and figures should be the relevant and appropriate route of exposure. Typically
when sufficient data exist, three LSE tables and two LSE figures are presented in the document.  
The three LSE tables present data on the three principal routes of exposure, i.e., inhalation, oral, 
and dermal (LSE Tables 3-1, 3-2, and 3-3, respectively).  LSE figures are limited to the inhalation
(LSE Figure 3-1) and oral (LSE Figure 3-2) routes.  Not all substances will have data on each
route of exposure and will not, therefore, have all five of the tables and figures.
(2)	 Exposure Period. Three exposure periods—acute (less than 15 days), intermediate (15– 
364 days), and chronic (365 days or more)—are presented within each relevant route of exposure.
In this example, an inhalation study of intermediate exposure duration is reported.  For quick
reference to health effects occurring from a known length of exposure, locate the applicable 
exposure period within the LSE table and figure.
(3)	 Health Effect. The major categories of health effects included in LSE tables and figures include 
death, systemic, immunological, neurological, developmental, reproductive, and cancer.  
NOAELs and LOAELs can be reported in the tables and figures for all effects but cancer.
Systemic effects are further defined in the "System" column of the LSE table (see key number
18).
(4)	 Key to Figure. Each key number in the LSE table links study information to one or more data
points using the same key number in the corresponding LSE figure.  In this example, the study
represented by key number 18 has been used to derive a NOAEL and a Less Serious LOAEL
(also see the two "18r" data points in sample Figure 3-1).
(5)	 Species. The test species, whether animal or human, are identified in this column.  Chapter 2,
"Relevance to Public Health," covers the relevance of animal data to human toxicity and
Section 3.4, "Toxicokinetics," contains any available information on comparative toxicokinetics.  
Although NOAELs and LOAELs are species specific, the levels are extrapolated to equivalent
human doses to derive an MRL.
(6)	 Exposure Frequency/Duration. The duration of the study and the weekly and daily exposure
regimens are provided in this column.  This permits comparison of NOAELs and LOAELs from
different studies.  In this case (key number 18), rats were exposed to “Chemical x” via inhalation
for 6 hours/day, 5 days/week, for 13 weeks.  For a more complete review of the dosing regimen, 
refer to the appropriate sections of the text or the original reference paper (i.e., Nitschke et al.
1981).
(7)	 System.  This column further defines the systemic effects. These systems include respiratory,
cardiovascular, gastrointestinal, hematological, musculoskeletal, hepatic, renal, and 
dermal/ocular. "Other" refers to any systemic effect (e.g., a decrease in body weight) not covered
in these systems.  In the example of key number 18, one systemic effect (respiratory) was 
investigated.
(8)	 NOAEL.  A NOAEL is the highest exposure level at which no adverse effects were seen in the 
organ system studied.  Key number 18 reports a NOAEL of 3 ppm for the respiratory system, 
which was used to derive an intermediate exposure, inhalation MRL of 0.005 ppm (see 
footnote "b").
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(9)	 LOAEL.  A LOAEL is the lowest dose used in the study that caused an adverse health effect.
LOAELs have been classified into "Less Serious" and "Serious" effects. These distinctions help
readers identify the levels of exposure at which adverse health effects first appear and the
gradation of effects with increasing dose.  A brief description of the specific end point used to 
quantify the adverse effect accompanies the LOAEL. The respiratory effect reported in key
number 18 (hyperplasia) is a Less Serious LOAEL of 10 ppm.  MRLs are not derived from
Serious LOAELs.
(10)	 Reference. The complete reference citation is given in Chapter 9 of the profile.
(11)	 CEL.  A CEL is the lowest exposure level associated with the onset of carcinogenesis in
experimental or epidemiologic studies.  CELs are always considered serious effects. The LSE
tables and figures do not contain NOAELs for cancer, but the text may report doses not causing
measurable cancer increases.
(12)	 Footnotes.  Explanations of abbreviations or reference notes for data in the LSE tables are found
in the footnotes.  Footnote "b" indicates that the NOAEL of 3 ppm in key number 18 was used to 
derive an MRL of 0.005 ppm.
LEGEND
See Sample Figure 3-1 (page B-7)
LSE figures graphically illustrate the data presented in the corresponding LSE tables.  Figures help the
reader quickly compare health effects according to exposure concentrations for particular exposure
periods.
(13)	 Exposure Period. The same exposure periods appear as in the LSE table.  In this example, health 
effects observed within the acute and intermediate exposure periods are illustrated.
(14)	 Health Effect. These are the categories of health effects for which reliable quantitative data 
exists. The same health effects appear in the LSE table.
(15)	 Levels of Exposure.  Concentrations or doses for each health effect in the LSE tables are 
graphically displayed in the LSE figures.  Exposure concentration or dose is measured on the log
scale "y" axis.  Inhalation exposure is reported in mg/m3 or ppm and oral exposure is reported in 
mg/kg/day.
(16)	 NOAEL. In this example, the open circle designated 18r identifies a NOAEL critical end point in 
the rat upon which an intermediate inhalation exposure MRL is based.  The key number 18 
corresponds to the entry in the LSE table.  The dashed descending arrow indicates the
extrapolation from the exposure level of 3 ppm (see entry 18 in the table) to the MRL of
0.005 ppm (see footnote "b" in the LSE table).
(17)	 CEL. Key number 38m is one of three studies for which CELs were derived.  The diamond 
symbol refers to a CEL for the test species-mouse.  The number 38 corresponds to the entry in the
LSE table.
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(18)	 Estimated Upper-Bound Human Cancer Risk Levels. This is the range associated with the upper-
bound for lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000.  These risk levels are derived 
from the EPA's Human Health Assessment Group's upper-bound estimates of the slope of the
cancer dose response curve at low dose levels (q1*).
(19)	 Key to LSE Figure. The Key explains the abbreviations and symbols used in the figure.
























    
      



























































































































































1 →	 Table 3-1.  Levels of Significant Exposure to [Chemical x] – Inhalation
LOAEL (effect)Exposure 
Less serious Serious (ppm)Key to 	 frequency/ NOAEL
(ppm)figurea Species duration System (ppm)	 Reference
2 →	 INTERMEDIATE EXPOSURE
5 6 7 8 9 10



























10	 (CEL, lung tumors,
nasal tumors)
10	 (CEL, lung tumors,
hemangiosarcomas)
↓
Nitschke et al. 1981
Wong et al. 1982
NTP 1982
NTP 1982
12 →	 a The number corresponds to entries in Figure 3-1.
b Used to derive an intermediate inhalation Minimal Risk Level (MRL) of 5x10-3 ppm; dose adjusted for intermittent exposure and divided 
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SILICA C-1
APPENDIX C. ACRONYMS, ABBREVIATIONS, AND SYMBOLS
ACGIH American Conference of Governmental Industrial Hygienists
ACOEM American College of Occupational and Environmental Medicine
ADI acceptable daily intake
ADME absorption, distribution, metabolism, and excretion
AED atomic emission detection
AFID alkali flame ionization detector
AFOSH Air Force Office of Safety and Health
ALT alanine aminotransferase
AML acute myeloid leukemia
AOAC Association of Official Analytical Chemists
AOEC Association of Occupational and Environmental Clinics
AP alkaline phosphatase
APHA American Public Health Association
AST aspartate aminotransferase
atm atmosphere
ATSDR Agency for Toxic Substances and Disease Registry
AWQC Ambient Water Quality Criteria
BAT best available technology
BCF bioconcentration factor
BEI Biological Exposure Index
BMD/C benchmark dose or benchmark concentration
BMDX dose that produces a X% change in response rate of an adverse effect
BMDLX 95% lower confidence limit on the BMDX 
BMDS Benchmark Dose Software 
BMR benchmark response
BSC Board of Scientific Counselors
C centigrade
CAA Clean Air Act
CAG Cancer Assessment Group of the U.S. Environmental Protection Agency
CAS Chemical Abstract Services
CDC Centers for Disease Control and Prevention
CEL cancer effect level
CELDS Computer-Environmental Legislative Data System
CERCLA Comprehensive Environmental Response, Compensation, and Liability Act
CFR Code of Federal Regulations
Ci curie
CI confidence interval
CLP Contract Laboratory Program
cm centimeter
CML chronic myeloid leukemia
CPSC Consumer Products Safety Commission
CWA Clean Water Act
DHEW Department of Health, Education, and Welfare
DHHS Department of Health and Human Services
DNA deoxyribonucleic acid
DOD Department of Defense
DOE Department of Energy
DOL Department of Labor
DOT Department of Transportation
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SILICA C-2
APPENDIX C
DOT/UN/ Department of Transportation/United Nations/
NA/IMDG North America/Intergovernmental Maritime Dangerous Goods Code
DWEL drinking water exposure level
ECD electron capture detection
ECG/EKG electrocardiogram
EEG electroencephalogram
EEGL Emergency Exposure Guidance Level
EPA Environmental Protection Agency
F Fahrenheit
F1 first-filial generation
FAO Food and Agricultural Organization of the United Nations
FDA Food and Drug Administration
FEMA Federal Emergency Management Agency
FIFRA Federal Insecticide, Fungicide, and Rodenticide Act
FPD flame photometric detection
fpm feet per minute
FR Federal Register




GLC gas liquid chromatography
GPC gel permeation chromatography
HPLC high-performance liquid chromatography
HRGC high resolution gas chromatography
HSDB Hazardous Substance Data Bank
IARC International Agency for Research on Cancer
IDLH immediately dangerous to life and health
ILO International Labor Organization
IRIS Integrated Risk Information System
Kd adsorption ratio
kg kilogram
kkg kilokilogram; 1 kilokilogram is equivalent to 1,000 kilograms and 1 metric ton
Koc organic carbon partition coefficient
Kow octanol-water partition coefficient
L liter
LC liquid chromatography
LC50 lethal concentration, 50% kill
LCLo lethal concentration, low
LD50 lethal dose, 50% kill




LSE Levels of Significant Exposure
LT50 lethal time, 50% kill
m meter
MA trans,trans-muconic acid
MAL maximum allowable level
mCi millicurie
MCL maximum contaminant level
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SILICA C-3
APPENDIX C
MCLG maximum contaminant level goal
MF modifying factor




mmHg millimeters of mercury
mmol millimole
mppcf millions of particles per cubic foot
MRL Minimal Risk Level
MS mass spectrometry
mt metric ton
NAAQS National Ambient Air Quality Standard
NAS National Academy of Science
NATICH National Air Toxics Information Clearinghouse
NATO North Atlantic Treaty Organization
NCE normochromatic erythrocytes
NCEH National Center for Environmental Health
NCI National Cancer Institute
ND not detected
NFPA National Fire Protection Association
ng nanogram
NHANES National Health and Nutrition Examination Survey
NIEHS National Institute of Environmental Health Sciences
NIOSH National Institute for Occupational Safety and Health
NIOSHTIC NIOSH's Computerized Information Retrieval System




NOES National Occupational Exposure Survey
NOHS National Occupational Hazard Survey
NPD nitrogen phosphorus detection
NPDES National Pollutant Discharge Elimination System
NPL National Priorities List
NR not reported
NRC National Research Council
NS not specified
NSPS New Source Performance Standards
NTIS National Technical Information Service
NTP National Toxicology Program
ODW Office of Drinking Water, EPA
OERR Office of Emergency and Remedial Response, EPA
OHM/TADS Oil and Hazardous Materials/Technical Assistance Data System
OPP Office of Pesticide Programs, EPA
OPPT Office of Pollution Prevention and Toxics, EPA
OPPTS Office of Prevention, Pesticides and Toxic Substances, EPA
OR odds ratio
OSHA Occupational Safety and Health Administration
OSW Office of Solid Waste, EPA
OTS Office of Toxic Substances
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OW Office of Water
OWRS Office of Water Regulations and Standards, EPA
PAH polycyclic aromatic hydrocarbon
PBPD physiologically based pharmacodynamic
PBPK physiologically based pharmacokinetic 
PCE polychromatic erythrocytes
PEL permissible exposure limit
PEL-C permissible exposure limit-ceiling value
pg picogram
PHS Public Health Service
PID photo ionization detector
pmol picomole
PMR proportionate mortality ratio
ppb parts per billion
ppm parts per million
ppt parts per trillion
PSNS pretreatment standards for new sources
RBC red blood cell
REL recommended exposure level/limit
REL-C recommended exposure level-ceiling value
RfC reference concentration (inhalation)
RfD reference dose (oral)
RNA ribonucleic acid
RQ reportable quantity
RTECS Registry of Toxic Effects of Chemical Substances
SARA Superfund Amendments and Reauthorization Act
SCE sister chromatid exchange
SGOT serum glutamic oxaloacetic transaminase (same as aspartate aminotransferase or AST)
SGPT serum glutamic pyruvic transaminase (same as alanine aminotransferase or ALT)
SIC standard industrial classification
SIM selected ion monitoring
SMCL secondary maximum contaminant level
SMR standardized mortality ratio
SNARL suggested no adverse response level
SPEGL Short-Term Public Emergency Guidance Level
STEL short term exposure limit
STORET Storage and Retrieval
TD50 toxic dose, 50% specific toxic effect
TLV threshold limit value
TLV-C threshold limit value-ceiling value
TOC total organic carbon
TPQ threshold planning quantity
TRI Toxics Release Inventory




USDA United States Department of Agriculture
USGS United States Geological Survey
VOC volatile organic compound
WBC white blood cell
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WHO World Health Organization
> greater than
≥ greater than or equal to
= equal to
< less than








q1* cancer slope factor
– negative
+ positive
(+) weakly positive result
(–) weakly negative result
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